data_1qw1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qw1 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.8 0.333 . . . . 3.42 110.832 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.01 -49.52 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 2.85 111.143 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.463 ' HB3' HG13 ' A' ' 153' ' ' ILE . 1.7 pt-20 -80.53 -8.34 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 3.04 111.113 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -54.96 -35.12 63.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.367 . . . . 7.91 110.989 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.15 127.61 32.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 8.38 110.941 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.57 113.04 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 4.97 110.809 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.06 171.51 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 4.79 111.159 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -127.13 -43.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 7.73 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.66 171.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 3.01 111.203 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.3 tp -110.81 72.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 2.97 110.902 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -153.09 160.97 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 6.22 110.855 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -151.0 -166.04 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 4.19 110.94 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -166.36 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 4.16 110.998 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t 75.13 172.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 4.71 110.888 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -102.34 -29.08 11.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 7.37 110.974 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.7 m -111.56 76.2 1.49 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 4.32 110.997 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -20.04 24.19 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.732 2.288 . . . . 4.39 112.345 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.78 150.42 27.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 4.99 110.938 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 147.31 157.22 7.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.728 . . . . 2.37 112.508 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.646 ' O ' ' O ' ' A' ' 129' ' ' GLY . 2.3 p30 49.2 141.77 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.111 0.482 . . . . 2.89 111.405 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.706 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 73.8 Cg_endo -75.92 141.02 23.64 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.934 2.423 . . . . 2.31 112.763 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.735 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 136.92 -27.46 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.546 . . . . 5.23 111.765 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 17.1 Cg_exo -66.47 53.66 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.764 2.31 . . . . 1.89 112.784 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.435 ' HA3' HG23 ' A' ' 168' ' ' ILE . . . -67.21 90.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.706 . . . . 1.36 112.232 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.47 -56.47 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 3.35 111.282 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -89.97 8.97 29.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.512 . . . . 3.87 111.374 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 169' ' ' ASN . 0.5 OUTLIER -90.13 -50.05 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.757 0.313 . . . . 2.87 111.04 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 140' ' ' VAL . 1.3 pp -45.29 -38.36 5.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 4.89 111.429 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.594 ' O ' ' CG2' ' A' ' 140' ' ' VAL . . . -45.87 86.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.849 -0.691 . . . . 3.01 112.92 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' A' ' 139' ' ' GLY . 1.9 t 145.3 -61.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.727 0.299 . . . . 4.35 111.211 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 142' ' ' ASN . . . -66.56 173.97 24.64 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.881 -0.676 . . . . 4.01 113.05 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 141' ' ' GLY . 3.2 p-10 169.25 122.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.669 0.271 . . . . 3.1 110.67 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 66.2 m -122.4 -179.1 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 3.73 111.212 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -164.61 -40.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.983 -0.553 . . . . 3.43 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.86 -172.18 2.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 4.42 111.169 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 65.7 154.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 3.86 111.098 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 149' ' ' GLY . . . -64.0 -56.65 22.94 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.352 -0.386 . . . . 3.16 111.16 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 10.4 Cg_exo -32.31 79.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.162 2.575 . . . . 4.19 112.763 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 62.16 125.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.693 -0.765 . . . . 2.76 112.331 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.424 ' HB ' ' CB ' ' A' ' 225' ' ' GLU . 13.9 t -102.93 -5.48 23.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 2.95 110.696 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.589 ' CG ' ' HA ' ' A' ' 220' ' ' THR . 0.0 OUTLIER 69.54 118.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 9.01 110.773 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 151' ' ' ARG . 29.3 t -31.85 -46.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 3.21 111.499 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.533 ' CG2' ' HB3' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -43.29 -35.55 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 2.84 110.993 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 151' ' ' ARG . 6.1 t0 -109.32 -25.38 10.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 1.93 110.809 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.22 58.96 0.25 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 1.89 111.113 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -175.43 34.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 2.11 111.027 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 t -157.3 -33.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 3.0 111.293 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.92 48.27 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.459 -0.337 . . . . 2.32 111.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 4.1 ttm 62.95 61.62 1.95 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 3.19 111.063 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.433 ' HB3' HD21 ' A' ' 226' ' ' LEU . 18.0 Cg_endo -59.3 149.26 82.06 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.839 2.359 . . . . 1.9 112.304 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -146.12 -47.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 3.35 110.84 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -170.04 95.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 2.95 110.835 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.428 ' O ' HG21 ' A' ' 163' ' ' VAL . 8.1 m -73.06 116.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 1.54 111.109 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 2.2 mtp180 -80.44 118.15 21.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 3.83 111.069 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.482 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -84.08 120.27 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 2.03 110.66 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.445 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 20.3 t -110.25 -23.0 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 2.14 111.58 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.506 ' HA ' ' CG1' ' A' ' 189' ' ' VAL . 1.8 mt-30 -178.63 -175.65 0.44 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 5.37 111.22 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.435 HG23 ' HA3' ' A' ' 134' ' ' GLY . 0.0 OUTLIER -136.1 -60.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 4.97 110.868 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 15.2 t-20 178.32 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.98 110.909 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -173.62 -163.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.448 . . . . 5.35 110.873 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.508 ' O ' ' C ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER -121.69 -12.39 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 4.56 111.254 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.508 ' C ' ' O ' ' A' ' 171' ' ' ILE . 2.8 t80 -26.86 -58.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 7.2 111.315 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -90.09 122.28 32.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 4.73 110.894 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.4 p -168.71 37.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 3.31 111.164 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -112.95 77.31 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 5.08 110.882 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.4 p -157.35 124.92 5.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 3.33 110.864 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -33.11 73.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 2.26 111.057 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -70.43 -33.13 70.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 3.61 110.944 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -76.97 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 4.5 111.009 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.1 m -56.52 -41.88 77.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 2.26 110.962 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -72.4 -35.11 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 3.4 110.931 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.04 -20.6 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 2.72 110.949 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.12 -8.43 59.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 2.54 111.078 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -31.64 56.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 2.26 110.955 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.3 -30.24 38.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 1.95 111.168 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 187' ' ' ILE . 3.1 t0 69.33 15.28 8.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 3.66 110.953 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.611 ' HA ' ' CB ' ' A' ' 131' ' ' PRO . 7.8 pt 32.93 90.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 3.74 111.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -84.37 93.39 8.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 3.29 110.759 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.506 ' CG1' ' HA ' ' A' ' 167' ' ' GLN . 8.5 m -57.66 122.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.012 -0.54 . . . . 2.4 111.073 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 165' ' ' ILE . . . 116.26 -5.27 19.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 1.3 112.55 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.417 ' N ' HG23 ' A' ' 165' ' ' ILE . 2.0 t -72.19 -161.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.336 . . . . 1.56 110.958 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -147.38 115.08 6.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 2.76 110.725 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.67 176.48 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 1.55 111.187 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.95 152.48 46.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 2.3 110.784 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.437 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 0.4 OUTLIER -128.41 153.96 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 3.12 111.172 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.437 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 5.6 m -157.83 145.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 2.76 111.113 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 170.39 16.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 2.36 110.893 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -169.98 105.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 4.15 110.968 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 49.41 51.0 17.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 3.14 110.996 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 60.74 68.04 1.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 2.12 112.417 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -170.07 155.58 5.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.804 0.335 . . . . 3.25 110.864 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.4 tt -105.3 140.14 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 2.46 111.128 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.1 t -160.03 122.21 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 2.01 110.959 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.86 119.23 25.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 2.31 110.776 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -96.9 117.63 31.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 1.33 111.012 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.564 ' O ' ' C ' ' A' ' 207' ' ' ASN . 10.6 t-80 -129.66 146.73 51.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 2.74 110.746 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.564 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.0 m120 -19.4 -55.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 4.41 111.303 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -54.36 -76.93 0.17 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.718 -0.754 . . . . 1.71 112.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 18.5 mtmt -159.72 -174.44 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.317 . . . . 3.86 110.763 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 149.24 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 2.07 110.635 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.41 178.04 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 1.95 111.213 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.77 -66.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 3.28 110.693 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 3.4 mp 57.03 77.18 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 2.58 110.949 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 17.9 tp -54.85 163.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 3.07 110.77 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 6.7 m-20 -54.59 -22.79 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 2.15 110.998 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . 0.485 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -81.89 -20.1 39.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.96 111.072 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 10.5 mp -89.97 -56.41 3.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 3.14 111.045 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.22 46.1 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 1.69 111.114 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 3.6 t-160 -90.06 -45.06 9.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 2.68 111.013 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.589 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 6.0 p -142.25 65.31 1.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.359 . . . . 2.39 111.633 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.513 ' O ' HD13 ' A' ' 223' ' ' ILE . 33.0 mm -89.76 158.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 116.33 -0.395 . . . . 2.46 110.614 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 2.6 mtt-85 -95.2 86.18 4.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 7.17 111.198 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 221' ' ' ILE . 0.2 OUTLIER -123.43 -154.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.99 110.497 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.473 ' H ' HG21 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -117.94 162.44 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.348 . . . . 3.25 111.003 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.424 ' CB ' ' HB ' ' A' ' 150' ' ' THR . 16.9 tt0 -89.9 99.67 12.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 2.8 110.849 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 160' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 2.73 111.008 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.764 0.316 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.1 m -76.42 -41.03 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.251 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -34.6 71.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -72.14 -38.52 69.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -71.35 -37.75 71.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -71.91 148.58 45.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.001 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.3 m -99.89 169.99 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -77.25 84.08 3.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 t -145.97 158.33 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -91.86 -42.67 9.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.03 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.89 111.91 23.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.36 -71.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.37 138.49 50.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 p -129.79 111.78 12.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -162.34 -43.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.0 m -85.52 132.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.39 176.19 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.566 2.177 . . . . 0.0 112.432 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -133.52 98.03 4.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.66 25.15 1.19 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.954 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -125.16 139.02 32.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 110.796 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.576 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.2 Cg_endo -75.74 135.35 17.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.676 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 148.91 -32.05 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.117 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 7.4 Cg_endo -86.68 83.82 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.491 2.127 . . . . 0.0 112.434 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.1 117.19 4.97 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.48 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 217' ' ' LEU . 3.5 tt -81.08 -59.51 2.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -89.51 11.89 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.468 ' CG ' ' HB ' ' A' ' 168' ' ' ILE . 0.6 OUTLIER -90.11 -38.61 13.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.02 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 pp -42.62 -35.47 1.11 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.536 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -51.84 151.39 7.0 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.714 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.0 t 58.6 101.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.237 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.97 141.64 6.1 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.425 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -164.57 96.13 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.342 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.439 ' N ' ' HD3' ' A' ' 151' ' ' ARG . 1.1 m -101.85 -175.89 2.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.52 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.85 -48.66 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.72 89.56 1.33 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.22 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.71 155.0 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.06 -61.61 6.53 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.09 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -34.44 -43.99 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.014 2.476 . . . . 0.0 112.627 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -161.71 140.25 6.5 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.857 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.8 t -112.41 -20.88 11.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.655 0.227 . . . . 0.0 111.488 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' A' ' 153' ' ' ILE . 18.5 ttp180 74.6 30.56 1.04 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.945 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.0 OUTLIER 52.51 -70.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.624 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.616 ' N ' ' O ' ' A' ' 151' ' ' ARG . 3.4 tt -44.04 85.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.296 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 152' ' ' VAL . 1.7 p30 168.06 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.38 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.63 -29.39 7.14 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.474 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.32 33.06 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.417 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.9 t -170.59 33.61 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.175 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.52 35.54 0.23 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.038 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.1 mtp 58.43 67.87 1.99 Allowed Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.14 155.67 44.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.81 2.34 . . . . 0.0 112.605 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.49 -55.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.504 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -170.26 91.84 0.19 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.062 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 15.9 m -69.99 170.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.565 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -139.81 116.53 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.443 ' HA ' HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -77.53 129.6 37.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.199 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.7 t -133.93 -25.43 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 222' ' ' ARG . 3.2 mt-30 -147.33 162.1 39.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.22 0.533 . . . . 0.0 111.775 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.468 ' HB ' ' CG ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -152.38 -80.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.772 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -179.72 -67.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.91 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -155.65 -178.9 7.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.88 -40.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.197 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.96 -35.71 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.215 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -64.62 121.09 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.7 p -172.07 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -102.86 -32.82 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.116 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.1 p -60.8 127.09 29.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.89 -35.51 67.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.03 -22.54 66.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -79.02 -8.67 59.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.9 m -57.71 -40.44 79.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.688 0.28 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.09 -41.77 97.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.69 -22.71 50.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.916 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.68 -26.7 46.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.297 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -34.95 40.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.95 38.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 187' ' ' ILE . 11.4 m-20 57.61 37.4 27.48 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER 9.68 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.267 0.627 . . . . 0.0 112.605 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -106.0 121.9 45.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.765 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 15.9 m -62.69 148.03 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.34 -11.75 47.59 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.719 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.8 t -70.06 -175.43 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -134.5 124.13 25.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.601 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.83 172.87 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 0.0 111.461 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.9 138.53 19.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.653 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.473 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 4.0 tt -110.25 158.49 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.15 0.5 . . . . 0.0 111.32 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.473 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 15.4 m -142.07 136.55 29.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.982 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.98 93.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.12 -177.66 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.27 79.16 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 66.99 38.97 93.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.606 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -160.96 150.57 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 0.0 111.017 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.5 tt -95.6 144.74 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -160.08 137.43 9.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.55 121.86 43.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.5 m -86.76 138.31 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 207' ' ' ASN . 3.0 t60 -165.12 172.31 12.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 206' ' ' HIS . 75.5 m-20 -28.17 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.82 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . 135.1 -81.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 23.0 mtmt -158.38 -88.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.614 0.245 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.25 158.34 34.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.01 172.68 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.014 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -79.94 -59.54 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 52.72 96.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.75 178.51 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -76.54 -8.41 57.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.381 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -65.95 0.97 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.116 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -61.14 -36.27 79.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.509 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 221' ' ' ILE . . . -89.76 24.48 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.577 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 3.3 t-160 -90.37 -67.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.8 p -103.86 53.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 152' ' ' VAL . 31.9 mt -91.57 150.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -92.81 104.07 16.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.999 0.428 . . . . 0.0 111.657 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -136.7 -179.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.824 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 6.3 tt0 -89.47 165.82 14.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 110.544 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -89.62 102.9 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.708 179.86 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.07 -43.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.386 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.12 -30.37 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.351 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -55.94 -43.2 77.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.336 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -67.46 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.944 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.9 tt 64.66 130.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 m -147.85 171.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -103.26 -33.85 9.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 m -61.02 140.73 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.394 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.1 tp -89.54 -42.51 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.35 131.04 44.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.04 -63.75 1.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.34 163.97 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.041 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 t -118.0 88.75 2.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -152.96 77.13 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.5 t 59.04 69.56 1.33 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.63 -28.29 80.77 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -106.82 149.64 27.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 155.5 134.45 1.86 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.72 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.421 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 10.4 p30 54.05 157.17 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.275 0 CA-C-O 121.059 0.457 . . . . 0.0 111.939 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 132' ' ' ILE . 91.8 Cg_endo -77.78 175.03 11.71 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.896 2.397 . . . . 0.0 112.324 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.557 ' CB ' ' O ' ' A' ' 131' ' ' PRO . 1.0 OUTLIER 108.46 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.428 ' HD2' ' C ' ' A' ' 131' ' ' PRO . 72.7 Cg_exo -43.12 118.66 1.36 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.338 2.025 . . . . 0.0 113.125 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.97 23.5 23.29 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.11 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 0.6 OUTLIER -50.24 -36.0 29.25 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.998 0.428 . . . . 0.0 110.478 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -22.36 21.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -178.28 0.53 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.89 102.33 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.745 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.33 127.05 8.6 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.058 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.9 -79.03 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.779 0.289 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.05 109.74 0.59 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.643 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.11 102.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 0.0 110.422 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.481 ' HA ' ' CG1' ' A' ' 153' ' ' ILE . 0.8 OUTLIER -81.81 162.05 23.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.268 0.556 . . . . 0.0 111.774 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 p30 49.4 -178.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.804 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.38 179.58 0.77 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.954 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.71 -71.26 0.14 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.988 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.27 174.7 5.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.69 89.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.567 2.178 . . . . 0.0 112.229 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -167.78 146.92 11.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.483 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -140.1 -48.53 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.554 0.216 . . . . 0.0 110.458 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.571 ' O ' ' CG2' ' A' ' 152' ' ' VAL . 34.9 mtt180 88.24 55.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.766 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' A' ' 151' ' ' ARG . 16.0 m 57.38 -47.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -43.99 -30.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 118.636 0.653 . . . . 0.0 112.345 -178.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.13 24.05 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.609 0.243 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.51 12.53 31.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.397 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -149.84 70.52 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.052 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.4 m -158.73 -52.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -79.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.359 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' MET . . . . . 0.403 ' HA ' ' HD2' ' A' ' 160' ' ' PRO . 26.5 ttm -155.76 92.09 2.69 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.681 0.276 . . . . 0.0 111.143 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.449 ' HA ' ' HB3' ' A' ' 226' ' ' LEU . 18.7 Cg_endo -60.27 140.33 91.47 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.723 2.282 . . . . 0.0 112.552 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -162.91 -49.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.81 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -168.62 119.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.418 ' HB ' ' CG2' ' A' ' 223' ' ' ILE . 26.8 m -102.1 134.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.675 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 12.4 mtt180 -79.78 126.09 30.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.889 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 24.4 mm -94.08 96.77 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 165' ' ' ILE . 86.2 t -159.89 92.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.416 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.613 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 170.07 105.54 0.01 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 111.063 179.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 167' ' ' GLN . 22.0 mt 98.25 -31.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 37.88 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.12 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.75 179.93 1.62 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.9 0.381 . . . . 0.0 111.446 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.04 125.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.085 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -63.82 -45.37 89.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.95 0.405 . . . . 0.0 110.686 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -123.03 143.29 50.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.492 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.53 94.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -161.69 91.67 0.83 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.849 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.0 p -153.62 135.97 14.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -67.9 -35.08 77.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.91 -32.61 74.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.08 -15.87 51.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.291 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 35.2 m -50.36 -39.36 46.19 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.742 0.306 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.62 -36.03 62.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.748 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -13.27 60.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.032 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -81.02 -2.27 47.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.538 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.09 -43.28 41.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.754 0.311 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.4 -30.15 16.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.029 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.545 ' O ' ' O ' ' A' ' 187' ' ' ILE . 6.5 m-20 73.71 2.86 4.36 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.736 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.545 ' O ' ' O ' ' A' ' 186' ' ' ASP . 41.2 pt 48.62 124.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 112.146 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.61 125.59 54.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.42 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.64 146.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.08 1.08 63.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 132' ' ' ILE . 17.4 t -81.31 174.67 11.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.24 131.14 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.11 -167.92 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -140.38 174.52 10.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.759 0.314 . . . . 0.0 110.827 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 195' ' ' ILE . 1.0 OUTLIER -160.03 154.76 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 14.8 m -155.1 174.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -86.01 160.05 19.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.766 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -163.9 102.08 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.072 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 t70 55.27 43.81 28.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.21 46.05 93.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.547 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -153.2 148.75 27.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.33 . . . . 0.0 110.906 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.4 tt -83.39 147.2 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.206 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.5 t -160.11 122.52 3.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 14.5 mt -82.37 113.78 20.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.807 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.7 m -97.08 140.43 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.828 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 207' ' ' ASN . 54.3 t60 -147.92 144.45 28.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.489 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.0 m120 -33.13 -40.56 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.72 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -68.65 -66.31 2.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt -157.69 -176.3 5.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.35 148.84 40.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.415 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.39 169.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -79.98 -64.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.7 tp 59.27 167.09 0.06 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.16 152.25 26.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -53.31 -26.2 17.76 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.206 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.78 -66.94 0.3 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 3.3 mm? -88.36 -20.84 24.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.14 29.46 1.23 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.859 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -33.94 16.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 151' ' ' ARG . 1.4 p -161.91 84.86 0.6 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.334 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.425 ' HB ' HD11 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -120.5 -164.11 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.613 ' HA ' ' CB ' ' A' ' 167' ' ' GLN . 11.7 ptt180 -86.22 80.38 8.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.263 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -151.43 176.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.574 178.048 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -120.87 -173.52 2.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.752 0.311 . . . . 0.0 111.019 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -89.84 89.18 7.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.449 ' HB3' ' HA ' ' A' ' 160' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.118 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.76 0.314 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.12 -34.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.79 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.949 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -57.66 89.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -90.12 -53.38 4.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.22 160.29 30.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.73 135.1 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -159.12 173.47 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.809 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 1.0 OUTLIER -88.25 -45.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.047 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.468 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 12.3 tp -170.69 -51.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.22 142.61 28.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -119.55 -63.0 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.2 m -72.42 176.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.195 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.4 m -71.46 -55.67 7.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.61 -56.55 5.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 m 61.41 86.1 0.16 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.31 155.23 25.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.618 2.212 . . . . 0.0 112.261 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.401 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 60.9 m-85 -142.97 33.97 1.37 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -106.58 -132.23 7.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.629 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 0.2 OUTLIER 54.5 -163.86 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.629 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 65.9 Cg_exo -50.68 -74.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.877 1.718 . . . . 0.0 112.591 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 165.2 127.78 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.449 0.166 . . . . 0.0 111.209 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 132' ' ' ILE . 3.0 Cg_exo -74.17 139.93 27.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.738 2.292 . . . . 0.0 111.969 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.28 93.37 1.86 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.807 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tt -83.58 -32.36 25.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.02 -10.78 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 138' ' ' LEU . 1.3 mt-10 -61.89 -49.61 75.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.736 0.303 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 137' ' ' GLU . 3.2 mp -29.94 -44.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.981 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -48.73 -44.9 30.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.879 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 105.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.739 0.304 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.76 114.14 0.78 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.544 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -171.17 142.8 1.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.741 0.305 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.436 ' HB2' ' HA3' ' A' ' 149' ' ' GLY . 13.8 t -95.9 162.15 13.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -162.41 -45.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.12 -45.0 1.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.84 -179.86 6.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.405 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -74.38 -58.28 1.92 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.518 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 5.9 Cg_exo -33.25 108.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 113.301 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 143' ' ' SER . . . 115.5 42.0 0.77 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.713 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.445 ' N ' HD11 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -103.53 -142.41 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.502 ' HB3' HG12 ' A' ' 223' ' ' ILE . 26.0 ttt180 65.13 -69.96 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.748 0.308 . . . . 0.0 111.623 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 218' ' ' ALA . 2.5 m -95.68 -38.23 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.521 ' O ' ' CB ' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -116.55 110.03 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.238 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 153' ' ' ILE . 55.7 m-20 99.26 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.705 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -42.93 -34.25 0.93 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.56 61.42 2.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.429 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.1 t -176.23 -35.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.346 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.7 m -89.3 54.2 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 45.3 mtt 55.0 57.21 11.37 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.391 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 226' ' ' LEU . 7.3 Cg_endo -49.32 129.57 22.86 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.168 2.579 . . . . 0.0 112.559 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -154.97 -47.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.567 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -170.28 91.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.4 m -70.0 178.42 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 223' ' ' ILE . 1.5 mpt_? -127.18 107.75 10.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.513 ' HA ' HG23 ' A' ' 223' ' ' ILE . 8.2 tt -70.63 134.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.39 11.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -168.65 100.57 0.4 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.947 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.65 -4.29 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.949 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 53.56 -92.76 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.738 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 62.18 -88.14 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 79.4 mt 59.89 -76.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.8 m-85 -62.65 -67.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.871 0.367 . . . . 0.0 111.332 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.92 121.98 12.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.081 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -172.44 -40.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.282 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -113.58 95.02 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.5 p -158.27 157.33 32.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.79 -37.31 83.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.61 -31.97 57.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -90.08 3.62 52.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.45 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.3 m -59.05 -44.21 91.79 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -72.99 -33.59 65.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 128' ' ' PHE . 8.1 mp -73.19 -21.8 60.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.4 mt -63.73 -33.32 75.39 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.598 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.68 -28.37 21.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.55 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 130' ' ' ASN . . . -51.66 -41.13 61.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.004 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.8 t70 78.85 -8.32 1.66 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.2 mt 61.01 125.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.738 0.304 . . . . 0.0 111.467 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.58 -43.23 3.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.507 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 189' ' ' VAL . 3.3 p 36.94 83.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 165' ' ' ILE . . . 135.3 2.26 3.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.518 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 t -85.19 -167.44 1.83 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.903 0.382 . . . . 0.0 111.289 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . 0.425 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 45.9 mt-10 -129.62 99.0 5.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.492 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 27.3 m -92.29 169.62 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.625 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.56 135.66 53.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 196' ' ' VAL . 0.7 OUTLIER -90.74 151.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.102 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.4 ' N ' HG13 ' A' ' 195' ' ' ILE . 14.9 p -170.32 151.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -131.77 172.16 12.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.749 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.25 118.14 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.334 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.5 t70 66.93 -68.82 0.14 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.56 49.65 0.16 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.304 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -149.06 145.07 27.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 9.9 tp -95.14 145.0 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.241 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.2 t -160.05 153.99 23.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.93 103.64 8.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 2.8 m -79.91 122.18 26.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 208' ' ' GLY . 59.8 t60 -175.73 162.19 2.67 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.4 m120 31.56 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.991 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -54.41 -78.97 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.439 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 22.9 mtmt -160.5 -75.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.495 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -155.48 133.19 11.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.27 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.38 141.51 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -79.84 -59.11 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.181 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 48.75 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.609 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 tp -165.95 164.13 18.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -46.75 -31.63 3.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.3 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -58.59 6.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.358 . . . . 0.0 110.591 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.414 ' O ' ' CD1' ' A' ' 221' ' ' ILE . 7.9 mp -80.39 -12.86 59.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.157 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.431 ' HA ' HG22 ' A' ' 152' ' ' VAL . . . -90.51 -28.02 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -90.43 -19.83 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 20.1 p -135.9 78.74 1.73 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.577 HG23 ' CD1' ' A' ' 223' ' ' ILE . 0.9 OUTLIER -149.01 156.96 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.444 ' N ' HG22 ' A' ' 221' ' ' ILE . 40.4 mtt-85 -101.04 124.25 46.48 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.577 ' CD1' HG23 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -150.42 178.37 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.815 178.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 164' ' ' ARG . 2.1 tm-20 -95.02 150.07 20.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.493 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -89.57 132.88 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 111.259 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 160' ' ' PRO . 4.6 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.322 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.707 0.289 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.2 m -69.55 -42.74 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.38 40.38 1.01 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.155 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -90.13 -51.49 5.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 136.54 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.32 170.14 8.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.62 -43.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.4 tttt 70.37 -66.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.7 m -69.41 143.06 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.218 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tt -86.03 95.26 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -154.78 136.44 14.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.19 140.91 30.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.01 109.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.8 t -159.92 -64.17 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -152.69 -72.35 0.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.822 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.422 ' CB ' ' HD3' ' A' ' 127' ' ' PRO . 0.6 OUTLIER 175.33 -53.44 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.422 ' HD3' ' CB ' ' A' ' 126' ' ' SER . 46.3 Cg_exo -56.6 -171.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.603 2.202 . . . . 0.0 112.557 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -125.13 -175.5 3.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.744 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.19 -158.67 9.27 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.664 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.486 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 0.6 OUTLIER -71.51 165.14 51.68 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.545 0.212 . . . . 0.0 110.81 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 38.3 Cg_endo -67.2 126.85 15.7 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.551 2.167 . . . . 0.0 112.787 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.513 HG13 ' HD2' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -172.58 -62.64 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.694 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.513 ' HD2' HG13 ' A' ' 132' ' ' ILE . 7.0 Cg_exo -38.92 118.3 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.288 2.658 . . . . 0.0 113.377 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.81 47.99 3.01 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.536 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.406 ' HA ' ' HG ' ' A' ' 217' ' ' LEU . 2.8 pp -51.02 -32.73 22.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.081 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -89.35 -22.36 22.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -174.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.154 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tt -90.28 102.86 15.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.375 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -88.25 128.28 8.99 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.392 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 p -172.91 -43.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 126.5 107.29 1.52 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.568 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -166.79 137.53 3.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.467 ' CB ' ' HB2' ' A' ' 151' ' ' ARG . 58.0 p -179.08 -34.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.83 -23.21 1.76 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.674 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.66 174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.743 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -107.46 140.65 40.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 168.38 167.54 0.14 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.561 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -56.44 -18.95 26.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.15 1.9 . . . . 0.0 110.973 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 224' ' ' GLU . . . -139.46 153.71 23.15 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.669 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 225' ' ' GLU . 10.8 t -97.2 -142.28 0.29 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 223' ' ' ILE . 60.9 mtt180 -150.58 72.16 1.08 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 154' ' ' ASP . 44.2 t 64.41 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.159 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.436 ' O ' ' CG1' ' A' ' 153' ' ' ILE . 1.3 tt -61.47 76.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.5 OUTLIER 162.73 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.598 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.436 ' HA ' HD21 ' A' ' 226' ' ' LEU . . . -89.89 46.0 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.431 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -145.16 36.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.8 p -160.07 -43.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.4 t -76.81 61.66 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.6 ttt 48.96 86.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.408 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.44 149.41 90.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.644 2.229 . . . . 0.0 112.576 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -156.55 -50.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.688 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -168.11 165.34 13.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 223' ' ' ILE . 3.4 m -155.04 140.41 10.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.626 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 0.2 OUTLIER -79.37 107.63 12.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.571 179.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -79.5 119.4 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.515 ' O ' ' C ' ' A' ' 167' ' ' GLN . 10.7 t -134.7 38.07 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.395 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.515 ' C ' ' O ' ' A' ' 166' ' ' VAL . 0.6 OUTLIER 5.67 -86.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.434 0.694 . . . . 0.0 112.86 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.431 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 0.4 OUTLIER 159.2 -52.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -169.48 -172.43 1.45 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 36.5 mt-10 -152.13 168.39 25.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.992 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 77.36 -21.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.131 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.29 -51.6 61.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -118.74 178.67 4.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.167 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.0 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.08 -178.21 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.197 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.7 p -68.42 -173.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.33 -5.05 33.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -57.89 -30.92 66.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.734 0.302 . . . . 0.0 110.986 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -90.13 11.58 20.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.6 m -54.24 -39.39 66.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.733 0.301 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.47 -41.25 69.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.42 -18.19 62.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.958 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -25.14 68.02 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.99 -40.26 57.56 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.04 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 187' ' ' ILE . 6.7 t70 60.89 24.65 14.64 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.282 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.46 ' HA ' ' CB ' ' A' ' 131' ' ' PRO . 1.1 pp 28.51 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.112 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.39 141.19 40.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.098 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.11 146.9 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.71 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.28 -12.8 26.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.791 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 165' ' ' ILE . 1.3 t -73.67 -165.3 0.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.004 0.431 . . . . 0.0 111.027 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -151.69 145.91 25.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.206 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 20.8 m -150.3 179.08 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.012 0.434 . . . . 0.0 111.876 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.99 101.73 1.95 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.38 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.4 pt -79.84 151.46 4.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.558 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.3 m -150.68 152.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.957 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.92 142.03 53.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.05 112.99 1.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.011 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.41 36.43 23.02 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.77 51.41 57.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.594 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -158.28 156.06 29.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.805 0.336 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -94.45 135.42 28.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 t -153.57 133.03 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.99 159.68 26.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.502 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 9.5 m -152.08 116.65 5.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.213 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.407 ' O ' ' N ' ' A' ' 208' ' ' GLY . 1.7 t-80 179.25 177.98 0.51 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.036 0.446 . . . . 0.0 111.504 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 12.8 m120 42.52 -90.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.783 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -73.08 -67.43 1.81 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.677 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 21.9 mtmt -159.17 -81.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 111.104 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -153.81 175.32 13.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.0 t -136.96 159.64 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.836 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -79.89 -61.5 1.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.315 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 3.0 mp 57.12 179.22 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.46 -179.95 7.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.94 13.61 12.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.596 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -84.65 -71.76 0.5 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.682 0.277 . . . . 0.0 110.767 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.406 ' HG ' ' HA ' ' A' ' 135' ' ' LEU . 4.4 mm? -90.2 -40.03 12.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.794 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 221' ' ' ILE . . . -56.76 -20.94 24.88 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -80.3 7.36 9.69 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 12.3 t -163.59 39.91 0.09 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.463 ' HB ' HD13 ' A' ' 223' ' ' ILE . 51.2 mm -89.8 154.57 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 63.5 ttt180 -89.69 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 111.901 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -146.8 -178.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.0 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.554 ' HA ' ' HA3' ' A' ' 149' ' ' GLY . 12.1 tm-20 -89.82 165.25 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.82 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 226' ' ' LEU . 33.8 tt0 -99.26 80.54 2.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.507 ' C ' ' O ' ' A' ' 225' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.712 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.773 0.321 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.99 -38.44 11.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.14 55.95 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.89 -33.14 17.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -70.24 158.75 35.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.9 mt -137.11 -52.28 0.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.71 127.05 50.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.261 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -173.19 -173.66 0.95 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -76.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.092 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.6 tt -165.46 -46.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -72.27 140.47 48.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.88 158.92 43.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.62 139.67 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.283 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -163.64 178.73 7.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -86.26 -40.31 15.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.71 93.47 37.45 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 112.72 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.639 2.226 . . . . 0.0 112.393 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 57.06 96.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.2 9.54 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.306 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.622 ' CB ' ' HD2' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 53.71 178.53 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.537 0.168 . . . . 0.0 110.648 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.622 ' HD2' ' CB ' ' A' ' 130' ' ' ASN . 2.6 Cg_endo -39.6 141.84 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.922 2.415 . . . . 0.0 112.898 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.1 tt -37.6 96.0 0.1 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.526 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -82.44 78.26 3.46 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.272 2.648 . . . . 0.0 111.243 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.522 ' HA3' ' HG2' ' A' ' 137' ' ' GLU . . . -70.3 111.68 3.92 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.616 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.46 -40.53 11.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -91.11 -4.62 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.272 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.522 ' HG2' ' HA3' ' A' ' 134' ' ' GLY . 0.0 OUTLIER -90.08 -35.94 15.16 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.401 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 140' ' ' VAL . 3.5 pp -39.93 -34.99 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.933 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.43 82.77 0.01 OUTLIER Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.013 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 138' ' ' LEU . 59.9 t -154.73 -55.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 110.726 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.18 104.1 0.18 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.388 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -57.16 108.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 111.054 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.429 ' N ' ' HB3' ' A' ' 151' ' ' ARG . 14.1 m -90.73 99.3 12.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -106.97 24.16 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.756 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.13 -167.07 1.16 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.43 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 67.58 164.34 0.13 Allowed Pre-proline 0 C--O 1.231 0.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.341 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.49 145.22 47.8 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.758 2.305 . . . . 0.0 112.487 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.94 101.85 1.23 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.609 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 224' ' ' GLU . 10.3 t -118.46 -161.07 0.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.283 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.429 ' HB3' ' N ' ' A' ' 143' ' ' SER . 22.3 ptt180 -125.93 33.11 5.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.548 ' CG2' HG12 ' A' ' 221' ' ' ILE . 0.4 OUTLIER 66.67 -59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 153' ' ' ILE . 1.7 pt -69.57 62.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.4 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.435 ' HA ' ' HG3' ' A' ' 224' ' ' GLU . . . -40.17 -36.1 0.47 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.781 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.32 76.62 1.71 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.05 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.5 m -159.51 -45.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.6 m -78.61 -78.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.7 ptm -146.59 54.74 2.22 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -44.55 106.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.419 2.746 . . . . 0.0 112.701 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -135.47 -40.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.844 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -161.77 96.14 1.01 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 0.0 OUTLIER -70.0 176.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 6.2 mtt180 -152.02 115.43 4.77 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 223' ' ' ILE . 8.3 tt -84.76 126.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.983 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.1 t -133.68 -72.73 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.02 122.45 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.032 0.444 . . . . 0.0 112.171 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.41 ' CG1' HG22 ' A' ' 189' ' ' VAL . 34.1 mm -153.55 -74.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 44.97 -171.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.804 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 172' ' ' PHE . 47.1 tt0 -156.28 -71.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.8 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.3 mt 63.26 -70.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.886 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.2 m-85 -51.87 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 111.49 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.77 120.72 11.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.13 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.9 p -175.77 39.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -134.99 -41.68 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.9 p -56.58 126.73 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.27 -33.44 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.59 -28.88 70.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -73.92 -19.31 60.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.262 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.0 m -50.86 -48.14 60.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -64.68 -31.53 72.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.85 -38.7 79.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.0 -12.74 37.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -23.29 8.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.379 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -53.9 -34.2 58.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.058 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.9 t70 50.32 73.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 131' ' ' PRO . 0.1 OUTLIER -117.64 -145.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.336 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.31 104.24 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.77 0.319 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 165' ' ' ILE . 10.7 p -60.44 115.57 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 142.56 1.76 1.18 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.412 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 165' ' ' ILE . 12.0 t -103.31 -165.15 1.14 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.073 0.437 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -104.5 145.94 29.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.438 ' C ' HG21 ' A' ' 163' ' ' VAL . 13.0 m -146.48 -163.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.228 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 9.5 pt-20 -150.38 163.24 38.85 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.643 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.499 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 4.2 tt -141.96 160.19 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.179 0.514 . . . . 0.0 111.408 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.499 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 18.3 m -146.64 113.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.01 175.42 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -153.94 172.69 17.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.03 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.49 51.97 50.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -165.78 136.35 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -107.91 131.55 57.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.841 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.6 t -160.02 135.31 8.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.031 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.9 mt -79.81 -176.18 5.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.561 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.4 m -154.49 109.44 3.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 208' ' ' GLY . 0.6 OUTLIER 179.8 -178.52 0.41 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.533 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 42.92 -88.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.48 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -78.48 -68.11 1.54 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.6 mtmt -160.32 -69.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.672 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.14 161.47 41.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.671 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.6 t -105.66 157.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.889 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -79.61 -63.49 1.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.707 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 41.9 mt 56.26 174.61 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.452 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 0.3 OUTLIER -171.0 174.16 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.685 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.92 -30.11 9.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.299 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.6 -65.02 1.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -44.9 78.23 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.792 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 152' ' ' VAL . . . -90.62 39.31 0.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.425 ' CD2' ' C ' ' A' ' 219' ' ' HIS . 2.7 t-160 -90.26 -54.0 4.21 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.643 0.258 . . . . 0.0 111.032 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.99 80.56 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.548 HG12 ' CG2' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -124.16 146.77 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -89.67 102.45 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.623 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -151.34 31.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.817 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.584 ' HB3' ' HB ' ' A' ' 150' ' ' THR . 2.1 tt0 -152.88 157.75 41.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.742 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -116.56 -19.73 9.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.93 -179.868 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.778 0.323 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 202' ' ' ILE . 89.1 t -64.04 -28.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.398 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -84.78 62.2 7.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.688 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -57.23 85.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 113' ' ' GLU . 66.4 mtp180 -41.33 -40.91 1.81 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.313 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.43 77.91 9.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.664 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.1 m -62.72 163.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.358 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -154.12 -49.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 120' ' ' LEU . 1.1 p -148.94 -166.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.402 ' H ' ' CG2' ' A' ' 119' ' ' VAL . 4.5 mm? -107.54 115.63 30.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -153.11 133.04 13.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.05 163.78 13.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -101.25 142.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.1 m 60.38 -89.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 176.26 159.44 0.3 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.6 m 60.08 73.24 0.66 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.46 -30.11 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.672 2.248 . . . . 0.0 112.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.71 150.83 45.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 143.42 136.92 3.21 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 129' ' ' GLY . 2.6 p-10 51.5 158.46 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.614 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.3 Cg_endo -76.41 135.45 16.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.703 2.269 . . . . 0.0 113.019 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.616 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 135.77 -32.12 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 124.058 0.849 . . . . 0.0 112.089 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 1.5 Cg_endo -79.92 72.04 6.73 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.427 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.11 118.12 4.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.244 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 tt -73.19 -45.49 56.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.233 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.28 9.25 29.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.514 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.21 -50.77 5.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.638 0.256 . . . . 0.0 111.225 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.441 ' HA ' HG23 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -53.97 -14.92 1.15 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.409 ' N ' HD11 ' A' ' 138' ' ' LEU . . . -45.42 -91.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.255 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.6 t -89.72 153.23 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.01 155.64 32.02 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.428 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.466 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 2.0 p30 -152.47 131.89 12.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.822 0.344 . . . . 0.0 111.405 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -97.85 170.6 8.85 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -158.68 -60.63 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 225' ' ' GLU . . . -162.9 -163.06 0.82 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 145' ' ' ALA . . . 94.07 108.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 63.87 162.49 0.12 Allowed Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.378 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 79.3 Cg_exo -39.69 146.71 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.858 2.372 . . . . 0.0 112.048 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.709 ' HA2' ' HB ' ' A' ' 163' ' ' VAL . . . 151.55 -152.35 24.13 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.892 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.467 ' OG1' HG21 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -152.13 144.59 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -67.12 2.76 1.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.407 ' CG2' ' CD1' ' A' ' 223' ' ' ILE . 2.4 t 74.03 -62.51 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.918 0.39 . . . . 0.0 110.484 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.9 pt -97.51 44.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.505 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 155' ' ' ALA . 5.0 t70 -162.79 -32.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.686 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 154' ' ' ASP . . . -27.86 -42.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 154' ' ' ASP . . . -76.99 62.0 2.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 0.0 111.319 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.0 t -173.32 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 t -77.5 -158.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 34.1 mtt -124.47 60.3 23.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.021 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.85 162.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.928 2.419 . . . . 0.0 113.181 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.2 mtp85 -152.14 -45.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.348 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -161.26 78.66 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.227 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.709 ' HB ' ' HA2' ' A' ' 149' ' ' GLY . 32.9 m -69.94 143.45 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.849 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' A' ' 148' ' ' PRO . 8.0 mtp85 -79.05 98.76 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.365 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.757 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -76.41 79.98 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.401 0.62 . . . . 0.0 111.833 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.413 ' HA ' ' CG2' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -160.88 97.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.696 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.56 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.9 OUTLIER 170.47 133.77 0.02 OUTLIER 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.585 0.707 . . . . 0.0 112.183 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.441 HG23 ' HA ' ' A' ' 138' ' ' LEU . 3.0 mm 75.86 -2.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.413 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -55.75 159.42 3.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.939 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -151.4 170.12 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.71 -47.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.055 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.44 -40.34 90.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -71.48 132.91 45.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.5 p -162.59 93.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.127 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 176' ' ' THR . 3.6 tt0 -138.64 178.42 7.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 175' ' ' GLU . 8.4 t 47.83 114.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.885 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.3 -2.97 15.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.775 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.53 -34.41 70.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.615 0.245 . . . . 0.0 111.431 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 2.4 p90 -75.44 -10.14 59.19 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.696 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.1 m -48.71 -40.92 30.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -70.69 -35.85 72.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.85 -22.88 59.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.024 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.63 -20.88 63.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.068 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -38.56 61.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -69.44 -27.6 65.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.526 ' O ' HG13 ' A' ' 187' ' ' ILE . 13.8 m-20 84.06 -36.52 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.558 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 186' ' ' ASP . 0.6 OUTLIER 62.18 130.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.384 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -126.82 88.79 2.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.862 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.413 ' CG2' ' HA ' ' A' ' 166' ' ' VAL . 7.6 p -70.99 96.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.543 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 165' ' ' ILE . . . 146.38 -1.21 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.375 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.5 t -97.03 -162.9 0.99 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.053 0.427 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.4 124.52 43.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 32.5 m -127.98 175.33 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.258 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.98 169.49 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.431 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -155.85 154.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.023 0.439 . . . . 0.0 111.135 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.431 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 17.6 m -141.5 155.2 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.952 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.94 155.38 40.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 43.1 ttm-85 -146.29 71.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.987 0.423 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.43 60.28 3.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.12 96.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.563 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -152.55 131.71 12.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 110.725 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 152' ' ' VAL . 13.8 tt -79.99 139.53 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 111.388 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 16.7 p -158.41 119.86 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.457 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.57 153.19 29.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.743 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 39.0 m -126.78 125.71 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.432 ' O ' ' N ' ' A' ' 208' ' ' GLY . 0.8 OUTLIER -178.61 176.08 1.03 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.989 0.423 . . . . 0.0 111.378 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 46.89 -87.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.782 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -83.65 -62.6 1.76 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.841 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.72 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.593 0.235 . . . . 0.0 111.231 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -138.14 178.87 6.8 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.16 179.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.63 -48.81 3.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.4 mt 56.99 176.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.35 177.7 8.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.57 -29.92 69.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.316 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.07 -54.77 6.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.155 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.95 -30.78 68.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.289 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.12 15.88 9.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.743 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -84.78 -58.83 2.55 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.809 0.337 . . . . 0.0 110.771 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 142' ' ' ASN . 3.0 p -147.0 88.05 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.444 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.594 ' CG2' ' N ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -111.58 -172.1 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.564 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.757 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.7 mtm180 -84.28 76.22 10.13 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.512 ' CD1' HG23 ' A' ' 221' ' ' ILE . 0.3 OUTLIER -153.51 134.0 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 148' ' ' PRO . 9.8 mt-10 -89.68 -108.8 0.08 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 145' ' ' ALA . 2.8 tt0 -150.99 112.44 4.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.206 0.457 . . . . 0.0 111.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 149' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.077 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.777 0.322 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -54.76 -75.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -87.48 62.52 7.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 110.722 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 77.52 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -51.72 -34.7 40.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.53 92.77 2.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -164.21 148.87 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -146.93 -68.22 0.26 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 m -76.0 165.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.305 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.6 148.22 26.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.798 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -152.1 -51.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.05 -175.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.442 ' O ' HG11 ' A' ' 123' ' ' VAL . 3.3 p 41.12 90.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.663 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 p -140.04 -56.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -107.86 -35.99 6.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.9 m -63.97 164.43 17.49 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.7 -161.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.78 2.32 . . . . 0.0 112.367 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.411 ' HB2' ' HA ' ' A' ' 182' ' ' LEU . 6.7 p90 -111.84 -54.97 2.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.959 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.2 -102.18 1.0 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.078 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.506 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 3.7 p30 -143.92 163.37 36.0 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.673 0.273 . . . . 0.0 110.976 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.612 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.46 138.42 80.37 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.951 2.434 . . . . 0.0 112.96 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.657 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 138.81 -29.57 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 O-C-N 124.033 0.833 . . . . 0.0 112.314 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 12.3 Cg_exo -68.09 62.46 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.481 2.121 . . . . 0.0 112.842 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.54 129.42 25.18 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.283 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.03 -44.25 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -90.15 9.0 30.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.437 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.06 -44.65 9.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.754 0.312 . . . . 0.0 110.994 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 pp -41.17 -36.81 0.79 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.833 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.78 65.73 3.87 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.766 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 90.6 t -152.79 -66.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.686 0.279 . . . . 0.0 111.019 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.4 -175.11 13.94 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.445 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -162.68 160.72 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 m -163.17 133.38 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.7 -45.47 8.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.01 114.64 2.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.322 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -174.03 -168.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.025 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.467 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . . . -56.83 -178.78 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.895 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 147' ' ' ALA . 95.3 Cg_exo -44.68 89.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.674 2.249 . . . . 0.0 112.648 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 154.78 55.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 225' ' ' GLU . 7.3 t -101.48 -163.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.513 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 220' ' ' THR . 34.0 ptt180 -107.4 107.61 18.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.471 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.1 p -41.6 -30.55 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.03 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 151' ' ' ARG . 23.3 pt -53.45 -42.09 47.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.909 0.385 . . . . 0.0 111.128 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.878 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.72 80.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.155 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -172.21 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.4 t -93.85 -3.62 51.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.47 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 38.9 m -94.05 37.6 1.09 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.756 0.312 . . . . 0.0 111.327 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 11.2 ttt 57.67 61.45 5.95 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.854 0.359 . . . . 0.0 111.235 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.73 170.69 6.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.814 2.342 . . . . 0.0 112.414 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.5 mtt85 -152.15 -47.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -170.02 89.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.59 -172.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.501 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 12.2 mtp85 -124.39 -170.95 2.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.076 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -147.69 79.89 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 110.426 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 1.3 m -160.48 98.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.085 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.627 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 170.34 110.84 0.01 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.22 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 167' ' ' GLN . 12.7 mt 109.53 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.363 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 168' ' ' ILE . 22.4 t-20 49.9 164.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.88 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 171.32 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.571 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 66.4 mt 63.5 -64.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.0 m-85 -47.31 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.426 ' O ' ' CG2' ' A' ' 174' ' ' VAL . 11.7 mm100 -64.98 116.51 6.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 173' ' ' GLN . 77.1 t -161.17 80.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -106.18 98.73 8.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.123 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -166.03 113.27 0.9 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.83 -26.66 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.146 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -72.3 -30.71 65.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.026 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -90.16 20.64 4.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.486 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.9 m -57.36 -33.37 67.71 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.79 0.329 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -72.25 -42.53 65.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.586 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 128' ' ' PHE . 9.5 mp -71.14 -14.83 62.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.942 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.8 -27.99 60.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.032 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.1 -43.07 51.41 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.6 -31.12 71.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 187' ' ' ILE . 30.5 m-20 67.43 13.67 9.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.545 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.539 ' HA ' ' CB ' ' A' ' 131' ' ' PRO . 6.1 pt 33.95 100.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -102.52 90.69 3.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.668 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' A' ' 165' ' ' ILE . 10.6 p -59.83 115.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 136.59 -8.4 3.97 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.823 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 t -83.66 -169.33 2.51 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.788 0.328 . . . . 0.0 111.061 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -135.54 122.27 20.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 33.5 m -120.56 -179.11 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.45 164.65 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.717 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.1 mp -128.97 153.27 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.182 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 8.8 m -154.26 110.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.96 157.79 37.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.98 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -159.21 118.5 2.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 6.5 t70 69.73 -66.86 0.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -179.64 49.86 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -156.45 149.73 24.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -102.19 133.59 45.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 30.4 p -142.83 129.37 20.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.98 105.01 10.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.811 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 209' ' ' LYS . 2.4 m -86.09 120.23 27.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 208' ' ' GLY . 21.9 t-80 -176.01 166.49 2.98 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 111.644 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.0 m120 40.69 -90.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.852 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -67.9 -71.3 0.97 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.606 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 205' ' ' SER . 2.4 ptpt -161.76 -63.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -152.93 174.28 14.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.543 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.928 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -112.04 55.73 0.67 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 111.226 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.25 173.05 11.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.609 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.04 164.79 12.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.954 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.17 -37.95 75.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.515 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.01 -45.1 95.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 3.0 mp -60.34 -37.78 81.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.72 14.12 14.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.755 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -67.85 70.57 0.14 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.964 0.411 . . . . 0.0 111.047 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 151' ' ' ARG . 6.5 p 59.13 85.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.289 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.407 ' HA ' ' CD1' ' A' ' 168' ' ' ILE . 0.8 OUTLIER -118.94 -147.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.627 ' HA ' ' CB ' ' A' ' 167' ' ' GLN . 6.3 ptt180 -84.95 88.41 7.44 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 222' ' ' ARG . 3.3 mp -151.42 151.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.256 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 2.3 tm-20 -89.85 159.03 17.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.633 0.254 . . . . 0.0 110.363 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.43 ' HA ' HG22 ' A' ' 150' ' ' THR . 0.5 OUTLIER -89.25 104.55 17.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.955 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.312 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.573 0.225 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 p -90.35 -45.52 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.699 0.285 . . . . 0.0 111.409 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -84.18 100.26 11.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -80.95 76.81 7.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -88.54 66.16 8.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -143.62 -51.59 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.3 m -69.81 148.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -112.99 -40.03 4.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.49 163.23 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.26 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.8 tt -94.53 118.4 31.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -147.08 173.91 12.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -152.57 152.33 31.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.98 101.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -167.01 -179.03 4.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -71.81 -37.9 70.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.3 p -164.33 79.45 1.43 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.22 -162.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.748 2.299 . . . . 0.0 112.18 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.0 p90 42.0 91.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.76 161.21 34.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.76 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER 61.91 144.61 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 120.611 0.243 . . . . 0.0 110.953 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 187' ' ' ILE . 1.9 Cg_endo -86.33 105.01 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.116 2.544 . . . . 0.0 112.658 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.49 ' CB ' ' HD3' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -164.83 -57.77 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' A' ' 132' ' ' ILE . 5.1 Cg_endo -85.08 121.82 2.44 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.727 2.284 . . . . 0.0 113.98 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.469 ' HA2' ' CD1' ' A' ' 187' ' ' ILE . . . -91.86 170.99 33.95 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.193 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.826 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -69.66 128.62 37.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -26.78 66.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.552 1.158 . . . . 0.0 113.03 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 135' ' ' LEU . 26.5 tt0 -90.63 -55.35 3.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.6 -16.91 27.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.59 -1.187 . . . . 0.0 109.744 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 116.08 8.67 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.792 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.44 -41.73 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.605 0.24 . . . . 0.0 111.249 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.19 86.74 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.655 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.34 -178.23 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.704 0.287 . . . . 0.0 110.787 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.9 p -76.6 -43.78 37.17 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.577 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.94 -178.01 1.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.07 -86.6 0.53 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.112 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.98 138.81 31.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.63 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.458 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . . . 57.54 -179.6 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.325 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 147' ' ' ALA . 53.8 Cg_exo -52.33 -176.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.244 1.963 . . . . 0.0 112.001 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 223' ' ' ILE . . . 162.77 140.32 2.84 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.382 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 155' ' ' ALA . 6.2 t -176.66 -33.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 150' ' ' THR . 4.7 tmm_? -20.08 -55.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 218' ' ' ALA . 0.0 OUTLIER -94.22 -44.78 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.658 0.266 . . . . 0.0 111.658 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -109.41 109.45 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.318 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' ILE . 58.3 m-20 98.58 -38.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.067 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.565 ' N ' ' OG1' ' A' ' 150' ' ' THR . . . -36.74 -46.88 0.63 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.11 65.56 3.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 m -162.9 -45.99 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.5 43.07 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.9 mtt 53.02 74.31 0.79 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.288 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.73 139.88 92.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.874 2.383 . . . . 0.0 112.663 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.26 -43.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -162.19 120.79 2.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.69 128.68 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.452 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 223' ' ' ILE . 12.3 mtt180 -80.02 123.21 27.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.489 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.597 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -90.34 124.27 42.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.327 . . . . 0.0 110.262 178.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 167' ' ' GLN . 21.4 t -144.61 87.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.966 0.412 . . . . 0.0 111.621 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 4.6 tt0 91.91 105.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.335 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.417 ' HA ' ' CG2' ' A' ' 221' ' ' ILE . 2.4 pp -142.1 -45.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -74.27 159.74 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 5.0 tt0 -104.48 -42.38 5.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.679 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 94.0 mt 69.12 -64.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.596 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -54.46 -34.79 62.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.248 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -99.16 127.4 45.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.9 p -168.12 96.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -138.01 -43.52 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.67 122.34 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.67 -25.66 59.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.15 -26.98 68.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -82.6 -6.2 59.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.424 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.3 m -56.34 -41.25 75.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.76 0.314 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.2 -35.82 81.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.49 -26.73 46.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 -23.72 63.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.1 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -32.98 61.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -68.01 -31.76 71.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' ILE . 13.9 m-20 83.83 -29.14 0.09 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.631 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 7.4 pt 39.89 103.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.315 0.579 . . . . 0.0 111.946 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -114.6 108.96 17.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 35.2 m -52.69 157.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.251 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 101.99 -15.96 56.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.302 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.7 t -74.55 -166.99 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.01 0.433 . . . . 0.0 111.301 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.29 136.86 20.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.61 175.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.967 0.413 . . . . 0.0 111.801 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -125.7 162.85 24.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.84 140.97 41.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.389 . . . . 0.0 110.856 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.0 m -154.25 118.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.023 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -70.0 159.25 34.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -168.91 143.18 3.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.0 t70 68.08 -70.53 0.12 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 175.19 43.03 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.05 165.71 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 tt -87.24 150.3 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.136 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.0 t -160.05 116.96 2.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.0 106.22 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.676 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.0 m -85.73 129.41 34.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -143.94 145.55 32.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -33.39 -40.02 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -62.65 -70.58 1.01 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.26 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.8 mtmt -158.87 -174.66 4.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.44 133.51 53.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.175 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.75 159.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.481 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -83.18 -58.3 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.7 mt 64.2 151.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.205 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.42 -175.59 4.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.716 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -28.95 67.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.394 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -67.61 0.24 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.82 -34.29 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.063 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.449 ' HA ' ' HB ' ' A' ' 152' ' ' VAL . . . -90.73 33.94 0.91 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.602 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -56.43 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 220' ' ' THR . 13.5 t -174.67 72.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.021 0.439 . . . . 0.0 111.162 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.417 ' CG2' ' HA ' ' A' ' 168' ' ' ILE . 4.9 mm -89.55 171.72 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.422 ' HB3' ' HB3' ' A' ' 167' ' ' GLN . 53.6 ttt180 -89.71 99.64 12.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 111.612 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.597 HG23 ' HA ' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -129.79 -149.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -118.85 -179.52 3.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 110.803 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 226' ' ' LEU . 30.3 tt0 -111.78 96.21 5.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 225' ' ' GLU . 1.7 pt? . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.77 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.761 0.315 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.16 -41.75 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.27 18.37 6.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -90.05 -51.94 5.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.44 147.96 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.5 mt -147.87 113.24 5.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -112.77 -37.48 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.307 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -109.3 172.37 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 m -89.63 -37.68 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.24 -58.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -78.1 157.8 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.975 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.66 -46.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.1 t 61.42 105.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.0 m -138.81 90.11 2.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.48 80.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m 59.27 86.12 0.17 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.37 -25.57 18.21 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.594 2.196 . . . . 0.0 112.338 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . 0.401 ' CG ' ' HB3' ' A' ' 181' ' ' GLN . 3.9 p90 -114.02 144.0 43.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.732 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.17 -98.83 0.16 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.811 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -56.31 153.75 18.43 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.758 0.313 . . . . 0.0 111.234 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.589 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 89.1 Cg_endo -81.83 137.57 10.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.892 2.395 . . . . 0.0 112.87 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.643 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 143.1 -30.99 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 O-C-N 123.922 0.763 . . . . 0.0 111.859 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 2.7 Cg_exo -73.53 63.34 4.59 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.362 2.042 . . . . 0.0 112.326 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.55 81.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.4 tp -70.86 -39.39 72.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.348 . . . . 0.0 110.803 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.11 8.63 31.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -88.94 -170.99 3.12 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.709 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 84.6 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.845 0.355 . . . . 0.0 111.126 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.49 32.26 5.09 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.913 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.1 t -128.82 116.5 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.689 0.281 . . . . 0.0 111.179 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.69 -172.33 16.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -175.4 166.43 3.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.728 0.299 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -137.35 -174.34 3.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.059 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.13 -43.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.119 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 146' ' ' ALA . . . -158.6 -157.93 0.66 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 145' ' ' ALA . . . 85.77 -179.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.499 ' CB ' ' HD2' ' A' ' 148' ' ' PRO . . . -56.71 -176.66 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 147' ' ' ALA . 68.4 Cg_exo -41.31 98.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.757 2.305 . . . . 0.0 112.928 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.74 41.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.079 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.6 t -80.6 -7.19 59.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 4.4 mpt_? 60.56 25.96 15.63 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 154' ' ' ASP . 21.4 t 70.68 -58.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.535 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.4 tt -55.41 79.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.999 0.428 . . . . 0.0 111.39 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 167.7 -35.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.382 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -52.27 -25.28 9.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.598 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -98.73 32.9 2.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.372 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.0 t -170.96 32.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.352 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.4 t -153.06 34.46 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.195 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 41.2 ttm 66.44 75.29 0.33 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.008 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . 0.403 ' HA ' ' CD2' ' A' ' 226' ' ' LEU . 29.0 Cg_endo -62.83 152.85 76.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.843 2.362 . . . . 0.0 112.799 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 -45.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -170.2 124.97 0.75 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.4 m -110.28 123.0 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 111.488 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -84.22 102.09 12.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -79.47 122.25 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.649 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.596 ' O ' ' CB ' ' A' ' 167' ' ' GLN . 20.4 t -144.39 85.86 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.596 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 33.4 tt0 103.54 147.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.074 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -149.59 -66.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.08 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -177.96 -168.52 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.543 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.03 -77.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.87 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.105 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -163.7 -55.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.862 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -163.85 -65.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.541 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 0.4 OUTLIER 72.0 107.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.292 0.568 . . . . 0.0 110.784 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 55.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.954 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 t -161.75 130.12 4.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -22.43 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -60.96 -31.49 71.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -76.09 -17.17 59.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.322 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 84.8 m -51.85 -43.84 63.39 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . 0.401 ' HB3' ' CG ' ' A' ' 128' ' ' PHE . 55.4 mt-30 -70.83 -33.02 70.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.58 -25.05 59.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.3 tp -84.48 -2.71 57.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.573 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.25 -50.25 30.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.057 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -82.9 -23.37 33.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.129 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 187' ' ' ILE . 9.3 m-20 65.89 16.2 10.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 187' ' ' ILE . 24.0 pt 38.15 99.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.1 0.476 . . . . 0.0 111.988 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 134.49 42.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.93 141.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 165' ' ' ILE . . . 104.54 -8.65 47.83 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.4 t -70.23 174.92 5.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -132.33 111.88 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.676 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.59 176.94 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.362 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -142.13 160.76 39.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.448 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 1.8 tt -134.62 155.7 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 111.152 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.448 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 7.1 m -156.92 132.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.27 145.55 35.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -157.35 116.6 3.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.143 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 51.99 40.76 28.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.88 62.15 6.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.459 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -159.48 158.47 32.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.77 0.319 . . . . 0.0 110.82 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.42 141.79 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.3 t -159.9 111.42 2.0 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.19 98.4 8.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.7 m -77.07 110.15 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -107.62 147.21 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.511 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -41.33 -34.4 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.296 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -77.25 -57.49 3.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.496 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -160.68 -175.19 4.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.687 0.279 . . . . 0.0 110.875 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.6 149.0 31.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.71 175.64 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.7 -66.56 0.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 7.8 mp 60.55 155.63 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 111.36 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.69 -175.45 4.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.68 -29.13 70.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.998 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -45.58 11.84 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.808 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -69.74 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.52 49.78 1.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -84.65 -38.78 19.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -156.55 90.37 1.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.891 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.47 ' HB ' HD12 ' A' ' 223' ' ' ILE . 23.8 mm -118.96 162.15 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.011 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -89.66 90.35 8.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 111.268 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.47 HD12 ' HB ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -137.62 175.16 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.124 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -89.64 162.78 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 110.824 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -89.66 56.04 3.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 160' ' ' PRO . 6.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.746 0.307 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.81 -46.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.34 48.86 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.13 -41.24 11.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.054 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -85.54 144.0 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mp -145.08 112.71 6.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.842 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -150.38 168.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.15 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -133.48 100.29 4.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.7 t -144.34 -44.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tt 65.39 46.41 2.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -100.08 -46.46 5.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.27 147.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.1 p -168.26 125.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.4 t -169.71 157.68 7.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -86.09 83.71 7.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.65 7.97 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.82 -19.26 8.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.705 2.27 . . . . 0.0 112.644 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 62.51 110.62 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -166.37 -150.78 6.49 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.701 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 8.1 p30 53.95 159.18 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.301 0 CA-C-O 120.966 0.412 . . . . 0.0 111.843 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.646 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 83.2 Cg_endo -78.84 137.12 13.83 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.824 2.349 . . . . 0.0 111.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 160.44 -31.03 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 23.8 Cg_exo -63.65 118.54 5.46 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.634 1.556 . . . . 0.0 112.986 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.23 -32.77 8.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.448 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 pp -36.59 -37.31 0.13 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.51 -50.76 71.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.207 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 138' ' ' LEU . 2.1 pm0 -90.67 -21.3 21.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.634 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 137' ' ' GLU . 6.5 tt -29.57 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.443 . . . . 0.0 112.018 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.35 -93.15 1.23 Allowed Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.427 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.8 t -145.46 42.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 111.181 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.36 -149.23 1.22 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.236 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.48 177.84 0.56 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.6 p -156.86 -173.47 4.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.778 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.91 74.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.48 -69.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.37 -62.4 1.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.41 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . . . -176.18 -63.01 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.073 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 147' ' ' ALA . 7.1 Cg_exo -33.94 97.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.219 2.613 . . . . 0.0 113.188 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 97.82 112.41 3.07 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.797 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.415 ' HA ' ' CG2' ' A' ' 153' ' ' ILE . 2.8 t 175.92 78.3 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.618 ' HB2' ' HB ' ' A' ' 221' ' ' ILE . 11.0 tpp180 -78.84 92.61 4.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 151' ' ' ARG . 8.1 p 48.91 20.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.461 ' O ' ' CG1' ' A' ' 153' ' ' ILE . 2.9 tt -106.32 10.55 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 121.221 0.534 . . . . 0.0 110.312 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.9 -35.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . . . -88.41 43.72 1.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.76 33.54 1.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.15 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.6 p -158.08 -41.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.088 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.2 84.85 3.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.407 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.2 mtt 57.36 61.31 6.35 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.645 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.2 124.74 14.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.848 2.365 . . . . 0.0 112.407 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -157.0 -47.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -159.98 148.82 17.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.43 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.465 ' HB ' HG23 ' A' ' 223' ' ' ILE . 15.4 m -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.444 . . . . 0.0 111.792 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 13.3 mtp85 -82.2 109.37 16.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.455 ' HA ' HG22 ' A' ' 223' ' ' ILE . 0.4 OUTLIER -84.13 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.978 0.418 . . . . 0.0 111.737 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.45 42.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.867 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.47 ' O ' ' CB ' ' A' ' 222' ' ' ARG . 59.0 mt-30 39.56 -108.9 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.482 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -172.36 -64.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.853 0.358 . . . . 0.0 110.527 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -138.15 -62.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -171.68 -75.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.011 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -176.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.1 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -163.94 -64.49 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . 0.456 ' O ' HG13 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -117.98 -83.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 173' ' ' GLN . 0.4 OUTLIER 68.95 13.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.06 94.41 5.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.797 0.332 . . . . 0.0 111.077 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.67 115.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.91 -41.25 95.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.1 -33.82 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -90.14 5.94 44.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.278 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.2 m -57.47 -26.79 61.77 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.45 -36.88 85.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.74 -33.27 64.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.0 mt -78.0 -28.76 49.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.52 -34.48 61.79 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 186' ' ' ASP . . . -76.4 -14.66 60.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.283 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 187' ' ' ILE . 11.4 m-20 81.09 -47.48 0.25 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.53 ' HA ' ' HB3' ' A' ' 131' ' ' PRO . 2.3 pt 53.76 125.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 174.95 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.43 147.21 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.95 65.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.536 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.412 ' N ' HG23 ' A' ' 165' ' ' ILE . 6.1 t -66.75 -169.1 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.035 0.445 . . . . 0.0 111.203 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.4 97.06 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.91 -178.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.84 177.98 9.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.12 169.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.5 m -150.14 98.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -71.64 98.37 1.89 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -70.01 -177.65 1.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.27 -26.44 66.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.32 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.517 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -158.96 139.8 12.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.992 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.0 tt -97.81 130.93 45.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.2 t -160.01 145.98 15.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.914 0.387 . . . . 0.0 111.234 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.98 169.58 9.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.656 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.9 m -148.96 136.7 20.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -153.12 157.24 40.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -51.04 97.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 141.37 -64.71 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.32 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -160.04 173.2 16.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 111.061 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.52 153.28 26.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.22 161.63 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.94 -63.03 1.5 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 3.7 mp 53.81 93.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.369 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.66 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -69.64 -33.48 72.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.412 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -56.42 12.12 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.729 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -69.65 -39.16 77.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.417 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.417 ' O ' ' HB ' ' A' ' 153' ' ' ILE . . . -90.5 33.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.313 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -90.57 -58.69 2.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.623 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 71.5 p -149.25 71.23 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.481 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 151' ' ' ARG . 30.1 mm -98.8 166.26 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.385 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.579 ' HA ' ' HA2' ' A' ' 149' ' ' GLY . 13.8 ttt180 -100.97 101.04 11.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.481 HD11 ' HB ' ' A' ' 221' ' ' ILE . 1.9 mp -147.23 171.87 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 1.5 tm-20 -89.12 167.82 12.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.332 . . . . 0.0 110.728 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 33.3 tt0 -89.55 81.53 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.352 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.791 0.329 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.1 m -65.23 -49.09 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.268 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -90.45 52.8 2.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -89.94 -36.94 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -84.31 140.03 31.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.2 mt -111.75 151.32 29.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -155.07 146.85 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.72 -49.35 7.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.89 172.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.52 92.2 2.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -130.26 123.76 30.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.71 163.88 23.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 m -69.84 161.53 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -83.38 73.76 10.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -154.23 -51.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 m -143.4 108.55 5.25 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.62 -29.8 62.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.552 2.168 . . . . 0.0 112.513 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -125.96 169.22 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 211' ' ' VAL . . . -92.0 -134.42 6.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.459 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.642 ' CB ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER -123.52 -60.97 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.547 0.213 . . . . 0.0 111.513 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.642 ' HD3' ' CB ' ' A' ' 130' ' ' ASN . 3.3 Cg_exo -84.82 56.34 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.495 2.797 . . . . 0.0 112.072 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.564 ' O ' ' CG2' ' A' ' 132' ' ' ILE . 0.1 OUTLIER 36.81 68.72 1.44 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.886 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.94 138.49 42.79 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.998 2.466 . . . . 0.0 112.639 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' CG2' ' A' ' 168' ' ' ILE . . . -90.83 78.53 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.051 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.88 -46.16 25.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.929 0.395 . . . . 0.0 110.44 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.56 4.09 52.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.051 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.7 -167.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tt -80.44 59.73 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.785 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.32 95.91 1.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.611 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.53 -59.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.093 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.78 -178.87 40.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.594 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.14 168.82 23.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.8 m -120.48 148.73 43.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.998 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.18 -44.77 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.785 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.59 -164.78 1.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.962 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 69.75 132.07 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.522 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -74.59 -46.92 5.53 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 12.5 Cg_exo -35.65 -38.81 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.976 2.451 . . . . 0.0 113.367 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -153.08 132.79 3.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.821 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' A' ' 225' ' ' GLU . 8.8 t -104.66 -26.44 12.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 153' ' ' ILE . 3.7 tpp180 66.95 63.54 0.47 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.538 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.0 OUTLIER 43.62 -82.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.178 179.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 151' ' ' ARG . 3.1 tt -51.29 82.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.949 0.404 . . . . 0.0 111.285 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 158.84 -40.51 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.026 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.63 -18.49 64.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.247 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -106.21 32.22 4.59 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.468 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.0 t -154.02 19.47 0.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.463 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -134.2 -66.85 0.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.739 0.304 . . . . 0.0 110.836 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 25.2 ttm -167.48 56.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.634 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.83 146.26 28.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.172 2.581 . . . . 0.0 112.818 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -161.77 -50.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.487 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -170.33 84.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 223' ' ' ILE . 19.3 m -70.16 143.52 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.443 ' HB2' ' CB ' ' A' ' 224' ' ' GLU . 6.3 mtt85 -90.36 106.94 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.76 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.519 ' HA ' HG22 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -77.4 143.24 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.455 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.79 -40.05 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -131.46 129.28 40.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.828 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.454 HG12 ' CD1' ' A' ' 165' ' ' ILE . 15.1 mm -146.52 -42.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.05 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -51.7 167.11 0.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -93.64 -175.27 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.66 -56.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.17 -66.48 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -88.91 170.36 10.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.7 p -168.77 -40.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.263 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.8 98.38 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.5 p -153.87 138.65 17.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.18 73.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -62.36 -26.19 68.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.189 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -90.07 -31.92 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -54.22 -38.21 65.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.975 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -28.12 69.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.87 -34.24 57.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.901 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.48 -32.25 73.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.0 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -25.07 20.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.06 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -57.39 -21.01 33.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.608 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 7.3 t70 65.42 85.19 0.14 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.761 0.315 . . . . 0.0 110.759 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.498 ' CG2' ' HA ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 166.39 144.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.577 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . 0.405 ' HA ' HG23 ' A' ' 132' ' ' ILE . 11.2 mpt_? -115.53 -87.82 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.962 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.446 HG12 HD11 ' A' ' 165' ' ' ILE . 33.8 m -155.43 169.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.75 -13.44 62.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.179 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' SER . . . . . 0.401 ' N ' HG21 ' A' ' 165' ' ' ILE . 5.4 t -68.56 -167.44 0.09 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.278 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -141.11 92.07 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.471 ' HA ' ' CG ' ' A' ' 206' ' ' HIS . 31.0 m -100.06 148.03 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.628 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -95.48 161.31 14.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.652 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.9 156.35 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.138 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.42 133.07 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.35 95.21 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.025 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -74.21 178.91 4.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.44 86.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 65.96 44.7 91.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.642 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -161.78 139.33 8.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.929 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . 0.472 HD13 HG22 ' A' ' 202' ' ' ILE . 0.1 OUTLIER -97.27 126.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.07 137.72 9.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.0 178.7 8.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -150.4 93.46 1.99 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.769 0.319 . . . . 0.0 111.259 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 208' ' ' GLY . 2.1 t60 178.66 -169.64 0.1 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 60.51 -72.2 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -118.62 -52.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.959 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -160.59 -77.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.756 0.312 . . . . 0.0 110.428 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -142.21 160.76 39.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . 0.421 HG13 ' HA3' ' A' ' 129' ' ' GLY . 10.8 t -114.69 142.97 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 213' ' ' LEU . 7.0 mm-40 -79.73 -51.86 8.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . 0.468 ' C ' ' O ' ' A' ' 212' ' ' GLU . 0.5 OUTLIER 23.14 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.164 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.14 161.72 10.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.87 -30.67 46.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.322 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -54.29 -53.92 47.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.972 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -40.99 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.038 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.41 -21.44 15.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.026 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -82.65 -16.65 47.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.301 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.2 t -141.7 80.82 1.74 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 221' ' ' ILE . 36.9 mt -126.51 159.62 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.86 107.6 20.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 112.161 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -148.04 168.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.678 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.443 ' CB ' ' HB2' ' A' ' 164' ' ' ARG . 3.4 tt0 -89.73 169.55 11.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.645 0.259 . . . . 0.0 110.452 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 22.8 tt0 -89.53 125.45 35.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.316 179.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.752 0.311 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.8 m -69.53 -42.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.91 70.68 5.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 52.2 2.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -70.9 132.9 45.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 tp -157.61 -51.7 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 m -90.75 157.48 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.216 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -88.13 -38.68 15.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.38 140.04 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.53 125.68 39.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -131.73 155.51 47.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -148.01 130.45 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.91 140.76 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.7 t 61.37 173.51 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -158.0 103.46 1.86 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.47 -61.92 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.46 106.83 2.35 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.474 2.116 . . . . 0.0 112.567 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -139.99 44.38 1.91 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.19 120.38 2.33 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.247 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 2.0 p-10 -175.15 163.31 2.28 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.502 ' O ' ' C ' ' A' ' 132' ' ' ILE . 5.3 Cg_endo -47.15 140.79 13.83 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.97 2.447 . . . . 0.0 112.908 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 131' ' ' PRO . 0.2 OUTLIER -6.86 84.01 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.064 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.31 142.75 74.24 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.04 2.493 . . . . 0.0 111.729 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.455 ' HA3' HG12 ' A' ' 221' ' ' ILE . . . -90.45 29.47 6.66 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.873 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.7 tt -79.03 -56.3 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.104 0.478 . . . . 0.0 110.198 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.19 12.02 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.229 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -87.04 -149.28 0.15 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.95 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.09 84.61 6.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.574 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 217' ' ' LEU . . . -90.33 111.42 3.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.248 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.76 -46.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.621 0.248 . . . . 0.0 111.477 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . 0.4 ' HA2' ' CG ' ' A' ' 219' ' ' HIS . . . 134.26 115.45 1.56 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.549 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.49 -173.06 0.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.825 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.76 122.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.07 -46.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.543 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.96 -173.99 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 62.05 -83.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.418 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -179.15 -59.55 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.49 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 5.1 Cg_exo -31.36 133.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.363 2.709 . . . . 0.0 113.546 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.82 125.94 0.04 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.688 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -167.97 -151.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.462 0.172 . . . . 0.0 110.876 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.48 ' HB2' ' CG2' ' A' ' 223' ' ' ILE . 36.4 ttp180 69.02 -70.15 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.264 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -95.25 -17.79 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.413 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.576 ' O ' ' CB ' ' A' ' 154' ' ' ASP . 0.1 OUTLIER -133.54 107.09 10.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.642 0.258 . . . . 0.0 111.419 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . 0.576 ' CB ' ' O ' ' A' ' 153' ' ' ILE . 15.7 t70 99.12 -37.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -48.33 -32.18 7.07 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.03 -54.71 41.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.546 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.9 t -63.23 -28.73 70.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.0 m -71.99 -155.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.09 71.12 1.35 Allowed Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.712 0.291 . . . . 0.0 111.147 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -38.32 132.48 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.261 2.641 . . . . 0.0 113.148 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -170.0 -49.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -170.17 84.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.651 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.445 ' HB ' ' CG2' ' A' ' 223' ' ' ILE . 31.3 m -69.95 -178.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.133 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 8.9 mtp85 -124.31 -167.7 1.69 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.529 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 28.4 mm -142.37 124.83 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.796 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 t -152.11 68.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.638 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . 14.5 tt0 44.77 -94.13 0.02 OUTLIER 'General case' 0 C--O 1.246 0.888 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 222' ' ' ARG . 48.6 mm 77.59 -5.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 36.2 p30 -157.9 -178.81 7.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.744 0.306 . . . . 0.0 111.139 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.09 -88.71 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.164 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.14 -55.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.683 0.278 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.5 t80 63.55 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -104.63 171.74 7.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.829 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 p -172.55 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.969 0.414 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.43 -173.33 4.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.645 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.4 p -128.0 -81.72 0.59 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.191 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.03 -43.78 86.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.453 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -67.86 -36.73 80.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.14 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -90.21 7.54 37.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.6 m -65.59 -48.4 72.44 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.43 -34.41 65.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.8 -23.96 67.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.2 mt -90.06 -32.09 16.87 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -19.27 10.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.526 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . 0.434 ' CB ' ' N ' ' A' ' 130' ' ' ASN . . . -81.6 11.9 4.29 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 62.35 100.93 0.03 OUTLIER 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.426 ' CA ' HG12 ' A' ' 132' ' ' ILE . 2.7 pt -83.51 87.14 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.401 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -125.0 107.81 11.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.691 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.49 ' HA ' HG23 ' A' ' 165' ' ' ILE . 18.3 m -56.77 156.91 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.05 -6.9 66.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.087 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.5 t -66.25 -170.43 0.09 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.038 0.446 . . . . 0.0 111.525 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.34 136.21 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.716 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . 0.406 HG12 ' CD2' ' A' ' 206' ' ' HIS . 35.5 m -138.92 -174.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.045 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.11 161.34 33.53 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.835 0.35 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 196' ' ' VAL . 0.3 OUTLIER -121.19 153.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.786 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.412 ' N ' HG13 ' A' ' 195' ' ' ILE . 13.5 p -141.89 141.4 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.36 91.6 8.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -70.12 -179.71 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.78 92.92 3.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.17 35.0 91.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.673 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -163.45 143.31 8.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.763 0.315 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.9 tt -98.48 111.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.6 t -120.69 133.97 55.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.32 120.9 31.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.7 m -102.44 140.28 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 207' ' ' ASN . 26.3 t-80 -158.71 145.0 16.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' HIS . 21.2 m120 -28.56 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.441 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -56.99 -76.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.093 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.1 mtmt -160.2 -174.51 4.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.91 133.93 48.05 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.86 148.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 111.588 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.39 -9.23 59.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.973 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 5.5 mp -36.99 106.92 0.05 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.784 0.326 . . . . 0.0 111.439 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 mp -93.34 -176.52 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 0.7 OUTLIER -63.08 -14.54 49.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.291 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.39 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 111.227 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 2.5 mm? -86.28 -24.06 26.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.343 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 152' ' ' VAL . . . -90.41 35.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.538 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 0.9 OUTLIER -85.86 -7.22 58.85 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.358 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 4.6 t -179.09 90.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.196 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.475 ' HB ' HD11 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -126.42 -163.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.638 ' HB3' ' CA ' ' A' ' 167' ' ' GLN . 0.4 OUTLIER -84.39 88.95 7.3 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 1.7 mp -151.76 144.41 16.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 164' ' ' ARG . 15.4 tt0 -89.86 161.15 16.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.3 118.61 29.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.086 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.288 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.749 0.309 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.66 -41.98 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -66.07 93.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -73.23 73.83 1.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.07 92.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.014 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mt -166.71 166.02 16.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -151.04 146.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -149.65 -48.38 0.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.9 t -146.76 -68.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.039 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 tp -172.75 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.24 176.07 5.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -139.21 -58.04 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.6 p -164.53 123.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t -166.7 164.8 16.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -114.91 -42.02 3.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.0 p -145.08 64.6 11.19 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.47 70.2 6.37 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.719 2.28 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -164.09 38.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -131.17 -175.24 13.93 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.65 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 1.8 p-10 50.62 166.51 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 122.273 0.229 . . . . 0.0 111.148 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 43.5 Cg_exo -23.07 139.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.31 3.34 . . . . 0.0 113.856 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.7 tt -46.45 121.99 6.58 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.17 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.2 140.16 12.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.771 2.314 . . . . 0.0 111.828 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.52 68.66 2.36 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.306 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.6 -65.77 0.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.98 3.43 54.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.168 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.438 ' HG2' HD11 ' A' ' 168' ' ' ILE . 2.6 mt-10 -77.71 -47.46 19.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.52 0.2 . . . . 0.0 111.331 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.7 pp -41.91 -31.8 0.37 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.805 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -40.81 -34.56 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.153 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.68 103.36 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 111.003 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 128.15 172.92 13.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.4 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.425 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 9.6 p30 -156.9 150.35 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -138.72 98.64 3.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.02 -53.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.45 153.0 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 61.17 174.73 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.119 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -73.39 -57.49 2.71 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 7.6 Cg_exo -33.68 109.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.175 2.583 . . . . 0.0 113.216 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 95.52 137.6 9.22 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.598 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' THR . . . . . 0.425 HG22 ' HB ' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -179.14 -80.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.535 0.207 . . . . 0.0 111.431 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ARG . . . . . 0.513 ' CB ' ' HB ' ' A' ' 221' ' ' ILE . 5.0 tpt180 70.08 38.98 1.42 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.958 0.409 . . . . 0.0 110.609 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER 82.68 2.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.903 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 150' ' ' THR . 2.9 tp -92.78 25.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 120.749 0.309 . . . . 0.0 111.369 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 170.46 -36.43 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.797 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.4 -21.16 65.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . 0.409 ' HA ' HD13 ' A' ' 195' ' ' ILE . . . -86.73 56.31 3.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -166.34 -43.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 83.91 5.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 66.8 mtt 59.49 62.59 3.79 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.285 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 124.61 11.05 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.697 2.265 . . . . 0.0 112.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -153.08 -48.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -164.61 113.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . 0.432 ' HB ' HG22 ' A' ' 223' ' ' ILE . 21.5 m -89.54 132.66 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.236 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ARG . . . . . 0.536 ' O ' HG21 ' A' ' 223' ' ' ILE . 13.8 mtt180 -79.88 98.24 7.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.283 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.49 HG12 ' CD1' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -70.72 124.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.698 0.285 . . . . 0.0 110.888 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -160.87 98.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.404 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 166' ' ' VAL . 16.9 mt-30 93.15 137.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.872 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ILE . . . . . 0.438 HD11 ' HG2' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -143.74 -48.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.835 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 172.69 -85.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.512 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.63 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.701 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.16 -60.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.9 t80 61.49 -81.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -116.63 134.89 54.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.972 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.3 p -163.26 94.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.04 -42.72 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.267 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.7 t -59.79 144.02 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.35 -33.33 71.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -31.73 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.391 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -90.06 -29.24 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.068 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.3 m -54.45 -32.01 56.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -71.37 -35.59 71.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 9.1 mp -55.78 -30.33 61.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.72 -31.88 46.6 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.824 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -23.78 3.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.103 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -51.9 -26.1 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.186 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.8 t70 57.84 78.47 0.24 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.267 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ILE . . . . . 0.475 ' CD1' ' N ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 178.98 160.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -144.61 172.58 12.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.479 ' HA ' HG21 ' A' ' 165' ' ' ILE . 24.6 m -54.21 174.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.839 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.69 -15.13 61.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.6 t -86.95 -164.7 1.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.394 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -132.2 86.62 2.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.397 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.23 175.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.89 168.17 20.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 156' ' ' ALA . 2.9 pp -139.96 167.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.333 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 m -154.94 142.19 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.005 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -70.08 85.02 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -78.89 88.91 4.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.209 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.26 54.77 9.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.339 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.41 39.07 96.77 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.654 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.19 145.0 31.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.736 0.303 . . . . 0.0 110.739 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 30.3 pt -80.0 139.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.241 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.6 t -160.17 129.95 5.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.822 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.02 151.38 23.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.616 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 43.5 m -143.44 123.08 13.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -174.87 168.79 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.6 t30 67.4 -69.92 0.13 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.449 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 172.76 29.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.231 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.7 165.5 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.47 146.46 39.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.522 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.85 163.57 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.94 -65.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.381 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 6.6 mp 36.0 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.778 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.95 -169.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.391 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -55.22 -25.09 30.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.998 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -57.26 6.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.963 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.36 -49.98 67.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.191 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.21 47.2 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.65 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -90.16 -43.09 10.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.708 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 142' ' ' ASN . 3.0 p -155.39 70.13 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ILE . . . . . 0.513 ' HB ' ' CB ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -106.94 165.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' ARG . . . . . 0.481 ' N ' ' CG2' ' A' ' 221' ' ' ILE . 33.6 mtt-85 -101.8 92.57 4.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 164' ' ' ARG . 3.8 mm -124.21 -162.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' GLU . . . . . 0.481 ' H ' ' CG2' ' A' ' 223' ' ' ILE . 12.8 tm-20 -112.14 133.22 54.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.943 0.338 . . . . 0.0 110.511 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.67 109.31 20.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.244 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.471 -0.252 . . . . 8.82 112.471 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.2 m -129.77 60.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 7.49 110.834 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.6 m80 59.61 -88.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 9.03 110.903 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.4 mtt 48.33 86.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.328 -0.396 . . . . 7.9 110.999 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -87.91 108.2 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 5.35 110.932 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -72.71 178.09 4.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 3.42 110.832 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.3 m -68.01 -49.52 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 2.85 111.143 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.463 ' HB3' HG13 ' A' ' 153' ' ' ILE . 1.7 pt-20 -80.53 -8.34 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 3.04 111.113 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -54.96 -35.12 63.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.367 . . . . 7.91 110.989 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.15 127.61 32.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 8.38 110.941 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.57 113.04 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 4.97 110.809 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.06 171.51 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 4.79 111.159 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -127.13 -43.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 7.73 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -63.66 171.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 3.01 111.203 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.3 tp -110.81 72.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 2.97 110.902 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -153.09 160.97 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 6.22 110.855 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -151.0 -166.04 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 4.19 110.94 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -166.36 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 4.16 110.998 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t 75.13 172.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 4.71 110.888 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -102.34 -29.08 11.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 7.37 110.974 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.7 m -111.56 76.2 1.49 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 4.32 110.997 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -20.04 24.19 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.732 2.288 . . . . 4.39 112.345 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.78 150.42 27.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 4.99 110.938 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 147.31 157.22 7.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.728 . . . . 2.37 112.508 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.646 ' O ' ' O ' ' A' ' 129' ' ' GLY . 2.3 p30 49.2 141.77 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.111 0.482 . . . . 2.89 111.405 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.706 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 73.8 Cg_endo -75.92 141.02 23.64 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.934 2.423 . . . . 2.31 112.763 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.735 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 136.92 -27.46 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.546 . . . . 5.23 111.765 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 17.1 Cg_exo -66.47 53.66 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.764 2.31 . . . . 1.89 112.784 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.435 ' HA3' HG23 ' A' ' 168' ' ' ILE . . . -67.21 90.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.706 . . . . 1.36 112.232 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 6.3 tt -67.47 -56.47 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 3.35 111.282 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -89.97 8.97 29.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.512 . . . . 3.87 111.374 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.425 ' O ' ' HB2' ' A' ' 169' ' ' ASN . 0.5 OUTLIER -90.13 -50.05 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.757 0.313 . . . . 2.87 111.04 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.525 ' O ' ' N ' ' A' ' 140' ' ' VAL . 1.3 pp -45.29 -38.36 5.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 4.89 111.429 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.594 ' O ' ' CG2' ' A' ' 140' ' ' VAL . . . -45.87 86.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.849 -0.691 . . . . 3.01 112.92 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.594 ' CG2' ' O ' ' A' ' 139' ' ' GLY . 1.9 t 145.3 -61.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.727 0.299 . . . . 4.35 111.211 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 142' ' ' ASN . . . -66.56 173.97 24.64 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.881 -0.676 . . . . 4.01 113.05 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.42 ' HB3' ' O ' ' A' ' 141' ' ' GLY . 3.2 p-10 169.25 122.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.669 0.271 . . . . 3.1 110.67 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 66.2 m -122.4 -179.1 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 3.73 111.212 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -164.61 -40.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.983 -0.553 . . . . 3.43 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.86 -172.18 2.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 4.42 111.169 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 65.7 154.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 3.86 111.098 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 149' ' ' GLY . . . -64.0 -56.65 22.94 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.352 -0.386 . . . . 3.16 111.16 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 10.4 Cg_exo -32.31 79.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.162 2.575 . . . . 4.19 112.763 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 62.16 125.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.693 -0.765 . . . . 2.76 112.331 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.424 ' HB ' ' CB ' ' A' ' 225' ' ' GLU . 13.9 t -102.93 -5.48 23.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 2.95 110.696 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.589 ' CG ' ' HA ' ' A' ' 220' ' ' THR . 0.0 OUTLIER 69.54 118.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 9.01 110.773 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 151' ' ' ARG . 29.3 t -31.85 -46.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 3.21 111.499 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.533 ' CG2' ' HB3' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -43.29 -35.55 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 2.84 110.993 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.404 ' N ' ' O ' ' A' ' 151' ' ' ARG . 6.1 t0 -109.32 -25.38 10.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 1.93 110.809 179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.22 58.96 0.25 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 1.89 111.113 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -175.43 34.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 2.11 111.027 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 t -157.3 -33.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 3.0 111.293 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.92 48.27 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.459 -0.337 . . . . 2.32 111.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 4.1 ttm 62.95 61.62 1.95 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 3.19 111.063 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.433 ' HB3' HD21 ' A' ' 226' ' ' LEU . 18.0 Cg_endo -59.3 149.26 82.06 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.839 2.359 . . . . 1.9 112.304 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -146.12 -47.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 3.35 110.84 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -170.04 95.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 2.95 110.835 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.428 ' O ' HG21 ' A' ' 163' ' ' VAL . 8.1 m -73.06 116.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 1.54 111.109 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 2.2 mtp180 -80.44 118.15 21.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 3.83 111.069 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.482 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -84.08 120.27 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 2.03 110.66 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.445 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 20.3 t -110.25 -23.0 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 2.14 111.58 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.506 ' HA ' ' CG1' ' A' ' 189' ' ' VAL . 1.8 mt-30 -178.63 -175.65 0.44 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 5.37 111.22 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.435 HG23 ' HA3' ' A' ' 134' ' ' GLY . 0.0 OUTLIER -136.1 -60.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 4.97 110.868 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.425 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 15.2 t-20 178.32 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.98 110.909 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -173.62 -163.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.448 . . . . 5.35 110.873 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.508 ' O ' ' C ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER -121.69 -12.39 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 4.56 111.254 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.508 ' C ' ' O ' ' A' ' 171' ' ' ILE . 2.8 t80 -26.86 -58.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 7.2 111.315 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -90.09 122.28 32.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 4.73 110.894 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 12.4 p -168.71 37.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 3.31 111.164 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -112.95 77.31 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 5.08 110.882 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.4 p -157.35 124.92 5.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 3.33 110.864 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -33.11 73.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 2.26 111.057 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -70.43 -33.13 70.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 3.61 110.944 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -76.97 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 4.5 111.009 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.1 m -56.52 -41.88 77.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 2.26 110.962 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -72.4 -35.11 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 3.4 110.931 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.04 -20.6 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 2.72 110.949 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.12 -8.43 59.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 2.54 111.078 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -31.64 56.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 2.26 110.955 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.3 -30.24 38.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 1.95 111.168 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 187' ' ' ILE . 3.1 t0 69.33 15.28 8.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 3.66 110.953 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.611 ' HA ' ' CB ' ' A' ' 131' ' ' PRO . 7.8 pt 32.93 90.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 3.74 111.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -84.37 93.39 8.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 3.29 110.759 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.506 ' CG1' ' HA ' ' A' ' 167' ' ' GLN . 8.5 m -57.66 122.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.012 -0.54 . . . . 2.4 111.073 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.431 ' CA ' ' O ' ' A' ' 165' ' ' ILE . . . 116.26 -5.27 19.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 1.3 112.55 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.417 ' N ' HG23 ' A' ' 165' ' ' ILE . 2.0 t -72.19 -161.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.336 . . . . 1.56 110.958 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -147.38 115.08 6.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 2.76 110.725 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 29.4 m -128.67 176.48 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 1.55 111.187 -179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.95 152.48 46.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 2.3 110.784 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.437 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 0.4 OUTLIER -128.41 153.96 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 3.12 111.172 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.437 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 5.6 m -157.83 145.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 2.76 111.113 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 170.39 16.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 2.36 110.893 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -169.98 105.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 4.15 110.968 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 49.41 51.0 17.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 3.14 110.996 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 60.74 68.04 1.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 2.12 112.417 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -170.07 155.58 5.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.804 0.335 . . . . 3.25 110.864 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.4 tt -105.3 140.14 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 2.46 111.128 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.1 t -160.03 122.21 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 2.01 110.959 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.86 119.23 25.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 2.31 110.776 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -96.9 117.63 31.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 1.33 111.012 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.564 ' O ' ' C ' ' A' ' 207' ' ' ASN . 10.6 t-80 -129.66 146.73 51.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 2.74 110.746 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.564 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.0 m120 -19.4 -55.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 4.41 111.303 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.514 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -54.36 -76.93 0.17 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.718 -0.754 . . . . 1.71 112.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.514 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 18.5 mtmt -159.72 -174.44 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.317 . . . . 3.86 110.763 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 149.24 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 2.07 110.635 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.41 178.04 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 1.95 111.213 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.77 -66.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 3.28 110.693 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 3.4 mp 57.03 77.18 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 2.58 110.949 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 17.9 tp -54.85 163.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 3.07 110.77 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.406 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 6.7 m-20 -54.59 -22.79 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 2.15 110.998 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . 0.485 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 0.1 OUTLIER -81.89 -20.1 39.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.96 111.072 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.407 ' O ' ' CD2' ' A' ' 138' ' ' LEU . 10.5 mp -89.97 -56.41 3.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 3.14 111.045 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.22 46.1 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 1.69 111.114 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.406 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 3.6 t-160 -90.06 -45.06 9.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 2.68 111.013 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.589 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 6.0 p -142.25 65.31 1.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.359 . . . . 2.39 111.633 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.513 ' O ' HD13 ' A' ' 223' ' ' ILE . 33.0 mm -89.76 158.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 116.33 -0.395 . . . . 2.46 110.614 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 2.6 mtt-85 -95.2 86.18 4.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 7.17 111.198 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.513 HD13 ' O ' ' A' ' 221' ' ' ILE . 0.2 OUTLIER -123.43 -154.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.99 110.497 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.473 ' H ' HG21 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -117.94 162.44 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.348 . . . . 3.25 111.003 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.424 ' CB ' ' HB ' ' A' ' 150' ' ' THR . 16.9 tt0 -89.9 99.67 12.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 2.8 110.849 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.433 HD21 ' HB3' ' A' ' 160' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 2.73 111.008 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m 69.74 -67.82 0.22 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.655 0.264 . . . . 0.0 111.099 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -95.29 146.71 24.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.867 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 29.1 mtt 58.86 94.16 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.035 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.99 166.81 13.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.72 139.16 35.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.1 m -76.42 -41.03 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.251 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.77 -34.6 71.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -72.14 -38.52 69.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -71.35 -37.75 71.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -71.91 148.58 45.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.001 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 10.3 m -99.89 169.99 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -77.25 84.08 3.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.7 t -145.97 158.33 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -91.86 -42.67 9.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.03 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.89 111.91 23.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.36 -71.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.37 138.49 50.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 p -129.79 111.78 12.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -162.34 -43.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.0 m -85.52 132.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.848 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -56.39 176.19 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.566 2.177 . . . . 0.0 112.432 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -133.52 98.03 4.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.66 25.15 1.19 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.954 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -125.16 139.02 32.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 110.796 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.576 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.2 Cg_endo -75.74 135.35 17.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.676 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.594 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 148.91 -32.05 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.117 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 7.4 Cg_endo -86.68 83.82 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.491 2.127 . . . . 0.0 112.434 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.1 117.19 4.97 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.48 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 217' ' ' LEU . 3.5 tt -81.08 -59.51 2.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -89.51 11.89 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.468 ' CG ' ' HB ' ' A' ' 168' ' ' ILE . 0.6 OUTLIER -90.11 -38.61 13.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.02 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 pp -42.62 -35.47 1.11 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.536 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -51.84 151.39 7.0 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.714 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.0 t 58.6 101.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.237 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.97 141.64 6.1 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.425 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -164.57 96.13 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.342 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.439 ' N ' ' HD3' ' A' ' 151' ' ' ARG . 1.1 m -101.85 -175.89 2.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.52 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.85 -48.66 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.72 89.56 1.33 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.22 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.71 155.0 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -64.06 -61.61 6.53 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.09 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_exo -34.44 -43.99 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.014 2.476 . . . . 0.0 112.627 179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -161.71 140.25 6.5 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.857 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.8 t -112.41 -20.88 11.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.655 0.227 . . . . 0.0 111.488 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.616 ' O ' ' N ' ' A' ' 153' ' ' ILE . 18.5 ttp180 74.6 30.56 1.04 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.945 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.554 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.0 OUTLIER 52.51 -70.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.624 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.616 ' N ' ' O ' ' A' ' 151' ' ' ARG . 3.4 tt -44.04 85.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.296 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 152' ' ' VAL . 1.7 p30 168.06 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.38 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -49.63 -29.39 7.14 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.474 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -95.32 33.06 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.417 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.9 t -170.59 33.61 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.175 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.52 35.54 0.23 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.038 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.1 mtp 58.43 67.87 1.99 Allowed Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -60.14 155.67 44.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.81 2.34 . . . . 0.0 112.605 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.49 -55.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.504 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -170.26 91.84 0.19 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.062 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 15.9 m -69.99 170.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.565 179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.43 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -139.81 116.53 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.443 ' HA ' HG22 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -77.53 129.6 37.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.199 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 17.7 t -133.93 -25.43 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.401 ' O ' ' CB ' ' A' ' 222' ' ' ARG . 3.2 mt-30 -147.33 162.1 39.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.22 0.533 . . . . 0.0 111.775 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.468 ' HB ' ' CG ' ' A' ' 137' ' ' GLU . 0.1 OUTLIER -152.38 -80.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.772 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -179.72 -67.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.91 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -155.65 -178.9 7.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.88 -40.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.197 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.96 -35.71 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.215 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -64.62 121.09 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 10.7 p -172.07 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -102.86 -32.82 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.116 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.1 p -60.8 127.09 29.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.89 -35.51 67.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.03 -22.54 66.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 14.0 t80 -79.02 -8.67 59.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.9 m -57.71 -40.44 79.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.688 0.28 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.09 -41.77 97.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -77.69 -22.71 50.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.916 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -55.68 -26.7 46.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.297 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -34.95 40.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.95 38.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.526 ' O ' ' C ' ' A' ' 187' ' ' ILE . 11.4 m-20 57.61 37.4 27.48 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.526 ' C ' ' O ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER 9.68 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.267 0.627 . . . . 0.0 112.605 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -106.0 121.9 45.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.765 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 15.9 m -62.69 148.03 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.039 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.34 -11.75 47.59 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.719 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.8 t -70.06 -175.43 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -134.5 124.13 25.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.601 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 21.1 m -131.83 172.87 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 0.0 111.461 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.9 138.53 19.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.653 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.473 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 4.0 tt -110.25 158.49 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.15 0.5 . . . . 0.0 111.32 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.473 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 15.4 m -142.07 136.55 29.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.982 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.98 93.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.12 -177.66 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.27 79.16 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 66.99 38.97 93.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.606 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -160.96 150.57 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 0.0 111.017 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.5 tt -95.6 144.74 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -160.08 137.43 9.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -115.55 121.86 43.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.5 m -86.76 138.31 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.427 ' O ' ' C ' ' A' ' 207' ' ' ASN . 3.0 t60 -165.12 172.31 12.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 206' ' ' HIS . 75.5 m-20 -28.17 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.82 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.408 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . 135.1 -81.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 23.0 mtmt -158.38 -88.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.614 0.245 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.25 158.34 34.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.01 172.68 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.014 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -79.94 -59.54 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 52.72 96.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -79.75 178.51 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -76.54 -8.41 57.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.381 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -65.95 0.97 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.116 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -61.14 -36.27 79.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.509 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.411 ' HA ' ' CD1' ' A' ' 221' ' ' ILE . . . -89.76 24.48 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.577 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 3.3 t-160 -90.37 -67.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.8 p -103.86 53.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.448 ' HB ' ' CG2' ' A' ' 152' ' ' VAL . 31.9 mt -91.57 150.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -92.81 104.07 16.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.999 0.428 . . . . 0.0 111.657 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.443 HG22 ' HA ' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -136.7 -179.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.824 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 6.3 tt0 -89.47 165.82 14.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 110.544 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -89.62 102.9 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.708 179.86 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.1 m -102.85 45.57 0.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.834 0.349 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -149.69 122.5 8.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 71.1 mtp 58.17 79.89 0.19 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.96 159.27 16.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.46 176.67 8.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.6 m -90.07 -43.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.386 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.12 -30.37 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.351 -179.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -55.94 -43.2 77.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.336 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -67.46 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.944 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.9 tt 64.66 130.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.1 m -147.85 171.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -103.26 -33.85 9.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 m -61.02 140.73 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.394 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.1 tp -89.54 -42.51 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.35 131.04 44.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.04 -63.75 1.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.34 163.97 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.041 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 t -118.0 88.75 2.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -152.96 77.13 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.5 t 59.04 69.56 1.33 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.63 -28.29 80.77 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -106.82 149.64 27.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 155.5 134.45 1.86 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.72 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.421 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 10.4 p30 54.05 157.17 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.275 0 CA-C-O 121.059 0.457 . . . . 0.0 111.939 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.557 ' O ' ' CB ' ' A' ' 132' ' ' ILE . 91.8 Cg_endo -77.78 175.03 11.71 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.896 2.397 . . . . 0.0 112.324 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.557 ' CB ' ' O ' ' A' ' 131' ' ' PRO . 1.0 OUTLIER 108.46 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.428 ' HD2' ' C ' ' A' ' 131' ' ' PRO . 72.7 Cg_exo -43.12 118.66 1.36 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.338 2.025 . . . . 0.0 113.125 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.97 23.5 23.29 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.11 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.456 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 0.6 OUTLIER -50.24 -36.0 29.25 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.998 0.428 . . . . 0.0 110.478 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -90.48 -22.36 21.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.337 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -178.28 0.53 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.89 102.33 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.745 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.33 127.05 8.6 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.058 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.9 -79.03 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.779 0.289 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.05 109.74 0.59 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.643 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.11 102.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 0.0 110.422 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.481 ' HA ' ' CG1' ' A' ' 153' ' ' ILE . 0.8 OUTLIER -81.81 162.05 23.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.268 0.556 . . . . 0.0 111.774 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 p30 49.4 -178.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.804 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.38 179.58 0.77 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.954 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.71 -71.26 0.14 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.988 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . -80.27 174.7 5.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.69 89.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.567 2.178 . . . . 0.0 112.229 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -167.78 146.92 11.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.483 -179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.459 ' O ' ' CB ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -140.1 -48.53 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.554 0.216 . . . . 0.0 110.458 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.571 ' O ' ' CG2' ' A' ' 152' ' ' VAL . 34.9 mtt180 88.24 55.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.766 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.571 ' CG2' ' O ' ' A' ' 151' ' ' ARG . 16.0 m 57.38 -47.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -43.99 -30.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 118.636 0.653 . . . . 0.0 112.345 -178.165 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.13 24.05 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.609 0.243 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -96.51 12.53 31.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.397 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -149.84 70.52 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.052 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.4 m -158.73 -52.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.087 179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.4 -79.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.359 -179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' MET . . . . . 0.403 ' HA ' ' HD2' ' A' ' 160' ' ' PRO . 26.5 ttm -155.76 92.09 2.69 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.681 0.276 . . . . 0.0 111.143 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.449 ' HA ' ' HB3' ' A' ' 226' ' ' LEU . 18.7 Cg_endo -60.27 140.33 91.47 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.723 2.282 . . . . 0.0 112.552 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -162.91 -49.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.81 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -168.62 119.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.418 ' HB ' ' CG2' ' A' ' 223' ' ' ILE . 26.8 m -102.1 134.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.675 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 12.4 mtt180 -79.78 126.09 30.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.889 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 24.4 mm -94.08 96.77 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 165' ' ' ILE . 86.2 t -159.89 92.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.416 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.613 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 170.07 105.54 0.01 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 111.063 179.224 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.531 ' HB ' ' O ' ' A' ' 167' ' ' GLN . 22.0 mt 98.25 -31.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 42.8 t-20 37.88 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.12 179.315 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.75 179.93 1.62 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.9 0.381 . . . . 0.0 111.446 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.04 125.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.085 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -63.82 -45.37 89.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.95 0.405 . . . . 0.0 110.686 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -123.03 143.29 50.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.492 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.53 94.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 -179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -161.69 91.67 0.83 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.849 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.0 p -153.62 135.97 14.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -67.9 -35.08 77.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.91 -32.61 74.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.08 -15.87 51.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.291 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 35.2 m -50.36 -39.36 46.19 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.742 0.306 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.62 -36.03 62.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.748 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -13.27 60.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.032 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -81.02 -2.27 47.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.538 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.09 -43.28 41.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.754 0.311 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.4 -30.15 16.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.029 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.545 ' O ' ' O ' ' A' ' 187' ' ' ILE . 6.5 m-20 73.71 2.86 4.36 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.736 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.545 ' O ' ' O ' ' A' ' 186' ' ' ASP . 41.2 pt 48.62 124.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 112.146 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.61 125.59 54.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.42 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 7.7 p -73.64 146.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.08 1.08 63.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.403 ' HB3' HD11 ' A' ' 132' ' ' ILE . 17.4 t -81.31 174.67 11.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.24 131.14 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 31.3 m -148.11 -167.92 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -140.38 174.52 10.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.759 0.314 . . . . 0.0 110.827 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.436 HG21 HD13 ' A' ' 195' ' ' ILE . 1.0 OUTLIER -160.03 154.76 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 14.8 m -155.1 174.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -86.01 160.05 19.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.766 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -163.9 102.08 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.072 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 t70 55.27 43.81 28.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.21 46.05 93.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.547 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -153.2 148.75 27.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.33 . . . . 0.0 110.906 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 18.4 tt -83.39 147.2 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.206 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.5 t -160.11 122.52 3.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 14.5 mt -82.37 113.78 20.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.807 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.7 m -97.08 140.43 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.828 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 207' ' ' ASN . 54.3 t60 -147.92 144.45 28.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.489 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.0 m120 -33.13 -40.56 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.72 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -68.65 -66.31 2.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 20.1 mtmt -157.69 -176.3 5.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.35 148.84 40.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.415 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.39 169.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -79.98 -64.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 2.7 tp 59.27 167.09 0.06 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -157.16 152.25 26.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -53.31 -26.2 17.76 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.206 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.78 -66.94 0.3 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 3.3 mm? -88.36 -20.84 24.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.14 29.46 1.23 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.859 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 -33.94 16.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.451 ' HA ' ' HB3' ' A' ' 151' ' ' ARG . 1.4 p -161.91 84.86 0.6 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.334 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.425 ' HB ' HD11 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -120.5 -164.11 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.613 ' HA ' ' CB ' ' A' ' 167' ' ' GLN . 11.7 ptt180 -86.22 80.38 8.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.263 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.675 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -151.43 176.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.574 178.048 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -120.87 -173.52 2.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.752 0.311 . . . . 0.0 111.019 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -89.84 89.18 7.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.449 ' HB3' ' HA ' ' A' ' 160' ' ' PRO . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.118 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.7 m -155.23 145.0 21.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.804 0.335 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 5.4 t60 66.02 134.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.089 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.5 mtt -150.48 130.36 13.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -88.24 108.35 19.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -90.1 122.22 32.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 33.3 m -90.12 -34.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.79 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.949 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -57.66 89.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -90.12 -53.38 4.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.22 160.29 30.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.73 135.1 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 10.9 tptt -159.12 173.47 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.809 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 1.0 OUTLIER -88.25 -45.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.047 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.468 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 12.3 tp -170.69 -51.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.22 142.61 28.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -119.55 -63.0 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.2 m -72.42 176.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.195 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.4 m -71.46 -55.67 7.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.61 -56.55 5.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.6 m 61.41 86.1 0.16 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.073 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.31 155.23 25.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.618 2.212 . . . . 0.0 112.261 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.401 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 60.9 m-85 -142.97 33.97 1.37 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -106.58 -132.23 7.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.629 ' CB ' ' CD ' ' A' ' 131' ' ' PRO . 0.2 OUTLIER 54.5 -163.86 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.629 ' CD ' ' CB ' ' A' ' 130' ' ' ASN . 65.9 Cg_exo -50.68 -74.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.877 1.718 . . . . 0.0 112.591 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 165.2 127.78 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.449 0.166 . . . . 0.0 111.209 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 132' ' ' ILE . 3.0 Cg_exo -74.17 139.93 27.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.738 2.292 . . . . 0.0 111.969 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.28 93.37 1.86 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.807 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.3 tt -83.58 -32.36 25.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.02 -10.78 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 138' ' ' LEU . 1.3 mt-10 -61.89 -49.61 75.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.736 0.303 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 137' ' ' GLU . 3.2 mp -29.94 -44.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.981 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -48.73 -44.9 30.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.879 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 105.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.739 0.304 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.76 114.14 0.78 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.544 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -171.17 142.8 1.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.741 0.305 . . . . 0.0 110.902 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.436 ' HB2' ' HA3' ' A' ' 149' ' ' GLY . 13.8 t -95.9 162.15 13.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -162.41 -45.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.12 -45.0 1.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.84 -179.86 6.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.405 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -74.38 -58.28 1.92 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.518 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.405 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 5.9 Cg_exo -33.25 108.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 113.301 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.436 ' HA3' ' HB2' ' A' ' 143' ' ' SER . . . 115.5 42.0 0.77 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.713 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.445 ' N ' HD11 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -103.53 -142.41 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.502 ' HB3' HG12 ' A' ' 223' ' ' ILE . 26.0 ttt180 65.13 -69.96 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.748 0.308 . . . . 0.0 111.623 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.431 HG22 ' HA ' ' A' ' 218' ' ' ALA . 2.5 m -95.68 -38.23 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.521 ' O ' ' CB ' ' A' ' 154' ' ' ASP . 1.0 OUTLIER -116.55 110.03 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.238 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 153' ' ' ILE . 55.7 m-20 99.26 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.705 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -42.93 -34.25 0.93 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.56 61.42 2.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.429 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 4.1 t -176.23 -35.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.346 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.7 m -89.3 54.2 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 45.3 mtt 55.0 57.21 11.37 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.391 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.424 ' HA ' ' CD1' ' A' ' 226' ' ' LEU . 7.3 Cg_endo -49.32 129.57 22.86 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.168 2.579 . . . . 0.0 112.559 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -154.97 -47.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.567 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -170.28 91.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 20.4 m -70.0 178.42 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.912 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 223' ' ' ILE . 1.5 mpt_? -127.18 107.75 10.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.513 ' HA ' HG23 ' A' ' 223' ' ' ILE . 8.2 tt -70.63 134.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.39 11.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -179.167 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -168.65 100.57 0.4 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.947 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 3.3 mp -117.65 -4.29 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.949 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 53.56 -92.76 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.738 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.443 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 62.18 -88.14 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 79.4 mt 59.89 -76.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.443 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.8 m-85 -62.65 -67.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.871 0.367 . . . . 0.0 111.332 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.92 121.98 12.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.081 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -172.44 -40.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.282 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -113.58 95.02 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.5 p -158.27 157.33 32.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.79 -37.31 83.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.61 -31.97 57.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -90.08 3.62 52.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.45 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.3 m -59.05 -44.21 91.79 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -72.99 -33.59 65.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 128' ' ' PHE . 8.1 mp -73.19 -21.8 60.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.4 mt -63.73 -33.32 75.39 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.598 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.68 -28.37 21.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.55 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.463 ' HB1' ' O ' ' A' ' 130' ' ' ASN . . . -51.66 -41.13 61.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.004 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.8 t70 78.85 -8.32 1.66 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . . . . . . . . . 44.2 mt 61.01 125.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.738 0.304 . . . . 0.0 111.467 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.58 -43.23 3.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.507 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.446 ' O ' HG12 ' A' ' 189' ' ' VAL . 3.3 p 36.94 83.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.421 ' CA ' ' O ' ' A' ' 165' ' ' ILE . . . 135.3 2.26 3.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.518 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 8.0 t -85.19 -167.44 1.83 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.903 0.382 . . . . 0.0 111.289 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . 0.425 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 45.9 mt-10 -129.62 99.0 5.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.492 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 27.3 m -92.29 169.62 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.625 -179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.56 135.66 53.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.4 HG13 ' N ' ' A' ' 196' ' ' VAL . 0.7 OUTLIER -90.74 151.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.102 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.4 ' N ' HG13 ' A' ' 195' ' ' ILE . 14.9 p -170.32 151.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -131.77 172.16 12.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.749 179.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.25 118.14 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.334 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.5 t70 66.93 -68.82 0.14 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.56 49.65 0.16 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.304 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -149.06 145.07 27.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 9.9 tp -95.14 145.0 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.241 -179.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.2 t -160.05 153.99 23.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 -179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -121.93 103.64 8.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 2.8 m -79.91 122.18 26.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.48 ' O ' ' N ' ' A' ' 208' ' ' GLY . 59.8 t60 -175.73 162.19 2.67 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.4 m120 31.56 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.991 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -54.41 -78.97 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.439 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 22.9 mtmt -160.5 -75.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.495 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -155.48 133.19 11.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.27 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 21.2 t -87.38 141.51 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -79.84 -59.11 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.181 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 48.75 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.609 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 6.0 tp -165.95 164.13 18.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -46.75 -31.63 3.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.3 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -62.62 -58.59 6.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.358 . . . . 0.0 110.591 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.414 ' O ' ' CD1' ' A' ' 221' ' ' ILE . 7.9 mp -80.39 -12.86 59.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.157 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.431 ' HA ' HG22 ' A' ' 152' ' ' VAL . . . -90.51 -28.02 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -90.43 -19.83 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 20.1 p -135.9 78.74 1.73 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.577 HG23 ' CD1' ' A' ' 223' ' ' ILE . 0.9 OUTLIER -149.01 156.96 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.414 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.444 ' N ' HG22 ' A' ' 221' ' ' ILE . 40.4 mtt-85 -101.04 124.25 46.48 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.577 ' CD1' HG23 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -150.42 178.37 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.815 178.998 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.476 ' CB ' ' HB2' ' A' ' 164' ' ' ARG . 2.1 tm-20 -95.02 150.07 20.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.493 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -89.57 132.88 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 111.259 -179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 160' ' ' PRO . 4.6 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.322 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -88.26 -50.87 6.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -124.12 -57.54 1.59 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.0 mtt -112.5 108.87 18.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.82 129.09 36.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.0 148.01 23.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 30.2 m -69.55 -42.74 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.196 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.38 40.38 1.01 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.155 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -90.13 -51.49 5.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 136.54 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.32 170.14 8.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.62 -43.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.4 tttt 70.37 -66.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.7 m -69.41 143.06 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.218 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tt -86.03 95.26 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -154.78 136.44 14.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.19 140.91 30.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.01 109.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.8 t -159.92 -64.17 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -152.69 -72.35 0.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.822 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.422 ' CB ' ' HD3' ' A' ' 127' ' ' PRO . 0.6 OUTLIER 175.33 -53.44 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.422 ' HD3' ' CB ' ' A' ' 126' ' ' SER . 46.3 Cg_exo -56.6 -171.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.603 2.202 . . . . 0.0 112.557 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -125.13 -175.5 3.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.744 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.19 -158.67 9.27 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.664 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.486 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 0.6 OUTLIER -71.51 165.14 51.68 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.545 0.212 . . . . 0.0 110.81 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 38.3 Cg_endo -67.2 126.85 15.7 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.551 2.167 . . . . 0.0 112.787 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.513 HG13 ' HD2' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -172.58 -62.64 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.694 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.513 ' HD2' HG13 ' A' ' 132' ' ' ILE . 7.0 Cg_exo -38.92 118.3 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.288 2.658 . . . . 0.0 113.377 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.81 47.99 3.01 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.536 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.406 ' HA ' ' HG ' ' A' ' 217' ' ' LEU . 2.8 pp -51.02 -32.73 22.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.081 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -89.35 -22.36 22.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -174.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.154 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tt -90.28 102.86 15.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.375 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -88.25 128.28 8.99 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.392 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.1 p -172.91 -43.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 126.5 107.29 1.52 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.568 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -166.79 137.53 3.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.467 ' CB ' ' HB2' ' A' ' 151' ' ' ARG . 58.0 p -179.08 -34.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.83 -23.21 1.76 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.674 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.66 174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.743 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -107.46 140.65 40.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 168.38 167.54 0.14 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.561 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -56.44 -18.95 26.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.15 1.9 . . . . 0.0 110.973 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.554 ' HA3' ' HA ' ' A' ' 224' ' ' GLU . . . -139.46 153.71 23.15 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.669 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.404 ' HB ' ' HB2' ' A' ' 225' ' ' GLU . 10.8 t -97.2 -142.28 0.29 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.474 ' HA ' HD12 ' A' ' 223' ' ' ILE . 60.9 mtt180 -150.58 72.16 1.08 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 154' ' ' ASP . 44.2 t 64.41 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.159 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.436 ' O ' ' CG1' ' A' ' 153' ' ' ILE . 1.3 tt -61.47 76.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.5 OUTLIER 162.73 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.598 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.436 ' HA ' HD21 ' A' ' 226' ' ' LEU . . . -89.89 46.0 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.431 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -145.16 36.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 2.8 p -160.07 -43.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 8.4 t -76.81 61.66 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.6 ttt 48.96 86.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.408 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.44 149.41 90.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.644 2.229 . . . . 0.0 112.576 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -156.55 -50.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.688 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -168.11 165.34 13.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 223' ' ' ILE . 3.4 m -155.04 140.41 10.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.626 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.558 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 0.2 OUTLIER -79.37 107.63 12.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.571 179.069 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.459 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -79.5 119.4 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.515 ' O ' ' C ' ' A' ' 167' ' ' GLN . 10.7 t -134.7 38.07 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.395 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.515 ' C ' ' O ' ' A' ' 166' ' ' VAL . 0.6 OUTLIER 5.67 -86.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.434 0.694 . . . . 0.0 112.86 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.431 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 0.4 OUTLIER 159.2 -52.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 27.1 p30 -169.48 -172.43 1.45 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.797 179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.414 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 36.5 mt-10 -152.13 168.39 25.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.992 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.414 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 77.36 -21.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.131 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.29 -51.6 61.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -118.74 178.67 4.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.167 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.4 p -167.0 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.08 -178.21 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.197 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.7 p -68.42 -173.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.33 -5.05 33.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -57.89 -30.92 66.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.734 0.302 . . . . 0.0 110.986 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 45.7 m-85 -90.13 11.58 20.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.6 m -54.24 -39.39 66.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.733 0.301 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.47 -41.25 69.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.42 -18.19 62.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.958 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -25.14 68.02 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.99 -40.26 57.56 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.04 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 187' ' ' ILE . 6.7 t70 60.89 24.65 14.64 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.282 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.46 ' HA ' ' CB ' ' A' ' 131' ' ' PRO . 1.1 pp 28.51 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.112 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.39 141.19 40.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.098 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 25.0 t -69.11 146.9 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.71 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.28 -12.8 26.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.791 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 165' ' ' ILE . 1.3 t -73.67 -165.3 0.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.004 0.431 . . . . 0.0 111.027 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -151.69 145.91 25.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.206 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 20.8 m -150.3 179.08 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.012 0.434 . . . . 0.0 111.876 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.99 101.73 1.95 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.38 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 41.4 pt -79.84 151.46 4.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.558 -179.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.3 m -150.68 152.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.957 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.92 142.03 53.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.05 112.99 1.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.011 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.41 36.43 23.02 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.77 51.41 57.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.594 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -158.28 156.06 29.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.805 0.336 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.405 HG22 HD13 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -94.45 135.42 28.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.7 t -153.57 133.03 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -79.99 159.68 26.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.502 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.493 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 9.5 m -152.08 116.65 5.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.213 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.407 ' O ' ' N ' ' A' ' 208' ' ' GLY . 1.7 t-80 179.25 177.98 0.51 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.036 0.446 . . . . 0.0 111.504 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 12.8 m120 42.52 -90.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.783 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -73.08 -67.43 1.81 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.677 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 21.9 mtmt -159.17 -81.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 111.104 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -153.81 175.32 13.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 3.0 t -136.96 159.64 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.836 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -79.89 -61.5 1.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.315 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 3.0 mp 57.12 179.22 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -151.46 -179.95 7.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.94 13.61 12.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.596 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -84.65 -71.76 0.5 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.682 0.277 . . . . 0.0 110.767 179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.406 ' HG ' ' HA ' ' A' ' 135' ' ' LEU . 4.4 mm? -90.2 -40.03 12.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.794 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.447 ' HA ' HG12 ' A' ' 221' ' ' ILE . . . -56.76 -20.94 24.88 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -80.3 7.36 9.69 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 12.3 t -163.59 39.91 0.09 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.463 ' HB ' HD13 ' A' ' 223' ' ' ILE . 51.2 mm -89.8 154.57 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 63.5 ttt180 -89.69 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 111.901 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 0.1 OUTLIER -146.8 -178.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.0 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.554 ' HA ' ' HA3' ' A' ' 149' ' ' GLY . 12.1 tm-20 -89.82 165.25 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.82 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.507 ' O ' ' C ' ' A' ' 226' ' ' LEU . 33.8 tt0 -99.26 80.54 2.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.507 ' C ' ' O ' ' A' ' 225' ' ' GLU . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.712 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -153.54 -53.54 0.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.682 0.277 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.4 t60 70.07 -67.71 0.23 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.9 mtt -105.24 126.35 52.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.05 101.95 13.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -89.97 -60.0 2.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.99 -38.44 11.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.14 55.95 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.89 -33.14 17.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -70.24 158.75 35.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.9 mt -137.11 -52.28 0.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.71 127.05 50.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.261 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 4.8 mmtm -173.19 -173.66 0.95 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -76.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.092 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.6 tt -165.46 -46.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -72.27 140.47 48.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.88 158.92 43.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.62 139.67 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.283 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -163.64 178.73 7.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -86.26 -40.31 15.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.71 93.47 37.45 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 112.72 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.639 2.226 . . . . 0.0 112.393 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 57.06 96.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.2 9.54 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.306 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.622 ' CB ' ' HD2' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 53.71 178.53 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.537 0.168 . . . . 0.0 110.648 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.622 ' HD2' ' CB ' ' A' ' 130' ' ' ASN . 2.6 Cg_endo -39.6 141.84 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.922 2.415 . . . . 0.0 112.898 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 16.1 tt -37.6 96.0 0.1 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.526 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_endo -82.44 78.26 3.46 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.272 2.648 . . . . 0.0 111.243 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.522 ' HA3' ' HG2' ' A' ' 137' ' ' GLU . . . -70.3 111.68 3.92 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.616 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.46 -40.53 11.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 178.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -91.11 -4.62 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.272 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.522 ' HG2' ' HA3' ' A' ' 134' ' ' GLY . 0.0 OUTLIER -90.08 -35.94 15.16 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.401 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.436 ' O ' ' N ' ' A' ' 140' ' ' VAL . 3.5 pp -39.93 -34.99 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.933 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -56.43 82.77 0.01 OUTLIER Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.013 -179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 138' ' ' LEU . 59.9 t -154.73 -55.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 110.726 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.18 104.1 0.18 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.388 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -57.16 108.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 111.054 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.429 ' N ' ' HB3' ' A' ' 151' ' ' ARG . 14.1 m -90.73 99.3 12.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -106.97 24.16 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.756 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.13 -167.07 1.16 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.43 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 67.58 164.34 0.13 Allowed Pre-proline 0 C--O 1.231 0.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.341 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -53.49 145.22 47.8 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.758 2.305 . . . . 0.0 112.487 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 90.94 101.85 1.23 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.609 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.584 ' HB ' ' HB3' ' A' ' 224' ' ' GLU . 10.3 t -118.46 -161.07 0.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.283 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.429 ' HB3' ' N ' ' A' ' 143' ' ' SER . 22.3 ptt180 -125.93 33.11 5.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.548 ' CG2' HG12 ' A' ' 221' ' ' ILE . 0.4 OUTLIER 66.67 -59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.423 HG13 ' O ' ' A' ' 153' ' ' ILE . 1.7 pt -69.57 62.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.4 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.435 ' HA ' ' HG3' ' A' ' 224' ' ' GLU . . . -40.17 -36.1 0.47 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.781 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.32 76.62 1.71 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.05 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.5 m -159.51 -45.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.6 m -78.61 -78.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.7 ptm -146.59 54.74 2.22 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -44.55 106.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.419 2.746 . . . . 0.0 112.701 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -135.47 -40.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.844 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -161.77 96.14 1.01 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.623 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 0.0 OUTLIER -70.0 176.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.616 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 6.2 mtt180 -152.02 115.43 4.77 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.564 ' HA ' ' HA ' ' A' ' 223' ' ' ILE . 8.3 tt -84.76 126.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.983 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 32.1 t -133.68 -72.73 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.02 122.45 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.032 0.444 . . . . 0.0 112.171 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.41 ' CG1' HG22 ' A' ' 189' ' ' VAL . 34.1 mm -153.55 -74.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 44.97 -171.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.804 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 172' ' ' PHE . 47.1 tt0 -156.28 -71.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.8 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.3 mt 63.26 -70.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.886 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.2 m-85 -51.87 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 111.49 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.77 120.72 11.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.13 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.9 p -175.77 39.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -134.99 -41.68 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.9 p -56.58 126.73 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.27 -33.44 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.59 -28.88 70.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -73.92 -19.31 60.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.262 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.0 m -50.86 -48.14 60.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -64.68 -31.53 72.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.85 -38.7 79.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.0 -12.74 37.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -23.29 8.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.379 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -53.9 -34.2 58.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.058 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.9 t70 50.32 73.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.403 HG12 ' HA ' ' A' ' 131' ' ' PRO . 0.1 OUTLIER -117.64 -145.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.336 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.31 104.24 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.77 0.319 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.476 ' HA ' HG12 ' A' ' 165' ' ' ILE . 10.7 p -60.44 115.57 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 142.56 1.76 1.18 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.412 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 165' ' ' ILE . 12.0 t -103.31 -165.15 1.14 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.073 0.437 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -104.5 145.94 29.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.438 ' C ' HG21 ' A' ' 163' ' ' VAL . 13.0 m -146.48 -163.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.228 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . 0.564 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 9.5 pt-20 -150.38 163.24 38.85 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.643 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.499 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 4.2 tt -141.96 160.19 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.179 0.514 . . . . 0.0 111.408 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.499 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 18.3 m -146.64 113.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.01 175.42 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -153.94 172.69 17.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.03 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.49 51.97 50.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -165.78 136.35 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.432 HD13 HG22 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -107.91 131.55 57.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.841 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.6 t -160.02 135.31 8.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.031 -179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.9 mt -79.81 -176.18 5.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.561 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.4 m -154.49 109.44 3.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.46 ' O ' ' N ' ' A' ' 208' ' ' GLY . 0.6 OUTLIER 179.8 -178.52 0.41 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.533 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 42.92 -88.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.48 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -78.48 -68.11 1.54 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.6 mtmt -160.32 -69.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.672 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.14 161.47 41.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.671 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 42.6 t -105.66 157.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.889 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -79.61 -63.49 1.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.707 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 41.9 mt 56.26 174.61 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.452 179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . 0.405 ' O ' ' HB2' ' A' ' 218' ' ' ALA . 0.3 OUTLIER -171.0 174.16 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.685 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.92 -30.11 9.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.299 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.6 -65.02 1.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.8 -44.9 78.23 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.792 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.473 ' HA ' HG21 ' A' ' 152' ' ' VAL . . . -90.62 39.31 0.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.425 ' CD2' ' C ' ' A' ' 219' ' ' HIS . 2.7 t-160 -90.26 -54.0 4.21 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.643 0.258 . . . . 0.0 111.032 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -147.99 80.56 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.548 HG12 ' CG2' ' A' ' 152' ' ' VAL . 0.6 OUTLIER -124.16 146.77 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -89.67 102.45 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.623 ' O ' ' HB ' ' A' ' 163' ' ' VAL . 0.3 OUTLIER -151.34 31.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.817 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.584 ' HB3' ' HB ' ' A' ' 150' ' ' THR . 2.1 tt0 -152.88 157.75 41.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.742 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -116.56 -19.73 9.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.93 -179.868 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.8 m -84.77 139.31 32.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.767 0.318 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -150.35 -51.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 47.3 mtt 60.83 104.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.019 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.15 147.01 34.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -87.38 -178.35 6.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.405 ' HB ' ' CG2' ' A' ' 202' ' ' ILE . 89.1 t -64.04 -28.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.398 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -84.78 62.2 7.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.688 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -57.23 85.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 113' ' ' GLU . 66.4 mtp180 -41.33 -40.91 1.81 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.313 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.43 77.91 9.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.664 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.1 m -62.72 163.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.358 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -154.12 -49.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.402 ' CG2' ' H ' ' A' ' 120' ' ' LEU . 1.1 p -148.94 -166.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.402 ' H ' ' CG2' ' A' ' 119' ' ' VAL . 4.5 mm? -107.54 115.63 30.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -153.11 133.04 13.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.05 163.78 13.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -101.25 142.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.1 m 60.38 -89.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 176.26 159.44 0.3 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.6 m 60.08 73.24 0.66 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.46 -30.11 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.672 2.248 . . . . 0.0 112.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.71 150.83 45.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 143.42 136.92 3.21 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.476 ' O ' ' O ' ' A' ' 129' ' ' GLY . 2.6 p-10 51.5 158.46 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.614 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.3 Cg_endo -76.41 135.45 16.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.703 2.269 . . . . 0.0 113.019 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.616 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 135.77 -32.12 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 124.058 0.849 . . . . 0.0 112.089 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 1.5 Cg_endo -79.92 72.04 6.73 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.427 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.11 118.12 4.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.244 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 1.9 tt -73.19 -45.49 56.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.233 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.28 9.25 29.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.514 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -90.21 -50.77 5.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.638 0.256 . . . . 0.0 111.225 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.441 ' HA ' HG23 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -53.97 -14.92 1.15 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.409 ' N ' HD11 ' A' ' 138' ' ' LEU . . . -45.42 -91.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.255 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 14.6 t -89.72 153.23 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 92.01 155.64 32.02 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.428 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.466 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 2.0 p30 -152.47 131.89 12.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.822 0.344 . . . . 0.0 111.405 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -97.85 170.6 8.85 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -158.68 -60.63 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.538 ' HA ' ' HB2' ' A' ' 225' ' ' GLU . . . -162.9 -163.06 0.82 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 145' ' ' ALA . . . 94.07 108.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . . . . . . . . . . . 63.87 162.49 0.12 Allowed Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.378 179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.585 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 79.3 Cg_exo -39.69 146.71 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.858 2.372 . . . . 0.0 112.048 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.709 ' HA2' ' HB ' ' A' ' 163' ' ' VAL . . . 151.55 -152.35 24.13 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.892 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.467 ' OG1' HG21 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -152.13 144.59 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.724 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . . . . . . . . . 53.8 ttt180 -67.12 2.76 1.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.407 ' CG2' ' CD1' ' A' ' 223' ' ' ILE . 2.4 t 74.03 -62.51 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.918 0.39 . . . . 0.0 110.484 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.9 pt -97.51 44.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.505 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.452 ' O ' ' C ' ' A' ' 155' ' ' ALA . 5.0 t70 -162.79 -32.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.686 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.452 ' C ' ' O ' ' A' ' 154' ' ' ASP . . . -27.86 -42.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.435 ' N ' ' O ' ' A' ' 154' ' ' ASP . . . -76.99 62.0 2.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 0.0 111.319 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 3.0 t -173.32 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.1 t -77.5 -158.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 34.1 mtt -124.47 60.3 23.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.021 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_exo -44.85 162.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.928 2.419 . . . . 0.0 113.181 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.2 mtp85 -152.14 -45.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.348 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -161.26 78.66 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.227 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.709 ' HB ' ' HA2' ' A' ' 149' ' ' GLY . 32.9 m -69.94 143.45 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.849 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.461 ' HG3' ' HB2' ' A' ' 148' ' ' PRO . 8.0 mtp85 -79.05 98.76 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.365 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.757 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -76.41 79.98 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.401 0.62 . . . . 0.0 111.833 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.413 ' HA ' ' CG2' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -160.88 97.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.696 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.56 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.9 OUTLIER 170.47 133.77 0.02 OUTLIER 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.585 0.707 . . . . 0.0 112.183 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.441 HG23 ' HA ' ' A' ' 138' ' ' LEU . 3.0 mm 75.86 -2.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.413 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -55.75 159.42 3.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.939 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -151.4 170.12 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.71 -47.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.055 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.44 -40.34 90.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -71.48 132.91 45.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.5 p -162.59 93.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.127 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 176' ' ' THR . 3.6 tt0 -138.64 178.42 7.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 175' ' ' GLU . 8.4 t 47.83 114.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.885 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.3 -2.97 15.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.775 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.53 -34.41 70.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.615 0.245 . . . . 0.0 111.431 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . 0.409 ' CD1' ' C ' ' A' ' 179' ' ' PHE . 2.4 p90 -75.44 -10.14 59.19 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.696 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.1 m -48.71 -40.92 30.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -70.69 -35.85 72.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 8.5 mp -73.85 -22.88 59.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.024 179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.63 -20.88 63.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.068 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -38.56 61.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -69.44 -27.6 65.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.526 ' O ' HG13 ' A' ' 187' ' ' ILE . 13.8 m-20 84.06 -36.52 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.558 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 186' ' ' ASP . 0.6 OUTLIER 62.18 130.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.384 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -126.82 88.79 2.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.862 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.413 ' CG2' ' HA ' ' A' ' 166' ' ' VAL . 7.6 p -70.99 96.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.543 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 165' ' ' ILE . . . 146.38 -1.21 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.375 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 4.5 t -97.03 -162.9 0.99 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.053 0.427 . . . . 0.0 110.891 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.4 124.52 43.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 32.5 m -127.98 175.33 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.258 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.98 169.49 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.431 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 0.9 OUTLIER -155.85 154.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.023 0.439 . . . . 0.0 111.135 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.431 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 17.6 m -141.5 155.2 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.952 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.94 155.38 40.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 43.1 ttm-85 -146.29 71.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.987 0.423 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.43 60.28 3.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.12 96.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.563 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 89.8 m-70 -152.55 131.71 12.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 110.725 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.406 ' CD1' ' O ' ' A' ' 152' ' ' VAL . 13.8 tt -79.99 139.53 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 111.388 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 16.7 p -158.41 119.86 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.457 179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.57 153.19 29.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.743 -179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 39.0 m -126.78 125.71 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.432 ' O ' ' N ' ' A' ' 208' ' ' GLY . 0.8 OUTLIER -178.61 176.08 1.03 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.989 0.423 . . . . 0.0 111.378 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 46.89 -87.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.782 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -83.65 -62.6 1.76 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.841 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.72 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.593 0.235 . . . . 0.0 111.231 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . 0.41 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -138.14 178.87 6.8 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -133.16 179.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.63 -48.81 3.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.4 mt 56.99 176.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.35 177.7 8.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.57 -29.92 69.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.316 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.07 -54.77 6.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.155 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.95 -30.78 68.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.289 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.12 15.88 9.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.743 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 4.0 t-160 -84.78 -58.83 2.55 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.809 0.337 . . . . 0.0 110.771 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.466 ' HB ' ' HA ' ' A' ' 142' ' ' ASN . 3.0 p -147.0 88.05 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.444 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.594 ' CG2' ' N ' ' A' ' 222' ' ' ARG . 0.4 OUTLIER -111.58 -172.1 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.564 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.757 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.7 mtm180 -84.28 76.22 10.13 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.512 ' CD1' HG23 ' A' ' 221' ' ' ILE . 0.3 OUTLIER -153.51 134.0 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.563 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.585 ' HB2' ' O ' ' A' ' 148' ' ' PRO . 9.8 mt-10 -89.68 -108.8 0.08 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.538 ' HB2' ' HA ' ' A' ' 145' ' ' ALA . 2.8 tt0 -150.99 112.44 4.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.206 0.457 . . . . 0.0 111.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 149' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.077 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.4 m -84.87 158.0 20.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -148.6 -52.98 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.8 mtt -82.97 119.2 24.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.36 136.95 33.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.72 173.31 12.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -54.76 -75.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -87.48 62.52 7.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 110.722 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 77.52 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -51.72 -34.7 40.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.53 92.77 2.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -164.21 148.87 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -146.93 -68.22 0.26 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 m -76.0 165.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.305 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.6 148.22 26.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.798 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -152.1 -51.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.05 -175.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.442 ' O ' HG11 ' A' ' 123' ' ' VAL . 3.3 p 41.12 90.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.663 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 p -140.04 -56.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -107.86 -35.99 6.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.9 m -63.97 164.43 17.49 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.7 -161.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.78 2.32 . . . . 0.0 112.367 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.411 ' HB2' ' HA ' ' A' ' 182' ' ' LEU . 6.7 p90 -111.84 -54.97 2.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.959 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.2 -102.18 1.0 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.078 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.506 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 3.7 p30 -143.92 163.37 36.0 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.673 0.273 . . . . 0.0 110.976 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.612 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.46 138.42 80.37 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.951 2.434 . . . . 0.0 112.96 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.657 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 138.81 -29.57 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 O-C-N 124.033 0.833 . . . . 0.0 112.314 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.657 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 12.3 Cg_exo -68.09 62.46 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.481 2.121 . . . . 0.0 112.842 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.54 129.42 25.18 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.283 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.03 -44.25 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -90.15 9.0 30.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.437 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.06 -44.65 9.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.754 0.312 . . . . 0.0 110.994 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.3 pp -41.17 -36.81 0.79 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.833 -179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.78 65.73 3.87 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.766 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 90.6 t -152.79 -66.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.686 0.279 . . . . 0.0 111.019 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.4 -175.11 13.94 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.445 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -162.68 160.72 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 m -163.17 133.38 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.7 -45.47 8.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.01 114.64 2.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.322 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -174.03 -168.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.025 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.467 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . . . -56.83 -178.78 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.895 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.467 ' CD ' ' CB ' ' A' ' 147' ' ' ALA . 95.3 Cg_exo -44.68 89.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.674 2.249 . . . . 0.0 112.648 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 154.78 55.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.43 HG22 ' HA ' ' A' ' 225' ' ' GLU . 7.3 t -101.48 -163.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.513 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.524 ' HA ' ' HA ' ' A' ' 220' ' ' THR . 34.0 ptt180 -107.4 107.61 18.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.471 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 7.1 p -41.6 -30.55 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.03 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.438 HG12 ' HB2' ' A' ' 151' ' ' ARG . 23.3 pt -53.45 -42.09 47.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.909 0.385 . . . . 0.0 111.128 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -84.16 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.878 179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -62.72 80.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.155 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -172.21 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.064 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.4 t -93.85 -3.62 51.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.47 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 38.9 m -94.05 37.6 1.09 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.756 0.312 . . . . 0.0 111.327 -179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 11.2 ttt 57.67 61.45 5.95 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.854 0.359 . . . . 0.0 111.235 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -62.73 170.69 6.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.814 2.342 . . . . 0.0 112.414 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.5 mtt85 -152.15 -47.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -170.02 89.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 26.8 m -80.59 -172.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.501 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 12.2 mtp85 -124.39 -170.95 2.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.076 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.57 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -147.69 79.89 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 110.426 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 1.3 m -160.48 98.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.085 -179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.627 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 170.34 110.84 0.01 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.22 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 167' ' ' GLN . 12.7 mt 109.53 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.363 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 168' ' ' ILE . 22.4 t-20 49.9 164.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.88 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 171.32 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.571 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 66.4 mt 63.5 -64.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.0 m-85 -47.31 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.426 ' O ' ' CG2' ' A' ' 174' ' ' VAL . 11.7 mm100 -64.98 116.51 6.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.426 ' CG2' ' O ' ' A' ' 173' ' ' GLN . 77.1 t -161.17 80.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -106.18 98.73 8.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.123 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -166.03 113.27 0.9 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.83 -26.66 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.146 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -72.3 -30.71 65.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.026 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 33.1 m-85 -90.16 20.64 4.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.486 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.9 m -57.36 -33.37 67.71 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.79 0.329 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -72.25 -42.53 65.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.586 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . 0.411 ' HA ' ' HB2' ' A' ' 128' ' ' PHE . 9.5 mp -71.14 -14.83 62.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.942 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.8 -27.99 60.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.032 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.1 -43.07 51.41 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -66.6 -31.12 71.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 187' ' ' ILE . 30.5 m-20 67.43 13.67 9.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.545 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.539 ' HA ' ' CB ' ' A' ' 131' ' ' PRO . 6.1 pt 33.95 100.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -102.52 90.69 3.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.668 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.452 ' HA ' HD12 ' A' ' 165' ' ' ILE . 10.6 p -59.83 115.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 136.59 -8.4 3.97 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.823 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 19.7 t -83.66 -169.33 2.51 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.788 0.328 . . . . 0.0 111.061 -179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -135.54 122.27 20.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 33.5 m -120.56 -179.11 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -144.45 164.65 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.717 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.1 mp -128.97 153.27 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.182 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 8.8 m -154.26 110.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.96 157.79 37.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.98 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -159.21 118.5 2.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 6.5 t70 69.73 -66.86 0.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -179.64 49.86 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -156.45 149.73 24.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.433 HD11 HG22 ' A' ' 202' ' ' ILE . 0.0 OUTLIER -102.19 133.59 45.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 30.4 p -142.83 129.37 20.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -79.98 105.01 10.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.811 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 209' ' ' LYS . 2.4 m -86.09 120.23 27.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 208' ' ' GLY . 21.9 t-80 -176.01 166.49 2.98 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 111.644 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.0 m120 40.69 -90.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.852 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -67.9 -71.3 0.97 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.606 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 205' ' ' SER . 2.4 ptpt -161.76 -63.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -152.93 174.28 14.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.543 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 12.3 t -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.928 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -112.04 55.73 0.67 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 111.226 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 4.2 pp -83.25 173.05 11.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.609 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -97.04 164.79 12.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.954 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.17 -37.95 75.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.515 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -62.01 -45.1 95.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 3.0 mp -60.34 -37.78 81.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.72 14.12 14.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.755 -179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -67.85 70.57 0.14 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.964 0.411 . . . . 0.0 111.047 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 151' ' ' ARG . 6.5 p 59.13 85.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.289 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.407 ' HA ' ' CD1' ' A' ' 168' ' ' ILE . 0.8 OUTLIER -118.94 -147.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.627 ' HA ' ' CB ' ' A' ' 167' ' ' GLN . 6.3 ptt180 -84.95 88.41 7.44 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 222' ' ' ARG . 3.3 mp -151.42 151.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.256 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 2.3 tm-20 -89.85 159.03 17.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.633 0.254 . . . . 0.0 110.363 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.43 ' HA ' HG22 ' A' ' 150' ' ' THR . 0.5 OUTLIER -89.25 104.55 17.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.955 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.312 -179.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.2 m -83.51 -52.4 6.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.3 t60 70.62 -66.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.072 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.6 mtt -113.25 163.37 14.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.05 142.57 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -90.05 -87.74 0.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.061 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 p -90.35 -45.52 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.699 0.285 . . . . 0.0 111.409 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -84.18 100.26 11.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -80.95 76.81 7.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -88.54 66.16 8.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -143.62 -51.59 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.3 m -69.81 148.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -112.99 -40.03 4.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.49 163.23 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.26 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.8 tt -94.53 118.4 31.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -147.08 173.91 12.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -152.57 152.33 31.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.3 p -151.98 101.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -167.01 -179.03 4.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -71.81 -37.9 70.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.3 p -164.33 79.45 1.43 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.22 -162.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.748 2.299 . . . . 0.0 112.18 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.0 p90 42.0 91.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.76 161.21 34.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.76 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.45 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER 61.91 144.61 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 120.611 0.243 . . . . 0.0 110.953 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 187' ' ' ILE . 1.9 Cg_endo -86.33 105.01 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.116 2.544 . . . . 0.0 112.658 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.49 ' CB ' ' HD3' ' A' ' 133' ' ' PRO . 0.0 OUTLIER -164.83 -57.77 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.49 ' HD3' ' CB ' ' A' ' 132' ' ' ILE . 5.1 Cg_endo -85.08 121.82 2.44 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.727 2.284 . . . . 0.0 113.98 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.469 ' HA2' ' CD1' ' A' ' 187' ' ' ILE . . . -91.86 170.99 33.95 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.193 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.826 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -69.66 128.62 37.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -26.78 66.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.552 1.158 . . . . 0.0 113.03 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 135' ' ' LEU . 26.5 tt0 -90.63 -55.35 3.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -90.6 -16.91 27.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.59 -1.187 . . . . 0.0 109.744 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 116.08 8.67 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.792 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.1 p -150.44 -41.73 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.605 0.24 . . . . 0.0 111.249 179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.19 86.74 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.655 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.34 -178.23 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.704 0.287 . . . . 0.0 110.787 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.9 p -76.6 -43.78 37.17 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.577 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.94 -178.01 1.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -110.07 -86.6 0.53 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.112 179.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -91.98 138.81 31.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.63 179.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.458 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . . . 57.54 -179.6 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.325 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.458 ' CD ' ' CB ' ' A' ' 147' ' ' ALA . 53.8 Cg_exo -52.33 -176.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.244 1.963 . . . . 0.0 112.001 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.427 ' HA2' ' C ' ' A' ' 223' ' ' ILE . . . 162.77 140.32 2.84 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.382 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.565 ' OG1' ' N ' ' A' ' 155' ' ' ALA . 6.2 t -176.66 -33.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.444 ' C ' ' O ' ' A' ' 150' ' ' THR . 4.7 tmm_? -20.08 -55.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.449 ' HB ' ' HA ' ' A' ' 218' ' ' ALA . 0.0 OUTLIER -94.22 -44.78 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.658 0.266 . . . . 0.0 111.658 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.535 ' O ' ' CB ' ' A' ' 154' ' ' ASP . 0.2 OUTLIER -109.41 109.45 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.318 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' ILE . 58.3 m-20 98.58 -38.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.067 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.565 ' N ' ' OG1' ' A' ' 150' ' ' THR . . . -36.74 -46.88 0.63 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.11 65.56 3.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.15 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 m -162.9 -45.99 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.5 43.07 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.9 mtt 53.02 74.31 0.79 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.288 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -58.73 139.88 92.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.874 2.383 . . . . 0.0 112.663 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.26 -43.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -162.19 120.79 2.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -122.69 128.68 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.452 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.527 ' O ' HG23 ' A' ' 223' ' ' ILE . 12.3 mtt180 -80.02 123.21 27.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.489 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.597 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -90.34 124.27 42.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.327 . . . . 0.0 110.262 178.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.484 ' O ' ' CB ' ' A' ' 167' ' ' GLN . 21.4 t -144.61 87.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.966 0.412 . . . . 0.0 111.621 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.484 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 4.6 tt0 91.91 105.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.335 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.417 ' HA ' ' CG2' ' A' ' 221' ' ' ILE . 2.4 pp -142.1 -45.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -74.27 159.74 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 -179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.424 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 5.0 tt0 -104.48 -42.38 5.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.679 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . 0.424 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 94.0 mt 69.12 -64.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.596 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -54.46 -34.79 62.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.248 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -99.16 127.4 45.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.9 p -168.12 96.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -138.01 -43.52 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -57.67 122.34 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.67 -25.66 59.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.15 -26.98 68.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 19.1 m-85 -82.6 -6.2 59.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.424 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.3 m -56.34 -41.25 75.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.76 0.314 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.2 -35.82 81.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.49 -26.73 46.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.55 -23.72 63.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.1 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -32.98 61.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -68.01 -31.76 71.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' ILE . 13.9 m-20 83.83 -29.14 0.09 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.631 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.511 ' HA ' ' HA ' ' A' ' 131' ' ' PRO . 7.4 pt 39.89 103.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.315 0.579 . . . . 0.0 111.946 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -114.6 108.96 17.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 35.2 m -52.69 157.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.251 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 101.99 -15.96 56.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.302 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 7.7 t -74.55 -166.99 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.01 0.433 . . . . 0.0 111.301 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.29 136.86 20.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 29.8 m -141.61 175.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.967 0.413 . . . . 0.0 111.801 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -125.7 162.85 24.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.84 140.97 41.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.389 . . . . 0.0 110.856 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 11.0 m -154.25 118.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.023 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -70.0 159.25 34.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -168.91 143.18 3.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.0 t70 68.08 -70.53 0.12 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 175.19 43.03 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.05 165.71 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.9 tt -87.24 150.3 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.136 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.0 t -160.05 116.96 2.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.0 106.22 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.676 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.0 m -85.73 129.41 34.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 10.9 t60 -143.94 145.55 32.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -33.39 -40.02 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.42 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -62.65 -70.58 1.01 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.26 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.8 mtmt -158.87 -174.66 4.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.44 133.51 53.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.175 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.75 159.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.481 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -83.18 -58.3 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 1.7 mt 64.2 151.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.205 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -140.42 -175.59 4.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.716 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -28.95 67.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.394 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -67.61 0.24 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.4 mp -78.82 -34.29 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.063 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.449 ' HA ' ' HB ' ' A' ' 152' ' ' VAL . . . -90.73 33.94 0.91 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.602 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -56.43 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 220' ' ' THR . 13.5 t -174.67 72.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.021 0.439 . . . . 0.0 111.162 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.417 ' CG2' ' HA ' ' A' ' 168' ' ' ILE . 4.9 mm -89.55 171.72 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.422 ' HB3' ' HB3' ' A' ' 167' ' ' GLN . 53.6 ttt180 -89.71 99.64 12.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 111.612 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.597 HG23 ' HA ' ' A' ' 165' ' ' ILE . 0.4 OUTLIER -129.79 -149.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.071 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.476 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -118.85 -179.52 3.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 110.803 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 226' ' ' LEU . 30.3 tt0 -111.78 96.21 5.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 225' ' ' GLU . 1.7 pt? . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.77 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.2 t -152.3 -53.94 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.743 0.306 . . . . 0.0 110.908 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -85.14 164.7 17.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.9 mtt -146.56 -59.89 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.91 115.46 27.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.97 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -86.43 167.3 14.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 35.2 m -76.16 -41.75 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -90.27 18.37 6.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -90.05 -51.94 5.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.44 147.96 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.5 mt -147.87 113.24 5.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -112.77 -37.48 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.307 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -109.3 172.37 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 m -89.63 -37.68 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.24 -58.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -78.1 157.8 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.975 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.66 -46.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.1 t 61.42 105.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.0 m -138.81 90.11 2.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.48 80.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m 59.27 86.12 0.17 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.37 -25.57 18.21 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.594 2.196 . . . . 0.0 112.338 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . 0.401 ' CG ' ' HB3' ' A' ' 181' ' ' GLN . 3.9 p90 -114.02 144.0 43.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.732 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.17 -98.83 0.16 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.811 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -56.31 153.75 18.43 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.758 0.313 . . . . 0.0 111.234 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.589 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 89.1 Cg_endo -81.83 137.57 10.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.892 2.395 . . . . 0.0 112.87 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.643 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 143.1 -30.99 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 O-C-N 123.922 0.763 . . . . 0.0 111.859 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 2.7 Cg_exo -73.53 63.34 4.59 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.362 2.042 . . . . 0.0 112.326 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.55 81.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 14.4 tp -70.86 -39.39 72.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.348 . . . . 0.0 110.803 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.11 8.63 31.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -88.94 -170.99 3.12 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.709 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -62.09 84.6 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.845 0.355 . . . . 0.0 111.126 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.49 32.26 5.09 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.913 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.1 t -128.82 116.5 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.689 0.281 . . . . 0.0 111.179 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.69 -172.33 16.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -175.4 166.43 3.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.728 0.299 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.412 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -137.35 -174.34 3.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.059 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.13 -43.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.119 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.465 ' O ' ' CB ' ' A' ' 146' ' ' ALA . . . -158.6 -157.93 0.66 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 145' ' ' ALA . . . 85.77 -179.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.499 ' CB ' ' HD2' ' A' ' 148' ' ' PRO . . . -56.71 -176.66 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.499 ' HD2' ' CB ' ' A' ' 147' ' ' ALA . 68.4 Cg_exo -41.31 98.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.757 2.305 . . . . 0.0 112.928 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.74 41.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.079 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 13.6 t -80.6 -7.19 59.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.414 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 4.4 mpt_? 60.56 25.96 15.63 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.511 ' O ' ' N ' ' A' ' 154' ' ' ASP . 21.4 t 70.68 -58.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.535 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 5.4 tt -55.41 79.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.999 0.428 . . . . 0.0 111.39 -179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 167.7 -35.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.382 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -52.27 -25.28 9.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.598 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -98.73 32.9 2.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.372 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.0 t -170.96 32.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.352 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.4 t -153.06 34.46 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.195 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 41.2 ttm 66.44 75.29 0.33 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.008 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . 0.403 ' HA ' ' CD2' ' A' ' 226' ' ' LEU . 29.0 Cg_endo -62.83 152.85 76.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.843 2.362 . . . . 0.0 112.799 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 -45.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -170.2 124.97 0.75 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 6.4 m -110.28 123.0 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 111.488 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -84.22 102.09 12.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 165' ' ' ILE . 0.2 OUTLIER -79.47 122.25 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.649 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.596 ' O ' ' CB ' ' A' ' 167' ' ' GLN . 20.4 t -144.39 85.86 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.596 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 33.4 tt0 103.54 147.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.074 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -149.59 -66.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.08 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -177.96 -168.52 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.543 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.03 -77.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.87 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.105 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -163.7 -55.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.862 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -163.85 -65.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.541 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 0.4 OUTLIER 72.0 107.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.292 0.568 . . . . 0.0 110.784 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 55.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.954 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 t -161.75 130.12 4.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -22.43 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -60.96 -31.49 71.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -76.09 -17.17 59.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.322 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 84.8 m -51.85 -43.84 63.39 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . 0.401 ' HB3' ' CG ' ' A' ' 128' ' ' PHE . 55.4 mt-30 -70.83 -33.02 70.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.58 -25.05 59.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.3 tp -84.48 -2.71 57.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.573 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.25 -50.25 30.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.057 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -82.9 -23.37 33.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.129 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 187' ' ' ILE . 9.3 m-20 65.89 16.2 10.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.51 ' O ' HG13 ' A' ' 187' ' ' ILE . 24.0 pt 38.15 99.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.1 0.476 . . . . 0.0 111.988 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 134.49 42.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.93 141.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 165' ' ' ILE . . . 104.54 -8.65 47.83 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 16.4 t -70.23 174.92 5.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -132.33 111.88 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.676 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 27.2 m -121.59 176.94 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.362 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -142.13 160.76 39.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.448 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 1.8 tt -134.62 155.7 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 111.152 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.448 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 7.1 m -156.92 132.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.27 145.55 35.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -157.35 116.6 3.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.143 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 51.99 40.76 28.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.88 62.15 6.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.459 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -159.48 158.47 32.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.77 0.319 . . . . 0.0 110.82 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.42 141.79 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.3 t -159.9 111.42 2.0 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -81.19 98.4 8.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.7 m -77.07 110.15 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 24.6 t-80 -107.62 147.21 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.511 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -41.33 -34.4 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.296 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -77.25 -57.49 3.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.496 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -160.68 -175.19 4.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.687 0.279 . . . . 0.0 110.875 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.6 149.0 31.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.71 175.64 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -90.7 -66.56 0.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 7.8 mp 60.55 155.63 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 111.36 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -144.69 -175.45 4.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.65 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.68 -29.13 70.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.998 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -45.58 11.84 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.808 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.61 -69.74 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.52 49.78 1.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -84.65 -38.78 19.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -156.55 90.37 1.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.891 -179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.47 ' HB ' HD12 ' A' ' 223' ' ' ILE . 23.8 mm -118.96 162.15 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.011 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.407 ' HB2' ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -89.66 90.35 8.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 111.268 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.47 HD12 ' HB ' ' A' ' 221' ' ' ILE . 0.1 OUTLIER -137.62 175.16 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.124 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.405 ' HA ' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -89.64 162.78 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 110.824 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -89.66 56.04 3.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.403 ' CD2' ' HA ' ' A' ' 160' ' ' PRO . 6.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.3 m -151.86 101.14 2.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.794 0.33 . . . . 0.0 110.957 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -93.45 174.45 7.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.9 ttm -152.45 -55.75 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -90.01 59.76 4.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.08 108.08 19.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.6 p -88.81 -46.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.136 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -90.34 48.86 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.13 -41.24 11.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.054 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -85.54 144.0 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mp -145.08 112.71 6.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.842 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -150.38 168.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.15 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -133.48 100.29 4.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.7 t -144.34 -44.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tt 65.39 46.41 2.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -100.08 -46.46 5.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.27 147.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 11.1 p -168.26 125.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.4 t -169.71 157.68 7.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -86.09 83.71 7.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.65 7.97 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.82 -19.26 8.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.705 2.27 . . . . 0.0 112.644 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 62.51 110.62 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -166.37 -150.78 6.49 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.701 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 8.1 p30 53.95 159.18 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.301 0 CA-C-O 120.966 0.412 . . . . 0.0 111.843 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.646 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 83.2 Cg_endo -78.84 137.12 13.83 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.824 2.349 . . . . 0.0 111.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 160.44 -31.03 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.373 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 23.8 Cg_exo -63.65 118.54 5.46 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.634 1.556 . . . . 0.0 112.986 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.23 -32.77 8.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.448 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.2 pp -36.59 -37.31 0.13 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.51 -50.76 71.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.207 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.424 ' O ' ' C ' ' A' ' 138' ' ' LEU . 2.1 pm0 -90.67 -21.3 21.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.634 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 137' ' ' GLU . 6.5 tt -29.57 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.443 . . . . 0.0 112.018 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.35 -93.15 1.23 Allowed Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.427 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.8 t -145.46 42.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 111.181 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.36 -149.23 1.22 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.236 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 179.48 177.84 0.56 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.6 p -156.86 -173.47 4.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.778 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.91 74.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.48 -69.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.37 -62.4 1.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.41 ' CB ' ' CD ' ' A' ' 148' ' ' PRO . . . -176.18 -63.01 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.073 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.41 ' CD ' ' CB ' ' A' ' 147' ' ' ALA . 7.1 Cg_exo -33.94 97.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.219 2.613 . . . . 0.0 113.188 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.579 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 97.82 112.41 3.07 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.797 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.415 ' HA ' ' CG2' ' A' ' 153' ' ' ILE . 2.8 t 175.92 78.3 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.618 ' HB2' ' HB ' ' A' ' 221' ' ' ILE . 11.0 tpp180 -78.84 92.61 4.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.422 ' CG1' ' O ' ' A' ' 151' ' ' ARG . 8.1 p 48.91 20.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.461 ' O ' ' CG1' ' A' ' 153' ' ' ILE . 2.9 tt -106.32 10.55 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 121.221 0.534 . . . . 0.0 110.312 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.9 -35.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.404 ' HB3' ' HA ' ' A' ' 225' ' ' GLU . . . -88.41 43.72 1.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -140.76 33.54 1.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.15 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.6 p -158.08 -41.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.088 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -76.2 84.85 3.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.407 -179.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.2 mtt 57.36 61.31 6.35 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.645 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -63.2 124.74 14.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.848 2.365 . . . . 0.0 112.407 179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -157.0 -47.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -159.98 148.82 17.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.43 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.465 ' HB ' HG23 ' A' ' 223' ' ' ILE . 15.4 m -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.444 . . . . 0.0 111.792 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.572 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 13.3 mtp85 -82.2 109.37 16.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.455 ' HA ' HG22 ' A' ' 223' ' ' ILE . 0.4 OUTLIER -84.13 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.978 0.418 . . . . 0.0 111.737 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 3.9 t -138.45 42.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.867 179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.47 ' O ' ' CB ' ' A' ' 222' ' ' ARG . 59.0 mt-30 39.56 -108.9 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.482 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.443 HG23 HD12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -172.36 -64.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.853 0.358 . . . . 0.0 110.527 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -138.15 -62.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -171.68 -75.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.011 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -176.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.1 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -163.94 -64.49 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . 0.456 ' O ' HG13 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -117.98 -83.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 173' ' ' GLN . 0.4 OUTLIER 68.95 13.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -106.06 94.41 5.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.797 0.332 . . . . 0.0 111.077 179.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -166.67 115.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.91 -41.25 95.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.1 -33.82 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -90.14 5.94 44.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.278 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.2 m -57.47 -26.79 61.77 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.45 -36.88 85.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -73.74 -33.27 64.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 7.0 mt -78.0 -28.76 49.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 179.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.52 -34.48 61.79 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 186' ' ' ASP . . . -76.4 -14.66 60.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.283 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.513 ' O ' HG12 ' A' ' 187' ' ' ILE . 11.4 m-20 81.09 -47.48 0.25 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.53 ' HA ' ' HB3' ' A' ' 131' ' ' PRO . 2.3 pt 53.76 125.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 174.95 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 11.0 p -101.43 147.21 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 -179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.95 65.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.536 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.412 ' N ' HG23 ' A' ' 165' ' ' ILE . 6.1 t -66.75 -169.1 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.035 0.445 . . . . 0.0 111.203 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.4 97.06 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 33.4 m -110.91 -178.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.84 177.98 9.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 1.4 pp -136.12 169.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 12.5 m -150.14 98.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -71.64 98.37 1.89 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -70.01 -177.65 1.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.27 -26.44 66.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.32 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.517 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -158.96 139.8 12.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.992 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 15.0 tt -97.81 130.93 45.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.2 t -160.01 145.98 15.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.914 0.387 . . . . 0.0 111.234 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -95.98 169.58 9.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.656 179.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.9 m -148.96 136.7 20.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -153.12 157.24 40.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -51.04 97.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 141.37 -64.71 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.32 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -160.04 173.2 16.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 111.061 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.52 153.28 26.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.22 161.63 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.94 -63.03 1.5 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 3.7 mp 53.81 93.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.369 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.66 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -69.64 -33.48 72.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.412 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -50.75 -56.42 12.12 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.729 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 217' ' ' LEU . 0.0 OUTLIER -69.65 -39.16 77.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.417 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.417 ' O ' ' HB ' ' A' ' 153' ' ' ILE . . . -90.5 33.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.313 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -90.57 -58.69 2.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.623 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 71.5 p -149.25 71.23 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.481 -178.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.618 ' HB ' ' HB2' ' A' ' 151' ' ' ARG . 30.1 mm -98.8 166.26 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.385 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.579 ' HA ' ' HA2' ' A' ' 149' ' ' GLY . 13.8 ttt180 -100.97 101.04 11.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.481 HD11 ' HB ' ' A' ' 221' ' ' ILE . 1.9 mp -147.23 171.87 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.572 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 1.5 tm-20 -89.12 167.82 12.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.332 . . . . 0.0 110.728 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.404 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 33.3 tt0 -89.55 81.53 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.352 179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.0 m -86.19 163.46 17.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.766 0.317 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -155.78 -46.56 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.985 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 45.9 mtt -139.94 111.7 7.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.27 -50.7 6.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -77.47 140.28 39.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.1 m -65.23 -49.09 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.268 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -90.45 52.8 2.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -89.94 -36.94 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -84.31 140.03 31.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.2 mt -111.75 151.32 29.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -155.07 146.85 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.72 -49.35 7.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.89 172.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.52 92.2 2.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -130.26 123.76 30.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.71 163.88 23.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 m -69.84 161.53 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -83.38 73.76 10.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -154.23 -51.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 m -143.4 108.55 5.25 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.62 -29.8 62.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.552 2.168 . . . . 0.0 112.513 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.2 p90 -125.96 169.22 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 211' ' ' VAL . . . -92.0 -134.42 6.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.459 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.642 ' CB ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER -123.52 -60.97 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.547 0.213 . . . . 0.0 111.513 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.642 ' HD3' ' CB ' ' A' ' 130' ' ' ASN . 3.3 Cg_exo -84.82 56.34 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.495 2.797 . . . . 0.0 112.072 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.564 ' O ' ' CG2' ' A' ' 132' ' ' ILE . 0.1 OUTLIER 36.81 68.72 1.44 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.886 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.94 138.49 42.79 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.998 2.466 . . . . 0.0 112.639 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' CG2' ' A' ' 168' ' ' ILE . . . -90.83 78.53 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.051 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 2.9 pp -76.88 -46.16 25.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.929 0.395 . . . . 0.0 110.44 179.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -90.56 4.09 52.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.051 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.7 -167.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.2 tt -80.44 59.73 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.785 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.32 95.91 1.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.611 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.53 -59.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.093 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.78 -178.87 40.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.594 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.14 168.82 23.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.8 m -120.48 148.73 43.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.998 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.18 -44.77 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.785 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -118.59 -164.78 1.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.962 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 69.75 132.07 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.522 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -74.59 -46.92 5.53 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 12.5 Cg_exo -35.65 -38.81 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.976 2.451 . . . . 0.0 113.367 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -153.08 132.79 3.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.821 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.426 ' HB ' ' HA ' ' A' ' 225' ' ' GLU . 8.8 t -104.66 -26.44 12.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 153' ' ' ILE . 3.7 tpp180 66.95 63.54 0.47 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.538 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 154' ' ' ASP . 0.0 OUTLIER 43.62 -82.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.178 179.416 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 151' ' ' ARG . 3.1 tt -51.29 82.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.949 0.404 . . . . 0.0 111.285 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 158.84 -40.51 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.026 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -68.63 -18.49 64.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.247 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -106.21 32.22 4.59 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.468 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.0 t -154.02 19.47 0.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.463 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -134.2 -66.85 0.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.739 0.304 . . . . 0.0 110.836 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 25.2 ttm -167.48 56.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.634 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -51.83 146.26 28.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.172 2.581 . . . . 0.0 112.818 -179.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -161.77 -50.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.487 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -170.33 84.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.426 ' HB ' HG23 ' A' ' 223' ' ' ILE . 19.3 m -70.16 143.52 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.443 ' HB2' ' CB ' ' A' ' 224' ' ' GLU . 6.3 mtt85 -90.36 106.94 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.76 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.519 ' HA ' HG22 ' A' ' 223' ' ' ILE . 0.0 OUTLIER -77.4 143.24 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.455 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . . . . . . . . . 11.4 t -142.79 -40.05 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -131.46 129.28 40.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.828 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.454 HG12 ' CD1' ' A' ' 165' ' ' ILE . 15.1 mm -146.52 -42.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.05 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -51.7 167.11 0.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -93.64 -175.27 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.66 -56.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.17 -66.48 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -88.91 170.36 10.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.7 p -168.77 -40.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.263 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.8 98.38 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.5 p -153.87 138.65 17.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.18 73.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -62.36 -26.19 68.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.189 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -90.07 -31.92 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -54.22 -38.21 65.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.975 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -28.12 69.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 7.2 mp -76.87 -34.24 57.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.901 179.757 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.48 -32.25 73.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.0 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -25.07 20.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.06 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -57.39 -21.01 33.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.608 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . 0.464 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 7.3 t70 65.42 85.19 0.14 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.761 0.315 . . . . 0.0 110.759 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.498 ' CG2' ' HA ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 166.39 144.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.577 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . 0.405 ' HA ' HG23 ' A' ' 132' ' ' ILE . 11.2 mpt_? -115.53 -87.82 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.962 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.446 HG12 HD11 ' A' ' 165' ' ' ILE . 33.8 m -155.43 169.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.75 -13.44 62.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.179 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' SER . . . . . 0.401 ' N ' HG21 ' A' ' 165' ' ' ILE . 5.4 t -68.56 -167.44 0.09 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.278 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -141.11 92.07 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.471 ' HA ' ' CG ' ' A' ' 206' ' ' HIS . 31.0 m -100.06 148.03 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.628 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -95.48 161.31 14.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.652 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -113.9 156.35 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.138 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.42 133.07 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.35 95.21 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.025 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -74.21 178.91 4.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.44 86.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 65.96 44.7 91.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.642 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -161.78 139.33 8.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.929 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . 0.472 HD13 HG22 ' A' ' 202' ' ' ILE . 0.1 OUTLIER -97.27 126.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -160.07 137.72 9.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 17.8 mt -80.0 178.7 8.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -150.4 93.46 1.99 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.769 0.319 . . . . 0.0 111.259 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.503 ' O ' ' N ' ' A' ' 208' ' ' GLY . 2.1 t60 178.66 -169.64 0.1 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 60.51 -72.2 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -118.62 -52.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.959 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -160.59 -77.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.756 0.312 . . . . 0.0 110.428 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -142.21 160.76 39.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . 0.421 HG13 ' HA3' ' A' ' 129' ' ' GLY . 10.8 t -114.69 142.97 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 213' ' ' LEU . 7.0 mm-40 -79.73 -51.86 8.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . 0.468 ' C ' ' O ' ' A' ' 212' ' ' GLU . 0.5 OUTLIER 23.14 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.164 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.14 161.72 10.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -53.87 -30.67 46.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.322 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -54.29 -53.92 47.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.972 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -40.99 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.038 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -55.41 -21.44 15.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.026 -179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -82.65 -16.65 47.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.301 -179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.2 t -141.7 80.82 1.74 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.434 HD11 HG22 ' A' ' 221' ' ' ILE . 36.9 mt -126.51 159.62 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.86 107.6 20.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 112.161 -179.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.519 HG22 ' HA ' ' A' ' 165' ' ' ILE . 0.2 OUTLIER -148.04 168.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.678 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.443 ' CB ' ' HB2' ' A' ' 164' ' ' ARG . 3.4 tt0 -89.73 169.55 11.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.645 0.259 . . . . 0.0 110.452 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . 0.426 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 22.8 tt0 -89.53 125.45 35.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 3.7 pp . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.316 179.915 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.1 t -153.56 -53.87 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.746 0.307 . . . . 0.0 110.917 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -87.33 148.63 24.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 36.4 mtt -148.13 136.88 21.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.78 98.45 11.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -89.98 156.68 18.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 28.8 m -69.53 -42.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -78.91 70.68 5.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.887 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 52.2 2.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -70.9 132.9 45.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 tp -157.61 -51.7 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 m -90.75 157.48 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.216 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -88.13 -38.68 15.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.38 140.04 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.53 125.68 39.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -131.73 155.51 47.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -148.01 130.45 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.91 140.76 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.7 t 61.37 173.51 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -158.0 103.46 1.86 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.47 -61.92 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.46 106.83 2.35 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.474 2.116 . . . . 0.0 112.567 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -139.99 44.38 1.91 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.19 120.38 2.33 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.247 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.462 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 2.0 p-10 -175.15 163.31 2.28 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.502 ' O ' ' C ' ' A' ' 132' ' ' ILE . 5.3 Cg_endo -47.15 140.79 13.83 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.97 2.447 . . . . 0.0 112.908 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.502 ' C ' ' O ' ' A' ' 131' ' ' PRO . 0.2 OUTLIER -6.86 84.01 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.064 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.31 142.75 74.24 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.04 2.493 . . . . 0.0 111.729 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.455 ' HA3' HG12 ' A' ' 221' ' ' ILE . . . -90.45 29.47 6.66 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.873 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.459 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.7 tt -79.03 -56.3 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.104 0.478 . . . . 0.0 110.198 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.19 12.02 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.229 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -87.04 -149.28 0.15 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.95 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.09 84.61 6.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.574 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . 0.435 ' HA3' ' HA ' ' A' ' 217' ' ' LEU . . . -90.33 111.42 3.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.248 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 8.7 p -146.76 -46.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.621 0.248 . . . . 0.0 111.477 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . 0.4 ' HA2' ' CG ' ' A' ' 219' ' ' HIS . . . 134.26 115.45 1.56 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.549 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.49 -173.06 0.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.825 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.76 122.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.07 -46.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.543 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.96 -173.99 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 62.05 -83.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.418 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -179.15 -59.55 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.49 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 5.1 Cg_exo -31.36 133.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.363 2.709 . . . . 0.0 113.546 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.82 125.94 0.04 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.688 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.429 ' HA ' ' O ' ' A' ' 153' ' ' ILE . 0.2 OUTLIER -167.97 -151.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.462 0.172 . . . . 0.0 110.876 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.48 ' HB2' ' CG2' ' A' ' 223' ' ' ILE . 36.4 ttp180 69.02 -70.15 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.264 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.41 ' HB ' ' O ' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -95.25 -17.79 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.413 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.576 ' O ' ' CB ' ' A' ' 154' ' ' ASP . 0.1 OUTLIER -133.54 107.09 10.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.642 0.258 . . . . 0.0 111.419 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . 0.576 ' CB ' ' O ' ' A' ' 153' ' ' ILE . 15.7 t70 99.12 -37.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -48.33 -32.18 7.07 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.03 -54.71 41.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.546 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.9 t -63.23 -28.73 70.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 3.0 m -71.99 -155.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.09 71.12 1.35 Allowed Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.712 0.291 . . . . 0.0 111.147 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_exo -38.32 132.48 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.261 2.641 . . . . 0.0 113.148 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -170.0 -49.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -170.17 84.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.651 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.445 ' HB ' ' CG2' ' A' ' 223' ' ' ILE . 31.3 m -69.95 -178.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.133 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 8.9 mtp85 -124.31 -167.7 1.69 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.529 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 28.4 mm -142.37 124.83 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.796 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 t -152.11 68.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.638 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . 14.5 tt0 44.77 -94.13 0.02 OUTLIER 'General case' 0 C--O 1.246 0.888 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.459 HG12 ' HA ' ' A' ' 222' ' ' ARG . 48.6 mm 77.59 -5.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 36.2 p30 -157.9 -178.81 7.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.744 0.306 . . . . 0.0 111.139 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.09 -88.71 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.164 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.14 -55.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.683 0.278 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.5 t80 63.55 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -104.63 171.74 7.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.829 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 9.4 p -172.55 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.969 0.414 . . . . 0.0 111.295 -179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.43 -173.33 4.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.645 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.4 p -128.0 -81.72 0.59 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.191 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.03 -43.78 86.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.453 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -67.86 -36.73 80.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.14 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -90.21 7.54 37.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 -179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.6 m -65.59 -48.4 72.44 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.43 -34.41 65.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 11.0 mp -62.8 -23.96 67.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.088 179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.2 mt -90.06 -32.09 16.87 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -19.27 10.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.526 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.434 ' CB ' ' N ' ' A' ' 130' ' ' ASN . . . -81.6 11.9 4.29 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 62.35 100.93 0.03 OUTLIER 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.426 ' CA ' HG12 ' A' ' 132' ' ' ILE . 2.7 pt -83.51 87.14 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.401 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -125.0 107.81 11.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.691 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.49 ' HA ' HG23 ' A' ' 165' ' ' ILE . 18.3 m -56.77 156.91 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.05 -6.9 66.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.087 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.5 t -66.25 -170.43 0.09 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.038 0.446 . . . . 0.0 111.525 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.34 136.21 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.716 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . 0.406 HG12 ' CD2' ' A' ' 206' ' ' HIS . 35.5 m -138.92 -174.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.045 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.11 161.34 33.53 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.835 0.35 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.412 HG13 ' N ' ' A' ' 196' ' ' VAL . 0.3 OUTLIER -121.19 153.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.786 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.412 ' N ' HG13 ' A' ' 195' ' ' ILE . 13.5 p -141.89 141.4 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.36 91.6 8.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -70.12 -179.71 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.78 92.92 3.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.17 35.0 91.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.673 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -163.45 143.31 8.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.763 0.315 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 20.9 tt -98.48 111.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.6 t -120.69 133.97 55.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -90.32 120.9 31.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.7 m -102.44 140.28 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . 0.45 ' O ' ' C ' ' A' ' 207' ' ' ASN . 26.3 t-80 -158.71 145.0 16.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' HIS . 21.2 m120 -28.56 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.441 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . 0.467 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -56.99 -76.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.093 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . 0.467 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.1 mtmt -160.2 -174.51 4.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.91 133.93 48.05 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.86 148.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 111.588 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.39 -9.23 59.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.973 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 5.5 mp -36.99 106.92 0.05 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.784 0.326 . . . . 0.0 111.439 -179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 4.1 mp -93.34 -176.52 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 0.7 OUTLIER -63.08 -14.54 49.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.291 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.39 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 111.227 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 135' ' ' LEU . 2.5 mm? -86.28 -24.06 26.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.343 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . 0.41 ' O ' ' HB ' ' A' ' 152' ' ' VAL . . . -90.41 35.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.538 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . 0.415 ' HB2' ' O ' ' A' ' 215' ' ' ASP . 0.9 OUTLIER -85.86 -7.22 58.85 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.358 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 4.6 t -179.09 90.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.196 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.475 ' HB ' HD11 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -126.42 -163.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.638 ' HB3' ' CA ' ' A' ' 167' ' ' GLN . 0.4 OUTLIER -84.39 88.95 7.3 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.52 ' HA ' ' O ' ' A' ' 164' ' ' ARG . 1.7 mp -151.76 144.41 16.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.481 ' CB ' ' HB2' ' A' ' 164' ' ' ARG . 15.4 tt0 -89.86 161.15 16.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -89.3 118.61 29.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.086 -179.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 2.1 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.288 179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.3 p -152.76 154.62 35.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.331 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -148.73 153.59 38.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.8 mtt -146.48 108.94 4.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -88.59 124.4 34.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -86.23 121.61 29.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.7 p -75.66 -41.98 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -66.07 93.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.899 179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -73.23 73.83 1.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.07 92.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.014 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mt -166.71 166.02 16.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -151.04 146.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -149.65 -48.38 0.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.9 t -146.76 -68.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.039 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 tp -172.75 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.24 176.07 5.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -139.21 -58.04 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 10.6 p -164.53 123.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t -166.7 164.8 16.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -114.91 -42.02 3.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.0 p -145.08 64.6 11.19 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.47 70.2 6.37 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.719 2.28 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -164.09 38.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -131.17 -175.24 13.93 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.65 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 1.8 p-10 50.62 166.51 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 122.273 0.229 . . . . 0.0 111.148 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.65 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 43.5 Cg_exo -23.07 139.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.31 3.34 . . . . 0.0 113.856 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 18.7 tt -46.45 121.99 6.58 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.17 -179.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -81.2 140.16 12.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.771 2.314 . . . . 0.0 111.828 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.52 68.66 2.36 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.306 -179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 9.9 tt -70.6 -65.77 0.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.98 3.43 54.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.168 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.438 ' HG2' HD11 ' A' ' 168' ' ' ILE . 2.6 mt-10 -77.71 -47.46 19.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.52 0.2 . . . . 0.0 111.331 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.7 pp -41.91 -31.8 0.37 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.805 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -40.81 -34.56 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.153 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.68 103.36 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 111.003 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 128.15 172.92 13.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.4 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.425 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 9.6 p30 -156.9 150.35 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -138.72 98.64 3.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.02 -53.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.45 153.0 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 61.17 174.73 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.119 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ALA . . . . . 0.421 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -73.39 -57.49 2.71 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PRO . . . . . 0.421 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 7.6 Cg_exo -33.68 109.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.175 2.583 . . . . 0.0 113.216 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 95.52 137.6 9.22 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.598 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' THR . . . . . 0.425 HG22 ' HB ' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -179.14 -80.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.535 0.207 . . . . 0.0 111.431 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ARG . . . . . 0.513 ' CB ' ' HB ' ' A' ' 221' ' ' ILE . 5.0 tpt180 70.08 38.98 1.42 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.958 0.409 . . . . 0.0 110.609 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.447 HG11 ' O ' ' A' ' 151' ' ' ARG . 0.3 OUTLIER 82.68 2.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.903 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ILE . . . . . 0.417 ' CG2' ' O ' ' A' ' 150' ' ' THR . 2.9 tp -92.78 25.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 120.749 0.309 . . . . 0.0 111.369 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 170.46 -36.43 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.797 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -67.4 -21.16 65.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . 0.409 ' HA ' HD13 ' A' ' 195' ' ' ILE . . . -86.73 56.31 3.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -166.34 -43.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 83.91 5.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 66.8 mtt 59.49 62.59 3.79 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.285 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 124.61 11.05 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.697 2.265 . . . . 0.0 112.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -153.08 -48.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -164.61 113.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . 0.432 ' HB ' HG22 ' A' ' 223' ' ' ILE . 21.5 m -89.54 132.66 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.236 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . 0.536 ' O ' HG21 ' A' ' 223' ' ' ILE . 13.8 mtt180 -79.88 98.24 7.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.283 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.49 HG12 ' CD1' ' A' ' 223' ' ' ILE . 0.3 OUTLIER -70.72 124.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.698 0.285 . . . . 0.0 110.888 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -160.87 98.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.404 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 166' ' ' VAL . 16.9 mt-30 93.15 137.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.872 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ILE . . . . . 0.438 HD11 ' HG2' ' A' ' 137' ' ' GLU . 0.6 OUTLIER -143.74 -48.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.835 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 172.69 -85.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.512 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.63 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.701 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.16 -60.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.9 t80 61.49 -81.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -116.63 134.89 54.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.972 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 7.3 p -163.26 94.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.04 -42.72 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.267 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.7 t -59.79 144.02 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.35 -33.33 71.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -31.73 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.391 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -90.06 -29.24 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.068 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.3 m -54.45 -32.01 56.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -71.37 -35.59 71.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 9.1 mp -55.78 -30.33 61.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.72 -31.88 46.6 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.824 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -23.78 3.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.103 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -51.9 -26.1 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.186 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.8 t70 57.84 78.47 0.24 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.267 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ILE . . . . . 0.475 ' CD1' ' N ' ' A' ' 187' ' ' ILE . 0.1 OUTLIER 178.98 160.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -144.61 172.58 12.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.479 ' HA ' HG21 ' A' ' 165' ' ' ILE . 24.6 m -54.21 174.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.839 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.69 -15.13 61.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.6 t -86.95 -164.7 1.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.394 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -132.2 86.62 2.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.397 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' VAL . . . . . . . . . . . . . 8.4 m -84.23 175.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.89 168.17 20.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ILE . . . . . 0.409 HD13 ' HA ' ' A' ' 156' ' ' ALA . 2.9 pp -139.96 167.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.333 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 m -154.94 142.19 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.005 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -70.08 85.02 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 20.4 tpt180 -78.89 88.91 4.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.209 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.26 54.77 9.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.339 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.41 39.07 96.77 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.654 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.19 145.0 31.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.736 0.303 . . . . 0.0 110.739 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 30.3 pt -80.0 139.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.241 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.6 t -160.17 129.95 5.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.822 179.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 25.7 mt -86.02 151.38 23.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.616 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 43.5 m -143.44 123.08 13.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -174.87 168.79 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.6 t30 67.4 -69.92 0.13 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.449 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 172.76 29.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.231 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.7 165.5 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.47 146.46 39.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.522 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.85 163.57 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.94 -65.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.381 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 6.6 mp 36.0 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.778 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.1 tp -75.95 -169.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.391 179.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -55.22 -25.09 30.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.998 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.4 -57.26 6.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.963 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.36 -49.98 67.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.191 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ALA . . . . . . . . . . . . . . . -90.21 47.2 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.65 179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -90.16 -43.09 10.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.708 -179.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 142' ' ' ASN . 3.0 p -155.39 70.13 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ILE . . . . . 0.513 ' HB ' ' CB ' ' A' ' 151' ' ' ARG . 0.7 OUTLIER -106.94 165.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' ARG . . . . . 0.481 ' N ' ' CG2' ' A' ' 221' ' ' ILE . 33.6 mtt-85 -101.8 92.57 4.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ILE . . . . . 0.536 HG21 ' O ' ' A' ' 164' ' ' ARG . 3.8 mm -124.21 -162.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' GLU . . . . . 0.481 ' H ' ' CG2' ' A' ' 223' ' ' ILE . 12.8 tm-20 -112.14 133.22 54.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.943 0.338 . . . . 0.0 110.511 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.67 109.31 20.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.244 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.8 0.333 . . . . 3.4199999999999999 110.832 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' HD12 ' A' ' 202' ' ' ILE . 27.3 m -68.01 -49.52 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 2.29 111.143 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 112' ' ' VAL . 1.7 pt-20 -80.53 -8.34 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 3.04 111.113 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -54.96 -35.12 63.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.367 . . . . 7.1399999999999997 110.989 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.15 127.61 32.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 7.6600000000000001 110.941 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.57 113.04 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 4.5300000000000002 110.809 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.467 HG21 HD21 ' A' ' 214' ' ' LEU . 13.0 m -128.06 171.51 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 4.1399999999999997 111.159 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -127.13 -43.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 7.3700000000000001 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 119' ' ' VAL . 0.4 OUTLIER -63.66 171.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 2.5499999999999998 111.203 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 135' ' ' LEU . 7.3 tp -110.81 72.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 2.6200000000000001 110.902 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.403 ' O ' HD22 ' A' ' 214' ' ' LEU . 74.9 mttt -153.09 160.97 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 5.8099999999999996 110.855 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -151.0 -166.04 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 4.1900000000000004 110.94 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -166.36 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 3.6400000000000001 110.998 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t 75.13 172.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 4.2800000000000002 110.888 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -102.34 -29.08 11.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 6.6399999999999997 110.974 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.7 m -111.56 76.2 1.49 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 3.8999999999999999 110.997 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -20.04 24.19 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.732 2.288 . . . . 3.79 112.345 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.78 150.42 27.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 4.1200000000000001 110.938 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 147.31 157.22 7.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.728 . . . . 1.8700000000000001 112.508 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.646 ' O ' ' O ' ' A' ' 129' ' ' GLY . 2.3 p30 49.2 141.77 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.111 0.482 . . . . 2.3700000000000001 111.405 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.708 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 73.8 Cg_endo -75.92 141.02 23.64 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.934 2.423 . . . . 1.8600000000000001 112.763 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.735 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 136.92 -27.46 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.546 . . . . 4.8200000000000003 111.765 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 17.1 Cg_exo -66.47 53.66 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.764 2.31 . . . . 1.5700000000000001 112.784 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.475 ' HA3' HG21 ' A' ' 168' ' ' ILE . . . -67.21 90.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.706 . . . . 1.25 112.232 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.592 HD11 HD21 ' A' ' 120' ' ' LEU . 6.3 tt -67.47 -56.47 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 2.9700000000000002 111.282 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -89.97 8.97 29.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.512 . . . . 3.8700000000000001 111.374 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 169' ' ' ASN . 0.5 OUTLIER -90.13 -50.05 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.757 0.313 . . . . 2.8700000000000001 111.04 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.571 HD22 ' O ' ' A' ' 217' ' ' LEU . 1.3 pp -45.29 -38.36 5.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 4.4000000000000004 111.429 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.727 ' O ' HG23 ' A' ' 140' ' ' VAL . . . -45.87 86.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.849 -0.691 . . . . 2.7400000000000002 112.92 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 139' ' ' GLY . 1.9 t 145.3 -61.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.727 0.299 . . . . 4.3499999999999996 111.211 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.55 ' N ' HG12 ' A' ' 140' ' ' VAL . . . -66.56 173.97 24.64 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.881 -0.676 . . . . 3.3700000000000001 113.05 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 141' ' ' GLY . 3.2 p-10 169.25 122.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.669 0.271 . . . . 2.71 110.67 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 66.2 m -122.4 -179.1 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 3.25 111.212 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -164.61 -40.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.983 -0.553 . . . . 3.1299999999999999 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.86 -172.18 2.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 4.0300000000000002 111.169 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 65.7 154.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 3.4500000000000002 111.098 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 149' ' ' GLY . . . -64.0 -56.65 22.94 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.352 -0.386 . . . . 2.73 111.16 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 10.4 Cg_exo -32.31 79.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.162 2.575 . . . . 3.5499999999999998 112.763 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 62.16 125.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.693 -0.765 . . . . 2.73 112.331 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.733 ' CG2' ' HB2' ' A' ' 155' ' ' ALA . 13.9 t -102.93 -5.48 23.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 2.6099999999999999 110.696 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.605 ' CG ' ' HA ' ' A' ' 220' ' ' THR . 0.0 OUTLIER 69.54 118.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 8.2200000000000006 110.773 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.659 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 29.3 t -31.85 -46.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 2.7400000000000002 111.499 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.537 ' CG2' ' HB3' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -43.29 -35.55 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 2.4100000000000001 110.993 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -109.32 -25.38 10.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 1.9299999999999999 110.809 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.733 ' HB2' ' CG2' ' A' ' 150' ' ' THR . . . -71.22 58.96 0.25 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 1.51 111.113 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.495 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -175.43 34.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 2.02 111.027 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 t -157.3 -33.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 2.5099999999999998 111.293 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.92 48.27 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.459 -0.337 . . . . 2.0499999999999998 111.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 4.1 ttm 62.95 61.62 1.95 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 2.8399999999999999 111.063 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.742 ' HB3' HD22 ' A' ' 226' ' ' LEU . 18.0 Cg_endo -59.3 149.26 82.06 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.839 2.359 . . . . 1.5800000000000001 112.304 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -146.12 -47.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.9900000000000002 110.84 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -170.04 95.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 2.4900000000000002 110.835 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 193' ' ' VAL . 8.1 m -73.06 116.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 1.0800000000000001 111.109 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 2.2 mtp180 -80.44 118.15 21.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 3.2999999999999998 111.069 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -84.08 120.27 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 1.3999999999999999 110.66 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.455 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 20.3 t -110.25 -23.0 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 1.8700000000000001 111.58 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.712 ' C ' HD13 ' A' ' 168' ' ' ILE . 1.8 mt-30 -178.63 -175.65 0.44 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 4.75 111.22 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.759 HG13 HD12 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -136.1 -60.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 4.5099999999999998 110.868 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 15.2 t-20 178.32 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.3200000000000003 110.909 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -173.62 -163.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.448 . . . . 5.3499999999999996 110.873 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.508 ' O ' ' C ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER -121.69 -12.39 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 4.1900000000000004 111.254 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.508 ' C ' ' O ' ' A' ' 171' ' ' ILE . 2.8 t80 -26.86 -58.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 6.4100000000000001 111.315 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -90.09 122.28 32.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 4.21 110.894 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 174' ' ' VAL . 12.4 p -168.71 37.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 2.7400000000000002 111.164 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 176' ' ' THR . 22.8 tt0 -112.95 77.31 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 5.0800000000000001 110.882 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 175' ' ' GLU . 1.4 p -157.35 124.92 5.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 2.9500000000000002 110.864 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -33.11 73.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 2.2599999999999998 111.057 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -70.43 -33.13 70.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 3.0800000000000001 110.944 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -76.97 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 3.7999999999999998 111.009 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.1 m -56.52 -41.88 77.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 1.8999999999999999 110.962 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -72.4 -35.11 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 3.2200000000000002 110.931 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.04 -20.6 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 2.1699999999999999 110.949 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.12 -8.43 59.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 2.1200000000000001 111.078 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -31.64 56.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 2.2599999999999998 110.955 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.3 -30.24 38.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 1.95 111.168 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 187' ' ' ILE . 3.1 t0 69.33 15.28 8.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 3.6600000000000001 110.953 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.759 HD12 HG13 ' A' ' 168' ' ' ILE . 7.8 pt 32.93 90.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 3.2799999999999998 111.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -84.37 93.39 8.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 2.9300000000000002 110.759 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 189' ' ' VAL . 8.5 m -57.66 122.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.012 -0.54 . . . . 1.8400000000000001 111.073 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.503 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 116.26 -5.27 19.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 1.3 112.55 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.435 ' C ' HG22 ' A' ' 165' ' ' ILE . 2.0 t -72.19 -161.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.336 . . . . 1.5600000000000001 110.958 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -147.38 115.08 6.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 2.7599999999999998 110.725 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.896 HG12 ' CD2' ' A' ' 206' ' ' HIS . 29.4 m -128.67 176.48 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 1.05 111.187 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.95 152.48 46.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 2.2999999999999998 110.784 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -128.41 153.96 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 2.54 111.172 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 195' ' ' ILE . 5.6 m -157.83 145.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 2.2799999999999998 111.113 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 170.39 16.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 2.3599999999999999 110.893 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -169.98 105.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 3.73 110.968 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 49.41 51.0 17.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 3.1400000000000001 110.996 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 60.74 68.04 1.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 2.0 112.417 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -170.07 155.58 5.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.804 0.335 . . . . 2.77 110.864 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.603 HD11 ' CG1' ' A' ' 152' ' ' VAL . 19.4 tt -105.3 140.14 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 1.8600000000000001 111.128 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.1 t -160.03 122.21 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 1.5800000000000001 110.959 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.414 HD13 ' HB ' ' A' ' 195' ' ' ILE . 3.1 mm? -84.86 119.23 25.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.71 110.776 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -96.9 117.63 31.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 1.27 111.012 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.896 ' CD2' HG12 ' A' ' 193' ' ' VAL . 10.6 t-80 -129.66 146.73 51.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 2.2000000000000002 110.746 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.564 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.0 m120 -19.4 -55.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 3.9100000000000001 111.303 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -54.36 -76.93 0.17 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.718 -0.754 . . . . 1.4099999999999999 112.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 18.5 mtmt -159.72 -174.44 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.317 . . . . 3.4900000000000002 110.763 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 149.24 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 2.0699999999999998 110.635 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.418 HG21 ' OD1' ' A' ' 130' ' ' ASN . 0.0 OUTLIER -122.41 178.04 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 1.5 111.213 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.77 -66.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 3.2799999999999998 110.693 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 218' ' ' ALA . 3.4 mp 57.03 77.18 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 2.1400000000000001 110.949 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 117' ' ' VAL . 17.9 tp -54.85 163.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 2.5299999999999998 110.77 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 6.7 m-20 -54.59 -22.79 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 2.1499999999999999 110.998 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.565 ' O ' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -81.89 -20.1 39.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.96 111.072 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.571 ' O ' HD22 ' A' ' 138' ' ' LEU . 10.5 mp -89.97 -56.41 3.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 2.6499999999999999 111.045 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.628 ' HB1' ' CB ' ' A' ' 152' ' ' VAL . . . -90.22 46.1 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 1.22 111.114 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.506 ' HB3' HD13 ' A' ' 138' ' ' LEU . 5.8 t-80 -90.06 -45.06 9.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 2.1699999999999999 111.013 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.605 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 6.0 p -142.25 65.31 1.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.359 . . . . 2.02 111.633 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.936 ' HB ' HD11 ' A' ' 223' ' ' ILE . 33.0 mm -89.76 158.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 116.33 -0.395 . . . . 1.9099999999999999 110.614 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 2.6 mtt-85 -95.2 86.18 4.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 6.5300000000000002 111.198 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.936 HD11 ' HB ' ' A' ' 221' ' ' ILE . 0.2 OUTLIER -123.43 -154.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.8500000000000001 110.497 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -117.94 162.44 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.348 . . . . 3.25 111.003 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.446 ' CB ' ' HB ' ' A' ' 150' ' ' THR . 16.9 tt0 -89.9 99.67 12.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 2.7999999999999998 110.849 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.742 HD22 ' HB3' ' A' ' 160' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 2.48 111.008 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.764 0.316 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 113' ' ' GLU . 34.1 m -76.42 -41.03 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.251 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.401 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -70.77 -34.6 71.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -72.14 -38.52 69.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -71.35 -37.75 71.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -71.91 148.58 45.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.001 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 119' ' ' VAL . 10.3 m -99.89 169.99 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -77.25 84.08 3.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 117' ' ' VAL . 7.7 t -145.97 158.33 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.403 ' N ' HG12 ' A' ' 119' ' ' VAL . 14.0 tp -91.86 -42.67 9.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.03 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.89 111.91 23.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.36 -71.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.37 138.49 50.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 p -129.79 111.78 12.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -162.34 -43.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 42.0 m -85.52 132.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.848 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 126' ' ' SER . 45.7 Cg_exo -56.39 176.19 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.566 2.177 . . . . 0.0 112.432 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -133.52 98.03 4.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.66 25.15 1.19 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.954 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -125.16 139.02 32.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 110.796 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.582 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.2 Cg_endo -75.74 135.35 17.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.676 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.61 HG13 HG21 ' A' ' 193' ' ' VAL . 0.0 OUTLIER 148.91 -32.05 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.117 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 7.4 Cg_endo -86.68 83.82 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.491 2.127 . . . . 0.0 112.434 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.1 117.19 4.97 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.48 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 217' ' ' LEU . 3.5 tt -81.08 -59.51 2.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -89.51 11.89 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.472 ' CG ' ' HB ' ' A' ' 168' ' ' ILE . 0.6 OUTLIER -90.11 -38.61 13.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.02 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 135' ' ' LEU . 2.2 pp -42.62 -35.47 1.11 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.536 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -51.84 151.39 7.0 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.714 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.0 t 58.6 101.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.237 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.97 141.64 6.1 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.425 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -164.57 96.13 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.342 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.443 ' N ' ' HD3' ' A' ' 151' ' ' ARG . 1.1 m -101.85 -175.89 2.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.52 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.85 -48.66 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.72 89.56 1.33 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.22 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.71 155.0 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -64.06 -61.61 6.53 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.09 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 8.2 Cg_exo -34.44 -43.99 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.014 2.476 . . . . 0.0 112.627 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -161.71 140.25 6.5 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.857 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.8 t -112.41 -20.88 11.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.655 0.227 . . . . 0.0 111.488 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.793 ' O ' HG22 ' A' ' 153' ' ' ILE . 18.5 ttp180 74.6 30.56 1.04 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.945 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER 52.51 -70.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.624 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.793 HG22 ' O ' ' A' ' 151' ' ' ARG . 3.4 tt -44.04 85.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.296 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 152' ' ' VAL . 1.7 p30 168.06 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.38 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.601 ' HA ' HD13 ' A' ' 226' ' ' LEU . . . -49.63 -29.39 7.14 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.474 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.682 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -95.32 33.06 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.417 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.9 t -170.59 33.61 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.175 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.576 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -158.52 35.54 0.23 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.038 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.1 mtp 58.43 67.87 1.99 Allowed Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.48 ' HA ' HD12 ' A' ' 226' ' ' LEU . 18.3 Cg_endo -60.14 155.67 44.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.81 2.34 . . . . 0.0 112.605 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.49 -55.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.504 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -170.26 91.84 0.19 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.062 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 193' ' ' VAL . 15.9 m -69.99 170.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.565 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -139.81 116.53 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.707 HD13 ' N ' ' A' ' 166' ' ' VAL . 0.2 OUTLIER -77.53 129.6 37.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.199 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.707 ' N ' HD13 ' A' ' 165' ' ' ILE . 17.7 t -133.93 -25.43 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.472 ' HA ' HG11 ' A' ' 189' ' ' VAL . 3.2 mt-30 -147.33 162.1 39.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.22 0.533 . . . . 0.0 111.775 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.565 HD13 HG12 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -152.38 -80.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.772 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -179.72 -67.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.91 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -155.65 -178.9 7.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.88 -40.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.197 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.96 -35.71 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.215 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -64.62 121.09 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 174' ' ' VAL . 10.7 p -172.07 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -102.86 -32.82 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.116 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.1 p -60.8 127.09 29.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.89 -35.51 67.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.03 -22.54 66.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.699 ' CZ ' HD12 ' A' ' 182' ' ' LEU . 14.0 t80 -79.02 -8.67 59.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.9 m -57.71 -40.44 79.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.688 0.28 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.09 -41.77 97.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.738 HD13 ' O ' ' A' ' 182' ' ' LEU . 3.2 tm? -77.69 -22.71 50.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.916 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 174' ' ' VAL . 0.7 OUTLIER -55.68 -26.7 46.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.297 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -34.95 40.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.95 38.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.719 ' C ' HD13 ' A' ' 187' ' ' ILE . 11.4 m-20 57.61 37.4 27.48 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.719 HD13 ' C ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER 9.68 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.267 0.627 . . . . 0.0 112.605 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -106.0 121.9 45.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.765 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.511 ' HA ' HD12 ' A' ' 165' ' ' ILE . 15.9 m -62.69 148.03 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.039 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.34 -11.75 47.59 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.719 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.8 t -70.06 -175.43 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -134.5 124.13 25.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.601 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 163' ' ' VAL . 21.1 m -131.83 172.87 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 0.0 111.461 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.9 138.53 19.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.653 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.682 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 4.0 tt -110.25 158.49 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.15 0.5 . . . . 0.0 111.32 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.473 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 15.4 m -142.07 136.55 29.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.982 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.98 93.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.12 -177.66 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.27 79.16 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 66.99 38.97 93.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.606 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -160.96 150.57 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 0.0 111.017 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.5 tt -95.6 144.74 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -160.08 137.43 9.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.466 HD23 HD22 ' A' ' 213' ' ' LEU . 3.6 mm? -115.55 121.86 43.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.5 m -86.76 138.31 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.534 ' CG ' HG12 ' A' ' 193' ' ' VAL . 3.0 t60 -165.12 172.31 12.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 206' ' ' HIS . 75.5 m-20 -28.17 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.82 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . 135.1 -81.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 23.0 mtmt -158.38 -88.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.614 0.245 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.25 158.34 34.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.01 172.68 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.014 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -79.94 -59.54 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.518 ' HA ' HD11 ' A' ' 217' ' ' LEU . 0.6 OUTLIER 52.72 96.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 3.9 mm? -79.75 178.51 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -76.54 -8.41 57.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.381 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -65.95 0.97 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.116 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -61.14 -36.27 79.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.509 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -89.76 24.48 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.595 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 4.6 t-80 -90.37 -67.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.8 p -103.86 53.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' A' ' 152' ' ' VAL . 31.9 mt -91.57 150.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -92.81 104.07 16.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.999 0.428 . . . . 0.0 111.657 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.562 HD11 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -136.7 -179.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.824 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.528 ' H ' HG22 ' A' ' 223' ' ' ILE . 6.3 tt0 -89.47 165.82 14.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 110.544 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -89.62 102.9 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.601 HD13 ' HA ' ' A' ' 155' ' ' ALA . 2.1 pt? . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.708 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 197' ' ' ASP . 27.6 m -90.07 -43.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.386 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -90.12 -30.37 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.351 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -55.94 -43.2 77.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.336 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -67.46 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.944 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 117' ' ' VAL . 1.9 tt 64.66 130.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.428 ' N ' HD23 ' A' ' 116' ' ' LEU . 7.1 m -147.85 171.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -103.26 -33.85 9.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 m -61.02 140.73 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.394 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.1 tp -89.54 -42.51 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.35 131.04 44.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.04 -63.75 1.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.34 163.97 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.041 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 t -118.0 88.75 2.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -152.96 77.13 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.5 t 59.04 69.56 1.33 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.63 -28.29 80.77 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -106.82 149.64 27.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 155.5 134.45 1.86 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.72 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.433 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 10.4 p30 54.05 157.17 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.275 0 CA-C-O 121.059 0.457 . . . . 0.0 111.939 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.562 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 91.8 Cg_endo -77.78 175.03 11.71 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.896 2.397 . . . . 0.0 112.324 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.591 HG23 ' CD1' ' A' ' 165' ' ' ILE . 1.0 OUTLIER 108.46 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.467 ' HD2' ' C ' ' A' ' 131' ' ' PRO . 72.7 Cg_exo -43.12 118.66 1.36 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.338 2.025 . . . . 0.0 113.125 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.789 ' HA3' HG21 ' A' ' 221' ' ' ILE . . . -90.97 23.5 23.29 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.11 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.459 ' HA ' ' HG ' ' A' ' 217' ' ' LEU . 0.6 OUTLIER -50.24 -36.0 29.25 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.998 0.428 . . . . 0.0 110.478 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD2' HG23 ' A' ' 174' ' ' VAL . 0.3 OUTLIER -90.48 -22.36 21.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -178.28 0.53 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.89 102.33 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.745 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.33 127.05 8.6 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.058 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.9 -79.03 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.779 0.289 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.05 109.74 0.59 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.643 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.11 102.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 0.0 110.422 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.515 ' HA ' HD11 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -81.81 162.05 23.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.268 0.556 . . . . 0.0 111.774 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 p30 49.4 -178.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.804 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.38 179.58 0.77 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.954 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.71 -71.26 0.14 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.988 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -80.27 174.7 5.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.745 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 76.2 Cg_exo -50.69 89.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.567 2.178 . . . . 0.0 112.229 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.406 ' HA2' ' HG2' ' A' ' 224' ' ' GLU . . . -167.78 146.92 11.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.483 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.792 ' O ' HD11 ' A' ' 153' ' ' ILE . 0.4 OUTLIER -140.1 -48.53 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.554 0.216 . . . . 0.0 110.458 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.814 ' O ' HD13 ' A' ' 153' ' ' ILE . 34.9 mtt180 88.24 55.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.766 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.726 HG13 ' CG1' ' A' ' 223' ' ' ILE . 16.0 m 57.38 -47.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.814 HD13 ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -43.99 -30.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 118.636 0.653 . . . . 0.0 112.345 -178.165 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.13 24.05 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.609 0.243 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -96.51 12.53 31.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.397 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.727 ' HB2' HG12 ' A' ' 195' ' ' ILE . . . -149.84 70.52 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.052 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.512 ' H ' HD21 ' A' ' 226' ' ' LEU . 7.4 m -158.73 -52.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.087 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.503 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.5 OUTLIER -71.4 -79.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.359 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.523 ' H ' HD22 ' A' ' 226' ' ' LEU . 26.5 ttm -155.76 92.09 2.69 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.681 0.276 . . . . 0.0 111.143 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 226' ' ' LEU . 18.7 Cg_endo -60.27 140.33 91.47 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.723 2.282 . . . . 0.0 112.552 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -162.91 -49.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.81 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -168.62 119.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.863 ' HB ' HG22 ' A' ' 223' ' ' ILE . 26.8 m -102.1 134.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 12.4 mtt180 -79.78 126.09 30.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.889 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.742 HD13 HG23 ' A' ' 223' ' ' ILE . 24.4 mm -94.08 96.77 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 165' ' ' ILE . 86.2 t -159.89 92.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.416 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.629 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 170.07 105.54 0.01 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 111.063 179.224 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 167' ' ' GLN . 22.0 mt 98.25 -31.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.463 ' OD1' HG11 ' A' ' 189' ' ' VAL . 42.8 t-20 37.88 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.12 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.75 179.93 1.62 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.9 0.381 . . . . 0.0 111.446 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.511 HD12 ' HB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -131.04 125.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.085 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -63.82 -45.37 89.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.95 0.405 . . . . 0.0 110.686 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -123.03 143.29 50.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.492 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 174' ' ' VAL . 7.3 p -164.53 94.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -161.69 91.67 0.83 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.849 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.0 p -153.62 135.97 14.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -67.9 -35.08 77.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.91 -32.61 74.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.08 -15.87 51.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.291 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 35.2 m -50.36 -39.36 46.19 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.742 0.306 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.62 -36.03 62.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.748 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -13.27 60.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.032 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -81.02 -2.27 47.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.538 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.09 -43.28 41.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.754 0.311 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.4 -30.15 16.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.029 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.545 ' O ' ' O ' ' A' ' 187' ' ' ILE . 6.5 m-20 73.71 2.86 4.36 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.736 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.545 ' O ' ' O ' ' A' ' 186' ' ' ASP . 41.2 pt 48.62 124.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 112.146 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.61 125.59 54.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.42 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.53 HG23 ' HD2' ' A' ' 222' ' ' ARG . 7.7 p -73.64 146.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.08 1.08 63.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 132' ' ' ILE . 17.4 t -81.31 174.67 11.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.24 131.14 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 132' ' ' ILE . 31.3 m -148.11 -167.92 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -140.38 174.52 10.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.759 0.314 . . . . 0.0 110.827 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.727 HG12 ' HB2' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -160.03 154.76 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 14.8 m -155.1 174.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 112' ' ' VAL . 11.0 m-20 -86.01 160.05 19.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.766 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -163.9 102.08 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.072 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 t70 55.27 43.81 28.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.21 46.05 93.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.547 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -153.2 148.75 27.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.33 . . . . 0.0 110.906 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.663 HG13 HD11 ' A' ' 195' ' ' ILE . 18.4 tt -83.39 147.2 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.206 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.5 t -160.11 122.52 3.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 195' ' ' ILE . 14.5 mt -82.37 113.78 20.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.807 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.7 m -97.08 140.43 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.828 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 207' ' ' ASN . 54.3 t60 -147.92 144.45 28.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.489 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.0 m120 -33.13 -40.56 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.72 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -68.65 -66.31 2.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.1 mtmt -157.69 -176.3 5.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.35 148.84 40.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.415 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -114.39 169.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -79.98 -64.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.401 HD13 HD12 ' A' ' 204' ' ' LEU . 2.7 tp 59.27 167.09 0.06 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 215' ' ' ASP . 0.2 OUTLIER -157.16 152.25 26.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.432 ' H ' HD13 ' A' ' 214' ' ' LEU . 71.6 m-20 -53.31 -26.2 17.76 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.206 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.78 -66.94 0.3 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 135' ' ' LEU . 3.3 mm? -88.36 -20.84 24.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.821 ' HA ' HD11 ' A' ' 221' ' ' ILE . . . -90.14 29.46 1.23 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.859 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 220' ' ' THR . 0.1 OUTLIER -90.12 -33.94 16.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 219' ' ' HIS . 1.4 p -161.91 84.86 0.6 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.334 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.821 HD11 ' HA ' ' A' ' 218' ' ' ALA . 0.0 OUTLIER -120.5 -164.11 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.643 ' HG3' HG23 ' A' ' 165' ' ' ILE . 11.7 ptt180 -86.22 80.38 8.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.263 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.863 HG22 ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -151.43 176.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.574 178.048 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -120.87 -173.52 2.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.752 0.311 . . . . 0.0 111.019 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.407 ' HA ' HG21 ' A' ' 150' ' ' THR . 1.6 pt-20 -89.84 89.18 7.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.523 HD22 ' H ' ' A' ' 159' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.118 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.76 0.314 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.62 ' HB ' HD13 ' A' ' 202' ' ' ILE . 33.3 m -90.12 -34.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.79 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.949 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -57.66 89.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -90.12 -53.38 4.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.22 160.29 30.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.73 135.1 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.563 ' HB3' HD21 ' A' ' 214' ' ' LEU . 10.9 tptt -159.12 173.47 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.809 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 1.0 OUTLIER -88.25 -45.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.047 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.468 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 12.3 tp -170.69 -51.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.22 142.61 28.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -119.55 -63.0 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 126' ' ' SER . 5.2 m -72.42 176.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.195 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.4 m -71.46 -55.67 7.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.61 -56.55 5.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 123' ' ' VAL . 2.6 m 61.41 86.1 0.16 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.073 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.31 155.23 25.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.618 2.212 . . . . 0.0 112.261 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 60.9 m-85 -142.97 33.97 1.37 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -106.58 -132.23 7.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.758 ' ND2' HG22 ' A' ' 211' ' ' VAL . 0.2 OUTLIER 54.5 -163.86 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.726 ' O ' ' HB1' ' A' ' 185' ' ' ALA . 65.9 Cg_exo -50.68 -74.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.877 1.718 . . . . 0.0 112.591 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.682 HG21 HG23 ' A' ' 187' ' ' ILE . 0.0 OUTLIER 165.2 127.78 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.449 0.166 . . . . 0.0 111.209 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.457 ' HB3' HD12 ' A' ' 213' ' ' LEU . 3.0 Cg_exo -74.17 139.93 27.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.738 2.292 . . . . 0.0 111.969 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.851 ' O ' HD11 ' A' ' 221' ' ' ILE . . . -90.28 93.37 1.86 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.807 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 135' ' ' LEU . 1.3 tt -83.58 -32.36 25.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.02 -10.78 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 169' ' ' ASN . 1.3 mt-10 -61.89 -49.61 75.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.736 0.303 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.496 HD21 ' C ' ' A' ' 216' ' ' ASP . 3.2 mp -29.94 -44.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.981 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -48.73 -44.9 30.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.879 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 105.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.739 0.304 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.76 114.14 0.78 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.544 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.473 ' HB3' HG22 ' A' ' 220' ' ' THR . 6.6 p30 -171.17 142.8 1.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.741 0.305 . . . . 0.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.45 ' HB2' ' HA3' ' A' ' 149' ' ' GLY . 13.8 t -95.9 162.15 13.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -162.41 -45.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.12 -45.0 1.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.84 -179.86 6.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.672 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -74.38 -58.28 1.92 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.518 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 5.9 Cg_exo -33.25 108.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 113.301 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 153' ' ' ILE . . . 115.5 42.0 0.77 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.713 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.904 ' O ' HD13 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -103.53 -142.41 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.803 ' N ' ' HB2' ' A' ' 155' ' ' ALA . 26.0 ttt180 65.13 -69.96 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.748 0.308 . . . . 0.0 111.623 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.618 HG11 HD22 ' A' ' 213' ' ' LEU . 2.5 m -95.68 -38.23 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 149' ' ' GLY . 1.0 OUTLIER -116.55 110.03 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.238 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 157' ' ' THR . 55.7 m-20 99.26 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.705 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.803 ' HB2' ' N ' ' A' ' 151' ' ' ARG . . . -42.93 -34.25 0.93 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.56 61.42 2.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.429 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 154' ' ' ASP . 4.1 t -176.23 -35.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.346 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.7 m -89.3 54.2 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 45.3 mtt 55.0 57.21 11.37 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.391 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 226' ' ' LEU . 7.3 Cg_endo -49.32 129.57 22.86 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.168 2.579 . . . . 0.0 112.559 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -154.97 -47.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.567 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -170.28 91.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 151' ' ' ARG . 20.4 m -70.0 178.42 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.912 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.48 ' HB2' ' CB ' ' A' ' 224' ' ' GLU . 1.5 mpt_? -127.18 107.75 10.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.798 ' HA ' HG23 ' A' ' 223' ' ' ILE . 8.2 tt -70.63 134.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.471 HG13 ' HA2' ' A' ' 190' ' ' GLY . 0.1 OUTLIER -156.39 11.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HB3' ' HB2' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -168.65 100.57 0.4 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.947 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.611 HD11 HD11 ' A' ' 165' ' ' ILE . 3.3 mp -117.65 -4.29 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.949 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 137' ' ' GLU . 25.2 t-20 53.56 -92.76 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.738 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 62.18 -88.14 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 79.4 mt 59.89 -76.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.8 m-85 -62.65 -67.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.871 0.367 . . . . 0.0 111.332 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.92 121.98 12.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.081 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -172.44 -40.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.282 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 176' ' ' THR . 26.5 tt0 -113.58 95.02 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 175' ' ' GLU . 1.5 p -158.27 157.33 32.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.79 -37.31 83.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.61 -31.97 57.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.459 ' CD1' HD22 ' A' ' 182' ' ' LEU . 8.4 t80 -90.08 3.62 52.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.45 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.3 m -59.05 -44.21 91.79 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -72.99 -33.59 65.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.459 HD22 ' CD1' ' A' ' 179' ' ' PHE . 8.1 mp -73.19 -21.8 60.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.4 mt -63.73 -33.32 75.39 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.598 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.68 -28.37 21.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.55 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.726 ' HB1' ' O ' ' A' ' 131' ' ' PRO . . . -51.66 -41.13 61.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.004 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.8 t70 78.85 -8.32 1.66 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.682 HG23 HG21 ' A' ' 132' ' ' ILE . 44.2 mt 61.01 125.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.738 0.304 . . . . 0.0 111.467 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.58 -43.23 3.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.507 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 168' ' ' ILE . 3.3 p 36.94 83.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.471 ' HA2' HG13 ' A' ' 166' ' ' VAL . . . 135.3 2.26 3.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.518 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.62 ' H ' HG23 ' A' ' 165' ' ' ILE . 8.0 t -85.19 -167.44 1.83 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.903 0.382 . . . . 0.0 111.289 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLU . . . . . 0.425 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 45.9 mt-10 -129.62 99.0 5.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.492 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.694 HG12 ' CD2' ' A' ' 206' ' ' HIS . 27.3 m -92.29 169.62 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.625 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.56 135.66 53.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.605 HD12 ' H ' ' A' ' 196' ' ' VAL . 0.7 OUTLIER -90.74 151.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.102 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.605 ' H ' HD12 ' A' ' 195' ' ' ILE . 14.9 p -170.32 151.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.464 ' HB3' HG12 ' A' ' 112' ' ' VAL . 2.0 p30 -131.77 172.16 12.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.749 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.25 118.14 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.334 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.5 t70 66.93 -68.82 0.14 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.56 49.65 0.16 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.304 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -149.06 145.07 27.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 112' ' ' VAL . 9.9 tp -95.14 145.0 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.241 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.505 HG23 HG13 ' A' ' 196' ' ' VAL . 2.2 t -160.05 153.99 23.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 211' ' ' VAL . 3.6 mm? -121.93 103.64 8.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 2.8 m -79.91 122.18 26.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.694 ' CD2' HG12 ' A' ' 193' ' ' VAL . 59.8 t60 -175.73 162.19 2.67 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.4 m120 31.56 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.991 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -54.41 -78.97 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.439 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 22.9 mtmt -160.5 -75.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.495 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -155.48 133.19 11.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.27 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.758 HG22 ' ND2' ' A' ' 130' ' ' ASN . 21.2 t -87.38 141.51 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -79.84 -59.11 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.181 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.618 HD22 HG11 ' A' ' 152' ' ' VAL . 0.2 OUTLIER 48.75 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.609 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 118' ' ' LYS . 6.0 tp -165.95 164.13 18.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -46.75 -31.63 3.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.3 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.496 ' C ' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.62 -58.59 6.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.358 . . . . 0.0 110.591 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.918 ' O ' HD13 ' A' ' 221' ' ' ILE . 7.9 mp -80.39 -12.86 59.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.157 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.428 ' HB2' HD23 ' A' ' 213' ' ' LEU . . . -90.51 -28.02 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -90.43 -19.83 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.907 ' O ' HD12 ' A' ' 221' ' ' ILE . 20.1 p -135.9 78.74 1.73 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.98 HG22 HD11 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -149.01 156.96 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.414 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 167' ' ' GLN . 40.4 mtt-85 -101.04 124.25 46.48 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.98 HD11 HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -150.42 178.37 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.815 178.998 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 223' ' ' ILE . 2.1 tm-20 -95.02 150.07 20.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.493 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.567 ' CB ' ' HB1' ' A' ' 147' ' ' ALA . 3.1 tt0 -89.57 132.88 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 111.259 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.405 ' CD1' ' HA ' ' A' ' 160' ' ' PRO . 4.6 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.322 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.707 0.289 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.477 HG11 ' HB1' ' A' ' 156' ' ' ALA . 30.2 m -69.55 -42.74 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.196 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -90.38 40.38 1.01 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.155 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -90.13 -51.49 5.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 136.54 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.32 170.14 8.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.62 -43.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.4 tttt 70.37 -66.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.7 m -69.41 143.06 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.218 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tt -86.03 95.26 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -154.78 136.44 14.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.19 140.91 30.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.01 109.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.8 t -159.92 -64.17 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -152.69 -72.35 0.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.822 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.43 ' CB ' ' HD3' ' A' ' 127' ' ' PRO . 0.6 OUTLIER 175.33 -53.44 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 126' ' ' SER . 46.3 Cg_exo -56.6 -171.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.603 2.202 . . . . 0.0 112.557 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -125.13 -175.5 3.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.744 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 211' ' ' VAL . . . -131.19 -158.67 9.27 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.664 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 0.6 OUTLIER -71.51 165.14 51.68 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.545 0.212 . . . . 0.0 110.81 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 38.3 Cg_endo -67.2 126.85 15.7 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.551 2.167 . . . . 0.0 112.787 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.759 ' H ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -172.58 -62.64 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.694 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.737 ' O ' HG21 ' A' ' 187' ' ' ILE . 7.0 Cg_exo -38.92 118.3 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.288 2.658 . . . . 0.0 113.377 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.542 ' HA3' HD12 ' A' ' 221' ' ' ILE . . . -90.81 47.99 3.01 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.536 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.427 ' HA ' ' HG ' ' A' ' 217' ' ' LEU . 2.8 pp -51.02 -32.73 22.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.081 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -89.35 -22.36 22.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -174.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.154 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tt -90.28 102.86 15.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.375 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.701 ' CA ' HD13 ' A' ' 217' ' ' LEU . . . -88.25 128.28 8.99 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.392 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 141' ' ' GLY . 14.1 p -172.91 -43.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 140' ' ' VAL . . . 126.5 107.29 1.52 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.568 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 2.9 m120 -166.79 137.53 3.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.732 ' OG ' HG23 ' A' ' 153' ' ' ILE . 58.0 p -179.08 -34.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.83 -23.21 1.76 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.674 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.66 174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.743 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 147' ' ' ALA . . . -107.46 140.65 40.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 168.38 167.54 0.14 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.561 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 36.9 Cg_exo -56.44 -18.95 26.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.15 1.9 . . . . 0.0 110.973 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 224' ' ' GLU . . . -139.46 153.71 23.15 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.669 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 225' ' ' GLU . 10.8 t -97.2 -142.28 0.29 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.481 ' HB2' ' CB ' ' A' ' 143' ' ' SER . 60.9 mtt180 -150.58 72.16 1.08 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.731 HG23 HD11 ' A' ' 223' ' ' ILE . 44.2 t 64.41 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.159 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.732 HG23 ' OG ' ' A' ' 143' ' ' SER . 1.3 tt -61.47 76.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.5 OUTLIER 162.73 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.598 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.826 ' HA ' HD22 ' A' ' 226' ' ' LEU . . . -89.89 46.0 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.431 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.663 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -145.16 36.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 156' ' ' ALA . 2.8 p -160.07 -43.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.522 ' HB3' HD21 ' A' ' 226' ' ' LEU . 8.4 t -76.81 61.66 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.6 ttt 48.96 86.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.408 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.44 149.41 90.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.644 2.229 . . . . 0.0 112.576 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -156.55 -50.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.688 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.9 mttt -168.11 165.34 13.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 193' ' ' VAL . 3.4 m -155.04 140.41 10.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.626 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.561 ' H ' ' CB ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -79.37 107.63 12.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.571 179.069 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.809 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -79.5 119.4 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.705 ' HA ' HG13 ' A' ' 189' ' ' VAL . 10.7 t -134.7 38.07 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.395 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.704 ' H ' HD13 ' A' ' 165' ' ' ILE . 0.6 OUTLIER 5.67 -86.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.434 0.694 . . . . 0.0 112.86 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 169' ' ' ASN . 0.4 OUTLIER 159.2 -52.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.471 ' N ' HG22 ' A' ' 168' ' ' ILE . 27.1 p30 -169.48 -172.43 1.45 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.797 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.428 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 36.5 mt-10 -152.13 168.39 25.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.992 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 77.36 -21.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.131 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.29 -51.6 61.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -118.74 178.67 4.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.167 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 174' ' ' VAL . 7.4 p -167.0 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.08 -178.21 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.197 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.7 p -68.42 -173.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.33 -5.05 33.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -57.89 -30.92 66.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.734 0.302 . . . . 0.0 110.986 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.617 ' CD1' HD22 ' A' ' 182' ' ' LEU . 45.7 m-85 -90.13 11.58 20.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.6 m -54.24 -39.39 66.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.733 0.301 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.47 -41.25 69.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.617 HD22 ' CD1' ' A' ' 179' ' ' PHE . 7.7 mp -71.42 -18.19 62.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.958 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -25.14 68.02 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.99 -40.26 57.56 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.04 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 187' ' ' ILE . 6.7 t70 60.89 24.65 14.64 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.282 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.759 HG22 ' H ' ' A' ' 132' ' ' ILE . 1.1 pp 28.51 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.112 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.39 141.19 40.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.098 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 166' ' ' VAL . 25.0 t -69.11 146.9 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.71 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.28 -12.8 26.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.791 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.489 ' N ' HG22 ' A' ' 165' ' ' ILE . 1.3 t -73.67 -165.3 0.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.004 0.431 . . . . 0.0 111.027 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -151.69 145.91 25.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.206 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.675 ' O ' HG22 ' A' ' 163' ' ' VAL . 20.8 m -150.3 179.08 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.012 0.434 . . . . 0.0 111.876 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.99 101.73 1.95 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.38 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.663 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 41.4 pt -79.84 151.46 4.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.558 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.3 m -150.68 152.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.957 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.92 142.03 53.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.05 112.99 1.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.011 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.41 36.43 23.02 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.77 51.41 57.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.594 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -158.28 156.06 29.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.805 0.336 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -94.45 135.42 28.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.763 ' N ' HD13 ' A' ' 202' ' ' ILE . 1.7 t -153.57 133.03 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.653 ' CD2' HD22 ' A' ' 213' ' ' LEU . 2.1 mm? -79.99 159.68 26.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.502 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 9.5 m -152.08 116.65 5.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.213 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.407 ' O ' ' N ' ' A' ' 208' ' ' GLY . 1.7 t-80 179.25 177.98 0.51 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.036 0.446 . . . . 0.0 111.504 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 12.8 m120 42.52 -90.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.783 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -73.08 -67.43 1.81 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.677 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 21.9 mtmt -159.17 -81.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 111.104 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -153.81 175.32 13.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.455 ' CG1' HD12 ' A' ' 213' ' ' LEU . 3.0 t -136.96 159.64 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.836 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -79.89 -61.5 1.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.315 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.838 HD23 ' HB2' ' A' ' 218' ' ' ALA . 3.0 mp 57.12 179.22 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.843 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -151.46 -179.95 7.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.94 13.61 12.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.596 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.623 ' HB2' HD12 ' A' ' 214' ' ' LEU . 12.4 t70 -84.65 -71.76 0.5 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.682 0.277 . . . . 0.0 110.767 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.701 HD13 ' CA ' ' A' ' 139' ' ' GLY . 4.4 mm? -90.2 -40.03 12.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.794 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -56.76 -20.94 24.88 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.497 ' CE1' HD12 ' A' ' 153' ' ' ILE . 13.1 t60 -80.3 7.36 9.69 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.448 HG21 ' H ' ' A' ' 140' ' ' VAL . 12.3 t -163.59 39.91 0.09 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.547 ' HB ' HD11 ' A' ' 223' ' ' ILE . 51.2 mm -89.8 154.57 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 63.5 ttt180 -89.69 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 111.901 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.809 HG23 ' HA ' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -146.8 -178.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.0 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.598 ' HA ' ' HA3' ' A' ' 149' ' ' GLY . 12.1 tm-20 -89.82 165.25 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.82 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.698 ' C ' HD23 ' A' ' 226' ' ' LEU . 33.8 tt0 -99.26 80.54 2.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.826 HD22 ' HA ' ' A' ' 155' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.712 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.773 0.321 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.99 -38.44 11.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.14 55.95 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.89 -33.14 17.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -70.24 158.75 35.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.9 mt -137.11 -52.28 0.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.71 127.05 50.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.261 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LYS . . . . . 0.625 ' HB3' HD21 ' A' ' 214' ' ' LEU . 4.8 mmtm -173.19 -173.66 0.95 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -76.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.092 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.719 ' HG ' HD21 ' A' ' 217' ' ' LEU . 6.6 tt -165.46 -46.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -72.27 140.47 48.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.88 158.92 43.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.62 139.67 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.283 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -163.64 178.73 7.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -86.26 -40.31 15.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.71 93.47 37.45 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 112.72 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.639 2.226 . . . . 0.0 112.393 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 57.06 96.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.2 9.54 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.306 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.625 ' CB ' ' HD2' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 53.71 178.53 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.537 0.168 . . . . 0.0 110.648 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.625 ' HD2' ' CB ' ' A' ' 130' ' ' ASN . 2.6 Cg_endo -39.6 141.84 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.922 2.415 . . . . 0.0 112.898 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.782 ' N ' HD13 ' A' ' 187' ' ' ILE . 16.1 tt -37.6 96.0 0.1 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.526 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.516 ' HD2' HD23 ' A' ' 182' ' ' LEU . 4.2 Cg_endo -82.44 78.26 3.46 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.272 2.648 . . . . 0.0 111.243 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.563 ' HA3' ' HG2' ' A' ' 137' ' ' GLU . . . -70.3 111.68 3.92 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.616 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.846 ' CB ' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -90.46 -40.53 11.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 178.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -91.11 -4.62 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.272 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.563 ' HG2' ' HA3' ' A' ' 134' ' ' GLY . 0.0 OUTLIER -90.08 -35.94 15.16 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.401 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 221' ' ' ILE . 3.5 pp -39.93 -34.99 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.933 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.43 82.77 0.01 OUTLIER Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.013 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 138' ' ' LEU . 59.9 t -154.73 -55.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 110.726 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.18 104.1 0.18 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.388 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -57.16 108.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 111.054 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.435 ' N ' ' HB3' ' A' ' 151' ' ' ARG . 14.1 m -90.73 99.3 12.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -106.97 24.16 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.756 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.13 -167.07 1.16 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.43 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 67.58 164.34 0.13 Allowed Pre-proline 0 C--O 1.231 0.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.341 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 51.4 Cg_exo -53.49 145.22 47.8 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.758 2.305 . . . . 0.0 112.487 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 143' ' ' SER . . . 90.94 101.85 1.23 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.609 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 224' ' ' GLU . 10.3 t -118.46 -161.07 0.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.283 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.577 ' C ' HG23 ' A' ' 152' ' ' VAL . 22.3 ptt180 -125.93 33.11 5.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.96 HG22 HG12 ' A' ' 221' ' ' ILE . 0.4 OUTLIER 66.67 -59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 218' ' ' ALA . 1.7 pt -69.57 62.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.4 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.616 ' HB1' HG21 ' A' ' 195' ' ' ILE . . . -40.17 -36.1 0.47 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.781 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.32 76.62 1.71 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.05 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.5 m -159.51 -45.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.6 m -78.61 -78.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.7 ptm -146.59 54.74 2.22 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.416 ' HA ' HD11 ' A' ' 226' ' ' LEU . 2.0 Cg_endo -44.55 106.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.419 2.746 . . . . 0.0 112.701 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -135.47 -40.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.844 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -161.77 96.14 1.01 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.624 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 0.0 OUTLIER -70.0 176.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 6.2 mtt180 -152.02 115.43 4.77 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.711 ' CG1' HG23 ' A' ' 189' ' ' VAL . 8.3 tt -84.76 126.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.983 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.662 ' O ' HG22 ' A' ' 189' ' ' VAL . 32.1 t -133.68 -72.73 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.02 122.45 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.032 0.444 . . . . 0.0 112.171 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.539 ' HB ' HG21 ' A' ' 189' ' ' VAL . 34.1 mm -153.55 -74.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 44.97 -171.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.804 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 172' ' ' PHE . 47.1 tt0 -156.28 -71.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.8 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.3 mt 63.26 -70.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.886 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.2 m-85 -51.87 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 111.49 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.77 120.72 11.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.13 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.525 ' O ' HG22 ' A' ' 174' ' ' VAL . 11.9 p -175.77 39.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -134.99 -41.68 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.9 p -56.58 126.73 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.27 -33.44 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.59 -28.88 70.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.444 ' CE2' HD21 ' A' ' 135' ' ' LEU . 11.8 t80 -73.92 -19.31 60.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.262 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.0 m -50.86 -48.14 60.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -64.68 -31.53 72.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.516 HD23 ' HD2' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -68.85 -38.7 79.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.0 -12.74 37.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -23.29 8.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.379 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.912 ' HB3' HD11 ' A' ' 187' ' ' ILE . . . -53.9 -34.2 58.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.058 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.9 t70 50.32 73.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.912 HD11 ' HB3' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -117.64 -145.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.336 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.31 104.24 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.77 0.319 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.711 HG23 ' CG1' ' A' ' 165' ' ' ILE . 10.7 p -60.44 115.57 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.59 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 142.56 1.76 1.18 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.412 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.532 ' O ' HG22 ' A' ' 165' ' ' ILE . 12.0 t -103.31 -165.15 1.14 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.073 0.437 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -104.5 145.94 29.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.522 HG12 ' ND1' ' A' ' 206' ' ' HIS . 13.0 m -146.48 -163.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.228 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.562 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 9.5 pt-20 -150.38 163.24 38.85 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.643 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.616 HG21 ' HB1' ' A' ' 155' ' ' ALA . 4.2 tt -141.96 160.19 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.179 0.514 . . . . 0.0 111.408 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.499 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 18.3 m -146.64 113.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.01 175.42 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -153.94 172.69 17.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.03 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.49 51.97 50.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -165.78 136.35 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.749 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.91 131.55 57.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.841 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.749 ' N ' HD13 ' A' ' 202' ' ' ILE . 1.6 t -160.02 135.31 8.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.031 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.476 HD23 ' HB ' ' A' ' 195' ' ' ILE . 54.9 mt -79.81 -176.18 5.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.561 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.428 ' OG ' HG22 ' A' ' 196' ' ' VAL . 3.4 m -154.49 109.44 3.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.522 ' ND1' HG12 ' A' ' 193' ' ' VAL . 0.6 OUTLIER 179.8 -178.52 0.41 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.533 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.408 ' HB2' ' HD3' ' A' ' 131' ' ' PRO . 1.6 m-80 42.92 -88.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.48 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -78.48 -68.11 1.54 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.6 mtmt -160.32 -69.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.672 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.14 161.47 41.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.671 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.608 HG22 ' OD1' ' A' ' 130' ' ' ASN . 42.6 t -105.66 157.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.889 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.453 ' N ' HG12 ' A' ' 211' ' ' VAL . 28.1 mt-10 -79.61 -63.49 1.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.707 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.755 ' HB3' ' HB2' ' A' ' 218' ' ' ALA . 41.9 mt 56.26 174.61 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.452 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -171.0 174.16 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.685 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.92 -30.11 9.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.299 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.6 -65.02 1.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.846 HD22 ' CB ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -55.8 -44.9 78.23 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.792 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 213' ' ' LEU . . . -90.62 39.31 0.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 4.3 t-80 -90.26 -54.0 4.21 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.643 0.258 . . . . 0.0 111.032 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -147.99 80.56 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.96 HG12 HG22 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -124.16 146.77 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -89.67 102.45 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.684 HG12 HD11 ' A' ' 221' ' ' ILE . 0.3 OUTLIER -151.34 31.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.817 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.666 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.1 tt0 -152.88 157.75 41.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.742 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -116.56 -19.73 9.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 160' ' ' PRO . 5.6 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.93 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.778 0.323 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.917 ' HB ' HG22 ' A' ' 202' ' ' ILE . 89.1 t -64.04 -28.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.398 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -84.78 62.2 7.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.688 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -57.23 85.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 113' ' ' GLU . 66.4 mtp180 -41.33 -40.91 1.81 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.313 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.43 77.91 9.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.664 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.1 m -62.72 163.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.358 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -154.12 -49.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.704 HG22 ' H ' ' A' ' 120' ' ' LEU . 1.1 p -148.94 -166.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.704 ' H ' HG22 ' A' ' 119' ' ' VAL . 4.5 mm? -107.54 115.63 30.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -153.11 133.04 13.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.05 163.78 13.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -101.25 142.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.1 m 60.38 -89.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 176.26 159.44 0.3 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.6 m 60.08 73.24 0.66 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.46 -30.11 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.672 2.248 . . . . 0.0 112.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.71 150.83 45.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 143.42 136.92 3.21 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.498 ' OD1' HG13 ' A' ' 211' ' ' VAL . 2.6 p-10 51.5 158.46 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.62 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.3 Cg_endo -76.41 135.45 16.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.703 2.269 . . . . 0.0 113.019 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.867 HD11 HG21 ' A' ' 221' ' ' ILE . 0.0 OUTLIER 135.77 -32.12 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 124.058 0.849 . . . . 0.0 112.089 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 1.5 Cg_endo -79.92 72.04 6.73 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.427 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.11 118.12 4.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.244 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 138' ' ' LEU . 1.9 tt -73.19 -45.49 56.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.233 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.28 9.25 29.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.514 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.83 ' O ' HG22 ' A' ' 168' ' ' ILE . 0.5 OUTLIER -90.21 -50.77 5.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.638 0.256 . . . . 0.0 111.225 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.816 HD13 ' N ' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -53.97 -14.92 1.15 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.816 ' N ' HD13 ' A' ' 138' ' ' LEU . . . -45.42 -91.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.255 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 168' ' ' ILE . 14.6 t -89.72 153.23 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.53 ' C ' HD12 ' A' ' 168' ' ' ILE . . . 92.01 155.64 32.02 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.428 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.455 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 2.0 p30 -152.47 131.89 12.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.822 0.344 . . . . 0.0 111.405 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -97.85 170.6 8.85 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -158.68 -60.63 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -162.9 -163.06 0.82 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 94.07 108.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 63.87 162.49 0.12 Allowed Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.378 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.613 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 79.3 Cg_exo -39.69 146.71 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.858 2.372 . . . . 0.0 112.048 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.718 ' HA2' ' HB ' ' A' ' 163' ' ' VAL . . . 151.55 -152.35 24.13 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.892 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -152.13 144.59 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.502 ' C ' HG23 ' A' ' 152' ' ' VAL . 53.8 ttt180 -67.12 2.76 1.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.943 HG22 ' CD1' ' A' ' 223' ' ' ILE . 2.4 t 74.03 -62.51 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.918 0.39 . . . . 0.0 110.484 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.9 pt -97.51 44.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.505 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 157' ' ' THR . 5.0 t70 -162.79 -32.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.686 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.829 ' HB1' HD13 ' A' ' 195' ' ' ILE . . . -27.86 -42.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 202' ' ' ILE . . . -76.99 62.0 2.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 0.0 111.319 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 154' ' ' ASP . 3.0 t -173.32 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.409 ' C ' ' HD3' ' A' ' 160' ' ' PRO . 3.1 t -77.5 -158.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 34.1 mtt -124.47 60.3 23.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.021 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 158' ' ' SER . 81.9 Cg_exo -44.85 162.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.928 2.419 . . . . 0.0 113.181 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.2 mtp85 -152.14 -45.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.348 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -161.26 78.66 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.227 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.745 ' HB ' HG22 ' A' ' 223' ' ' ILE . 32.9 m -69.94 143.45 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.849 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.464 ' HG3' ' HB2' ' A' ' 148' ' ' PRO . 8.0 mtp85 -79.05 98.76 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.365 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.785 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -76.41 79.98 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.401 0.62 . . . . 0.0 111.833 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.632 HG13 ' HA2' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -160.88 97.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.696 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.56 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.9 OUTLIER 170.47 133.77 0.02 OUTLIER 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.585 0.707 . . . . 0.0 112.183 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 137' ' ' GLU . 3.0 mm 75.86 -2.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.413 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.595 ' HB2' HG21 ' A' ' 189' ' ' VAL . 22.8 t30 -55.75 159.42 3.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.939 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -151.4 170.12 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.71 -47.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.055 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.44 -40.34 90.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -71.48 132.91 45.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 174' ' ' VAL . 7.5 p -162.59 93.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 176' ' ' THR . 3.6 tt0 -138.64 178.42 7.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 175' ' ' GLU . 8.4 t 47.83 114.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.885 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.3 -2.97 15.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.775 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.53 -34.41 70.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.615 0.245 . . . . 0.0 111.431 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.462 ' HB3' HD13 ' A' ' 135' ' ' LEU . 2.4 p90 -75.44 -10.14 59.19 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.696 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.1 m -48.71 -40.92 30.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -70.69 -35.85 72.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 133' ' ' PRO . 8.5 mp -73.85 -22.88 59.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.024 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.522 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -69.63 -20.88 63.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.068 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -38.56 61.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -69.44 -27.6 65.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 187' ' ' ILE . 13.8 m-20 84.06 -36.52 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.558 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.703 HD13 ' NH1' ' A' ' 222' ' ' ARG . 0.6 OUTLIER 62.18 130.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.384 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -126.82 88.79 2.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.862 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 189' ' ' VAL . 7.6 p -70.99 96.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.543 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.734 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 146.38 -1.21 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.375 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.739 ' O ' HG22 ' A' ' 165' ' ' ILE . 4.5 t -97.03 -162.9 0.99 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.053 0.427 . . . . 0.0 110.891 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.4 124.52 43.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.51 HG12 ' CG ' ' A' ' 206' ' ' HIS . 32.5 m -127.98 175.33 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.258 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.98 169.49 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.829 HD13 ' HB1' ' A' ' 155' ' ' ALA . 0.9 OUTLIER -155.85 154.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.023 0.439 . . . . 0.0 111.135 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.431 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 17.6 m -141.5 155.2 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.952 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.94 155.38 40.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 43.1 ttm-85 -146.29 71.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.987 0.423 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.43 60.28 3.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.12 96.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.563 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' HIS . . . . . 0.482 ' HA ' HG23 ' A' ' 112' ' ' VAL . 89.8 m-70 -152.55 131.71 12.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 110.725 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.917 HG22 ' HB ' ' A' ' 112' ' ' VAL . 13.8 tt -79.99 139.53 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 111.388 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 202' ' ' ILE . 16.7 p -158.41 119.86 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.457 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.697 HD22 HD12 ' A' ' 195' ' ' ILE . 1.0 OUTLIER -79.57 153.19 29.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.743 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 39.0 m -126.78 125.71 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.51 ' CG ' HG12 ' A' ' 193' ' ' VAL . 0.8 OUTLIER -178.61 176.08 1.03 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.989 0.423 . . . . 0.0 111.378 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.9 m120 46.89 -87.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.782 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -83.65 -62.6 1.76 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.841 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.72 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.593 0.235 . . . . 0.0 111.231 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -138.14 178.87 6.8 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.498 HG13 ' OD1' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -133.16 179.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.63 -48.81 3.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.4 mt 56.99 176.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.35 177.7 8.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.57 -29.92 69.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.316 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.07 -54.77 6.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.155 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.95 -30.78 68.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.289 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.438 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -90.12 15.88 9.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.743 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -84.78 -58.83 2.55 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.809 0.337 . . . . 0.0 110.771 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.693 ' O ' HG21 ' A' ' 168' ' ' ILE . 3.0 p -147.0 88.05 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.444 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.867 HG21 HD11 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -111.58 -172.1 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.564 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.785 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.7 mtm180 -84.28 76.22 10.13 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.943 ' CD1' HG22 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -153.51 134.0 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.563 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 148' ' ' PRO . 9.8 mt-10 -89.68 -108.8 0.08 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 145' ' ' ALA . 2.8 tt0 -150.99 112.44 4.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.206 0.457 . . . . 0.0 111.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 149' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.077 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.777 0.322 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.655 HG13 ' H ' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -54.76 -75.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.655 ' H ' HG13 ' A' ' 112' ' ' VAL . 5.6 pt-20 -87.48 62.52 7.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 110.722 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 77.52 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -51.72 -34.7 40.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.53 92.77 2.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -164.21 148.87 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -146.93 -68.22 0.26 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 m -76.0 165.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.305 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.6 148.22 26.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.798 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -152.1 -51.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.05 -175.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 123' ' ' VAL . 3.3 p 41.12 90.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.663 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 p -140.04 -56.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -107.86 -35.99 6.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.9 m -63.97 164.43 17.49 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.7 -161.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.78 2.32 . . . . 0.0 112.367 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.662 ' O ' HG13 ' A' ' 211' ' ' VAL . 6.7 p90 -111.84 -54.97 2.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.959 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.2 -102.18 1.0 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.078 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.584 ' H ' HG22 ' A' ' 211' ' ' VAL . 3.7 p30 -143.92 163.37 36.0 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.673 0.273 . . . . 0.0 110.976 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.618 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.46 138.42 80.37 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.951 2.434 . . . . 0.0 112.96 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.657 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 138.81 -29.57 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 O-C-N 124.033 0.833 . . . . 0.0 112.314 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.786 ' HB2' HD23 ' A' ' 182' ' ' LEU . 12.3 Cg_exo -68.09 62.46 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.481 2.121 . . . . 0.0 112.842 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.54 129.42 25.18 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.283 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.693 HD22 ' CD2' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -90.03 -44.25 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -90.15 9.0 30.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.437 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' O ' HD13 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -90.06 -44.65 9.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.754 0.312 . . . . 0.0 110.994 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 216' ' ' ASP . 3.3 pp -41.17 -36.81 0.79 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.833 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.78 65.73 3.87 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.766 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 90.6 t -152.79 -66.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.686 0.279 . . . . 0.0 111.019 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.4 -175.11 13.94 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.445 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 220' ' ' THR . 2.3 p-10 -162.68 160.72 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 m -163.17 133.38 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.7 -45.47 8.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.01 114.64 2.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.322 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -174.03 -168.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.025 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -56.83 -178.78 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.895 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 95.3 Cg_exo -44.68 89.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.674 2.249 . . . . 0.0 112.648 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 154.78 55.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.525 HG21 ' HA ' ' A' ' 225' ' ' GLU . 7.3 t -101.48 -163.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.513 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.781 ' HD2' HD11 ' A' ' 153' ' ' ILE . 34.0 ptt180 -107.4 107.61 18.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.471 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.777 HG13 ' HB1' ' A' ' 218' ' ' ALA . 7.1 p -41.6 -30.55 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.03 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.781 HD11 ' HD2' ' A' ' 151' ' ' ARG . 23.3 pt -53.45 -42.09 47.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.909 0.385 . . . . 0.0 111.128 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.409 ' N ' HG13 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -84.16 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.878 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 195' ' ' ILE . . . -62.72 80.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.155 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 195' ' ' ILE . . . -172.21 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.064 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.4 t -93.85 -3.62 51.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.47 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 226' ' ' LEU . 38.9 m -94.05 37.6 1.09 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.756 0.312 . . . . 0.0 111.327 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 11.2 ttt 57.67 61.45 5.95 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.854 0.359 . . . . 0.0 111.235 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.524 ' HB3' HD22 ' A' ' 226' ' ' LEU . 29.5 Cg_endo -62.73 170.69 6.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.814 2.342 . . . . 0.0 112.414 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.5 mtt85 -152.15 -47.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -170.02 89.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 195' ' ' ILE . 26.8 m -80.59 -172.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 12.2 mtp85 -124.39 -170.95 2.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.076 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.749 ' O ' HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -147.69 79.89 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 110.426 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 165' ' ' ILE . 1.3 m -160.48 98.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.085 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.637 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 170.34 110.84 0.01 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.22 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 221' ' ' ILE . 12.7 mt 109.53 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.363 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 168' ' ' ILE . 22.4 t-20 49.9 164.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.88 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 171.32 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.571 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.728 HD11 HG12 ' A' ' 189' ' ' VAL . 66.4 mt 63.5 -64.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.0 m-85 -47.31 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.474 ' O ' HG23 ' A' ' 174' ' ' VAL . 11.7 mm100 -64.98 116.51 6.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.608 HG11 ' CD2' ' A' ' 183' ' ' LEU . 77.1 t -161.17 80.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 176' ' ' THR . 14.0 mt-10 -106.18 98.73 8.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.123 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.656 HG21 HD13 ' A' ' 135' ' ' LEU . 1.0 OUTLIER -166.03 113.27 0.9 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.83 -26.66 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.146 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -72.3 -30.71 65.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.026 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.693 ' CD2' HD22 ' A' ' 135' ' ' LEU . 33.1 m-85 -90.16 20.64 4.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.486 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.9 m -57.36 -33.37 67.71 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.79 0.329 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -72.25 -42.53 65.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.586 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 133' ' ' PRO . 9.5 mp -71.14 -14.83 62.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.942 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.608 ' CD2' HG11 ' A' ' 174' ' ' VAL . 0.3 OUTLIER -74.8 -27.99 60.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.032 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.1 -43.07 51.41 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.503 ' HB1' ' HD3' ' A' ' 131' ' ' PRO . . . -66.6 -31.12 71.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 187' ' ' ILE . 30.5 m-20 67.43 13.67 9.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.545 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.727 HD12 HH22 ' A' ' 222' ' ' ARG . 6.1 pt 33.95 100.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -102.52 90.69 3.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.668 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.728 HG12 HD11 ' A' ' 171' ' ' ILE . 10.6 p -59.83 115.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.641 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 136.59 -8.4 3.97 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.823 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.657 ' O ' HG22 ' A' ' 165' ' ' ILE . 19.7 t -83.66 -169.33 2.51 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.788 0.328 . . . . 0.0 111.061 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -135.54 122.27 20.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.804 HG12 ' CG ' ' A' ' 206' ' ' HIS . 33.5 m -120.56 -179.11 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' GLU . . . . . 0.449 ' HA ' HG22 ' A' ' 163' ' ' VAL . 10.3 pt-20 -144.45 164.65 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 156' ' ' ALA . 1.1 mp -128.97 153.27 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.182 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 196' ' ' VAL . 8.8 m -154.26 110.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.96 157.79 37.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.98 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -159.21 118.5 2.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 6.5 t70 69.73 -66.86 0.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -179.64 49.86 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -156.45 149.73 24.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.754 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -102.19 133.59 45.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.754 ' N ' HD13 ' A' ' 202' ' ' ILE . 30.4 p -142.83 129.37 20.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 211' ' ' VAL . 4.2 mm? -79.98 105.01 10.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 209' ' ' LYS . 2.4 m -86.09 120.23 27.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.804 ' CG ' HG12 ' A' ' 193' ' ' VAL . 21.9 t-80 -176.01 166.49 2.98 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 111.644 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.0 m120 40.69 -90.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.852 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -67.9 -71.3 0.97 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.606 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 205' ' ' SER . 2.4 ptpt -161.76 -63.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -152.93 174.28 14.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.543 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.738 HG11 ' HG3' ' A' ' 133' ' ' PRO . 12.3 t -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.928 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -112.04 55.73 0.67 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 111.226 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 218' ' ' ALA . 4.2 pp -83.25 173.05 11.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.609 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.473 HD12 ' CB ' ' A' ' 216' ' ' ASP . 0.3 OUTLIER -97.04 164.79 12.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.954 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.17 -37.95 75.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.515 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.511 ' O ' HD22 ' A' ' 138' ' ' LEU . 0.8 OUTLIER -62.01 -45.1 95.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.544 HD21 ' CE1' ' A' ' 179' ' ' PHE . 3.0 mp -60.34 -37.78 81.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 153' ' ' ILE . . . -90.72 14.12 14.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.755 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -67.85 70.57 0.14 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.964 0.411 . . . . 0.0 111.047 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.769 HG22 ' CB ' ' A' ' 151' ' ' ARG . 6.5 p 59.13 85.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.289 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.639 ' HA ' HD12 ' A' ' 168' ' ' ILE . 0.8 OUTLIER -118.94 -147.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.727 HH22 HD12 ' A' ' 187' ' ' ILE . 6.3 ptt180 -84.95 88.41 7.44 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 222' ' ' ARG . 3.3 mp -151.42 151.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.256 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 2.3 tm-20 -89.85 159.03 17.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.633 0.254 . . . . 0.0 110.363 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.525 ' HA ' HG21 ' A' ' 150' ' ' THR . 0.5 OUTLIER -89.25 104.55 17.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.955 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 160' ' ' PRO . 3.1 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.312 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.573 0.225 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 113' ' ' GLU . 14.7 p -90.35 -45.52 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.699 0.285 . . . . 0.0 111.409 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.47 ' N ' HG13 ' A' ' 112' ' ' VAL . 33.1 mt-10 -84.18 100.26 11.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -80.95 76.81 7.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -88.54 66.16 8.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -143.62 -51.59 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.3 m -69.81 148.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -112.99 -40.03 4.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.49 163.23 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.26 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.8 tt -94.53 118.4 31.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -147.08 173.91 12.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -152.57 152.33 31.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 123' ' ' VAL . 7.3 p -151.98 101.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -167.01 -179.03 4.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -71.81 -37.9 70.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.3 p -164.33 79.45 1.43 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.22 -162.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.748 2.299 . . . . 0.0 112.18 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.0 p90 42.0 91.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.76 161.21 34.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.76 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER 61.91 144.61 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 120.611 0.243 . . . . 0.0 110.953 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.509 ' CB ' ' HA ' ' A' ' 187' ' ' ILE . 1.9 Cg_endo -86.33 105.01 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.116 2.544 . . . . 0.0 112.658 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.723 HG21 HG21 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -164.83 -57.77 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.508 ' HB3' HD21 ' A' ' 213' ' ' LEU . 5.1 Cg_endo -85.08 121.82 2.44 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.727 2.284 . . . . 0.0 113.98 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.499 ' HA2' HD12 ' A' ' 187' ' ' ILE . . . -91.86 170.99 33.95 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.193 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.826 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -69.66 128.62 37.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -26.78 66.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.552 1.158 . . . . 0.0 113.03 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 135' ' ' LEU . 26.5 tt0 -90.63 -55.35 3.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 145' ' ' ALA . 3.9 mm? -90.6 -16.91 27.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.59 -1.187 . . . . 0.0 109.744 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 116.08 8.67 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.792 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.546 ' H ' HG22 ' A' ' 220' ' ' THR . 8.1 p -150.44 -41.73 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.605 0.24 . . . . 0.0 111.249 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.19 86.74 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.655 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.34 -178.23 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.704 0.287 . . . . 0.0 110.787 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.9 p -76.6 -43.78 37.17 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.577 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.94 -178.01 1.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.441 ' HB2' HD12 ' A' ' 138' ' ' LEU . . . -110.07 -86.6 0.53 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.617 ' HB3' ' NE ' ' A' ' 222' ' ' ARG . . . -91.98 138.81 31.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.63 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 57.54 -179.6 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.325 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 53.8 Cg_exo -52.33 -176.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.244 1.963 . . . . 0.0 112.001 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.442 ' HA2' ' C ' ' A' ' 223' ' ' ILE . . . 162.77 140.32 2.84 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.382 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.803 HG21 HD22 ' A' ' 226' ' ' LEU . 6.2 t -176.66 -33.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.848 ' CB ' HG21 ' A' ' 223' ' ' ILE . 4.7 tmm_? -20.08 -55.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -94.22 -44.78 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.658 0.266 . . . . 0.0 111.658 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.793 HD13 ' O ' ' A' ' 219' ' ' HIS . 0.2 OUTLIER -109.41 109.45 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.318 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' ILE . 58.3 m-20 98.58 -38.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.067 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.629 ' HB2' ' C ' ' A' ' 150' ' ' THR . . . -36.74 -46.88 0.63 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 195' ' ' ILE . . . -78.11 65.56 3.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.15 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 m -162.9 -45.99 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.503 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -95.5 43.07 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.9 mtt 53.02 74.31 0.79 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.288 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.593 ' HA ' HD12 ' A' ' 226' ' ' LEU . 18.8 Cg_endo -58.73 139.88 92.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.874 2.383 . . . . 0.0 112.663 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.26 -43.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -162.19 120.79 2.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.52 HG21 ' CG ' ' A' ' 151' ' ' ARG . 1.0 OUTLIER -122.69 128.68 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.452 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 12.3 mtt180 -80.02 123.21 27.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.489 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -90.34 124.27 42.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.327 . . . . 0.0 110.262 178.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.728 ' N ' HD13 ' A' ' 165' ' ' ILE . 21.4 t -144.61 87.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.966 0.412 . . . . 0.0 111.621 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.621 ' HA ' HG11 ' A' ' 189' ' ' VAL . 4.6 tt0 91.91 105.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.335 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.794 HG22 HG21 ' A' ' 221' ' ' ILE . 2.4 pp -142.1 -45.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.656 ' OD1' HD11 ' A' ' 187' ' ' ILE . 52.3 t30 -74.27 159.74 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 5.0 tt0 -104.48 -42.38 5.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.679 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 94.0 mt 69.12 -64.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.596 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -54.46 -34.79 62.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.248 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -99.16 127.4 45.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 174' ' ' VAL . 7.9 p -168.12 96.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -138.01 -43.52 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.504 ' HG1' ' HD2' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -57.67 122.34 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.67 -25.66 59.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.15 -26.98 68.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.504 ' HD2' ' HG1' ' A' ' 176' ' ' THR . 19.1 m-85 -82.6 -6.2 59.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.424 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.3 m -56.34 -41.25 75.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.76 0.314 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -66.2 -35.82 81.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.49 -26.73 46.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -69.55 -23.72 63.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.1 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -32.98 61.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -68.01 -31.76 71.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' ILE . 13.9 m-20 83.83 -29.14 0.09 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.631 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.656 HD11 ' OD1' ' A' ' 169' ' ' ASN . 7.4 pt 39.89 103.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.315 0.579 . . . . 0.0 111.946 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -114.6 108.96 17.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.779 ' HA ' HD12 ' A' ' 165' ' ' ILE . 35.2 m -52.69 157.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.251 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.706 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 101.99 -15.96 56.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.302 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.735 ' O ' HG22 ' A' ' 165' ' ' ILE . 7.7 t -74.55 -166.99 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.01 0.433 . . . . 0.0 111.301 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.29 136.86 20.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.786 HG12 ' CG ' ' A' ' 206' ' ' HIS . 29.8 m -141.61 175.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.967 0.413 . . . . 0.0 111.801 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -125.7 162.85 24.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.798 HD12 ' N ' ' A' ' 196' ' ' VAL . 0.1 OUTLIER -136.84 140.97 41.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.389 . . . . 0.0 110.856 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.798 ' N ' HD12 ' A' ' 195' ' ' ILE . 11.0 m -154.25 118.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.023 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -70.0 159.25 34.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -168.91 143.18 3.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.0 t70 68.08 -70.53 0.12 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 175.19 43.03 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.05 165.71 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.441 ' HB ' HG22 ' A' ' 112' ' ' VAL . 19.9 tt -87.24 150.3 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.136 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.0 t -160.05 116.96 2.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.0 106.22 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.676 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.0 m -85.73 129.41 34.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.786 ' CG ' HG12 ' A' ' 193' ' ' VAL . 10.9 t60 -143.94 145.55 32.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -33.39 -40.02 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -62.65 -70.58 1.01 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.26 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.8 mtmt -158.87 -174.66 4.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.44 133.51 53.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.175 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.75 159.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.481 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -83.18 -58.3 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.512 HD13 HG12 ' A' ' 152' ' ' VAL . 1.7 mt 64.2 151.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.205 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 0.4 OUTLIER -140.42 -175.59 4.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.716 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -28.95 67.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.394 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -67.61 0.24 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.597 ' O ' HD11 ' A' ' 221' ' ' ILE . 6.4 mp -78.82 -34.29 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.063 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -90.73 33.94 0.91 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.602 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.793 ' O ' HD13 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -81.71 -56.43 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.723 ' HA ' HG21 ' A' ' 153' ' ' ILE . 13.5 t -174.67 72.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.021 0.439 . . . . 0.0 111.162 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.794 HG21 HG22 ' A' ' 168' ' ' ILE . 4.9 mm -89.55 171.72 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.617 ' NE ' ' HB3' ' A' ' 146' ' ' ALA . 53.6 ttt180 -89.71 99.64 12.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 111.612 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.848 HG21 ' CB ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -129.79 -149.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.071 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.587 ' O ' HG22 ' A' ' 150' ' ' THR . 0.0 OUTLIER -118.85 -179.52 3.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 110.803 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 226' ' ' LEU . 30.3 tt0 -111.78 96.21 5.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.803 HD22 HG21 ' A' ' 150' ' ' THR . 1.7 pt? . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.77 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.761 0.315 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 156' ' ' ALA . 35.2 m -76.16 -41.75 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.419 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.4 OUTLIER -90.27 18.37 6.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -90.05 -51.94 5.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.44 147.96 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.5 mt -147.87 113.24 5.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -112.77 -37.48 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.307 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -109.3 172.37 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 m -89.63 -37.68 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.24 -58.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -78.1 157.8 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.975 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.66 -46.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.1 t 61.42 105.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.0 m -138.81 90.11 2.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.48 80.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m 59.27 86.12 0.17 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.495 ' O ' HG12 ' A' ' 211' ' ' VAL . 60.0 Cg_endo -72.37 -25.57 18.21 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.594 2.196 . . . . 0.0 112.338 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' CG ' ' HB3' ' A' ' 181' ' ' GLN . 3.9 p90 -114.02 144.0 43.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.732 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.17 -98.83 0.16 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.811 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -56.31 153.75 18.43 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.758 0.313 . . . . 0.0 111.234 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.599 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 89.1 Cg_endo -81.83 137.57 10.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.892 2.395 . . . . 0.0 112.87 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.741 ' H ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER 143.1 -30.99 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 O-C-N 123.922 0.763 . . . . 0.0 111.859 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 2.7 Cg_exo -73.53 63.34 4.59 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.362 2.042 . . . . 0.0 112.326 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.55 81.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.493 HD23 ' CZ ' ' A' ' 179' ' ' PHE . 14.4 tp -70.86 -39.39 72.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.348 . . . . 0.0 110.803 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.11 8.63 31.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.409 ' HG2' ' HB ' ' A' ' 168' ' ' ILE . 2.5 mp0 -88.94 -170.99 3.12 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.792 ' O ' HG23 ' A' ' 220' ' ' THR . 1.0 OUTLIER -62.09 84.6 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.845 0.355 . . . . 0.0 111.126 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.49 32.26 5.09 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.913 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.696 ' C ' HG21 ' A' ' 220' ' ' THR . 18.1 t -128.82 116.5 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.689 0.281 . . . . 0.0 111.179 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.69 -172.33 16.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -175.4 166.43 3.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.728 0.299 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -137.35 -174.34 3.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.059 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.13 -43.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.119 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -158.6 -157.93 0.66 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 85.77 -179.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.967 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -56.71 -176.66 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.967 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 68.4 Cg_exo -41.31 98.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.757 2.305 . . . . 0.0 112.928 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.74 41.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.079 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 152' ' ' VAL . 13.6 t -80.6 -7.19 59.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 4.4 mpt_? 60.56 25.96 15.63 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.012 HG11 ' HB1' ' A' ' 218' ' ' ALA . 21.4 t 70.68 -58.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.535 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 153' ' ' ILE . 5.4 tt -55.41 79.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.999 0.428 . . . . 0.0 111.39 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 167.7 -35.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.382 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 226' ' ' LEU . . . -52.27 -25.28 9.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.598 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 112' ' ' VAL . . . -98.73 32.9 2.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.372 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.0 t -170.96 32.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.352 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.448 ' HB3' HD12 ' A' ' 226' ' ' LEU . 7.4 t -153.06 34.46 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.195 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' MET . . . . . 0.402 ' C ' HD13 ' A' ' 226' ' ' LEU . 41.2 ttm 66.44 75.29 0.33 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.008 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.651 ' HA ' HD22 ' A' ' 226' ' ' LEU . 29.0 Cg_endo -62.83 152.85 76.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.843 2.362 . . . . 0.0 112.799 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 -45.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -170.2 124.97 0.75 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 193' ' ' VAL . 6.4 m -110.28 123.0 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 111.488 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -84.22 102.09 12.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.681 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -79.47 122.25 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.649 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.606 ' N ' HD13 ' A' ' 165' ' ' ILE . 20.4 t -144.39 85.86 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.596 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 33.4 tt0 103.54 147.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.074 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.881 HG22 HG23 ' A' ' 221' ' ' ILE . 0.4 OUTLIER -149.59 -66.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.08 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -177.96 -168.52 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.543 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.03 -77.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.87 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.105 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -163.7 -55.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.862 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -163.85 -65.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.541 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 0.4 OUTLIER 72.0 107.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.292 0.568 . . . . 0.0 110.784 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 55.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.954 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 t -161.75 130.12 4.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -22.43 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -60.96 -31.49 71.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.493 ' CZ ' HD23 ' A' ' 135' ' ' LEU . 5.4 m-85 -76.09 -17.17 59.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.322 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 84.8 m -51.85 -43.84 63.39 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLN . . . . . 0.423 ' HB3' ' CG ' ' A' ' 128' ' ' PHE . 55.4 mt-30 -70.83 -33.02 70.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.58 -25.05 59.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.3 tp -84.48 -2.71 57.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.573 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.25 -50.25 30.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.057 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -82.9 -23.37 33.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.129 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 187' ' ' ILE . 9.3 m-20 65.89 16.2 10.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.741 HG22 ' H ' ' A' ' 132' ' ' ILE . 24.0 pt 38.15 99.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.1 0.476 . . . . 0.0 111.988 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 134.49 42.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.93 141.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.543 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 104.54 -8.65 47.83 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 165' ' ' ILE . 16.4 t -70.23 174.92 5.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -132.33 111.88 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.676 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.744 HG12 ' CD2' ' A' ' 206' ' ' HIS . 27.2 m -121.59 176.94 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.362 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -142.13 160.76 39.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.448 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 1.8 tt -134.62 155.7 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 111.152 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.448 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 7.1 m -156.92 132.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.27 145.55 35.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -157.35 116.6 3.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.143 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 51.99 40.76 28.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.88 62.15 6.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.459 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -159.48 158.47 32.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.77 0.319 . . . . 0.0 110.82 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.42 141.79 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 203' ' ' THR . 6.3 t -159.9 111.42 2.0 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.875 HD23 HD22 ' A' ' 213' ' ' LEU . 3.6 mm? -81.19 98.4 8.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.7 m -77.07 110.15 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.744 ' CD2' HG12 ' A' ' 193' ' ' VAL . 24.6 t-80 -107.62 147.21 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.511 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -41.33 -34.4 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.296 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -77.25 -57.49 3.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.496 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -160.68 -175.19 4.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.687 0.279 . . . . 0.0 110.875 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.6 149.0 31.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -116.71 175.64 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.44 ' OE1' HD23 ' A' ' 214' ' ' LEU . 1.4 tm-20 -90.7 -66.56 0.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.875 HD22 HD23 ' A' ' 204' ' ' LEU . 7.8 mp 60.55 155.63 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 111.36 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 213' ' ' LEU . 0.5 OUTLIER -144.69 -175.45 4.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.65 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.68 -29.13 70.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.998 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -45.58 11.84 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.808 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.447 HD22 ' HG ' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -55.61 -69.74 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 1.012 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.52 49.78 1.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -84.65 -38.78 19.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.792 HG23 ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -156.55 90.37 1.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.891 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.881 HG23 HG22 ' A' ' 168' ' ' ILE . 23.8 mm -118.96 162.15 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.011 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -89.66 90.35 8.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 111.268 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.681 HG23 ' HA ' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -137.62 175.16 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.124 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -89.64 162.78 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 110.824 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -89.66 56.04 3.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 155' ' ' ALA . 6.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.746 0.307 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 156' ' ' ALA . 14.6 p -88.81 -46.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.476 ' N ' HG13 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -90.34 48.86 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.13 -41.24 11.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.054 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -85.54 144.0 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mp -145.08 112.71 6.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.842 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -150.38 168.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.15 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -133.48 100.29 4.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.7 t -144.34 -44.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tt 65.39 46.41 2.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -100.08 -46.46 5.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.27 147.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 123' ' ' VAL . 11.1 p -168.26 125.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.4 t -169.71 157.68 7.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -86.09 83.71 7.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.65 7.97 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.82 -19.26 8.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.705 2.27 . . . . 0.0 112.644 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 62.51 110.62 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -166.37 -150.78 6.49 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.701 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 8.1 p30 53.95 159.18 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.301 0 CA-C-O 120.966 0.412 . . . . 0.0 111.843 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.647 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 83.2 Cg_endo -78.84 137.12 13.83 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.824 2.349 . . . . 0.0 111.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 160.44 -31.03 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.373 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 23.8 Cg_exo -63.65 118.54 5.46 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.634 1.556 . . . . 0.0 112.986 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.23 -32.77 8.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.448 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.808 ' CB ' HD12 ' A' ' 217' ' ' LEU . 2.2 pp -36.59 -37.31 0.13 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.51 -50.76 71.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.207 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.679 ' HG2' HD11 ' A' ' 168' ' ' ILE . 2.1 pm0 -90.67 -21.3 21.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.634 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.742 HD12 HD11 ' A' ' 221' ' ' ILE . 6.5 tt -29.57 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.443 . . . . 0.0 112.018 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.35 -93.15 1.23 Allowed Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.427 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.8 t -145.46 42.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 111.181 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.36 -149.23 1.22 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.236 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 0.9 OUTLIER 179.48 177.84 0.56 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.6 p -156.86 -173.47 4.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.778 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.91 74.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.48 -69.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.37 -62.4 1.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -176.18 -63.01 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.073 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 7.1 Cg_exo -33.94 97.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.219 2.613 . . . . 0.0 113.188 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 97.82 112.41 3.07 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.797 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 149' ' ' GLY . 2.8 t 175.92 78.3 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.667 ' HB2' ' HB ' ' A' ' 221' ' ' ILE . 11.0 tpp180 -78.84 92.61 4.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.947 HG13 HD11 ' A' ' 202' ' ' ILE . 8.1 p 48.91 20.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 219' ' ' HIS . 2.9 tt -106.32 10.55 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 121.221 0.534 . . . . 0.0 110.312 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.9 -35.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.572 ' HA ' HD11 ' A' ' 226' ' ' LEU . . . -88.41 43.72 1.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.502 ' HB3' HG11 ' A' ' 112' ' ' VAL . . . -140.76 33.54 1.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.15 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.48 ' H ' HD21 ' A' ' 226' ' ' LEU . 12.6 p -158.08 -41.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.647 ' HB3' HD13 ' A' ' 226' ' ' LEU . 0.4 OUTLIER -76.2 84.85 3.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.407 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.2 mtt 57.36 61.31 6.35 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.645 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.617 ' HA ' HD23 ' A' ' 226' ' ' LEU . 30.8 Cg_endo -63.2 124.74 14.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.848 2.365 . . . . 0.0 112.407 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -157.0 -47.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -159.98 148.82 17.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.43 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 193' ' ' VAL . 15.4 m -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.444 . . . . 0.0 111.792 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 13.3 mtp85 -82.2 109.37 16.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 191' ' ' SER . 0.4 OUTLIER -84.13 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.978 0.418 . . . . 0.0 111.737 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.421 ' N ' HD13 ' A' ' 165' ' ' ILE . 3.9 t -138.45 42.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.867 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.777 ' O ' HD13 ' A' ' 168' ' ' ILE . 59.0 mt-30 39.56 -108.9 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.482 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.777 HD13 ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -172.36 -64.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.853 0.358 . . . . 0.0 110.527 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -138.15 -62.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -171.68 -75.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.011 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -176.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.1 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -163.94 -64.49 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLN . . . . . 0.619 ' O ' HG12 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -117.98 -83.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.776 HG22 HD11 ' A' ' 183' ' ' LEU . 0.4 OUTLIER 68.95 13.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 176' ' ' THR . 0.0 OUTLIER -106.06 94.41 5.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.797 0.332 . . . . 0.0 111.077 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -166.67 115.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.91 -41.25 95.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.1 -33.82 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -90.14 5.94 44.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.278 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.2 m -57.47 -26.79 61.77 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -63.45 -36.88 85.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 182' ' ' LEU . 3.7 mm? -73.74 -33.27 64.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' LEU . . . . . 0.776 HD11 HG22 ' A' ' 174' ' ' VAL . 7.0 mt -78.0 -28.76 49.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.52 -34.48 61.79 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -76.4 -14.66 60.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.283 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.543 ' O ' HG12 ' A' ' 187' ' ' ILE . 11.4 m-20 81.09 -47.48 0.25 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 186' ' ' ASP . 2.3 pt 53.76 125.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 174.95 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 167' ' ' GLN . 11.0 p -101.43 147.21 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.95 65.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.536 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.532 ' N ' HG22 ' A' ' 165' ' ' ILE . 6.1 t -66.75 -169.1 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.035 0.445 . . . . 0.0 111.203 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.4 97.06 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.584 HG11 ' HB ' ' A' ' 132' ' ' ILE . 33.4 m -110.91 -178.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.84 177.98 9.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.6 ' CG2' HD13 ' A' ' 204' ' ' LEU . 1.4 pp -136.12 169.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 196' ' ' VAL . 12.5 m -150.14 98.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -71.64 98.37 1.89 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -70.01 -177.65 1.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.27 -26.44 66.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.32 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.517 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -158.96 139.8 12.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.992 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.947 HD11 HG13 ' A' ' 152' ' ' VAL . 15.0 tt -97.81 130.93 45.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.2 t -160.01 145.98 15.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.914 0.387 . . . . 0.0 111.234 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.6 HD13 ' CG2' ' A' ' 195' ' ' ILE . 3.4 mm? -95.98 169.58 9.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.656 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.9 m -148.96 136.7 20.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.486 ' ND1' HG12 ' A' ' 193' ' ' VAL . 73.4 t60 -153.12 157.24 40.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -51.04 97.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 141.37 -64.71 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.32 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -160.04 173.2 16.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 111.061 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.52 153.28 26.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.22 161.63 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.94 -63.03 1.5 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.732 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.7 mp 53.81 93.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.369 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.66 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -69.64 -33.48 72.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.412 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.42 ' HB3' HD13 ' A' ' 217' ' ' LEU . 0.4 OUTLIER -50.75 -56.42 12.12 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.729 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.808 HD12 ' CB ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.65 -39.16 77.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.417 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.431 ' O ' ' HB ' ' A' ' 153' ' ' ILE . . . -90.5 33.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.313 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.828 ' O ' HD13 ' A' ' 153' ' ' ILE . 2.0 t-80 -90.57 -58.69 2.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.623 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 142' ' ' ASN . 71.5 p -149.25 71.23 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.481 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.742 HD11 HD12 ' A' ' 138' ' ' LEU . 30.1 mm -98.8 166.26 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.385 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.624 ' HA ' ' HA2' ' A' ' 149' ' ' GLY . 13.8 ttt180 -100.97 101.04 11.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' A' ' 221' ' ' ILE . 1.9 mp -147.23 171.87 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 1.5 tm-20 -89.12 167.82 12.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.332 . . . . 0.0 110.728 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.628 ' C ' HD12 ' A' ' 226' ' ' LEU . 33.3 tt0 -89.55 81.53 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.647 HD13 ' HB3' ' A' ' 158' ' ' SER . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.352 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.791 0.329 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.554 HG21 HG12 ' A' ' 202' ' ' ILE . 24.1 m -65.23 -49.09 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.268 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.497 ' N ' HG23 ' A' ' 112' ' ' VAL . 22.3 mt-10 -90.45 52.8 2.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -89.94 -36.94 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -84.31 140.03 31.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.2 mt -111.75 151.32 29.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -155.07 146.85 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.72 -49.35 7.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.89 172.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.52 92.2 2.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -130.26 123.76 30.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.71 163.88 23.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 m -69.84 161.53 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -83.38 73.76 10.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -154.23 -51.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 m -143.4 108.55 5.25 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.62 -29.8 62.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.552 2.168 . . . . 0.0 112.513 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' PHE . . . . . 0.611 ' HB3' HD12 ' A' ' 182' ' ' LEU . 4.2 p90 -125.96 169.22 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.584 ' HA3' HG13 ' A' ' 211' ' ' VAL . . . -92.0 -134.42 6.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.459 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.628 ' CB ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER -123.52 -60.97 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.547 0.213 . . . . 0.0 111.513 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.813 ' HA ' HG21 ' A' ' 187' ' ' ILE . 3.3 Cg_exo -84.82 56.34 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.495 2.797 . . . . 0.0 112.072 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER 36.81 68.72 1.44 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.886 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.94 138.49 42.79 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.998 2.466 . . . . 0.0 112.639 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' CG2' ' A' ' 168' ' ' ILE . . . -90.83 78.53 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.051 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.552 HD23 ' CD2' ' A' ' 182' ' ' LEU . 2.9 pp -76.88 -46.16 25.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.929 0.395 . . . . 0.0 110.44 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.53 ' N ' HD12 ' A' ' 135' ' ' LEU . 12.4 m-20 -90.56 4.09 52.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.051 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.7 -167.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 171' ' ' ILE . 2.2 tt -80.44 59.73 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.785 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.32 95.91 1.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.611 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.53 -59.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.093 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.78 -178.87 40.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.594 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.14 168.82 23.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.8 m -120.48 148.73 43.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.998 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.18 -44.77 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.785 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -118.59 -164.78 1.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 69.75 132.07 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -74.59 -46.92 5.53 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 12.5 Cg_exo -35.65 -38.81 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.976 2.451 . . . . 0.0 113.367 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -153.08 132.79 3.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.821 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.696 HG21 ' HB2' ' A' ' 155' ' ' ALA . 8.8 t -104.66 -26.44 12.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 153' ' ' ILE . 3.7 tpp180 66.95 63.54 0.47 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.538 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.784 HG11 HD12 ' A' ' 221' ' ' ILE . 0.0 OUTLIER 43.62 -82.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.178 179.416 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 151' ' ' ARG . 3.1 tt -51.29 82.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.949 0.404 . . . . 0.0 111.285 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 158.84 -40.51 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.026 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.696 ' HB2' HG21 ' A' ' 150' ' ' THR . . . -68.63 -18.49 64.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.247 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.868 ' HB2' HG21 ' A' ' 195' ' ' ILE . . . -106.21 32.22 4.59 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.468 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.0 t -154.02 19.47 0.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.463 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -134.2 -66.85 0.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.739 0.304 . . . . 0.0 110.836 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 25.2 ttm -167.48 56.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.634 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.491 ' HB3' HD13 ' A' ' 195' ' ' ILE . 10.0 Cg_endo -51.83 146.26 28.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.172 2.581 . . . . 0.0 112.818 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -161.77 -50.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.487 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -170.33 84.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 1.15 HG13 HD11 ' A' ' 195' ' ' ILE . 19.3 m -70.16 143.52 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.449 ' HB2' ' CB ' ' A' ' 224' ' ' GLU . 6.3 mtt85 -90.36 106.94 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.76 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.981 HD11 HG12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -77.4 143.24 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.455 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.839 ' N ' HD13 ' A' ' 165' ' ' ILE . 11.4 t -142.79 -40.05 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.658 ' O ' HD13 ' A' ' 168' ' ' ILE . 1.6 mt-30 -131.46 129.28 40.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.828 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.981 HG12 HD11 ' A' ' 165' ' ' ILE . 15.1 mm -146.52 -42.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.05 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -51.7 167.11 0.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -93.64 -175.27 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -131.66 -56.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.17 -66.48 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -88.91 170.36 10.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.7 p -168.77 -40.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.263 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.8 98.38 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.5 p -153.87 138.65 17.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.18 73.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -62.36 -26.19 68.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.189 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -90.07 -31.92 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -54.22 -38.21 65.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.975 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -28.12 69.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 128' ' ' PHE . 7.2 mp -76.87 -34.24 57.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.901 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.48 -32.25 73.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.0 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -25.07 20.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.06 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 130' ' ' ASN . . . -57.39 -21.01 33.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.608 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 7.3 t70 65.42 85.19 0.14 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.761 0.315 . . . . 0.0 110.759 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.813 HG21 ' HA ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 166.39 144.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.577 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ARG . . . . . 0.508 ' N ' HD13 ' A' ' 187' ' ' ILE . 11.2 mpt_? -115.53 -87.82 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.962 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 165' ' ' ILE . 33.8 m -155.43 169.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . 0.667 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 98.75 -13.44 62.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.179 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' SER . . . . . 0.442 ' O ' HG22 ' A' ' 165' ' ' ILE . 5.4 t -68.56 -167.44 0.09 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.278 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -141.11 92.07 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 206' ' ' HIS . 31.0 m -100.06 148.03 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.628 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -95.48 161.31 14.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.652 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 1.15 HD11 HG13 ' A' ' 163' ' ' VAL . 0.6 OUTLIER -113.9 156.35 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.138 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.42 133.07 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.35 95.21 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.025 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -74.21 178.91 4.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.44 86.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 65.96 44.7 91.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.642 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -161.78 139.33 8.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.929 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -97.27 126.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.697 ' N ' HD13 ' A' ' 202' ' ' ILE . 0.6 OUTLIER -160.07 137.72 9.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.443 HD13 HG21 ' A' ' 193' ' ' VAL . 17.8 mt -80.0 178.7 8.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -150.4 93.46 1.99 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.769 0.319 . . . . 0.0 111.259 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 193' ' ' VAL . 0.4 OUTLIER 178.66 -169.64 0.1 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 60.51 -72.2 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -118.62 -52.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.959 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -160.59 -77.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.756 0.312 . . . . 0.0 110.428 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -142.21 160.76 39.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.584 HG13 ' HA3' ' A' ' 129' ' ' GLY . 10.8 t -114.69 142.97 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 213' ' ' LEU . 7.0 mm-40 -79.73 -51.86 8.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' A' ' 203' ' ' THR . 0.5 OUTLIER 23.14 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.164 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.14 161.72 10.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 1.8 m-20 -53.87 -30.67 46.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.322 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -54.29 -53.92 47.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.972 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -40.99 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.038 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.527 ' HA ' HD11 ' A' ' 221' ' ' ILE . . . -55.41 -21.44 15.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.026 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.472 ' NE2' HD13 ' A' ' 153' ' ' ILE . 58.1 t-80 -82.65 -16.65 47.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.301 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.2 t -141.7 80.82 1.74 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.784 HD12 HG11 ' A' ' 152' ' ' VAL . 36.9 mt -126.51 159.62 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -97.86 107.6 20.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 112.161 -179.129 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -148.04 168.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.678 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.571 ' O ' HG22 ' A' ' 150' ' ' THR . 3.4 tt0 -89.73 169.55 11.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.645 0.259 . . . . 0.0 110.452 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 22.8 tt0 -89.53 125.45 35.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 155' ' ' ALA . 3.7 pp . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.316 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.752 0.311 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 113' ' ' GLU . 28.8 m -69.53 -42.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -78.91 70.68 5.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.887 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 52.2 2.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -70.9 132.9 45.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 tp -157.61 -51.7 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 m -90.75 157.48 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.216 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -88.13 -38.68 15.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.38 140.04 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.53 125.68 39.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -131.73 155.51 47.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -148.01 130.45 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.91 140.76 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.7 t 61.37 173.51 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -158.0 103.46 1.86 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.47 -61.92 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.46 106.83 2.35 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.474 2.116 . . . . 0.0 112.567 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -139.99 44.38 1.91 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.19 120.38 2.33 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.247 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.468 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 2.0 p-10 -175.15 163.31 2.28 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.51 ' HG2' HG11 ' A' ' 193' ' ' VAL . 5.3 Cg_endo -47.15 140.79 13.83 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.97 2.447 . . . . 0.0 112.908 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.789 HD12 ' HD2' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -6.86 84.01 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.064 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.31 142.75 74.24 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.04 2.493 . . . . 0.0 111.729 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.582 ' HA3' HG21 ' A' ' 221' ' ' ILE . . . -90.45 29.47 6.66 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.873 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.7 tt -79.03 -56.3 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.104 0.478 . . . . 0.0 110.198 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.19 12.02 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.229 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.41 ' HB2' ' HA2' ' A' ' 134' ' ' GLY . 3.9 tp10 -87.04 -149.28 0.15 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.95 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.09 84.61 6.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.574 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 217' ' ' LEU . . . -90.33 111.42 3.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.248 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 141' ' ' GLY . 8.7 p -146.76 -46.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.621 0.248 . . . . 0.0 111.477 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 140' ' ' VAL . . . 134.26 115.45 1.56 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.549 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.49 -173.06 0.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.825 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.76 122.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.07 -46.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.543 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.96 -173.99 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 62.05 -83.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.685 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -179.15 -59.55 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.49 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 5.1 Cg_exo -31.36 133.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.363 2.709 . . . . 0.0 113.546 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.82 125.94 0.04 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.688 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 225' ' ' GLU . 0.2 OUTLIER -167.97 -151.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.462 0.172 . . . . 0.0 110.876 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.94 ' HB2' HG21 ' A' ' 223' ' ' ILE . 36.4 ttp180 69.02 -70.15 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.264 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.732 HG21 ' HB1' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -95.25 -17.79 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.413 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 153' ' ' ILE . 0.1 OUTLIER -133.54 107.09 10.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.642 0.258 . . . . 0.0 111.419 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASP . . . . . 0.603 ' O ' HG22 ' A' ' 157' ' ' THR . 15.7 t70 99.12 -37.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.82 ' HB2' ' H ' ' A' ' 151' ' ' ARG . . . -48.33 -32.18 7.07 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.03 -54.71 41.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.546 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 154' ' ' ASP . 7.9 t -63.23 -28.73 70.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.573 ' HB2' HD12 ' A' ' 226' ' ' LEU . 3.0 m -71.99 -155.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.09 71.12 1.35 Allowed Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.712 0.291 . . . . 0.0 111.147 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' PRO . . . . . 0.404 ' N ' HD13 ' A' ' 226' ' ' LEU . 78.7 Cg_exo -38.32 132.48 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.261 2.641 . . . . 0.0 113.148 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -170.0 -49.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -170.17 84.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.651 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 193' ' ' VAL . 31.3 m -69.95 -178.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.133 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.723 ' O ' HG23 ' A' ' 223' ' ' ILE . 8.9 mtp85 -124.31 -167.7 1.69 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.529 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.716 HG23 ' HG3' ' A' ' 222' ' ' ARG . 28.4 mm -142.37 124.83 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.796 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 t -152.11 68.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.668 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . 14.5 tt0 44.77 -94.13 0.02 OUTLIER 'General case' 0 C--O 1.246 0.888 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 168' ' ' ILE . 48.6 mm 77.59 -5.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 36.2 p30 -157.9 -178.81 7.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.744 0.306 . . . . 0.0 111.139 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.09 -88.71 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.164 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.14 -55.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.683 0.278 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.5 t80 63.55 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -104.63 171.74 7.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.829 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 174' ' ' VAL . 9.4 p -172.55 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.969 0.414 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.43 -173.33 4.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.645 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.4 p -128.0 -81.72 0.59 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.191 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.03 -43.78 86.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.453 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -67.86 -36.73 80.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.14 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.419 ' CD1' HD22 ' A' ' 182' ' ' LEU . 6.6 t80 -90.21 7.54 37.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.6 m -65.59 -48.4 72.44 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.43 -34.41 65.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.419 HD22 ' CD1' ' A' ' 179' ' ' PHE . 11.0 mp -62.8 -23.96 67.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.088 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.2 mt -90.06 -32.09 16.87 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -19.27 10.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.526 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.434 ' CB ' ' N ' ' A' ' 130' ' ' ASN . . . -81.6 11.9 4.29 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 62.35 100.93 0.03 OUTLIER 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.56 HG22 ' HA ' ' A' ' 132' ' ' ILE . 2.7 pt -83.51 87.14 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.401 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -125.0 107.81 11.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.691 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.58 ' N ' HD11 ' A' ' 132' ' ' ILE . 18.3 m -56.77 156.91 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.05 -6.9 66.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.087 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.5 t -66.25 -170.43 0.09 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.038 0.446 . . . . 0.0 111.525 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.34 136.21 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.716 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.793 HG12 ' CD2' ' A' ' 206' ' ' HIS . 35.5 m -138.92 -174.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.045 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.11 161.34 33.53 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.835 0.35 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 196' ' ' VAL . 0.3 OUTLIER -121.19 153.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.786 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.576 ' H ' HD12 ' A' ' 195' ' ' ILE . 13.5 p -141.89 141.4 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.36 91.6 8.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.432 ' HB2' HG22 ' A' ' 203' ' ' THR . 6.3 ttt180 -70.12 -179.71 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.78 92.92 3.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.17 35.0 91.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.673 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -163.45 143.31 8.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.763 0.315 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.651 HD13 HG12 ' A' ' 152' ' ' VAL . 20.9 tt -98.48 111.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.45 HG23 ' CG1' ' A' ' 196' ' ' VAL . 9.6 t -120.69 133.97 55.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.656 HD11 HG22 ' A' ' 152' ' ' VAL . 1.3 mm? -90.32 120.9 31.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.7 m -102.44 140.28 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' HIS . . . . . 0.793 ' CD2' HG12 ' A' ' 193' ' ' VAL . 26.3 t-80 -158.71 145.0 16.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' HIS . 21.2 m120 -28.56 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.441 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -56.99 -76.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.093 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 209' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.1 mtmt -160.2 -174.51 4.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.91 133.93 48.05 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.441 HG21 ' ND2' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -112.86 148.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 111.588 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.39 -9.23 59.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.973 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.425 ' HB2' HD23 ' A' ' 204' ' ' LEU . 5.5 mp -36.99 106.92 0.05 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.784 0.326 . . . . 0.0 111.439 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 4.1 mp -93.34 -176.52 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 0.7 OUTLIER -63.08 -14.54 49.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.291 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.39 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 111.227 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LEU . . . . . 0.478 ' HA ' ' HA3' ' A' ' 139' ' ' GLY . 2.5 mm? -86.28 -24.06 26.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.343 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 152' ' ' VAL . . . -90.41 35.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.538 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.465 ' HA ' HG21 ' A' ' 153' ' ' ILE . 0.9 OUTLIER -85.86 -7.22 58.85 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.358 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 220' ' ' THR . 4.6 t -179.09 90.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.196 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.582 HG21 ' HA3' ' A' ' 134' ' ' GLY . 0.1 OUTLIER -126.42 -163.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.789 ' HD2' HD12 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -84.39 88.95 7.3 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.398 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.94 HG21 ' HB2' ' A' ' 151' ' ' ARG . 1.7 mp -151.76 144.41 16.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.48 ' CB ' ' HB2' ' A' ' 164' ' ' ARG . 15.4 tt0 -89.86 161.15 16.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.662 ' HA ' HG21 ' A' ' 150' ' ' THR . 35.7 tt0 -89.3 118.61 29.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.086 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 158' ' ' SER . 2.1 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.288 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.749 0.309 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 156' ' ' ALA . 14.7 p -75.66 -41.98 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.416 ' N ' HG13 ' A' ' 112' ' ' VAL . 35.2 mt-10 -66.07 93.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -73.23 73.83 1.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.07 92.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.014 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mt -166.71 166.02 16.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -151.04 146.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -149.65 -48.38 0.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.9 t -146.76 -68.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.039 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 tp -172.75 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.24 176.07 5.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -139.21 -58.04 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 123' ' ' VAL . 10.6 p -164.53 123.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t -166.7 164.8 16.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -114.91 -42.02 3.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.0 p -145.08 64.6 11.19 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.47 70.2 6.37 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.719 2.28 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -164.09 38.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -131.17 -175.24 13.93 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.66 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 1.8 p-10 50.62 166.51 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 122.273 0.229 . . . . 0.0 111.148 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PRO . . . . . 0.66 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 43.5 Cg_exo -23.07 139.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.31 3.34 . . . . 0.0 113.856 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.87 ' N ' HD13 ' A' ' 187' ' ' ILE . 18.7 tt -46.45 121.99 6.58 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.17 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.561 ' HB3' HD11 ' A' ' 213' ' ' LEU . 83.6 Cg_endo -81.2 140.16 12.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.771 2.314 . . . . 0.0 111.828 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . 0.697 ' O ' HD11 ' A' ' 221' ' ' ILE . . . -90.52 68.66 2.36 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.306 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 135' ' ' LEU . 9.9 tt -70.6 -65.77 0.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.98 3.43 54.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.168 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.503 ' CD ' HD13 ' A' ' 168' ' ' ILE . 2.6 mt-10 -77.71 -47.46 19.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.52 0.2 . . . . 0.0 111.331 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.612 ' HB3' HD12 ' A' ' 221' ' ' ILE . 1.7 pp -41.91 -31.8 0.37 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.805 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -40.81 -34.56 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.153 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.68 103.36 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 111.003 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 128.15 172.92 13.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.4 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 9.6 p30 -156.9 150.35 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -138.72 98.64 3.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.02 -53.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.45 153.0 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 61.17 174.73 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.119 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ALA . . . . . 0.677 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -73.39 -57.49 2.71 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 7.6 Cg_exo -33.68 109.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.175 2.583 . . . . 0.0 113.216 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 95.52 137.6 9.22 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.598 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' THR . . . . . 0.84 HG23 ' HB ' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -179.14 -80.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.535 0.207 . . . . 0.0 111.431 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ARG . . . . . 0.689 ' O ' HG12 ' A' ' 152' ' ' VAL . 5.0 tpt180 70.08 38.98 1.42 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.958 0.409 . . . . 0.0 110.609 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 195' ' ' ILE . 0.3 OUTLIER 82.68 2.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.903 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 150' ' ' THR . 2.9 tp -92.78 25.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 120.749 0.309 . . . . 0.0 111.369 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 170.46 -36.43 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.797 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 225' ' ' GLU . . . -67.4 -21.16 65.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ALA . . . . . 0.637 ' O ' HG23 ' A' ' 157' ' ' THR . . . -86.73 56.31 3.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -166.34 -43.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 83.91 5.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 66.8 mtt 59.49 62.59 3.79 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.285 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 124.61 11.05 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.697 2.265 . . . . 0.0 112.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -153.08 -48.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -164.61 113.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 m -89.54 132.66 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.236 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ARG . . . . . 0.453 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 13.8 mtt180 -79.88 98.24 7.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.283 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.974 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.3 OUTLIER -70.72 124.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.698 0.285 . . . . 0.0 110.888 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' VAL . . . . . 0.595 ' N ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -160.87 98.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.404 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 16.9 mt-30 93.15 137.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.872 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 169' ' ' ASN . 0.6 OUTLIER -143.74 -48.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.835 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 168' ' ' ILE . 16.0 t30 172.69 -85.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.512 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.63 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.701 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.16 -60.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.9 t80 61.49 -81.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -116.63 134.89 54.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.972 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 174' ' ' VAL . 7.3 p -163.26 94.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.04 -42.72 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.267 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.7 t -59.79 144.02 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.35 -33.33 71.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -31.73 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.391 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PHE . . . . . 0.482 ' CD1' HD22 ' A' ' 182' ' ' LEU . 82.0 t80 -90.06 -29.24 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.068 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.3 m -54.45 -32.01 56.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -71.37 -35.59 71.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LEU . . . . . 0.521 HD23 ' HG2' ' A' ' 133' ' ' PRO . 9.1 mp -55.78 -30.33 61.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.72 -31.88 46.6 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.824 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -23.78 3.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.103 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ALA . . . . . 0.795 ' HB3' HD11 ' A' ' 187' ' ' ILE . . . -51.9 -26.1 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.186 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 187' ' ' ILE . 7.8 t70 57.84 78.47 0.24 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.267 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ILE . . . . . 0.87 HD13 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER 178.98 160.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -144.61 172.58 12.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 165' ' ' ILE . 24.6 m -54.21 174.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.839 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.69 -15.13 61.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.6 t -86.95 -164.7 1.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.394 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -132.2 86.62 2.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.397 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' VAL . . . . . 0.476 HG12 ' CG ' ' A' ' 131' ' ' PRO . 8.4 m -84.23 175.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.89 168.17 20.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ILE . . . . . 0.723 ' CG2' HD23 ' A' ' 204' ' ' LEU . 2.9 pp -139.96 167.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.333 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 m -154.94 142.19 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.005 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -70.08 85.02 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ARG . . . . . 0.543 ' HB2' HG21 ' A' ' 203' ' ' THR . 20.4 tpt180 -78.89 88.91 4.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.209 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.26 54.77 9.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.339 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.41 39.07 96.77 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.654 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.19 145.0 31.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.736 0.303 . . . . 0.0 110.739 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . 0.694 HD11 ' C ' ' A' ' 214' ' ' LEU . 30.3 pt -80.0 139.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.241 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 198' ' ' ARG . 2.6 t -160.17 129.95 5.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.822 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LEU . . . . . 0.871 HD12 HD22 ' A' ' 213' ' ' LEU . 25.7 mt -86.02 151.38 23.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.616 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 43.5 m -143.44 123.08 13.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -174.87 168.79 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.6 t30 67.4 -69.92 0.13 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.449 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 172.76 29.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.231 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.7 165.5 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.47 146.46 39.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.522 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -117.85 163.57 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.94 -65.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.381 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' LEU . . . . . 0.871 HD22 HD12 ' A' ' 204' ' ' LEU . 6.6 mp 36.0 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.778 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.694 ' C ' HD11 ' A' ' 202' ' ' ILE . 1.1 tp -75.95 -169.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.391 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASP . . . . . 0.401 ' N ' HD11 ' A' ' 202' ' ' ILE . 13.7 t70 -55.22 -25.09 30.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.998 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . 0.588 ' O ' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -68.4 -57.26 6.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.963 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.36 -49.98 67.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.191 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ALA . . . . . 0.514 ' O ' HD13 ' A' ' 153' ' ' ILE . . . -90.21 47.2 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.65 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 220' ' ' THR . 6.3 t-80 -90.16 -43.09 10.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.708 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' THR . . . . . 0.443 ' HB ' ' HA ' ' A' ' 142' ' ' ASN . 3.0 p -155.39 70.13 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ILE . . . . . 0.697 HD11 ' O ' ' A' ' 134' ' ' GLY . 0.7 OUTLIER -106.94 165.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 222' ' ' ARG . . . . . 0.672 ' C ' HD13 ' A' ' 223' ' ' ILE . 33.6 mtt-85 -101.8 92.57 4.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ILE . . . . . 0.974 HG23 ' HA ' ' A' ' 165' ' ' ILE . 3.8 mm -124.21 -162.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' GLU . . . . . 0.801 ' H ' HG22 ' A' ' 223' ' ' ILE . 12.8 tm-20 -112.14 133.22 54.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.943 0.338 . . . . 0.0 110.511 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 0.8 OUTLIER -89.67 109.31 20.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.244 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.471 -0.252 . . . . 8.3900000000000006 112.471 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.2 m -129.77 60.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 7.2400000000000002 110.834 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.6 m80 59.61 -88.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 8.3900000000000006 110.903 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.4 mtt 48.33 86.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.328 -0.396 . . . . 7.4400000000000004 110.999 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -87.91 108.2 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 5.3499999999999996 110.932 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -72.71 178.09 4.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 3.4199999999999999 110.832 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' HD12 ' A' ' 202' ' ' ILE . 27.3 m -68.01 -49.52 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 2.29 111.143 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 112' ' ' VAL . 1.7 pt-20 -80.53 -8.34 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 3.04 111.113 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -54.96 -35.12 63.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.367 . . . . 7.1399999999999997 110.989 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.15 127.61 32.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 7.6600000000000001 110.941 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.57 113.04 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 4.5300000000000002 110.809 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.467 HG21 HD21 ' A' ' 214' ' ' LEU . 13.0 m -128.06 171.51 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 4.1399999999999997 111.159 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -127.13 -43.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 7.3700000000000001 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 119' ' ' VAL . 0.4 OUTLIER -63.66 171.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 2.5499999999999998 111.203 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 135' ' ' LEU . 7.3 tp -110.81 72.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 2.6200000000000001 110.902 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.403 ' O ' HD22 ' A' ' 214' ' ' LEU . 74.9 mttt -153.09 160.97 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 5.8099999999999996 110.855 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -151.0 -166.04 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 4.1900000000000004 110.94 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -166.36 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 3.6400000000000001 110.998 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t 75.13 172.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 4.2800000000000002 110.888 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -102.34 -29.08 11.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 6.6399999999999997 110.974 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.7 m -111.56 76.2 1.49 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 3.8999999999999999 110.997 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -20.04 24.19 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.732 2.288 . . . . 3.79 112.345 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.78 150.42 27.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 4.1200000000000001 110.938 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 147.31 157.22 7.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.728 . . . . 1.8700000000000001 112.508 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.646 ' O ' ' O ' ' A' ' 129' ' ' GLY . 2.3 p30 49.2 141.77 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.111 0.482 . . . . 2.3700000000000001 111.405 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.708 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 73.8 Cg_endo -75.92 141.02 23.64 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.934 2.423 . . . . 1.8600000000000001 112.763 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.735 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 136.92 -27.46 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.546 . . . . 4.8200000000000003 111.765 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 17.1 Cg_exo -66.47 53.66 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.764 2.31 . . . . 1.5700000000000001 112.784 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.475 ' HA3' HG21 ' A' ' 168' ' ' ILE . . . -67.21 90.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.706 . . . . 1.25 112.232 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.592 HD11 HD21 ' A' ' 120' ' ' LEU . 6.3 tt -67.47 -56.47 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 2.9700000000000002 111.282 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -89.97 8.97 29.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.512 . . . . 3.8700000000000001 111.374 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 169' ' ' ASN . 0.5 OUTLIER -90.13 -50.05 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.757 0.313 . . . . 2.8700000000000001 111.04 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.571 HD22 ' O ' ' A' ' 217' ' ' LEU . 1.3 pp -45.29 -38.36 5.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 4.4000000000000004 111.429 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.727 ' O ' HG23 ' A' ' 140' ' ' VAL . . . -45.87 86.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.849 -0.691 . . . . 2.7400000000000002 112.92 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 139' ' ' GLY . 1.9 t 145.3 -61.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.727 0.299 . . . . 4.3499999999999996 111.211 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.55 ' N ' HG12 ' A' ' 140' ' ' VAL . . . -66.56 173.97 24.64 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.881 -0.676 . . . . 3.3700000000000001 113.05 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 141' ' ' GLY . 3.2 p-10 169.25 122.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.669 0.271 . . . . 2.71 110.67 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 66.2 m -122.4 -179.1 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 3.25 111.212 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -164.61 -40.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.983 -0.553 . . . . 3.1299999999999999 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.86 -172.18 2.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 4.0300000000000002 111.169 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 65.7 154.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 3.4500000000000002 111.098 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 149' ' ' GLY . . . -64.0 -56.65 22.94 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.352 -0.386 . . . . 2.73 111.16 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 10.4 Cg_exo -32.31 79.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.162 2.575 . . . . 3.5499999999999998 112.763 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 62.16 125.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.693 -0.765 . . . . 2.73 112.331 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.733 ' CG2' ' HB2' ' A' ' 155' ' ' ALA . 13.9 t -102.93 -5.48 23.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 2.6099999999999999 110.696 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.605 ' CG ' ' HA ' ' A' ' 220' ' ' THR . 0.0 OUTLIER 69.54 118.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 8.2200000000000006 110.773 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.659 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 29.3 t -31.85 -46.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 2.7400000000000002 111.499 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.537 ' CG2' ' HB3' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -43.29 -35.55 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 2.4100000000000001 110.993 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -109.32 -25.38 10.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 1.9299999999999999 110.809 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.733 ' HB2' ' CG2' ' A' ' 150' ' ' THR . . . -71.22 58.96 0.25 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 1.51 111.113 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.495 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -175.43 34.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 2.02 111.027 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 t -157.3 -33.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 2.5099999999999998 111.293 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.92 48.27 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.459 -0.337 . . . . 2.0499999999999998 111.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 4.1 ttm 62.95 61.62 1.95 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 2.8399999999999999 111.063 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.742 ' HB3' HD22 ' A' ' 226' ' ' LEU . 18.0 Cg_endo -59.3 149.26 82.06 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.839 2.359 . . . . 1.5800000000000001 112.304 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -146.12 -47.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.9900000000000002 110.84 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -170.04 95.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 2.4900000000000002 110.835 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 193' ' ' VAL . 8.1 m -73.06 116.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 1.0800000000000001 111.109 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 2.2 mtp180 -80.44 118.15 21.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 3.2999999999999998 111.069 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -84.08 120.27 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 1.3999999999999999 110.66 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.455 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 20.3 t -110.25 -23.0 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 1.8700000000000001 111.58 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.712 ' C ' HD13 ' A' ' 168' ' ' ILE . 1.8 mt-30 -178.63 -175.65 0.44 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 4.75 111.22 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.759 HG13 HD12 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -136.1 -60.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 4.5099999999999998 110.868 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 15.2 t-20 178.32 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.3200000000000003 110.909 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -173.62 -163.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.448 . . . . 5.3499999999999996 110.873 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.508 ' O ' ' C ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER -121.69 -12.39 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 4.1900000000000004 111.254 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.508 ' C ' ' O ' ' A' ' 171' ' ' ILE . 2.8 t80 -26.86 -58.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 6.4100000000000001 111.315 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -90.09 122.28 32.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 4.21 110.894 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.578 ' O ' HG22 ' A' ' 174' ' ' VAL . 12.4 p -168.71 37.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 2.7400000000000002 111.164 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 176' ' ' THR . 22.8 tt0 -112.95 77.31 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 5.0800000000000001 110.882 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 175' ' ' GLU . 1.4 p -157.35 124.92 5.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 2.9500000000000002 110.864 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -33.11 73.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 2.2599999999999998 111.057 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -70.43 -33.13 70.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 3.0800000000000001 110.944 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -76.97 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 3.7999999999999998 111.009 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.1 m -56.52 -41.88 77.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 1.8999999999999999 110.962 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -72.4 -35.11 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 3.2200000000000002 110.931 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.04 -20.6 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 2.1699999999999999 110.949 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.12 -8.43 59.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 2.1200000000000001 111.078 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -31.64 56.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 2.2599999999999998 110.955 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.3 -30.24 38.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 1.95 111.168 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 187' ' ' ILE . 3.1 t0 69.33 15.28 8.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 3.6600000000000001 110.953 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.759 HD12 HG13 ' A' ' 168' ' ' ILE . 7.8 pt 32.93 90.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 3.2799999999999998 111.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -84.37 93.39 8.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 2.9300000000000002 110.759 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 189' ' ' VAL . 8.5 m -57.66 122.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.012 -0.54 . . . . 1.8400000000000001 111.073 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.503 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 116.26 -5.27 19.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 1.3 112.55 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.435 ' C ' HG22 ' A' ' 165' ' ' ILE . 2.0 t -72.19 -161.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.336 . . . . 1.5600000000000001 110.958 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -147.38 115.08 6.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 2.7599999999999998 110.725 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.896 HG12 ' CD2' ' A' ' 206' ' ' HIS . 29.4 m -128.67 176.48 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 1.05 111.187 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.95 152.48 46.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 2.2999999999999998 110.784 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -128.41 153.96 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 2.54 111.172 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 195' ' ' ILE . 5.6 m -157.83 145.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 2.2799999999999998 111.113 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 170.39 16.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 2.3599999999999999 110.893 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -169.98 105.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 3.73 110.968 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 49.41 51.0 17.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 3.1400000000000001 110.996 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 60.74 68.04 1.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 2.0 112.417 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -170.07 155.58 5.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.804 0.335 . . . . 2.77 110.864 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.603 HD11 ' CG1' ' A' ' 152' ' ' VAL . 19.4 tt -105.3 140.14 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 1.8600000000000001 111.128 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.1 t -160.03 122.21 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 1.5800000000000001 110.959 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.414 HD13 ' HB ' ' A' ' 195' ' ' ILE . 3.1 mm? -84.86 119.23 25.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.71 110.776 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -96.9 117.63 31.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 1.27 111.012 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.896 ' CD2' HG12 ' A' ' 193' ' ' VAL . 10.6 t-80 -129.66 146.73 51.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 2.2000000000000002 110.746 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.564 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.0 m120 -19.4 -55.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 3.9100000000000001 111.303 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -54.36 -76.93 0.17 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.718 -0.754 . . . . 1.4099999999999999 112.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 18.5 mtmt -159.72 -174.44 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.317 . . . . 3.4900000000000002 110.763 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 149.24 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 2.0699999999999998 110.635 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.418 HG21 ' OD1' ' A' ' 130' ' ' ASN . 0.0 OUTLIER -122.41 178.04 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 1.5 111.213 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.77 -66.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 3.2799999999999998 110.693 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 218' ' ' ALA . 3.4 mp 57.03 77.18 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 2.1400000000000001 110.949 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 117' ' ' VAL . 17.9 tp -54.85 163.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 2.5299999999999998 110.77 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 6.7 m-20 -54.59 -22.79 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 2.1499999999999999 110.998 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.565 ' O ' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -81.89 -20.1 39.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.96 111.072 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.571 ' O ' HD22 ' A' ' 138' ' ' LEU . 10.5 mp -89.97 -56.41 3.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 2.6499999999999999 111.045 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.628 ' HB1' ' CB ' ' A' ' 152' ' ' VAL . . . -90.22 46.1 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 1.22 111.114 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.506 ' HB3' HD13 ' A' ' 138' ' ' LEU . 5.8 t-80 -90.06 -45.06 9.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 2.1699999999999999 111.013 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.605 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 6.0 p -142.25 65.31 1.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.359 . . . . 2.02 111.633 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.936 ' HB ' HD11 ' A' ' 223' ' ' ILE . 33.0 mm -89.76 158.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 116.33 -0.395 . . . . 1.9099999999999999 110.614 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 2.6 mtt-85 -95.2 86.18 4.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 6.5300000000000002 111.198 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.936 HD11 ' HB ' ' A' ' 221' ' ' ILE . 0.2 OUTLIER -123.43 -154.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.8500000000000001 110.497 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -117.94 162.44 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.348 . . . . 3.25 111.003 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.446 ' CB ' ' HB ' ' A' ' 150' ' ' THR . 16.9 tt0 -89.9 99.67 12.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 2.7999999999999998 110.849 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.742 HD22 ' HB3' ' A' ' 160' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 2.48 111.008 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m 69.74 -67.82 0.22 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.655 0.264 . . . . 0.0 111.099 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -95.29 146.71 24.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.867 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 29.1 mtt 58.86 94.16 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.035 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.99 166.81 13.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.72 139.16 35.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 113' ' ' GLU . 34.1 m -76.42 -41.03 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.251 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.401 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -70.77 -34.6 71.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -72.14 -38.52 69.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -71.35 -37.75 71.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -71.91 148.58 45.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.001 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 119' ' ' VAL . 10.3 m -99.89 169.99 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -77.25 84.08 3.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 117' ' ' VAL . 7.7 t -145.97 158.33 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.403 ' N ' HG12 ' A' ' 119' ' ' VAL . 14.0 tp -91.86 -42.67 9.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.03 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.89 111.91 23.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.36 -71.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.37 138.49 50.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 p -129.79 111.78 12.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -162.34 -43.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 42.0 m -85.52 132.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.848 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 126' ' ' SER . 45.7 Cg_exo -56.39 176.19 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.566 2.177 . . . . 0.0 112.432 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -133.52 98.03 4.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.66 25.15 1.19 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.954 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -125.16 139.02 32.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 110.796 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.582 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.2 Cg_endo -75.74 135.35 17.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.676 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.61 HG13 HG21 ' A' ' 193' ' ' VAL . 0.0 OUTLIER 148.91 -32.05 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.117 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 7.4 Cg_endo -86.68 83.82 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.491 2.127 . . . . 0.0 112.434 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.1 117.19 4.97 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.48 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 217' ' ' LEU . 3.5 tt -81.08 -59.51 2.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -89.51 11.89 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.472 ' CG ' ' HB ' ' A' ' 168' ' ' ILE . 0.6 OUTLIER -90.11 -38.61 13.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.02 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 135' ' ' LEU . 2.2 pp -42.62 -35.47 1.11 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.536 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -51.84 151.39 7.0 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.714 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.0 t 58.6 101.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.237 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.97 141.64 6.1 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.425 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -164.57 96.13 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.342 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.443 ' N ' ' HD3' ' A' ' 151' ' ' ARG . 1.1 m -101.85 -175.89 2.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.52 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.85 -48.66 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.72 89.56 1.33 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.22 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.71 155.0 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -64.06 -61.61 6.53 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.09 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 8.2 Cg_exo -34.44 -43.99 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.014 2.476 . . . . 0.0 112.627 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -161.71 140.25 6.5 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.857 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.8 t -112.41 -20.88 11.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.655 0.227 . . . . 0.0 111.488 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.793 ' O ' HG22 ' A' ' 153' ' ' ILE . 18.5 ttp180 74.6 30.56 1.04 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.945 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER 52.51 -70.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.624 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.793 HG22 ' O ' ' A' ' 151' ' ' ARG . 3.4 tt -44.04 85.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.296 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 152' ' ' VAL . 1.7 p30 168.06 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.38 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.601 ' HA ' HD13 ' A' ' 226' ' ' LEU . . . -49.63 -29.39 7.14 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.474 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.682 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -95.32 33.06 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.417 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.9 t -170.59 33.61 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.175 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.576 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -158.52 35.54 0.23 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.038 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.1 mtp 58.43 67.87 1.99 Allowed Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.48 ' HA ' HD12 ' A' ' 226' ' ' LEU . 18.3 Cg_endo -60.14 155.67 44.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.81 2.34 . . . . 0.0 112.605 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.49 -55.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.504 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -170.26 91.84 0.19 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.062 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 193' ' ' VAL . 15.9 m -69.99 170.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.565 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -139.81 116.53 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.707 HD13 ' N ' ' A' ' 166' ' ' VAL . 0.2 OUTLIER -77.53 129.6 37.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.199 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.707 ' N ' HD13 ' A' ' 165' ' ' ILE . 17.7 t -133.93 -25.43 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.472 ' HA ' HG11 ' A' ' 189' ' ' VAL . 3.2 mt-30 -147.33 162.1 39.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.22 0.533 . . . . 0.0 111.775 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.565 HD13 HG12 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -152.38 -80.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.772 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -179.72 -67.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.91 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -155.65 -178.9 7.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.88 -40.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.197 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.96 -35.71 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.215 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -64.62 121.09 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.633 HG13 ' O ' ' A' ' 174' ' ' VAL . 10.7 p -172.07 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -102.86 -32.82 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.116 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.1 p -60.8 127.09 29.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.89 -35.51 67.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.03 -22.54 66.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.699 ' CZ ' HD12 ' A' ' 182' ' ' LEU . 14.0 t80 -79.02 -8.67 59.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.9 m -57.71 -40.44 79.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.688 0.28 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.09 -41.77 97.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.738 HD13 ' O ' ' A' ' 182' ' ' LEU . 3.2 tm? -77.69 -22.71 50.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.916 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 174' ' ' VAL . 0.7 OUTLIER -55.68 -26.7 46.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.297 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -34.95 40.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.95 38.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.719 ' C ' HD13 ' A' ' 187' ' ' ILE . 11.4 m-20 57.61 37.4 27.48 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.719 HD13 ' C ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER 9.68 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.267 0.627 . . . . 0.0 112.605 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -106.0 121.9 45.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.765 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.511 ' HA ' HD12 ' A' ' 165' ' ' ILE . 15.9 m -62.69 148.03 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.039 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.34 -11.75 47.59 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.719 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.8 t -70.06 -175.43 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -134.5 124.13 25.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.601 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 163' ' ' VAL . 21.1 m -131.83 172.87 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 0.0 111.461 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.9 138.53 19.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.653 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.682 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 4.0 tt -110.25 158.49 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.15 0.5 . . . . 0.0 111.32 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.473 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 15.4 m -142.07 136.55 29.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.982 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.98 93.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.12 -177.66 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.27 79.16 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 66.99 38.97 93.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.606 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -160.96 150.57 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 0.0 111.017 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.5 tt -95.6 144.74 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -160.08 137.43 9.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.466 HD23 HD22 ' A' ' 213' ' ' LEU . 3.6 mm? -115.55 121.86 43.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.5 m -86.76 138.31 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.534 ' CG ' HG12 ' A' ' 193' ' ' VAL . 3.0 t60 -165.12 172.31 12.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 206' ' ' HIS . 75.5 m-20 -28.17 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.82 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . 135.1 -81.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 23.0 mtmt -158.38 -88.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.614 0.245 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.25 158.34 34.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.01 172.68 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.014 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -79.94 -59.54 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.518 ' HA ' HD11 ' A' ' 217' ' ' LEU . 0.6 OUTLIER 52.72 96.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 3.9 mm? -79.75 178.51 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -76.54 -8.41 57.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.381 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -65.95 0.97 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.116 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -61.14 -36.27 79.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.509 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -89.76 24.48 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.595 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 4.6 t-80 -90.37 -67.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.8 p -103.86 53.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' A' ' 152' ' ' VAL . 31.9 mt -91.57 150.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -92.81 104.07 16.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.999 0.428 . . . . 0.0 111.657 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.562 HD11 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -136.7 -179.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.824 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.528 ' H ' HG22 ' A' ' 223' ' ' ILE . 6.3 tt0 -89.47 165.82 14.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 110.544 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -89.62 102.9 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.601 HD13 ' HA ' ' A' ' 155' ' ' ALA . 2.1 pt? . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.708 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.1 m -102.85 45.57 0.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.834 0.349 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -149.69 122.5 8.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 71.1 mtp 58.17 79.89 0.19 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.96 159.27 16.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.46 176.67 8.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 197' ' ' ASP . 27.6 m -90.07 -43.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.386 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -90.12 -30.37 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.351 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -55.94 -43.2 77.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.336 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -67.46 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.944 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 117' ' ' VAL . 1.9 tt 64.66 130.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.428 ' N ' HD23 ' A' ' 116' ' ' LEU . 7.1 m -147.85 171.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -103.26 -33.85 9.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 m -61.02 140.73 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.394 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.1 tp -89.54 -42.51 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.35 131.04 44.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.04 -63.75 1.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.34 163.97 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.041 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 t -118.0 88.75 2.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -152.96 77.13 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.5 t 59.04 69.56 1.33 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.63 -28.29 80.77 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -106.82 149.64 27.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 155.5 134.45 1.86 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.72 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.433 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 10.4 p30 54.05 157.17 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.275 0 CA-C-O 121.059 0.457 . . . . 0.0 111.939 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.562 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 91.8 Cg_endo -77.78 175.03 11.71 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.896 2.397 . . . . 0.0 112.324 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.591 HG23 ' CD1' ' A' ' 165' ' ' ILE . 1.0 OUTLIER 108.46 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.467 ' HD2' ' C ' ' A' ' 131' ' ' PRO . 72.7 Cg_exo -43.12 118.66 1.36 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.338 2.025 . . . . 0.0 113.125 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.789 ' HA3' HG21 ' A' ' 221' ' ' ILE . . . -90.97 23.5 23.29 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.11 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.459 ' HA ' ' HG ' ' A' ' 217' ' ' LEU . 0.6 OUTLIER -50.24 -36.0 29.25 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.998 0.428 . . . . 0.0 110.478 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD2' HG23 ' A' ' 174' ' ' VAL . 0.3 OUTLIER -90.48 -22.36 21.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -178.28 0.53 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.89 102.33 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.745 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.33 127.05 8.6 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.058 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.9 -79.03 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.779 0.289 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.05 109.74 0.59 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.643 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.11 102.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 0.0 110.422 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.515 ' HA ' HD11 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -81.81 162.05 23.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.268 0.556 . . . . 0.0 111.774 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 p30 49.4 -178.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.804 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.38 179.58 0.77 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.954 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.71 -71.26 0.14 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.988 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -80.27 174.7 5.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.745 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 76.2 Cg_exo -50.69 89.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.567 2.178 . . . . 0.0 112.229 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.406 ' HA2' ' HG2' ' A' ' 224' ' ' GLU . . . -167.78 146.92 11.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.483 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.792 ' O ' HD11 ' A' ' 153' ' ' ILE . 0.4 OUTLIER -140.1 -48.53 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.554 0.216 . . . . 0.0 110.458 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.814 ' O ' HD13 ' A' ' 153' ' ' ILE . 34.9 mtt180 88.24 55.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.766 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.726 HG13 ' CG1' ' A' ' 223' ' ' ILE . 16.0 m 57.38 -47.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.814 HD13 ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -43.99 -30.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 118.636 0.653 . . . . 0.0 112.345 -178.165 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.13 24.05 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.609 0.243 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -96.51 12.53 31.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.397 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.727 ' HB2' HG12 ' A' ' 195' ' ' ILE . . . -149.84 70.52 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.052 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.512 ' H ' HD21 ' A' ' 226' ' ' LEU . 7.4 m -158.73 -52.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.087 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.503 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.5 OUTLIER -71.4 -79.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.359 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.523 ' H ' HD22 ' A' ' 226' ' ' LEU . 26.5 ttm -155.76 92.09 2.69 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.681 0.276 . . . . 0.0 111.143 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 226' ' ' LEU . 18.7 Cg_endo -60.27 140.33 91.47 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.723 2.282 . . . . 0.0 112.552 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -162.91 -49.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.81 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -168.62 119.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.863 ' HB ' HG22 ' A' ' 223' ' ' ILE . 26.8 m -102.1 134.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 12.4 mtt180 -79.78 126.09 30.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.889 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.742 HD13 HG23 ' A' ' 223' ' ' ILE . 24.4 mm -94.08 96.77 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 165' ' ' ILE . 86.2 t -159.89 92.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.416 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.629 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 170.07 105.54 0.01 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 111.063 179.224 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 167' ' ' GLN . 22.0 mt 98.25 -31.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.463 ' OD1' HG11 ' A' ' 189' ' ' VAL . 42.8 t-20 37.88 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.12 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.75 179.93 1.62 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.9 0.381 . . . . 0.0 111.446 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.511 HD12 ' HB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -131.04 125.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.085 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -63.82 -45.37 89.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.95 0.405 . . . . 0.0 110.686 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -123.03 143.29 50.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.492 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 174' ' ' VAL . 7.3 p -164.53 94.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -161.69 91.67 0.83 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.849 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.0 p -153.62 135.97 14.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -67.9 -35.08 77.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.91 -32.61 74.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.08 -15.87 51.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.291 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 35.2 m -50.36 -39.36 46.19 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.742 0.306 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.62 -36.03 62.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.748 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -13.27 60.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.032 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -81.02 -2.27 47.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.538 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.09 -43.28 41.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.754 0.311 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.4 -30.15 16.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.029 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.545 ' O ' ' O ' ' A' ' 187' ' ' ILE . 6.5 m-20 73.71 2.86 4.36 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.736 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.545 ' O ' ' O ' ' A' ' 186' ' ' ASP . 41.2 pt 48.62 124.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 112.146 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.61 125.59 54.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.42 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.53 HG23 ' HD2' ' A' ' 222' ' ' ARG . 7.7 p -73.64 146.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.08 1.08 63.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 132' ' ' ILE . 17.4 t -81.31 174.67 11.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.24 131.14 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 132' ' ' ILE . 31.3 m -148.11 -167.92 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -140.38 174.52 10.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.759 0.314 . . . . 0.0 110.827 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.727 HG12 ' HB2' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -160.03 154.76 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 14.8 m -155.1 174.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 112' ' ' VAL . 11.0 m-20 -86.01 160.05 19.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.766 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -163.9 102.08 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.072 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 t70 55.27 43.81 28.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.21 46.05 93.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.547 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -153.2 148.75 27.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.33 . . . . 0.0 110.906 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.663 HG13 HD11 ' A' ' 195' ' ' ILE . 18.4 tt -83.39 147.2 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.206 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.5 t -160.11 122.52 3.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 195' ' ' ILE . 14.5 mt -82.37 113.78 20.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.807 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.7 m -97.08 140.43 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.828 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 207' ' ' ASN . 54.3 t60 -147.92 144.45 28.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.489 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.0 m120 -33.13 -40.56 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.72 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -68.65 -66.31 2.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.1 mtmt -157.69 -176.3 5.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.35 148.84 40.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.415 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -114.39 169.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -79.98 -64.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.401 HD13 HD12 ' A' ' 204' ' ' LEU . 2.7 tp 59.27 167.09 0.06 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 215' ' ' ASP . 0.2 OUTLIER -157.16 152.25 26.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.432 ' H ' HD13 ' A' ' 214' ' ' LEU . 71.6 m-20 -53.31 -26.2 17.76 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.206 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.78 -66.94 0.3 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 135' ' ' LEU . 3.3 mm? -88.36 -20.84 24.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.821 ' HA ' HD11 ' A' ' 221' ' ' ILE . . . -90.14 29.46 1.23 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.859 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 220' ' ' THR . 0.1 OUTLIER -90.12 -33.94 16.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 219' ' ' HIS . 1.4 p -161.91 84.86 0.6 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.334 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.821 HD11 ' HA ' ' A' ' 218' ' ' ALA . 0.0 OUTLIER -120.5 -164.11 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.643 ' HG3' HG23 ' A' ' 165' ' ' ILE . 11.7 ptt180 -86.22 80.38 8.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.263 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.863 HG22 ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -151.43 176.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.574 178.048 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -120.87 -173.52 2.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.752 0.311 . . . . 0.0 111.019 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.407 ' HA ' HG21 ' A' ' 150' ' ' THR . 1.6 pt-20 -89.84 89.18 7.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.523 HD22 ' H ' ' A' ' 159' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.118 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.7 m -155.23 145.0 21.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.804 0.335 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 5.4 t60 66.02 134.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.089 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.5 mtt -150.48 130.36 13.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -88.24 108.35 19.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -90.1 122.22 32.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.62 ' HB ' HD13 ' A' ' 202' ' ' ILE . 33.3 m -90.12 -34.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.79 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.949 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -57.66 89.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -90.12 -53.38 4.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.22 160.29 30.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.73 135.1 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.563 ' HB3' HD21 ' A' ' 214' ' ' LEU . 10.9 tptt -159.12 173.47 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.809 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 1.0 OUTLIER -88.25 -45.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.047 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.468 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 12.3 tp -170.69 -51.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.22 142.61 28.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -119.55 -63.0 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 126' ' ' SER . 5.2 m -72.42 176.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.195 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.4 m -71.46 -55.67 7.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.61 -56.55 5.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 123' ' ' VAL . 2.6 m 61.41 86.1 0.16 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.073 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.31 155.23 25.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.618 2.212 . . . . 0.0 112.261 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 60.9 m-85 -142.97 33.97 1.37 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -106.58 -132.23 7.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.758 ' ND2' HG22 ' A' ' 211' ' ' VAL . 0.2 OUTLIER 54.5 -163.86 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.726 ' O ' ' HB1' ' A' ' 185' ' ' ALA . 65.9 Cg_exo -50.68 -74.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.877 1.718 . . . . 0.0 112.591 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.682 HG21 HG23 ' A' ' 187' ' ' ILE . 0.0 OUTLIER 165.2 127.78 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.449 0.166 . . . . 0.0 111.209 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.457 ' HB3' HD12 ' A' ' 213' ' ' LEU . 3.0 Cg_exo -74.17 139.93 27.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.738 2.292 . . . . 0.0 111.969 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.851 ' O ' HD11 ' A' ' 221' ' ' ILE . . . -90.28 93.37 1.86 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.807 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.434 HD23 ' O ' ' A' ' 135' ' ' LEU . 1.3 tt -83.58 -32.36 25.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.02 -10.78 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 169' ' ' ASN . 1.3 mt-10 -61.89 -49.61 75.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.736 0.303 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.496 HD21 ' C ' ' A' ' 216' ' ' ASP . 3.2 mp -29.94 -44.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.981 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -48.73 -44.9 30.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.879 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 105.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.739 0.304 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.76 114.14 0.78 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.544 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.473 ' HB3' HG22 ' A' ' 220' ' ' THR . 6.6 p30 -171.17 142.8 1.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.741 0.305 . . . . 0.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.45 ' HB2' ' HA3' ' A' ' 149' ' ' GLY . 13.8 t -95.9 162.15 13.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -162.41 -45.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.12 -45.0 1.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.84 -179.86 6.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.672 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -74.38 -58.28 1.92 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.518 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 5.9 Cg_exo -33.25 108.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 113.301 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 153' ' ' ILE . . . 115.5 42.0 0.77 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.713 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.904 ' O ' HD13 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -103.53 -142.41 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.803 ' N ' ' HB2' ' A' ' 155' ' ' ALA . 26.0 ttt180 65.13 -69.96 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.748 0.308 . . . . 0.0 111.623 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.618 HG11 HD22 ' A' ' 213' ' ' LEU . 2.5 m -95.68 -38.23 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 149' ' ' GLY . 1.0 OUTLIER -116.55 110.03 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.238 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 157' ' ' THR . 55.7 m-20 99.26 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.705 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.803 ' HB2' ' N ' ' A' ' 151' ' ' ARG . . . -42.93 -34.25 0.93 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.56 61.42 2.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.429 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 154' ' ' ASP . 4.1 t -176.23 -35.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.346 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.7 m -89.3 54.2 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 45.3 mtt 55.0 57.21 11.37 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.391 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 226' ' ' LEU . 7.3 Cg_endo -49.32 129.57 22.86 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.168 2.579 . . . . 0.0 112.559 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -154.97 -47.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.567 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -170.28 91.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 151' ' ' ARG . 20.4 m -70.0 178.42 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.912 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.48 ' HB2' ' CB ' ' A' ' 224' ' ' GLU . 1.5 mpt_? -127.18 107.75 10.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.798 ' HA ' HG23 ' A' ' 223' ' ' ILE . 8.2 tt -70.63 134.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.471 HG13 ' HA2' ' A' ' 190' ' ' GLY . 0.1 OUTLIER -156.39 11.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HB3' ' HB2' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -168.65 100.57 0.4 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.947 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.611 HD11 HD11 ' A' ' 165' ' ' ILE . 3.3 mp -117.65 -4.29 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.949 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 137' ' ' GLU . 25.2 t-20 53.56 -92.76 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.738 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 62.18 -88.14 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 79.4 mt 59.89 -76.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.8 m-85 -62.65 -67.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.871 0.367 . . . . 0.0 111.332 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.92 121.98 12.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.081 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -172.44 -40.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.282 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 176' ' ' THR . 26.5 tt0 -113.58 95.02 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 175' ' ' GLU . 1.5 p -158.27 157.33 32.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.79 -37.31 83.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.61 -31.97 57.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.459 ' CD1' HD22 ' A' ' 182' ' ' LEU . 8.4 t80 -90.08 3.62 52.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.45 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.3 m -59.05 -44.21 91.79 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -72.99 -33.59 65.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.459 HD22 ' CD1' ' A' ' 179' ' ' PHE . 8.1 mp -73.19 -21.8 60.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.4 mt -63.73 -33.32 75.39 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.598 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.68 -28.37 21.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.55 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.726 ' HB1' ' O ' ' A' ' 131' ' ' PRO . . . -51.66 -41.13 61.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.004 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.8 t70 78.85 -8.32 1.66 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.682 HG23 HG21 ' A' ' 132' ' ' ILE . 44.2 mt 61.01 125.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.738 0.304 . . . . 0.0 111.467 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.58 -43.23 3.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.507 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 168' ' ' ILE . 3.3 p 36.94 83.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.471 ' HA2' HG13 ' A' ' 166' ' ' VAL . . . 135.3 2.26 3.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.518 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.62 ' H ' HG23 ' A' ' 165' ' ' ILE . 8.0 t -85.19 -167.44 1.83 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.903 0.382 . . . . 0.0 111.289 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLU . . . . . 0.425 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 45.9 mt-10 -129.62 99.0 5.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.492 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.694 HG12 ' CD2' ' A' ' 206' ' ' HIS . 27.3 m -92.29 169.62 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.625 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.56 135.66 53.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.605 HD12 ' H ' ' A' ' 196' ' ' VAL . 0.7 OUTLIER -90.74 151.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.102 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.605 ' H ' HD12 ' A' ' 195' ' ' ILE . 14.9 p -170.32 151.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.464 ' HB3' HG12 ' A' ' 112' ' ' VAL . 2.0 p30 -131.77 172.16 12.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.749 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.25 118.14 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.334 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.5 t70 66.93 -68.82 0.14 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.56 49.65 0.16 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.304 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -149.06 145.07 27.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 112' ' ' VAL . 9.9 tp -95.14 145.0 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.241 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.505 HG23 HG13 ' A' ' 196' ' ' VAL . 2.2 t -160.05 153.99 23.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 211' ' ' VAL . 3.6 mm? -121.93 103.64 8.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 2.8 m -79.91 122.18 26.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.694 ' CD2' HG12 ' A' ' 193' ' ' VAL . 59.8 t60 -175.73 162.19 2.67 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.4 m120 31.56 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.991 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -54.41 -78.97 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.439 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 22.9 mtmt -160.5 -75.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.495 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -155.48 133.19 11.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.27 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.758 HG22 ' ND2' ' A' ' 130' ' ' ASN . 21.2 t -87.38 141.51 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -79.84 -59.11 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.181 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.618 HD22 HG11 ' A' ' 152' ' ' VAL . 0.2 OUTLIER 48.75 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.609 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 118' ' ' LYS . 6.0 tp -165.95 164.13 18.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -46.75 -31.63 3.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.3 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.496 ' C ' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.62 -58.59 6.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.358 . . . . 0.0 110.591 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.918 ' O ' HD13 ' A' ' 221' ' ' ILE . 7.9 mp -80.39 -12.86 59.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.157 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.428 ' HB2' HD23 ' A' ' 213' ' ' LEU . . . -90.51 -28.02 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 60.8 t-80 -90.43 -19.83 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.907 ' O ' HD12 ' A' ' 221' ' ' ILE . 20.1 p -135.9 78.74 1.73 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.98 HG22 HD11 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -149.01 156.96 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.414 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 167' ' ' GLN . 40.4 mtt-85 -101.04 124.25 46.48 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.98 HD11 HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -150.42 178.37 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.815 178.998 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 223' ' ' ILE . 2.1 tm-20 -95.02 150.07 20.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.493 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.567 ' CB ' ' HB1' ' A' ' 147' ' ' ALA . 3.1 tt0 -89.57 132.88 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 111.259 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.405 ' CD1' ' HA ' ' A' ' 160' ' ' PRO . 4.6 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.322 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -88.26 -50.87 6.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -124.12 -57.54 1.59 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.0 mtt -112.5 108.87 18.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.82 129.09 36.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.0 148.01 23.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.477 HG11 ' HB1' ' A' ' 156' ' ' ALA . 30.2 m -69.55 -42.74 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.196 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -90.38 40.38 1.01 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.155 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -90.13 -51.49 5.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 136.54 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.32 170.14 8.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.62 -43.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.4 tttt 70.37 -66.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.7 m -69.41 143.06 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.218 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tt -86.03 95.26 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -154.78 136.44 14.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.19 140.91 30.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.01 109.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.8 t -159.92 -64.17 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -152.69 -72.35 0.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.822 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.43 ' CB ' ' HD3' ' A' ' 127' ' ' PRO . 0.6 OUTLIER 175.33 -53.44 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 126' ' ' SER . 46.3 Cg_exo -56.6 -171.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.603 2.202 . . . . 0.0 112.557 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -125.13 -175.5 3.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.744 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 211' ' ' VAL . . . -131.19 -158.67 9.27 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.664 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 0.6 OUTLIER -71.51 165.14 51.68 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.545 0.212 . . . . 0.0 110.81 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 38.3 Cg_endo -67.2 126.85 15.7 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.551 2.167 . . . . 0.0 112.787 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.759 ' H ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -172.58 -62.64 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.694 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.737 ' O ' HG21 ' A' ' 187' ' ' ILE . 7.0 Cg_exo -38.92 118.3 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.288 2.658 . . . . 0.0 113.377 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.542 ' HA3' HD12 ' A' ' 221' ' ' ILE . . . -90.81 47.99 3.01 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.536 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.427 ' HA ' ' HG ' ' A' ' 217' ' ' LEU . 2.8 pp -51.02 -32.73 22.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.081 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -89.35 -22.36 22.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -174.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.154 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tt -90.28 102.86 15.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.375 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.701 ' CA ' HD13 ' A' ' 217' ' ' LEU . . . -88.25 128.28 8.99 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.392 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 141' ' ' GLY . 14.1 p -172.91 -43.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 140' ' ' VAL . . . 126.5 107.29 1.52 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.568 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 2.9 m120 -166.79 137.53 3.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.732 ' OG ' HG23 ' A' ' 153' ' ' ILE . 58.0 p -179.08 -34.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.83 -23.21 1.76 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.674 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.66 174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.743 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 147' ' ' ALA . . . -107.46 140.65 40.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 168.38 167.54 0.14 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.561 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 36.9 Cg_exo -56.44 -18.95 26.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.15 1.9 . . . . 0.0 110.973 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 224' ' ' GLU . . . -139.46 153.71 23.15 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.669 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 225' ' ' GLU . 10.8 t -97.2 -142.28 0.29 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.481 ' HB2' ' CB ' ' A' ' 143' ' ' SER . 60.9 mtt180 -150.58 72.16 1.08 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.731 HG23 HD11 ' A' ' 223' ' ' ILE . 44.2 t 64.41 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.159 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.732 HG23 ' OG ' ' A' ' 143' ' ' SER . 1.3 tt -61.47 76.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.5 OUTLIER 162.73 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.598 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.826 ' HA ' HD22 ' A' ' 226' ' ' LEU . . . -89.89 46.0 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.431 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.663 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -145.16 36.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 156' ' ' ALA . 2.8 p -160.07 -43.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.522 ' HB3' HD21 ' A' ' 226' ' ' LEU . 8.4 t -76.81 61.66 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.6 ttt 48.96 86.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.408 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.44 149.41 90.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.644 2.229 . . . . 0.0 112.576 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -156.55 -50.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.688 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.9 mttt -168.11 165.34 13.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 193' ' ' VAL . 3.4 m -155.04 140.41 10.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.626 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.561 ' H ' ' CB ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -79.37 107.63 12.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.571 179.069 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.809 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -79.5 119.4 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.705 ' HA ' HG13 ' A' ' 189' ' ' VAL . 10.7 t -134.7 38.07 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.395 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.704 ' H ' HD13 ' A' ' 165' ' ' ILE . 0.6 OUTLIER 5.67 -86.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.434 0.694 . . . . 0.0 112.86 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 169' ' ' ASN . 0.4 OUTLIER 159.2 -52.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.471 ' N ' HG22 ' A' ' 168' ' ' ILE . 27.1 p30 -169.48 -172.43 1.45 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.797 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.428 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 36.5 mt-10 -152.13 168.39 25.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.992 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 77.36 -21.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.131 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.29 -51.6 61.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -118.74 178.67 4.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.167 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.612 HG13 ' O ' ' A' ' 174' ' ' VAL . 7.4 p -167.0 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.08 -178.21 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.197 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.7 p -68.42 -173.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.33 -5.05 33.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -57.89 -30.92 66.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.734 0.302 . . . . 0.0 110.986 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.617 ' CD1' HD22 ' A' ' 182' ' ' LEU . 45.7 m-85 -90.13 11.58 20.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.6 m -54.24 -39.39 66.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.733 0.301 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.47 -41.25 69.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.617 HD22 ' CD1' ' A' ' 179' ' ' PHE . 7.7 mp -71.42 -18.19 62.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.958 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -25.14 68.02 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.99 -40.26 57.56 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.04 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 187' ' ' ILE . 6.7 t70 60.89 24.65 14.64 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.282 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.759 HG22 ' H ' ' A' ' 132' ' ' ILE . 1.1 pp 28.51 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.112 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.39 141.19 40.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.098 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 166' ' ' VAL . 25.0 t -69.11 146.9 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.71 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.28 -12.8 26.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.791 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.489 ' N ' HG22 ' A' ' 165' ' ' ILE . 1.3 t -73.67 -165.3 0.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.004 0.431 . . . . 0.0 111.027 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -151.69 145.91 25.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.206 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.675 ' O ' HG22 ' A' ' 163' ' ' VAL . 20.8 m -150.3 179.08 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.012 0.434 . . . . 0.0 111.876 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.99 101.73 1.95 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.38 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.663 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 41.4 pt -79.84 151.46 4.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.558 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.3 m -150.68 152.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.957 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.92 142.03 53.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.05 112.99 1.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.011 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.41 36.43 23.02 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.77 51.41 57.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.594 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -158.28 156.06 29.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.805 0.336 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -94.45 135.42 28.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.763 ' N ' HD13 ' A' ' 202' ' ' ILE . 1.7 t -153.57 133.03 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.653 ' CD2' HD22 ' A' ' 213' ' ' LEU . 2.1 mm? -79.99 159.68 26.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.502 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 9.5 m -152.08 116.65 5.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.213 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.407 ' O ' ' N ' ' A' ' 208' ' ' GLY . 1.7 t-80 179.25 177.98 0.51 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.036 0.446 . . . . 0.0 111.504 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 12.8 m120 42.52 -90.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.783 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -73.08 -67.43 1.81 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.677 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 21.9 mtmt -159.17 -81.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 111.104 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -153.81 175.32 13.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.455 ' CG1' HD12 ' A' ' 213' ' ' LEU . 3.0 t -136.96 159.64 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.836 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -79.89 -61.5 1.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.315 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.838 HD23 ' HB2' ' A' ' 218' ' ' ALA . 3.0 mp 57.12 179.22 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.843 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -151.46 -179.95 7.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.94 13.61 12.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.596 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.623 ' HB2' HD12 ' A' ' 214' ' ' LEU . 12.4 t70 -84.65 -71.76 0.5 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.682 0.277 . . . . 0.0 110.767 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.701 HD13 ' CA ' ' A' ' 139' ' ' GLY . 4.4 mm? -90.2 -40.03 12.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.794 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -56.76 -20.94 24.88 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.497 ' CE1' HD12 ' A' ' 153' ' ' ILE . 13.1 t60 -80.3 7.36 9.69 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.448 HG21 ' H ' ' A' ' 140' ' ' VAL . 12.3 t -163.59 39.91 0.09 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.547 ' HB ' HD11 ' A' ' 223' ' ' ILE . 51.2 mm -89.8 154.57 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 63.5 ttt180 -89.69 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 111.901 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.809 HG23 ' HA ' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -146.8 -178.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.0 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.598 ' HA ' ' HA3' ' A' ' 149' ' ' GLY . 12.1 tm-20 -89.82 165.25 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.82 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.698 ' C ' HD23 ' A' ' 226' ' ' LEU . 33.8 tt0 -99.26 80.54 2.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.826 HD22 ' HA ' ' A' ' 155' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.712 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -153.54 -53.54 0.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.682 0.277 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.4 t60 70.07 -67.71 0.23 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.9 mtt -105.24 126.35 52.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.05 101.95 13.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -89.97 -60.0 2.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.99 -38.44 11.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.14 55.95 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.89 -33.14 17.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -70.24 158.75 35.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.9 mt -137.11 -52.28 0.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.71 127.05 50.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.261 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LYS . . . . . 0.625 ' HB3' HD21 ' A' ' 214' ' ' LEU . 4.8 mmtm -173.19 -173.66 0.95 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -76.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.092 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.719 ' HG ' HD21 ' A' ' 217' ' ' LEU . 6.6 tt -165.46 -46.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -72.27 140.47 48.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.88 158.92 43.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.62 139.67 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.283 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -163.64 178.73 7.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -86.26 -40.31 15.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.71 93.47 37.45 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 112.72 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.639 2.226 . . . . 0.0 112.393 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 57.06 96.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.2 9.54 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.306 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.625 ' CB ' ' HD2' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 53.71 178.53 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.537 0.168 . . . . 0.0 110.648 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.625 ' HD2' ' CB ' ' A' ' 130' ' ' ASN . 2.6 Cg_endo -39.6 141.84 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.922 2.415 . . . . 0.0 112.898 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.782 ' N ' HD13 ' A' ' 187' ' ' ILE . 16.1 tt -37.6 96.0 0.1 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.526 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.516 ' HD2' HD23 ' A' ' 182' ' ' LEU . 4.2 Cg_endo -82.44 78.26 3.46 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.272 2.648 . . . . 0.0 111.243 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.563 ' HA3' ' HG2' ' A' ' 137' ' ' GLU . . . -70.3 111.68 3.92 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.616 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.846 ' CB ' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -90.46 -40.53 11.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 178.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -91.11 -4.62 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.272 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.563 ' HG2' ' HA3' ' A' ' 134' ' ' GLY . 0.0 OUTLIER -90.08 -35.94 15.16 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.401 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 221' ' ' ILE . 3.5 pp -39.93 -34.99 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.933 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.43 82.77 0.01 OUTLIER Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.013 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 138' ' ' LEU . 59.9 t -154.73 -55.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 110.726 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.18 104.1 0.18 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.388 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -57.16 108.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 111.054 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.435 ' N ' ' HB3' ' A' ' 151' ' ' ARG . 14.1 m -90.73 99.3 12.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -106.97 24.16 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.756 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.13 -167.07 1.16 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.43 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 67.58 164.34 0.13 Allowed Pre-proline 0 C--O 1.231 0.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.341 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 51.4 Cg_exo -53.49 145.22 47.8 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.758 2.305 . . . . 0.0 112.487 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 143' ' ' SER . . . 90.94 101.85 1.23 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.609 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 224' ' ' GLU . 10.3 t -118.46 -161.07 0.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.283 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.577 ' C ' HG23 ' A' ' 152' ' ' VAL . 22.3 ptt180 -125.93 33.11 5.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.96 HG22 HG12 ' A' ' 221' ' ' ILE . 0.4 OUTLIER 66.67 -59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 218' ' ' ALA . 1.7 pt -69.57 62.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.4 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.616 ' HB1' HG21 ' A' ' 195' ' ' ILE . . . -40.17 -36.1 0.47 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.781 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.32 76.62 1.71 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.05 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.5 m -159.51 -45.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.6 m -78.61 -78.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.7 ptm -146.59 54.74 2.22 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.416 ' HA ' HD11 ' A' ' 226' ' ' LEU . 2.0 Cg_endo -44.55 106.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.419 2.746 . . . . 0.0 112.701 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -135.47 -40.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.844 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -161.77 96.14 1.01 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.624 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 0.0 OUTLIER -70.0 176.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 6.2 mtt180 -152.02 115.43 4.77 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.711 ' CG1' HG23 ' A' ' 189' ' ' VAL . 8.3 tt -84.76 126.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.983 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.662 ' O ' HG22 ' A' ' 189' ' ' VAL . 32.1 t -133.68 -72.73 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.02 122.45 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.032 0.444 . . . . 0.0 112.171 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.539 ' HB ' HG21 ' A' ' 189' ' ' VAL . 34.1 mm -153.55 -74.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 44.97 -171.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.804 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 172' ' ' PHE . 47.1 tt0 -156.28 -71.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.8 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.3 mt 63.26 -70.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.886 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.2 m-85 -51.87 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 111.49 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.77 120.72 11.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.13 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.525 ' O ' HG22 ' A' ' 174' ' ' VAL . 11.9 p -175.77 39.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -134.99 -41.68 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.9 p -56.58 126.73 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.27 -33.44 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.59 -28.88 70.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.444 ' CE2' HD21 ' A' ' 135' ' ' LEU . 11.8 t80 -73.92 -19.31 60.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.262 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.0 m -50.86 -48.14 60.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -64.68 -31.53 72.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.516 HD23 ' HD2' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -68.85 -38.7 79.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.0 -12.74 37.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -23.29 8.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.379 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.912 ' HB3' HD11 ' A' ' 187' ' ' ILE . . . -53.9 -34.2 58.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.058 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.9 t70 50.32 73.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.912 HD11 ' HB3' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -117.64 -145.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.336 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.31 104.24 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.77 0.319 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.711 HG23 ' CG1' ' A' ' 165' ' ' ILE . 10.7 p -60.44 115.57 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.59 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 142.56 1.76 1.18 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.412 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.532 ' O ' HG22 ' A' ' 165' ' ' ILE . 12.0 t -103.31 -165.15 1.14 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.073 0.437 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -104.5 145.94 29.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.522 HG12 ' ND1' ' A' ' 206' ' ' HIS . 13.0 m -146.48 -163.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.228 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.562 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 9.5 pt-20 -150.38 163.24 38.85 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.643 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.616 HG21 ' HB1' ' A' ' 155' ' ' ALA . 4.2 tt -141.96 160.19 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.179 0.514 . . . . 0.0 111.408 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.499 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 18.3 m -146.64 113.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.01 175.42 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -153.94 172.69 17.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.03 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.49 51.97 50.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -165.78 136.35 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.749 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.91 131.55 57.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.841 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.749 ' N ' HD13 ' A' ' 202' ' ' ILE . 1.6 t -160.02 135.31 8.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.031 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.476 HD23 ' HB ' ' A' ' 195' ' ' ILE . 54.9 mt -79.81 -176.18 5.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.561 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.428 ' OG ' HG22 ' A' ' 196' ' ' VAL . 3.4 m -154.49 109.44 3.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.522 ' ND1' HG12 ' A' ' 193' ' ' VAL . 0.6 OUTLIER 179.8 -178.52 0.41 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.533 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.408 ' HB2' ' HD3' ' A' ' 131' ' ' PRO . 1.6 m-80 42.92 -88.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.48 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -78.48 -68.11 1.54 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.6 mtmt -160.32 -69.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.672 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.14 161.47 41.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.671 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.608 HG22 ' OD1' ' A' ' 130' ' ' ASN . 42.6 t -105.66 157.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.889 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.453 ' N ' HG12 ' A' ' 211' ' ' VAL . 28.1 mt-10 -79.61 -63.49 1.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.707 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.755 ' HB3' ' HB2' ' A' ' 218' ' ' ALA . 41.9 mt 56.26 174.61 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.452 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -171.0 174.16 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.685 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.92 -30.11 9.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.299 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.6 -65.02 1.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.846 HD22 ' CB ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -55.8 -44.9 78.23 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.792 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 213' ' ' LEU . . . -90.62 39.31 0.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 4.3 t-80 -90.26 -54.0 4.21 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.643 0.258 . . . . 0.0 111.032 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -147.99 80.56 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.96 HG12 HG22 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -124.16 146.77 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -89.67 102.45 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.684 HG12 HD11 ' A' ' 221' ' ' ILE . 0.3 OUTLIER -151.34 31.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.817 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.666 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.1 tt0 -152.88 157.75 41.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.742 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -116.56 -19.73 9.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 160' ' ' PRO . 5.6 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.93 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.8 m -84.77 139.31 32.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.767 0.318 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -150.35 -51.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 47.3 mtt 60.83 104.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.019 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.15 147.01 34.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -87.38 -178.35 6.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.917 ' HB ' HG22 ' A' ' 202' ' ' ILE . 89.1 t -64.04 -28.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.398 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -84.78 62.2 7.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.688 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -57.23 85.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 113' ' ' GLU . 66.4 mtp180 -41.33 -40.91 1.81 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.313 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.43 77.91 9.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.664 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.1 m -62.72 163.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.358 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -154.12 -49.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.704 HG22 ' H ' ' A' ' 120' ' ' LEU . 1.1 p -148.94 -166.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.704 ' H ' HG22 ' A' ' 119' ' ' VAL . 4.5 mm? -107.54 115.63 30.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -153.11 133.04 13.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.05 163.78 13.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -101.25 142.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.1 m 60.38 -89.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 176.26 159.44 0.3 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.6 m 60.08 73.24 0.66 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.46 -30.11 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.672 2.248 . . . . 0.0 112.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.71 150.83 45.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 143.42 136.92 3.21 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.498 ' OD1' HG13 ' A' ' 211' ' ' VAL . 2.6 p-10 51.5 158.46 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.62 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.3 Cg_endo -76.41 135.45 16.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.703 2.269 . . . . 0.0 113.019 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.867 HD11 HG21 ' A' ' 221' ' ' ILE . 0.0 OUTLIER 135.77 -32.12 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 124.058 0.849 . . . . 0.0 112.089 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 1.5 Cg_endo -79.92 72.04 6.73 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.427 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.11 118.12 4.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.244 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 138' ' ' LEU . 1.9 tt -73.19 -45.49 56.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.233 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.28 9.25 29.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.514 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.83 ' O ' HG22 ' A' ' 168' ' ' ILE . 0.5 OUTLIER -90.21 -50.77 5.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.638 0.256 . . . . 0.0 111.225 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.816 HD13 ' N ' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -53.97 -14.92 1.15 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.816 ' N ' HD13 ' A' ' 138' ' ' LEU . . . -45.42 -91.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.255 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 168' ' ' ILE . 14.6 t -89.72 153.23 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.53 ' C ' HD12 ' A' ' 168' ' ' ILE . . . 92.01 155.64 32.02 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.428 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.455 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 2.0 p30 -152.47 131.89 12.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.822 0.344 . . . . 0.0 111.405 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -97.85 170.6 8.85 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -158.68 -60.63 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -162.9 -163.06 0.82 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 94.07 108.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 63.87 162.49 0.12 Allowed Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.378 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.613 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 79.3 Cg_exo -39.69 146.71 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.858 2.372 . . . . 0.0 112.048 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.718 ' HA2' ' HB ' ' A' ' 163' ' ' VAL . . . 151.55 -152.35 24.13 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.892 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -152.13 144.59 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.724 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.502 ' C ' HG23 ' A' ' 152' ' ' VAL . 53.8 ttt180 -67.12 2.76 1.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.943 HG22 ' CD1' ' A' ' 223' ' ' ILE . 2.4 t 74.03 -62.51 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.918 0.39 . . . . 0.0 110.484 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.9 pt -97.51 44.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.505 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 157' ' ' THR . 5.0 t70 -162.79 -32.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.686 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.829 ' HB1' HD13 ' A' ' 195' ' ' ILE . . . -27.86 -42.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 202' ' ' ILE . . . -76.99 62.0 2.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 0.0 111.319 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 154' ' ' ASP . 3.0 t -173.32 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.409 ' C ' ' HD3' ' A' ' 160' ' ' PRO . 3.1 t -77.5 -158.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 34.1 mtt -124.47 60.3 23.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.021 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 158' ' ' SER . 81.9 Cg_exo -44.85 162.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.928 2.419 . . . . 0.0 113.181 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.2 mtp85 -152.14 -45.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.348 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -161.26 78.66 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.227 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.745 ' HB ' HG22 ' A' ' 223' ' ' ILE . 32.9 m -69.94 143.45 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.849 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.464 ' HG3' ' HB2' ' A' ' 148' ' ' PRO . 8.0 mtp85 -79.05 98.76 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.365 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.785 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -76.41 79.98 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.401 0.62 . . . . 0.0 111.833 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.632 HG13 ' HA2' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -160.88 97.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.696 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.56 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.9 OUTLIER 170.47 133.77 0.02 OUTLIER 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.585 0.707 . . . . 0.0 112.183 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 137' ' ' GLU . 3.0 mm 75.86 -2.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.413 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.595 ' HB2' HG21 ' A' ' 189' ' ' VAL . 22.8 t30 -55.75 159.42 3.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.939 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -151.4 170.12 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.71 -47.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.055 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.44 -40.34 90.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -71.48 132.91 45.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.587 HG13 ' O ' ' A' ' 174' ' ' VAL . 7.5 p -162.59 93.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 176' ' ' THR . 3.6 tt0 -138.64 178.42 7.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 175' ' ' GLU . 8.4 t 47.83 114.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.885 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.3 -2.97 15.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.775 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.53 -34.41 70.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.615 0.245 . . . . 0.0 111.431 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.462 ' HB3' HD13 ' A' ' 135' ' ' LEU . 2.4 p90 -75.44 -10.14 59.19 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.696 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.1 m -48.71 -40.92 30.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -70.69 -35.85 72.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 133' ' ' PRO . 8.5 mp -73.85 -22.88 59.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.024 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.522 ' O ' HD13 ' A' ' 183' ' ' LEU . 0.2 OUTLIER -69.63 -20.88 63.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.068 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -38.56 61.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -69.44 -27.6 65.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 187' ' ' ILE . 13.8 m-20 84.06 -36.52 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.558 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.703 HD13 ' NH1' ' A' ' 222' ' ' ARG . 0.6 OUTLIER 62.18 130.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.384 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -126.82 88.79 2.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.862 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.601 HG13 ' O ' ' A' ' 189' ' ' VAL . 7.6 p -70.99 96.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.543 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.734 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 146.38 -1.21 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.375 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.739 ' O ' HG22 ' A' ' 165' ' ' ILE . 4.5 t -97.03 -162.9 0.99 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.053 0.427 . . . . 0.0 110.891 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.4 124.52 43.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.51 HG12 ' CG ' ' A' ' 206' ' ' HIS . 32.5 m -127.98 175.33 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.258 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.98 169.49 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.829 HD13 ' HB1' ' A' ' 155' ' ' ALA . 0.9 OUTLIER -155.85 154.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.023 0.439 . . . . 0.0 111.135 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.431 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 17.6 m -141.5 155.2 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.952 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.94 155.38 40.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 43.1 ttm-85 -146.29 71.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.987 0.423 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.43 60.28 3.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.12 96.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.563 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' HIS . . . . . 0.482 ' HA ' HG23 ' A' ' 112' ' ' VAL . 89.8 m-70 -152.55 131.71 12.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 110.725 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.917 HG22 ' HB ' ' A' ' 112' ' ' VAL . 13.8 tt -79.99 139.53 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 111.388 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 202' ' ' ILE . 16.7 p -158.41 119.86 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.457 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.697 HD22 HD12 ' A' ' 195' ' ' ILE . 1.0 OUTLIER -79.57 153.19 29.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.743 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 39.0 m -126.78 125.71 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.51 ' CG ' HG12 ' A' ' 193' ' ' VAL . 0.8 OUTLIER -178.61 176.08 1.03 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.989 0.423 . . . . 0.0 111.378 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.9 m120 46.89 -87.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.782 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -83.65 -62.6 1.76 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.841 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.72 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.593 0.235 . . . . 0.0 111.231 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -138.14 178.87 6.8 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.498 HG13 ' OD1' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -133.16 179.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.63 -48.81 3.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.4 mt 56.99 176.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.35 177.7 8.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.57 -29.92 69.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.316 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.07 -54.77 6.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.155 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.95 -30.78 68.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.289 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.438 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -90.12 15.88 9.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.743 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 9.7 t-80 -84.78 -58.83 2.55 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.809 0.337 . . . . 0.0 110.771 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.693 ' O ' HG21 ' A' ' 168' ' ' ILE . 3.0 p -147.0 88.05 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.444 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.867 HG21 HD11 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -111.58 -172.1 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.564 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.785 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.7 mtm180 -84.28 76.22 10.13 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.943 ' CD1' HG22 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -153.51 134.0 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.563 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 148' ' ' PRO . 9.8 mt-10 -89.68 -108.8 0.08 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 145' ' ' ALA . 2.8 tt0 -150.99 112.44 4.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.206 0.457 . . . . 0.0 111.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 149' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.077 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.4 m -84.87 158.0 20.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -148.6 -52.98 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.8 mtt -82.97 119.2 24.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.36 136.95 33.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.72 173.31 12.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.655 HG13 ' H ' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -54.76 -75.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.655 ' H ' HG13 ' A' ' 112' ' ' VAL . 5.6 pt-20 -87.48 62.52 7.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 110.722 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 77.52 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -51.72 -34.7 40.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.53 92.77 2.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -164.21 148.87 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -146.93 -68.22 0.26 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 m -76.0 165.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.305 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.6 148.22 26.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.798 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -152.1 -51.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.05 -175.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 123' ' ' VAL . 3.3 p 41.12 90.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.663 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 p -140.04 -56.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -107.86 -35.99 6.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.9 m -63.97 164.43 17.49 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.7 -161.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.78 2.32 . . . . 0.0 112.367 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.662 ' O ' HG13 ' A' ' 211' ' ' VAL . 6.7 p90 -111.84 -54.97 2.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.959 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.2 -102.18 1.0 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.078 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.584 ' H ' HG22 ' A' ' 211' ' ' VAL . 3.7 p30 -143.92 163.37 36.0 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.673 0.273 . . . . 0.0 110.976 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.618 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.46 138.42 80.37 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.951 2.434 . . . . 0.0 112.96 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.657 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 138.81 -29.57 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 O-C-N 124.033 0.833 . . . . 0.0 112.314 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.786 ' HB2' HD23 ' A' ' 182' ' ' LEU . 12.3 Cg_exo -68.09 62.46 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.481 2.121 . . . . 0.0 112.842 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.54 129.42 25.18 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.283 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.693 HD22 ' CD2' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -90.03 -44.25 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -90.15 9.0 30.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.437 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' O ' HD13 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -90.06 -44.65 9.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.754 0.312 . . . . 0.0 110.994 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 216' ' ' ASP . 3.3 pp -41.17 -36.81 0.79 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.833 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.78 65.73 3.87 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.766 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 90.6 t -152.79 -66.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.686 0.279 . . . . 0.0 111.019 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.4 -175.11 13.94 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.445 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 220' ' ' THR . 2.3 p-10 -162.68 160.72 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 m -163.17 133.38 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.7 -45.47 8.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.01 114.64 2.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.322 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -174.03 -168.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.025 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -56.83 -178.78 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.895 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 95.3 Cg_exo -44.68 89.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.674 2.249 . . . . 0.0 112.648 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 154.78 55.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.525 HG21 ' HA ' ' A' ' 225' ' ' GLU . 7.3 t -101.48 -163.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.513 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.781 ' HD2' HD11 ' A' ' 153' ' ' ILE . 34.0 ptt180 -107.4 107.61 18.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.471 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.777 HG13 ' HB1' ' A' ' 218' ' ' ALA . 7.1 p -41.6 -30.55 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.03 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.781 HD11 ' HD2' ' A' ' 151' ' ' ARG . 23.3 pt -53.45 -42.09 47.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.909 0.385 . . . . 0.0 111.128 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.409 ' N ' HG13 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -84.16 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.878 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 195' ' ' ILE . . . -62.72 80.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.155 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 195' ' ' ILE . . . -172.21 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.064 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.4 t -93.85 -3.62 51.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.47 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 226' ' ' LEU . 38.9 m -94.05 37.6 1.09 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.756 0.312 . . . . 0.0 111.327 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 11.2 ttt 57.67 61.45 5.95 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.854 0.359 . . . . 0.0 111.235 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.524 ' HB3' HD22 ' A' ' 226' ' ' LEU . 29.5 Cg_endo -62.73 170.69 6.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.814 2.342 . . . . 0.0 112.414 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.5 mtt85 -152.15 -47.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -170.02 89.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 195' ' ' ILE . 26.8 m -80.59 -172.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 12.2 mtp85 -124.39 -170.95 2.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.076 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.749 ' O ' HG23 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -147.69 79.89 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 110.426 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 165' ' ' ILE . 1.3 m -160.48 98.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.085 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.637 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 170.34 110.84 0.01 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.22 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 221' ' ' ILE . 12.7 mt 109.53 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.363 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 168' ' ' ILE . 22.4 t-20 49.9 164.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.88 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 171.32 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.571 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.728 HD11 HG12 ' A' ' 189' ' ' VAL . 66.4 mt 63.5 -64.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.0 m-85 -47.31 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.474 ' O ' HG23 ' A' ' 174' ' ' VAL . 11.7 mm100 -64.98 116.51 6.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.608 HG11 ' CD2' ' A' ' 183' ' ' LEU . 77.1 t -161.17 80.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 176' ' ' THR . 14.0 mt-10 -106.18 98.73 8.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.123 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.656 HG21 HD13 ' A' ' 135' ' ' LEU . 1.0 OUTLIER -166.03 113.27 0.9 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.83 -26.66 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.146 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -72.3 -30.71 65.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.026 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.693 ' CD2' HD22 ' A' ' 135' ' ' LEU . 33.1 m-85 -90.16 20.64 4.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.486 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.9 m -57.36 -33.37 67.71 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.79 0.329 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -72.25 -42.53 65.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.586 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 133' ' ' PRO . 9.5 mp -71.14 -14.83 62.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.942 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.608 ' CD2' HG11 ' A' ' 174' ' ' VAL . 0.3 OUTLIER -74.8 -27.99 60.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.032 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.1 -43.07 51.41 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.503 ' HB1' ' HD3' ' A' ' 131' ' ' PRO . . . -66.6 -31.12 71.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 187' ' ' ILE . 30.5 m-20 67.43 13.67 9.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.545 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.727 HD12 HH22 ' A' ' 222' ' ' ARG . 6.1 pt 33.95 100.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -102.52 90.69 3.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.668 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.728 HG12 HD11 ' A' ' 171' ' ' ILE . 10.6 p -59.83 115.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.641 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 136.59 -8.4 3.97 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.823 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.657 ' O ' HG22 ' A' ' 165' ' ' ILE . 19.7 t -83.66 -169.33 2.51 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.788 0.328 . . . . 0.0 111.061 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -135.54 122.27 20.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.804 HG12 ' CG ' ' A' ' 206' ' ' HIS . 33.5 m -120.56 -179.11 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLU . . . . . 0.449 ' HA ' HG22 ' A' ' 163' ' ' VAL . 10.3 pt-20 -144.45 164.65 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 156' ' ' ALA . 1.1 mp -128.97 153.27 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.182 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 196' ' ' VAL . 8.8 m -154.26 110.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.96 157.79 37.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.98 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -159.21 118.5 2.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 6.5 t70 69.73 -66.86 0.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -179.64 49.86 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -156.45 149.73 24.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.754 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -102.19 133.59 45.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.754 ' N ' HD13 ' A' ' 202' ' ' ILE . 30.4 p -142.83 129.37 20.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 211' ' ' VAL . 4.2 mm? -79.98 105.01 10.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 209' ' ' LYS . 2.4 m -86.09 120.23 27.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.804 ' CG ' HG12 ' A' ' 193' ' ' VAL . 21.9 t-80 -176.01 166.49 2.98 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 111.644 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.0 m120 40.69 -90.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.852 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -67.9 -71.3 0.97 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.606 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 205' ' ' SER . 2.4 ptpt -161.76 -63.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -152.93 174.28 14.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.543 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.738 HG11 ' HG3' ' A' ' 133' ' ' PRO . 12.3 t -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.928 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -112.04 55.73 0.67 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 111.226 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 218' ' ' ALA . 4.2 pp -83.25 173.05 11.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.609 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.473 HD12 ' CB ' ' A' ' 216' ' ' ASP . 0.3 OUTLIER -97.04 164.79 12.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.954 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.17 -37.95 75.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.515 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.511 ' O ' HD22 ' A' ' 138' ' ' LEU . 0.8 OUTLIER -62.01 -45.1 95.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.544 HD21 ' CE1' ' A' ' 179' ' ' PHE . 3.0 mp -60.34 -37.78 81.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 153' ' ' ILE . . . -90.72 14.12 14.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.755 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -67.85 70.57 0.14 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.964 0.411 . . . . 0.0 111.047 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.769 HG22 ' CB ' ' A' ' 151' ' ' ARG . 6.5 p 59.13 85.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.289 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.639 ' HA ' HD12 ' A' ' 168' ' ' ILE . 0.8 OUTLIER -118.94 -147.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.727 HH22 HD12 ' A' ' 187' ' ' ILE . 6.3 ptt180 -84.95 88.41 7.44 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 222' ' ' ARG . 3.3 mp -151.42 151.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.256 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 2.3 tm-20 -89.85 159.03 17.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.633 0.254 . . . . 0.0 110.363 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.525 ' HA ' HG21 ' A' ' 150' ' ' THR . 0.5 OUTLIER -89.25 104.55 17.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.955 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 160' ' ' PRO . 3.1 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.312 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.2 m -83.51 -52.4 6.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.3 t60 70.62 -66.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.072 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.6 mtt -113.25 163.37 14.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.05 142.57 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -90.05 -87.74 0.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.061 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 113' ' ' GLU . 14.7 p -90.35 -45.52 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.699 0.285 . . . . 0.0 111.409 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.47 ' N ' HG13 ' A' ' 112' ' ' VAL . 33.1 mt-10 -84.18 100.26 11.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -80.95 76.81 7.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -88.54 66.16 8.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -143.62 -51.59 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.3 m -69.81 148.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -112.99 -40.03 4.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.49 163.23 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.26 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.8 tt -94.53 118.4 31.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -147.08 173.91 12.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -152.57 152.33 31.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 123' ' ' VAL . 7.3 p -151.98 101.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -167.01 -179.03 4.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -71.81 -37.9 70.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.3 p -164.33 79.45 1.43 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.22 -162.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.748 2.299 . . . . 0.0 112.18 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.0 p90 42.0 91.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.76 161.21 34.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.76 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER 61.91 144.61 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 120.611 0.243 . . . . 0.0 110.953 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.509 ' CB ' ' HA ' ' A' ' 187' ' ' ILE . 1.9 Cg_endo -86.33 105.01 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.116 2.544 . . . . 0.0 112.658 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.723 HG21 HG21 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -164.83 -57.77 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.508 ' HB3' HD21 ' A' ' 213' ' ' LEU . 5.1 Cg_endo -85.08 121.82 2.44 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.727 2.284 . . . . 0.0 113.98 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.499 ' HA2' HD12 ' A' ' 187' ' ' ILE . . . -91.86 170.99 33.95 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.193 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.826 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -69.66 128.62 37.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -26.78 66.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.552 1.158 . . . . 0.0 113.03 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 135' ' ' LEU . 26.5 tt0 -90.63 -55.35 3.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 145' ' ' ALA . 3.9 mm? -90.6 -16.91 27.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.59 -1.187 . . . . 0.0 109.744 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 116.08 8.67 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.792 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.546 ' H ' HG22 ' A' ' 220' ' ' THR . 8.1 p -150.44 -41.73 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.605 0.24 . . . . 0.0 111.249 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.19 86.74 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.655 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.34 -178.23 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.704 0.287 . . . . 0.0 110.787 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.9 p -76.6 -43.78 37.17 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.577 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.94 -178.01 1.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.441 ' HB2' HD12 ' A' ' 138' ' ' LEU . . . -110.07 -86.6 0.53 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.617 ' HB3' ' NE ' ' A' ' 222' ' ' ARG . . . -91.98 138.81 31.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.63 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 57.54 -179.6 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.325 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 53.8 Cg_exo -52.33 -176.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.244 1.963 . . . . 0.0 112.001 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.442 ' HA2' ' C ' ' A' ' 223' ' ' ILE . . . 162.77 140.32 2.84 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.382 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.803 HG21 HD22 ' A' ' 226' ' ' LEU . 6.2 t -176.66 -33.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.848 ' CB ' HG21 ' A' ' 223' ' ' ILE . 4.7 tmm_? -20.08 -55.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -94.22 -44.78 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.658 0.266 . . . . 0.0 111.658 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.793 HD13 ' O ' ' A' ' 219' ' ' HIS . 0.2 OUTLIER -109.41 109.45 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.318 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' ILE . 58.3 m-20 98.58 -38.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.067 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.629 ' HB2' ' C ' ' A' ' 150' ' ' THR . . . -36.74 -46.88 0.63 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 195' ' ' ILE . . . -78.11 65.56 3.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.15 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 m -162.9 -45.99 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.503 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -95.5 43.07 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.9 mtt 53.02 74.31 0.79 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.288 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.593 ' HA ' HD12 ' A' ' 226' ' ' LEU . 18.8 Cg_endo -58.73 139.88 92.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.874 2.383 . . . . 0.0 112.663 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.26 -43.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -162.19 120.79 2.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.52 HG21 ' CG ' ' A' ' 151' ' ' ARG . 1.0 OUTLIER -122.69 128.68 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.452 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 12.3 mtt180 -80.02 123.21 27.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.489 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -90.34 124.27 42.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.327 . . . . 0.0 110.262 178.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.728 ' N ' HD13 ' A' ' 165' ' ' ILE . 21.4 t -144.61 87.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.966 0.412 . . . . 0.0 111.621 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.621 ' HA ' HG11 ' A' ' 189' ' ' VAL . 4.6 tt0 91.91 105.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.335 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.794 HG22 HG21 ' A' ' 221' ' ' ILE . 2.4 pp -142.1 -45.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.656 ' OD1' HD11 ' A' ' 187' ' ' ILE . 52.3 t30 -74.27 159.74 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 5.0 tt0 -104.48 -42.38 5.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.679 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 94.0 mt 69.12 -64.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.596 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -54.46 -34.79 62.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.248 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -99.16 127.4 45.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.62 HG13 ' O ' ' A' ' 174' ' ' VAL . 7.9 p -168.12 96.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -138.01 -43.52 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.504 ' HG1' ' HD2' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -57.67 122.34 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.67 -25.66 59.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.15 -26.98 68.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.504 ' HD2' ' HG1' ' A' ' 176' ' ' THR . 19.1 m-85 -82.6 -6.2 59.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.424 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.3 m -56.34 -41.25 75.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.76 0.314 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -66.2 -35.82 81.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.49 -26.73 46.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.445 HD23 ' O ' ' A' ' 183' ' ' LEU . 0.9 OUTLIER -69.55 -23.72 63.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.1 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -32.98 61.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -68.01 -31.76 71.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' ILE . 13.9 m-20 83.83 -29.14 0.09 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.631 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.656 HD11 ' OD1' ' A' ' 169' ' ' ASN . 7.4 pt 39.89 103.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.315 0.579 . . . . 0.0 111.946 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -114.6 108.96 17.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.779 ' HA ' HD12 ' A' ' 165' ' ' ILE . 35.2 m -52.69 157.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.251 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.706 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 101.99 -15.96 56.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.302 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.735 ' O ' HG22 ' A' ' 165' ' ' ILE . 7.7 t -74.55 -166.99 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.01 0.433 . . . . 0.0 111.301 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.29 136.86 20.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.786 HG12 ' CG ' ' A' ' 206' ' ' HIS . 29.8 m -141.61 175.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.967 0.413 . . . . 0.0 111.801 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -125.7 162.85 24.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.798 HD12 ' N ' ' A' ' 196' ' ' VAL . 0.1 OUTLIER -136.84 140.97 41.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.389 . . . . 0.0 110.856 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.798 ' N ' HD12 ' A' ' 195' ' ' ILE . 11.0 m -154.25 118.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.023 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -70.0 159.25 34.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -168.91 143.18 3.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.0 t70 68.08 -70.53 0.12 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 175.19 43.03 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.05 165.71 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.441 ' HB ' HG22 ' A' ' 112' ' ' VAL . 19.9 tt -87.24 150.3 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.136 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.0 t -160.05 116.96 2.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.0 106.22 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.676 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.0 m -85.73 129.41 34.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.786 ' CG ' HG12 ' A' ' 193' ' ' VAL . 10.9 t60 -143.94 145.55 32.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -33.39 -40.02 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -62.65 -70.58 1.01 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.26 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.8 mtmt -158.87 -174.66 4.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.44 133.51 53.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.175 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.75 159.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.481 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -83.18 -58.3 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.512 HD13 HG12 ' A' ' 152' ' ' VAL . 1.7 mt 64.2 151.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.205 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 0.4 OUTLIER -140.42 -175.59 4.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.716 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -28.95 67.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.394 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -67.61 0.24 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.597 ' O ' HD11 ' A' ' 221' ' ' ILE . 6.4 mp -78.82 -34.29 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.063 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -90.73 33.94 0.91 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.602 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.793 ' O ' HD13 ' A' ' 153' ' ' ILE . 0.2 OUTLIER -81.71 -56.43 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.723 ' HA ' HG21 ' A' ' 153' ' ' ILE . 13.5 t -174.67 72.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.021 0.439 . . . . 0.0 111.162 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.794 HG21 HG22 ' A' ' 168' ' ' ILE . 4.9 mm -89.55 171.72 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.617 ' NE ' ' HB3' ' A' ' 146' ' ' ALA . 53.6 ttt180 -89.71 99.64 12.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 111.612 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.848 HG21 ' CB ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -129.79 -149.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.071 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.587 ' O ' HG22 ' A' ' 150' ' ' THR . 0.0 OUTLIER -118.85 -179.52 3.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 110.803 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 226' ' ' LEU . 30.3 tt0 -111.78 96.21 5.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.803 HD22 HG21 ' A' ' 150' ' ' THR . 1.7 pt? . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.77 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.2 t -152.3 -53.94 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.743 0.306 . . . . 0.0 110.908 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -85.14 164.7 17.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.9 mtt -146.56 -59.89 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.91 115.46 27.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.97 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -86.43 167.3 14.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 156' ' ' ALA . 35.2 m -76.16 -41.75 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.419 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.4 OUTLIER -90.27 18.37 6.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -90.05 -51.94 5.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.44 147.96 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.5 mt -147.87 113.24 5.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -112.77 -37.48 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.307 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -109.3 172.37 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 m -89.63 -37.68 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.24 -58.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -78.1 157.8 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.975 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.66 -46.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.1 t 61.42 105.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.0 m -138.81 90.11 2.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.48 80.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m 59.27 86.12 0.17 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.495 ' O ' HG12 ' A' ' 211' ' ' VAL . 60.0 Cg_endo -72.37 -25.57 18.21 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.594 2.196 . . . . 0.0 112.338 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' CG ' ' HB3' ' A' ' 181' ' ' GLN . 3.9 p90 -114.02 144.0 43.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.732 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.17 -98.83 0.16 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.811 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -56.31 153.75 18.43 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.758 0.313 . . . . 0.0 111.234 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.599 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 89.1 Cg_endo -81.83 137.57 10.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.892 2.395 . . . . 0.0 112.87 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.741 ' H ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER 143.1 -30.99 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 O-C-N 123.922 0.763 . . . . 0.0 111.859 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 2.7 Cg_exo -73.53 63.34 4.59 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.362 2.042 . . . . 0.0 112.326 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.55 81.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.493 HD23 ' CZ ' ' A' ' 179' ' ' PHE . 14.4 tp -70.86 -39.39 72.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.348 . . . . 0.0 110.803 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.11 8.63 31.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.409 ' HG2' ' HB ' ' A' ' 168' ' ' ILE . 2.5 mp0 -88.94 -170.99 3.12 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.792 ' O ' HG23 ' A' ' 220' ' ' THR . 1.0 OUTLIER -62.09 84.6 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.845 0.355 . . . . 0.0 111.126 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.49 32.26 5.09 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.913 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.696 ' C ' HG21 ' A' ' 220' ' ' THR . 18.1 t -128.82 116.5 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.689 0.281 . . . . 0.0 111.179 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.69 -172.33 16.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -175.4 166.43 3.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.728 0.299 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -137.35 -174.34 3.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.059 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.13 -43.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.119 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -158.6 -157.93 0.66 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 85.77 -179.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.967 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -56.71 -176.66 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.967 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 68.4 Cg_exo -41.31 98.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.757 2.305 . . . . 0.0 112.928 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.74 41.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.079 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 152' ' ' VAL . 13.6 t -80.6 -7.19 59.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 4.4 mpt_? 60.56 25.96 15.63 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.012 HG11 ' HB1' ' A' ' 218' ' ' ALA . 21.4 t 70.68 -58.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.535 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.475 HG23 ' O ' ' A' ' 153' ' ' ILE . 5.4 tt -55.41 79.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.999 0.428 . . . . 0.0 111.39 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 167.7 -35.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.382 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 226' ' ' LEU . . . -52.27 -25.28 9.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.598 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 112' ' ' VAL . . . -98.73 32.9 2.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.372 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.0 t -170.96 32.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.352 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.448 ' HB3' HD12 ' A' ' 226' ' ' LEU . 7.4 t -153.06 34.46 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.195 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' MET . . . . . 0.402 ' C ' HD13 ' A' ' 226' ' ' LEU . 41.2 ttm 66.44 75.29 0.33 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.008 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.651 ' HA ' HD22 ' A' ' 226' ' ' LEU . 29.0 Cg_endo -62.83 152.85 76.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.843 2.362 . . . . 0.0 112.799 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 -45.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -170.2 124.97 0.75 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 193' ' ' VAL . 6.4 m -110.28 123.0 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 111.488 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -84.22 102.09 12.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.681 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -79.47 122.25 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.649 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.606 ' N ' HD13 ' A' ' 165' ' ' ILE . 20.4 t -144.39 85.86 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.596 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 33.4 tt0 103.54 147.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.074 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.881 HG22 HG23 ' A' ' 221' ' ' ILE . 0.4 OUTLIER -149.59 -66.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.08 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.5 t30 -177.96 -168.52 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.543 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.03 -77.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.87 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.105 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -163.7 -55.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.862 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -163.85 -65.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.541 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 0.4 OUTLIER 72.0 107.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.292 0.568 . . . . 0.0 110.784 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 55.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.954 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 t -161.75 130.12 4.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -22.43 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -60.96 -31.49 71.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.493 ' CZ ' HD23 ' A' ' 135' ' ' LEU . 5.4 m-85 -76.09 -17.17 59.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.322 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 84.8 m -51.85 -43.84 63.39 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLN . . . . . 0.423 ' HB3' ' CG ' ' A' ' 128' ' ' PHE . 55.4 mt-30 -70.83 -33.02 70.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.58 -25.05 59.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.3 tp -84.48 -2.71 57.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.573 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.25 -50.25 30.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.057 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -82.9 -23.37 33.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.129 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 187' ' ' ILE . 9.3 m-20 65.89 16.2 10.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.741 HG22 ' H ' ' A' ' 132' ' ' ILE . 24.0 pt 38.15 99.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.1 0.476 . . . . 0.0 111.988 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 134.49 42.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.93 141.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.543 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 104.54 -8.65 47.83 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 165' ' ' ILE . 16.4 t -70.23 174.92 5.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -132.33 111.88 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.676 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.744 HG12 ' CD2' ' A' ' 206' ' ' HIS . 27.2 m -121.59 176.94 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.362 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -142.13 160.76 39.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.448 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 1.8 tt -134.62 155.7 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 111.152 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.448 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 7.1 m -156.92 132.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.27 145.55 35.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -157.35 116.6 3.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.143 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 51.99 40.76 28.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.88 62.15 6.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.459 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -159.48 158.47 32.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.77 0.319 . . . . 0.0 110.82 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.42 141.79 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 203' ' ' THR . 6.3 t -159.9 111.42 2.0 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.875 HD23 HD22 ' A' ' 213' ' ' LEU . 3.6 mm? -81.19 98.4 8.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.7 m -77.07 110.15 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.744 ' CD2' HG12 ' A' ' 193' ' ' VAL . 24.6 t-80 -107.62 147.21 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.511 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -41.33 -34.4 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.296 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -77.25 -57.49 3.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.496 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -160.68 -175.19 4.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.687 0.279 . . . . 0.0 110.875 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.6 149.0 31.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -116.71 175.64 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.44 ' OE1' HD23 ' A' ' 214' ' ' LEU . 1.4 tm-20 -90.7 -66.56 0.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.875 HD22 HD23 ' A' ' 204' ' ' LEU . 7.8 mp 60.55 155.63 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 111.36 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 213' ' ' LEU . 0.5 OUTLIER -144.69 -175.45 4.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.65 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.68 -29.13 70.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.998 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -45.58 11.84 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.808 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.447 HD22 ' HG ' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -55.61 -69.74 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 1.012 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.52 49.78 1.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -84.65 -38.78 19.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.792 HG23 ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -156.55 90.37 1.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.891 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.881 HG23 HG22 ' A' ' 168' ' ' ILE . 23.8 mm -118.96 162.15 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.011 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -89.66 90.35 8.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 111.268 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.681 HG23 ' HA ' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -137.62 175.16 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.124 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -89.64 162.78 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 110.824 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -89.66 56.04 3.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 155' ' ' ALA . 6.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.3 m -151.86 101.14 2.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.794 0.33 . . . . 0.0 110.957 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -93.45 174.45 7.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.9 ttm -152.45 -55.75 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -90.01 59.76 4.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.08 108.08 19.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 156' ' ' ALA . 14.6 p -88.81 -46.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.476 ' N ' HG13 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -90.34 48.86 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.13 -41.24 11.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.054 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -85.54 144.0 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mp -145.08 112.71 6.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.842 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -150.38 168.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.15 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -133.48 100.29 4.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.7 t -144.34 -44.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tt 65.39 46.41 2.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -100.08 -46.46 5.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.27 147.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 123' ' ' VAL . 11.1 p -168.26 125.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.4 t -169.71 157.68 7.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -86.09 83.71 7.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.65 7.97 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.82 -19.26 8.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.705 2.27 . . . . 0.0 112.644 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 62.51 110.62 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -166.37 -150.78 6.49 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.701 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 8.1 p30 53.95 159.18 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.301 0 CA-C-O 120.966 0.412 . . . . 0.0 111.843 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.647 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 83.2 Cg_endo -78.84 137.12 13.83 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.824 2.349 . . . . 0.0 111.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 160.44 -31.03 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.373 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 23.8 Cg_exo -63.65 118.54 5.46 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.634 1.556 . . . . 0.0 112.986 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.23 -32.77 8.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.448 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.808 ' CB ' HD12 ' A' ' 217' ' ' LEU . 2.2 pp -36.59 -37.31 0.13 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.51 -50.76 71.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.207 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.679 ' HG2' HD11 ' A' ' 168' ' ' ILE . 2.1 pm0 -90.67 -21.3 21.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.634 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.742 HD12 HD11 ' A' ' 221' ' ' ILE . 6.5 tt -29.57 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.443 . . . . 0.0 112.018 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.35 -93.15 1.23 Allowed Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.427 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.8 t -145.46 42.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 111.181 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.36 -149.23 1.22 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.236 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 0.9 OUTLIER 179.48 177.84 0.56 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.6 p -156.86 -173.47 4.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.778 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.91 74.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.48 -69.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.37 -62.4 1.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -176.18 -63.01 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.073 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 7.1 Cg_exo -33.94 97.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.219 2.613 . . . . 0.0 113.188 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 97.82 112.41 3.07 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.797 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 149' ' ' GLY . 2.8 t 175.92 78.3 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.667 ' HB2' ' HB ' ' A' ' 221' ' ' ILE . 11.0 tpp180 -78.84 92.61 4.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.947 HG13 HD11 ' A' ' 202' ' ' ILE . 8.1 p 48.91 20.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 219' ' ' HIS . 2.9 tt -106.32 10.55 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 121.221 0.534 . . . . 0.0 110.312 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.9 -35.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.572 ' HA ' HD11 ' A' ' 226' ' ' LEU . . . -88.41 43.72 1.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.502 ' HB3' HG11 ' A' ' 112' ' ' VAL . . . -140.76 33.54 1.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.15 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.48 ' H ' HD21 ' A' ' 226' ' ' LEU . 12.6 p -158.08 -41.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.647 ' HB3' HD13 ' A' ' 226' ' ' LEU . 0.4 OUTLIER -76.2 84.85 3.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.407 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.2 mtt 57.36 61.31 6.35 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.645 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.617 ' HA ' HD23 ' A' ' 226' ' ' LEU . 30.8 Cg_endo -63.2 124.74 14.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.848 2.365 . . . . 0.0 112.407 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -157.0 -47.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -159.98 148.82 17.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.43 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 193' ' ' VAL . 15.4 m -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.444 . . . . 0.0 111.792 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 13.3 mtp85 -82.2 109.37 16.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 191' ' ' SER . 0.4 OUTLIER -84.13 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.978 0.418 . . . . 0.0 111.737 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.421 ' N ' HD13 ' A' ' 165' ' ' ILE . 3.9 t -138.45 42.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.867 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.777 ' O ' HD13 ' A' ' 168' ' ' ILE . 59.0 mt-30 39.56 -108.9 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.482 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.777 HD13 ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -172.36 -64.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.853 0.358 . . . . 0.0 110.527 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -138.15 -62.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -171.68 -75.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.011 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -176.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.1 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -163.94 -64.49 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLN . . . . . 0.619 ' O ' HG12 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -117.98 -83.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.776 HG22 HD11 ' A' ' 183' ' ' LEU . 0.4 OUTLIER 68.95 13.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 176' ' ' THR . 0.0 OUTLIER -106.06 94.41 5.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.797 0.332 . . . . 0.0 111.077 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -166.67 115.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.91 -41.25 95.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.1 -33.82 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -90.14 5.94 44.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.278 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.2 m -57.47 -26.79 61.77 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 30.4 mt-30 -63.45 -36.88 85.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.43 ' N ' HD22 ' A' ' 182' ' ' LEU . 3.7 mm? -73.74 -33.27 64.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.776 HD11 HG22 ' A' ' 174' ' ' VAL . 7.0 mt -78.0 -28.76 49.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.52 -34.48 61.79 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -76.4 -14.66 60.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.283 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.543 ' O ' HG12 ' A' ' 187' ' ' ILE . 11.4 m-20 81.09 -47.48 0.25 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 186' ' ' ASP . 2.3 pt 53.76 125.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 174.95 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 167' ' ' GLN . 11.0 p -101.43 147.21 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.95 65.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.536 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.532 ' N ' HG22 ' A' ' 165' ' ' ILE . 6.1 t -66.75 -169.1 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.035 0.445 . . . . 0.0 111.203 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.4 97.06 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.584 HG11 ' HB ' ' A' ' 132' ' ' ILE . 33.4 m -110.91 -178.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.84 177.98 9.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.6 ' CG2' HD13 ' A' ' 204' ' ' LEU . 1.4 pp -136.12 169.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 196' ' ' VAL . 12.5 m -150.14 98.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -71.64 98.37 1.89 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -70.01 -177.65 1.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.27 -26.44 66.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.32 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.517 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -158.96 139.8 12.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.992 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.947 HD11 HG13 ' A' ' 152' ' ' VAL . 15.0 tt -97.81 130.93 45.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.2 t -160.01 145.98 15.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.914 0.387 . . . . 0.0 111.234 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.6 HD13 ' CG2' ' A' ' 195' ' ' ILE . 3.4 mm? -95.98 169.58 9.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.656 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.9 m -148.96 136.7 20.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.486 ' ND1' HG12 ' A' ' 193' ' ' VAL . 73.4 t60 -153.12 157.24 40.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -51.04 97.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 141.37 -64.71 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.32 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -160.04 173.2 16.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 111.061 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.52 153.28 26.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.22 161.63 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.94 -63.03 1.5 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.732 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.7 mp 53.81 93.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.369 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.66 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -69.64 -33.48 72.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.412 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.42 ' HB3' HD13 ' A' ' 217' ' ' LEU . 0.4 OUTLIER -50.75 -56.42 12.12 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.729 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.808 HD12 ' CB ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.65 -39.16 77.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.417 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.431 ' O ' ' HB ' ' A' ' 153' ' ' ILE . . . -90.5 33.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.313 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.828 ' O ' HD13 ' A' ' 153' ' ' ILE . 2.0 t-80 -90.57 -58.69 2.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.623 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.433 ' HB ' ' HA ' ' A' ' 142' ' ' ASN . 71.5 p -149.25 71.23 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.481 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.742 HD11 HD12 ' A' ' 138' ' ' LEU . 30.1 mm -98.8 166.26 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.385 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.624 ' HA ' ' HA2' ' A' ' 149' ' ' GLY . 13.8 ttt180 -100.97 101.04 11.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' A' ' 221' ' ' ILE . 1.9 mp -147.23 171.87 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 1.5 tm-20 -89.12 167.82 12.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.332 . . . . 0.0 110.728 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.628 ' C ' HD12 ' A' ' 226' ' ' LEU . 33.3 tt0 -89.55 81.53 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.647 HD13 ' HB3' ' A' ' 158' ' ' SER . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.352 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.0 m -86.19 163.46 17.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.766 0.317 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -155.78 -46.56 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.985 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 45.9 mtt -139.94 111.7 7.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.27 -50.7 6.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -77.47 140.28 39.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.554 HG21 HG12 ' A' ' 202' ' ' ILE . 24.1 m -65.23 -49.09 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.268 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.497 ' N ' HG23 ' A' ' 112' ' ' VAL . 22.3 mt-10 -90.45 52.8 2.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -89.94 -36.94 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -84.31 140.03 31.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.2 mt -111.75 151.32 29.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -155.07 146.85 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.72 -49.35 7.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.89 172.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.52 92.2 2.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -130.26 123.76 30.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.71 163.88 23.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 m -69.84 161.53 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -83.38 73.76 10.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -154.23 -51.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 m -143.4 108.55 5.25 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.62 -29.8 62.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.552 2.168 . . . . 0.0 112.513 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PHE . . . . . 0.611 ' HB3' HD12 ' A' ' 182' ' ' LEU . 4.2 p90 -125.96 169.22 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.584 ' HA3' HG13 ' A' ' 211' ' ' VAL . . . -92.0 -134.42 6.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.459 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.628 ' CB ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER -123.52 -60.97 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.547 0.213 . . . . 0.0 111.513 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.813 ' HA ' HG21 ' A' ' 187' ' ' ILE . 3.3 Cg_exo -84.82 56.34 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.495 2.797 . . . . 0.0 112.072 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.801 HG23 ' O ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER 36.81 68.72 1.44 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.886 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.94 138.49 42.79 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.998 2.466 . . . . 0.0 112.639 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' CG2' ' A' ' 168' ' ' ILE . . . -90.83 78.53 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.051 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.552 HD23 ' CD2' ' A' ' 182' ' ' LEU . 2.9 pp -76.88 -46.16 25.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.929 0.395 . . . . 0.0 110.44 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.53 ' N ' HD12 ' A' ' 135' ' ' LEU . 12.4 m-20 -90.56 4.09 52.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.051 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.7 -167.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 171' ' ' ILE . 2.2 tt -80.44 59.73 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.785 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.32 95.91 1.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.611 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.53 -59.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.093 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.78 -178.87 40.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.594 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.14 168.82 23.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.8 m -120.48 148.73 43.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.998 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.18 -44.77 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.785 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -118.59 -164.78 1.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 69.75 132.07 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -74.59 -46.92 5.53 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 12.5 Cg_exo -35.65 -38.81 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.976 2.451 . . . . 0.0 113.367 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -153.08 132.79 3.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.821 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.696 HG21 ' HB2' ' A' ' 155' ' ' ALA . 8.8 t -104.66 -26.44 12.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 153' ' ' ILE . 3.7 tpp180 66.95 63.54 0.47 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.538 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.784 HG11 HD12 ' A' ' 221' ' ' ILE . 0.0 OUTLIER 43.62 -82.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.178 179.416 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 151' ' ' ARG . 3.1 tt -51.29 82.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.949 0.404 . . . . 0.0 111.285 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 158.84 -40.51 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.026 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.696 ' HB2' HG21 ' A' ' 150' ' ' THR . . . -68.63 -18.49 64.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.247 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.868 ' HB2' HG21 ' A' ' 195' ' ' ILE . . . -106.21 32.22 4.59 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.468 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.0 t -154.02 19.47 0.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.463 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -134.2 -66.85 0.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.739 0.304 . . . . 0.0 110.836 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 25.2 ttm -167.48 56.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.634 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.491 ' HB3' HD13 ' A' ' 195' ' ' ILE . 10.0 Cg_endo -51.83 146.26 28.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.172 2.581 . . . . 0.0 112.818 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -161.77 -50.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.487 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -170.33 84.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 1.15 HG13 HD11 ' A' ' 195' ' ' ILE . 19.3 m -70.16 143.52 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.449 ' HB2' ' CB ' ' A' ' 224' ' ' GLU . 6.3 mtt85 -90.36 106.94 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.76 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.981 HD11 HG12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -77.4 143.24 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.455 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.839 ' N ' HD13 ' A' ' 165' ' ' ILE . 11.4 t -142.79 -40.05 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.658 ' O ' HD13 ' A' ' 168' ' ' ILE . 1.6 mt-30 -131.46 129.28 40.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.828 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.981 HG12 HD11 ' A' ' 165' ' ' ILE . 15.1 mm -146.52 -42.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.05 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -51.7 167.11 0.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -93.64 -175.27 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -131.66 -56.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.17 -66.48 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -88.91 170.36 10.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.7 p -168.77 -40.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.263 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.8 98.38 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.5 p -153.87 138.65 17.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.18 73.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -62.36 -26.19 68.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.189 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -90.07 -31.92 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -54.22 -38.21 65.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.975 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -28.12 69.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 128' ' ' PHE . 7.2 mp -76.87 -34.24 57.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.901 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.48 -32.25 73.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.0 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -25.07 20.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.06 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 130' ' ' ASN . . . -57.39 -21.01 33.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.608 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 7.3 t70 65.42 85.19 0.14 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.761 0.315 . . . . 0.0 110.759 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.813 HG21 ' HA ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 166.39 144.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.577 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ARG . . . . . 0.508 ' N ' HD13 ' A' ' 187' ' ' ILE . 11.2 mpt_? -115.53 -87.82 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.962 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 165' ' ' ILE . 33.8 m -155.43 169.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . 0.667 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 98.75 -13.44 62.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.179 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' SER . . . . . 0.442 ' O ' HG22 ' A' ' 165' ' ' ILE . 5.4 t -68.56 -167.44 0.09 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.278 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -141.11 92.07 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 206' ' ' HIS . 31.0 m -100.06 148.03 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.628 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -95.48 161.31 14.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.652 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 1.15 HD11 HG13 ' A' ' 163' ' ' VAL . 0.6 OUTLIER -113.9 156.35 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.138 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.42 133.07 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.35 95.21 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.025 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -74.21 178.91 4.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.44 86.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 65.96 44.7 91.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.642 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -161.78 139.33 8.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.929 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -97.27 126.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.697 ' N ' HD13 ' A' ' 202' ' ' ILE . 0.6 OUTLIER -160.07 137.72 9.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.443 HD13 HG21 ' A' ' 193' ' ' VAL . 17.8 mt -80.0 178.7 8.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -150.4 93.46 1.99 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.769 0.319 . . . . 0.0 111.259 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 193' ' ' VAL . 0.4 OUTLIER 178.66 -169.64 0.1 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 60.51 -72.2 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -118.62 -52.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.959 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -160.59 -77.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.756 0.312 . . . . 0.0 110.428 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -142.21 160.76 39.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.584 HG13 ' HA3' ' A' ' 129' ' ' GLY . 10.8 t -114.69 142.97 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 213' ' ' LEU . 7.0 mm-40 -79.73 -51.86 8.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' A' ' 203' ' ' THR . 0.5 OUTLIER 23.14 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.164 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.14 161.72 10.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 1.8 m-20 -53.87 -30.67 46.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.322 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -54.29 -53.92 47.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.972 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -40.99 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.038 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.527 ' HA ' HD11 ' A' ' 221' ' ' ILE . . . -55.41 -21.44 15.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.026 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.472 ' NE2' HD13 ' A' ' 153' ' ' ILE . 58.1 t-80 -82.65 -16.65 47.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.301 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.2 t -141.7 80.82 1.74 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.784 HD12 HG11 ' A' ' 152' ' ' VAL . 36.9 mt -126.51 159.62 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -97.86 107.6 20.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 112.161 -179.129 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -148.04 168.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.678 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.571 ' O ' HG22 ' A' ' 150' ' ' THR . 3.4 tt0 -89.73 169.55 11.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.645 0.259 . . . . 0.0 110.452 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 22.8 tt0 -89.53 125.45 35.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 155' ' ' ALA . 3.7 pp . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.316 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.1 t -153.56 -53.87 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.746 0.307 . . . . 0.0 110.917 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -87.33 148.63 24.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 36.4 mtt -148.13 136.88 21.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.78 98.45 11.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -89.98 156.68 18.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 113' ' ' GLU . 28.8 m -69.53 -42.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -78.91 70.68 5.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.887 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 52.2 2.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -70.9 132.9 45.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 tp -157.61 -51.7 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 m -90.75 157.48 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.216 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -88.13 -38.68 15.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.38 140.04 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.53 125.68 39.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -131.73 155.51 47.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -148.01 130.45 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.91 140.76 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.7 t 61.37 173.51 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -158.0 103.46 1.86 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.47 -61.92 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.46 106.83 2.35 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.474 2.116 . . . . 0.0 112.567 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -139.99 44.38 1.91 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.19 120.38 2.33 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.247 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.468 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 2.0 p-10 -175.15 163.31 2.28 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.51 ' HG2' HG11 ' A' ' 193' ' ' VAL . 5.3 Cg_endo -47.15 140.79 13.83 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.97 2.447 . . . . 0.0 112.908 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.789 HD12 ' HD2' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -6.86 84.01 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.064 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.31 142.75 74.24 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.04 2.493 . . . . 0.0 111.729 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.582 ' HA3' HG21 ' A' ' 221' ' ' ILE . . . -90.45 29.47 6.66 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.873 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.7 tt -79.03 -56.3 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.104 0.478 . . . . 0.0 110.198 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.19 12.02 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.229 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.41 ' HB2' ' HA2' ' A' ' 134' ' ' GLY . 3.9 tp10 -87.04 -149.28 0.15 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.95 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.09 84.61 6.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.574 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 217' ' ' LEU . . . -90.33 111.42 3.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.248 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 141' ' ' GLY . 8.7 p -146.76 -46.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.621 0.248 . . . . 0.0 111.477 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 140' ' ' VAL . . . 134.26 115.45 1.56 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.549 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.49 -173.06 0.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.825 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.76 122.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.07 -46.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.543 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.96 -173.99 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 62.05 -83.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.685 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -179.15 -59.55 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.49 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 5.1 Cg_exo -31.36 133.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.363 2.709 . . . . 0.0 113.546 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.82 125.94 0.04 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.688 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 225' ' ' GLU . 0.2 OUTLIER -167.97 -151.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.462 0.172 . . . . 0.0 110.876 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.94 ' HB2' HG21 ' A' ' 223' ' ' ILE . 36.4 ttp180 69.02 -70.15 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.264 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.732 HG21 ' HB1' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -95.25 -17.79 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.413 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.647 HD13 ' N ' ' A' ' 153' ' ' ILE . 0.1 OUTLIER -133.54 107.09 10.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.642 0.258 . . . . 0.0 111.419 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASP . . . . . 0.603 ' O ' HG22 ' A' ' 157' ' ' THR . 15.7 t70 99.12 -37.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.82 ' HB2' ' H ' ' A' ' 151' ' ' ARG . . . -48.33 -32.18 7.07 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.03 -54.71 41.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.546 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 154' ' ' ASP . 7.9 t -63.23 -28.73 70.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.573 ' HB2' HD12 ' A' ' 226' ' ' LEU . 3.0 m -71.99 -155.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.09 71.12 1.35 Allowed Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.712 0.291 . . . . 0.0 111.147 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' PRO . . . . . 0.404 ' N ' HD13 ' A' ' 226' ' ' LEU . 78.7 Cg_exo -38.32 132.48 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.261 2.641 . . . . 0.0 113.148 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -170.0 -49.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -170.17 84.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.651 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 193' ' ' VAL . 31.3 m -69.95 -178.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.133 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.723 ' O ' HG23 ' A' ' 223' ' ' ILE . 8.9 mtp85 -124.31 -167.7 1.69 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.529 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.716 HG23 ' HG3' ' A' ' 222' ' ' ARG . 28.4 mm -142.37 124.83 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.796 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 t -152.11 68.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.668 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . 14.5 tt0 44.77 -94.13 0.02 OUTLIER 'General case' 0 C--O 1.246 0.888 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.54 ' O ' HG22 ' A' ' 168' ' ' ILE . 48.6 mm 77.59 -5.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 36.2 p30 -157.9 -178.81 7.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.744 0.306 . . . . 0.0 111.139 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.09 -88.71 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.164 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.14 -55.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.683 0.278 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.5 t80 63.55 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -104.63 171.74 7.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.829 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.635 HG13 ' O ' ' A' ' 174' ' ' VAL . 9.4 p -172.55 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.969 0.414 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.43 -173.33 4.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.645 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.4 p -128.0 -81.72 0.59 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.191 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.03 -43.78 86.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.453 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -67.86 -36.73 80.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.14 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.419 ' CD1' HD22 ' A' ' 182' ' ' LEU . 6.6 t80 -90.21 7.54 37.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.6 m -65.59 -48.4 72.44 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.43 -34.41 65.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.419 HD22 ' CD1' ' A' ' 179' ' ' PHE . 11.0 mp -62.8 -23.96 67.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.088 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.2 mt -90.06 -32.09 16.87 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -19.27 10.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.526 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.434 ' CB ' ' N ' ' A' ' 130' ' ' ASN . . . -81.6 11.9 4.29 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 62.35 100.93 0.03 OUTLIER 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.56 HG22 ' HA ' ' A' ' 132' ' ' ILE . 2.7 pt -83.51 87.14 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.401 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -125.0 107.81 11.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.691 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.58 ' N ' HD11 ' A' ' 132' ' ' ILE . 18.3 m -56.77 156.91 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.05 -6.9 66.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.087 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.5 t -66.25 -170.43 0.09 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.038 0.446 . . . . 0.0 111.525 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.34 136.21 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.716 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.793 HG12 ' CD2' ' A' ' 206' ' ' HIS . 35.5 m -138.92 -174.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.045 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.11 161.34 33.53 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.835 0.35 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 196' ' ' VAL . 0.3 OUTLIER -121.19 153.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.786 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.576 ' H ' HD12 ' A' ' 195' ' ' ILE . 13.5 p -141.89 141.4 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.36 91.6 8.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.432 ' HB2' HG22 ' A' ' 203' ' ' THR . 6.3 ttt180 -70.12 -179.71 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.78 92.92 3.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.17 35.0 91.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.673 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -163.45 143.31 8.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.763 0.315 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.651 HD13 HG12 ' A' ' 152' ' ' VAL . 20.9 tt -98.48 111.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.45 HG23 ' CG1' ' A' ' 196' ' ' VAL . 9.6 t -120.69 133.97 55.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.656 HD11 HG22 ' A' ' 152' ' ' VAL . 1.3 mm? -90.32 120.9 31.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.7 m -102.44 140.28 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' HIS . . . . . 0.793 ' CD2' HG12 ' A' ' 193' ' ' VAL . 26.3 t-80 -158.71 145.0 16.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' HIS . 21.2 m120 -28.56 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.441 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -56.99 -76.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.093 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 209' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.1 mtmt -160.2 -174.51 4.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.91 133.93 48.05 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.441 HG21 ' ND2' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -112.86 148.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 111.588 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.39 -9.23 59.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.973 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.425 ' HB2' HD23 ' A' ' 204' ' ' LEU . 5.5 mp -36.99 106.92 0.05 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.784 0.326 . . . . 0.0 111.439 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 4.1 mp -93.34 -176.52 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 0.7 OUTLIER -63.08 -14.54 49.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.291 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.39 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 111.227 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LEU . . . . . 0.478 ' HA ' ' HA3' ' A' ' 139' ' ' GLY . 2.5 mm? -86.28 -24.06 26.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.343 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 152' ' ' VAL . . . -90.41 35.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.538 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.465 ' HA ' HG21 ' A' ' 153' ' ' ILE . 0.9 OUTLIER -85.86 -7.22 58.85 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.358 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.472 HG23 ' O ' ' A' ' 220' ' ' THR . 4.6 t -179.09 90.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.196 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.582 HG21 ' HA3' ' A' ' 134' ' ' GLY . 0.1 OUTLIER -126.42 -163.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.789 ' HD2' HD12 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -84.39 88.95 7.3 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.94 HG21 ' HB2' ' A' ' 151' ' ' ARG . 1.7 mp -151.76 144.41 16.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.48 ' CB ' ' HB2' ' A' ' 164' ' ' ARG . 15.4 tt0 -89.86 161.15 16.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.662 ' HA ' HG21 ' A' ' 150' ' ' THR . 35.7 tt0 -89.3 118.61 29.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.086 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 158' ' ' SER . 2.1 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.288 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.3 p -152.76 154.62 35.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.331 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -148.73 153.59 38.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.8 mtt -146.48 108.94 4.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -88.59 124.4 34.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -86.23 121.61 29.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 156' ' ' ALA . 14.7 p -75.66 -41.98 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.416 ' N ' HG13 ' A' ' 112' ' ' VAL . 35.2 mt-10 -66.07 93.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -73.23 73.83 1.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.07 92.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.014 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mt -166.71 166.02 16.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -151.04 146.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -149.65 -48.38 0.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.9 t -146.76 -68.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.039 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 tp -172.75 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.24 176.07 5.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -139.21 -58.04 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 123' ' ' VAL . 10.6 p -164.53 123.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t -166.7 164.8 16.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -114.91 -42.02 3.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.0 p -145.08 64.6 11.19 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.47 70.2 6.37 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.719 2.28 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -164.09 38.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -131.17 -175.24 13.93 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.66 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 1.8 p-10 50.62 166.51 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 122.273 0.229 . . . . 0.0 111.148 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.66 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 43.5 Cg_exo -23.07 139.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.31 3.34 . . . . 0.0 113.856 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.87 ' N ' HD13 ' A' ' 187' ' ' ILE . 18.7 tt -46.45 121.99 6.58 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.17 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.561 ' HB3' HD11 ' A' ' 213' ' ' LEU . 83.6 Cg_endo -81.2 140.16 12.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.771 2.314 . . . . 0.0 111.828 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . 0.697 ' O ' HD11 ' A' ' 221' ' ' ILE . . . -90.52 68.66 2.36 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.306 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.426 HD23 ' C ' ' A' ' 135' ' ' LEU . 9.9 tt -70.6 -65.77 0.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.98 3.43 54.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.168 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.503 ' CD ' HD13 ' A' ' 168' ' ' ILE . 2.6 mt-10 -77.71 -47.46 19.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.52 0.2 . . . . 0.0 111.331 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.612 ' HB3' HD12 ' A' ' 221' ' ' ILE . 1.7 pp -41.91 -31.8 0.37 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.805 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -40.81 -34.56 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.153 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.68 103.36 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 111.003 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 128.15 172.92 13.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.4 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 9.6 p30 -156.9 150.35 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -138.72 98.64 3.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.02 -53.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.45 153.0 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 61.17 174.73 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.119 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ALA . . . . . 0.677 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -73.39 -57.49 2.71 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 7.6 Cg_exo -33.68 109.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.175 2.583 . . . . 0.0 113.216 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 95.52 137.6 9.22 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.598 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' THR . . . . . 0.84 HG23 ' HB ' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -179.14 -80.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.535 0.207 . . . . 0.0 111.431 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ARG . . . . . 0.689 ' O ' HG12 ' A' ' 152' ' ' VAL . 5.0 tpt180 70.08 38.98 1.42 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.958 0.409 . . . . 0.0 110.609 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 195' ' ' ILE . 0.3 OUTLIER 82.68 2.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.903 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 150' ' ' THR . 2.9 tp -92.78 25.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 120.749 0.309 . . . . 0.0 111.369 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 170.46 -36.43 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.797 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 225' ' ' GLU . . . -67.4 -21.16 65.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ALA . . . . . 0.637 ' O ' HG23 ' A' ' 157' ' ' THR . . . -86.73 56.31 3.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -166.34 -43.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 83.91 5.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 66.8 mtt 59.49 62.59 3.79 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.285 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 124.61 11.05 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.697 2.265 . . . . 0.0 112.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -153.08 -48.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -164.61 113.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 m -89.54 132.66 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.236 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ARG . . . . . 0.453 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 13.8 mtt180 -79.88 98.24 7.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.283 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.974 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.3 OUTLIER -70.72 124.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.698 0.285 . . . . 0.0 110.888 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' VAL . . . . . 0.595 ' N ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -160.87 98.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.404 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 16.9 mt-30 93.15 137.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.872 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 169' ' ' ASN . 0.6 OUTLIER -143.74 -48.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.835 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 168' ' ' ILE . 16.0 t30 172.69 -85.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.512 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.63 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.701 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.16 -60.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.9 t80 61.49 -81.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -116.63 134.89 54.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.972 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.594 HG13 ' O ' ' A' ' 174' ' ' VAL . 7.3 p -163.26 94.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.04 -42.72 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.267 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.7 t -59.79 144.02 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.35 -33.33 71.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -31.73 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.391 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PHE . . . . . 0.482 ' CD1' HD22 ' A' ' 182' ' ' LEU . 82.0 t80 -90.06 -29.24 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.068 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.3 m -54.45 -32.01 56.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -71.37 -35.59 71.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LEU . . . . . 0.521 HD23 ' HG2' ' A' ' 133' ' ' PRO . 9.1 mp -55.78 -30.33 61.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.72 -31.88 46.6 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.824 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -23.78 3.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.103 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.795 ' HB3' HD11 ' A' ' 187' ' ' ILE . . . -51.9 -26.1 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.186 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 187' ' ' ILE . 7.8 t70 57.84 78.47 0.24 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.267 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ILE . . . . . 0.87 HD13 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER 178.98 160.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -144.61 172.58 12.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 165' ' ' ILE . 24.6 m -54.21 174.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.839 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.69 -15.13 61.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.6 t -86.95 -164.7 1.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.394 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -132.2 86.62 2.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.397 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' VAL . . . . . 0.476 HG12 ' CG ' ' A' ' 131' ' ' PRO . 8.4 m -84.23 175.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.89 168.17 20.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ILE . . . . . 0.723 ' CG2' HD23 ' A' ' 204' ' ' LEU . 2.9 pp -139.96 167.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.333 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 m -154.94 142.19 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.005 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -70.08 85.02 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ARG . . . . . 0.543 ' HB2' HG21 ' A' ' 203' ' ' THR . 20.4 tpt180 -78.89 88.91 4.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.209 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.26 54.77 9.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.339 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.41 39.07 96.77 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.654 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.19 145.0 31.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.736 0.303 . . . . 0.0 110.739 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . 0.694 HD11 ' C ' ' A' ' 214' ' ' LEU . 30.3 pt -80.0 139.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.241 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 198' ' ' ARG . 2.6 t -160.17 129.95 5.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.822 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . 0.871 HD12 HD22 ' A' ' 213' ' ' LEU . 25.7 mt -86.02 151.38 23.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.616 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 43.5 m -143.44 123.08 13.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -174.87 168.79 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.6 t30 67.4 -69.92 0.13 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.449 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 172.76 29.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.231 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.7 165.5 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.47 146.46 39.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.522 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -117.85 163.57 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.94 -65.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.381 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' LEU . . . . . 0.871 HD22 HD12 ' A' ' 204' ' ' LEU . 6.6 mp 36.0 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.778 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.694 ' C ' HD11 ' A' ' 202' ' ' ILE . 1.1 tp -75.95 -169.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.391 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASP . . . . . 0.401 ' N ' HD11 ' A' ' 202' ' ' ILE . 13.7 t70 -55.22 -25.09 30.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.998 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . 0.588 ' O ' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -68.4 -57.26 6.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.963 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.36 -49.98 67.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.191 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ALA . . . . . 0.514 ' O ' HD13 ' A' ' 153' ' ' ILE . . . -90.21 47.2 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.65 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 220' ' ' THR . 6.3 t-80 -90.16 -43.09 10.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.708 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' THR . . . . . 0.443 ' HB ' ' HA ' ' A' ' 142' ' ' ASN . 3.0 p -155.39 70.13 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ILE . . . . . 0.697 HD11 ' O ' ' A' ' 134' ' ' GLY . 0.7 OUTLIER -106.94 165.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 222' ' ' ARG . . . . . 0.672 ' C ' HD13 ' A' ' 223' ' ' ILE . 33.6 mtt-85 -101.8 92.57 4.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ILE . . . . . 0.974 HG23 ' HA ' ' A' ' 165' ' ' ILE . 3.8 mm -124.21 -162.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' GLU . . . . . 0.801 ' H ' HG22 ' A' ' 223' ' ' ILE . 12.8 tm-20 -112.14 133.22 54.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.943 0.338 . . . . 0.0 110.511 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 0.8 OUTLIER -89.67 109.31 20.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.244 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.8 0.333 . . . . 3.42 110.832 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' HD12 ' A' ' 202' ' ' ILE . 27.3 m -68.01 -49.52 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 2.29 111.143 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 112' ' ' VAL . 1.7 pt-20 -80.53 -8.34 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 3.04 111.113 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -54.96 -35.12 63.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.367 . . . . 7.14 110.989 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.15 127.61 32.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 7.66 110.941 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.57 113.04 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 4.53 110.809 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.467 HG21 HD21 ' A' ' 214' ' ' LEU . 13.0 m -128.06 171.51 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 4.14 111.159 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -127.13 -43.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 7.37 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 119' ' ' VAL . 0.4 OUTLIER -63.66 171.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 2.55 111.203 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 135' ' ' LEU . 7.3 tp -110.81 72.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 2.62 110.902 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.403 ' O ' HD22 ' A' ' 214' ' ' LEU . 74.9 mttt -153.09 160.97 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 5.81 110.855 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -151.0 -166.04 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 4.19 110.94 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -166.36 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 3.64 110.998 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t 75.13 172.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 4.28 110.888 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -102.34 -29.08 11.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 6.64 110.974 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.7 m -111.56 76.2 1.49 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 3.9 110.997 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -20.04 24.19 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.732 2.288 . . . . 3.79 112.345 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.78 150.42 27.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 4.12 110.938 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 147.31 157.22 7.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.728 . . . . 1.87 112.508 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.646 ' O ' ' O ' ' A' ' 129' ' ' GLY . 2.3 p30 49.2 141.77 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.111 0.482 . . . . 2.37 111.405 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.708 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 73.8 Cg_endo -75.92 141.02 23.64 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.934 2.423 . . . . 1.86 112.763 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.735 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 136.92 -27.46 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.546 . . . . 4.82 111.765 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 17.1 Cg_exo -66.47 53.66 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.764 2.31 . . . . 1.57 112.784 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.475 ' HA3' HG21 ' A' ' 168' ' ' ILE . . . -67.21 90.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.706 . . . . 1.25 112.232 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.592 HD11 HD21 ' A' ' 120' ' ' LEU . 6.3 tt -67.47 -56.47 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 2.97 111.282 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -89.97 8.97 29.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.512 . . . . 3.87 111.374 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 169' ' ' ASN . 0.5 OUTLIER -90.13 -50.05 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.757 0.313 . . . . 2.87 111.04 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.571 HD22 ' O ' ' A' ' 217' ' ' LEU . 1.3 pp -45.29 -38.36 5.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 4.4 111.429 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.727 ' O ' HG23 ' A' ' 140' ' ' VAL . . . -45.87 86.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.849 -0.691 . . . . 2.74 112.92 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 139' ' ' GLY . 1.9 t 145.3 -61.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.727 0.299 . . . . 4.35 111.211 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.55 ' N ' HG12 ' A' ' 140' ' ' VAL . . . -66.56 173.97 24.64 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.881 -0.676 . . . . 3.37 113.05 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 141' ' ' GLY . 3.2 p-10 169.25 122.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.669 0.271 . . . . 2.71 110.67 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 66.2 m -122.4 -179.1 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 3.25 111.212 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -164.61 -40.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.983 -0.553 . . . . 3.13 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.86 -172.18 2.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 4.03 111.169 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 65.7 154.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 3.45 111.098 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 149' ' ' GLY . . . -64.0 -56.65 22.94 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.352 -0.386 . . . . 2.73 111.16 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 10.4 Cg_exo -32.31 79.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.162 2.575 . . . . 3.55 112.763 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 62.16 125.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.693 -0.765 . . . . 2.73 112.331 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.733 ' CG2' ' HB2' ' A' ' 155' ' ' ALA . 13.9 t -102.93 -5.48 23.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 2.61 110.696 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.605 ' CG ' ' HA ' ' A' ' 220' ' ' THR . 0.0 OUTLIER 69.54 118.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 8.22 110.773 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.659 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 29.3 t -31.85 -46.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 2.74 111.499 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.537 ' CG2' ' HB3' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -43.29 -35.55 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 2.41 110.993 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -109.32 -25.38 10.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 1.93 110.809 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.733 ' HB2' ' CG2' ' A' ' 150' ' ' THR . . . -71.22 58.96 0.25 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 1.51 111.113 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.495 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -175.43 34.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 2.02 111.027 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 t -157.3 -33.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 2.51 111.293 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.92 48.27 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.459 -0.337 . . . . 2.05 111.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 4.1 ttm 62.95 61.62 1.95 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 2.84 111.063 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.742 ' HB3' HD22 ' A' ' 226' ' ' LEU . 18.0 Cg_endo -59.3 149.26 82.06 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.839 2.359 . . . . 1.58 112.304 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -146.12 -47.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.99 110.84 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -170.04 95.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 2.49 110.835 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 193' ' ' VAL . 8.1 m -73.06 116.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 1.08 111.109 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 2.2 mtp180 -80.44 118.15 21.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 3.3 111.069 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -84.08 120.27 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 1.4 110.66 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.455 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 20.3 t -110.25 -23.0 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 1.87 111.58 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.712 ' C ' HD13 ' A' ' 168' ' ' ILE . 1.8 mt-30 -178.63 -175.65 0.44 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 4.75 111.22 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.759 HG13 HD12 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -136.1 -60.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 4.51 110.868 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 15.2 t-20 178.32 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.32 110.909 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -173.62 -163.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.448 . . . . 5.35 110.873 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.508 ' O ' ' C ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER -121.69 -12.39 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 4.19 111.254 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.508 ' C ' ' O ' ' A' ' 171' ' ' ILE . 2.8 t80 -26.86 -58.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 6.41 111.315 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -90.09 122.28 32.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 4.21 110.894 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 174' ' ' VAL . 12.4 p -168.71 37.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 2.74 111.164 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 176' ' ' THR . 22.8 tt0 -112.95 77.31 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 5.08 110.882 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 175' ' ' GLU . 1.4 p -157.35 124.92 5.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 2.95 110.864 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -33.11 73.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 2.26 111.057 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -70.43 -33.13 70.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 3.08 110.944 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -76.97 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 3.8 111.009 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.1 m -56.52 -41.88 77.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 1.9 110.962 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -72.4 -35.11 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 3.22 110.931 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.04 -20.6 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 2.17 110.949 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.12 -8.43 59.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 2.12 111.078 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -31.64 56.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 2.26 110.955 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.3 -30.24 38.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 1.95 111.168 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 187' ' ' ILE . 3.1 t0 69.33 15.28 8.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 3.66 110.953 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.759 HD12 HG13 ' A' ' 168' ' ' ILE . 7.8 pt 32.93 90.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 3.28 111.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -84.37 93.39 8.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 2.93 110.759 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 189' ' ' VAL . 8.5 m -57.66 122.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.012 -0.54 . . . . 1.84 111.073 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.503 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 116.26 -5.27 19.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 1.3 112.55 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.435 ' C ' HG22 ' A' ' 165' ' ' ILE . 2.0 t -72.19 -161.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.336 . . . . 1.56 110.958 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -147.38 115.08 6.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 2.76 110.725 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.896 HG12 ' CD2' ' A' ' 206' ' ' HIS . 29.4 m -128.67 176.48 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 1.05 111.187 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.95 152.48 46.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 2.3 110.784 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -128.41 153.96 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 2.54 111.172 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 195' ' ' ILE . 5.6 m -157.83 145.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 2.28 111.113 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 170.39 16.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 2.36 110.893 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -169.98 105.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 3.73 110.968 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 49.41 51.0 17.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 3.14 110.996 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 60.74 68.04 1.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 2.0 112.417 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -170.07 155.58 5.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.804 0.335 . . . . 2.77 110.864 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.603 HD11 ' CG1' ' A' ' 152' ' ' VAL . 19.4 tt -105.3 140.14 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 1.86 111.128 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.1 t -160.03 122.21 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 1.58 110.959 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.414 HD13 ' HB ' ' A' ' 195' ' ' ILE . 3.1 mm? -84.86 119.23 25.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.71 110.776 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -96.9 117.63 31.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 1.27 111.012 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.896 ' CD2' HG12 ' A' ' 193' ' ' VAL . 10.6 t-80 -129.66 146.73 51.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 2.2 110.746 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.564 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.0 m120 -19.4 -55.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 3.91 111.303 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -54.36 -76.93 0.17 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.718 -0.754 . . . . 1.41 112.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 18.5 mtmt -159.72 -174.44 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.317 . . . . 3.49 110.763 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 149.24 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 2.07 110.635 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.418 HG21 ' OD1' ' A' ' 130' ' ' ASN . 0.0 OUTLIER -122.41 178.04 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 1.5 111.213 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.77 -66.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 3.28 110.693 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 218' ' ' ALA . 3.4 mp 57.03 77.18 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 2.14 110.949 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 117' ' ' VAL . 17.9 tp -54.85 163.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 2.53 110.77 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 6.7 m-20 -54.59 -22.79 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 2.15 110.998 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.565 ' O ' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -81.89 -20.1 39.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.96 111.072 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.571 ' O ' HD22 ' A' ' 138' ' ' LEU . 10.5 mp -89.97 -56.41 3.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 2.65 111.045 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.628 ' HB1' ' CB ' ' A' ' 152' ' ' VAL . . . -90.22 46.1 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 1.22 111.114 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.506 ' HB3' HD13 ' A' ' 138' ' ' LEU . 3.6 t-160 -90.06 -45.06 9.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 2.17 111.013 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.605 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 6.0 p -142.25 65.31 1.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.359 . . . . 2.02 111.633 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.936 ' HB ' HD11 ' A' ' 223' ' ' ILE . 33.0 mm -89.76 158.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 116.33 -0.395 . . . . 1.91 110.614 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 2.6 mtt-85 -95.2 86.18 4.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 6.53 111.198 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.936 HD11 ' HB ' ' A' ' 221' ' ' ILE . 0.2 OUTLIER -123.43 -154.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.85 110.497 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -117.94 162.44 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.348 . . . . 3.25 111.003 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.446 ' CB ' ' HB ' ' A' ' 150' ' ' THR . 16.9 tt0 -89.9 99.67 12.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 2.8 110.849 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.742 HD22 ' HB3' ' A' ' 160' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 2.48 111.008 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.764 0.316 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 113' ' ' GLU . 34.1 m -76.42 -41.03 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.251 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.401 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -70.77 -34.6 71.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -72.14 -38.52 69.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -71.35 -37.75 71.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -71.91 148.58 45.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.001 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 119' ' ' VAL . 10.3 m -99.89 169.99 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -77.25 84.08 3.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 117' ' ' VAL . 7.7 t -145.97 158.33 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.403 ' N ' HG12 ' A' ' 119' ' ' VAL . 14.0 tp -91.86 -42.67 9.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.03 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.89 111.91 23.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.36 -71.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.37 138.49 50.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 p -129.79 111.78 12.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -162.34 -43.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 42.0 m -85.52 132.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.848 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 126' ' ' SER . 45.7 Cg_exo -56.39 176.19 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.566 2.177 . . . . 0.0 112.432 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -133.52 98.03 4.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.66 25.15 1.19 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.954 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -125.16 139.02 32.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 110.796 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.582 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.2 Cg_endo -75.74 135.35 17.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.676 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.61 HG13 HG21 ' A' ' 193' ' ' VAL . 0.0 OUTLIER 148.91 -32.05 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.117 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 7.4 Cg_endo -86.68 83.82 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.491 2.127 . . . . 0.0 112.434 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.1 117.19 4.97 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.48 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 217' ' ' LEU . 3.5 tt -81.08 -59.51 2.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -89.51 11.89 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.472 ' CG ' ' HB ' ' A' ' 168' ' ' ILE . 0.6 OUTLIER -90.11 -38.61 13.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.02 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 135' ' ' LEU . 2.2 pp -42.62 -35.47 1.11 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.536 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -51.84 151.39 7.0 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.714 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.0 t 58.6 101.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.237 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.97 141.64 6.1 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.425 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -164.57 96.13 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.342 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.443 ' N ' ' HD3' ' A' ' 151' ' ' ARG . 1.1 m -101.85 -175.89 2.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.52 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.85 -48.66 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.72 89.56 1.33 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.22 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.71 155.0 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -64.06 -61.61 6.53 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.09 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 8.2 Cg_exo -34.44 -43.99 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.014 2.476 . . . . 0.0 112.627 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -161.71 140.25 6.5 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.857 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.8 t -112.41 -20.88 11.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.655 0.227 . . . . 0.0 111.488 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.793 ' O ' HG22 ' A' ' 153' ' ' ILE . 18.5 ttp180 74.6 30.56 1.04 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.945 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER 52.51 -70.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.624 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.793 HG22 ' O ' ' A' ' 151' ' ' ARG . 3.4 tt -44.04 85.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.296 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 152' ' ' VAL . 1.7 p30 168.06 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.38 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.601 ' HA ' HD13 ' A' ' 226' ' ' LEU . . . -49.63 -29.39 7.14 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.474 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.682 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -95.32 33.06 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.417 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.9 t -170.59 33.61 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.175 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.576 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -158.52 35.54 0.23 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.038 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.1 mtp 58.43 67.87 1.99 Allowed Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.48 ' HA ' HD12 ' A' ' 226' ' ' LEU . 18.3 Cg_endo -60.14 155.67 44.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.81 2.34 . . . . 0.0 112.605 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.49 -55.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.504 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -170.26 91.84 0.19 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.062 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 193' ' ' VAL . 15.9 m -69.99 170.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.565 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -139.81 116.53 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.707 HD13 ' N ' ' A' ' 166' ' ' VAL . 0.2 OUTLIER -77.53 129.6 37.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.199 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.707 ' N ' HD13 ' A' ' 165' ' ' ILE . 17.7 t -133.93 -25.43 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.472 ' HA ' HG11 ' A' ' 189' ' ' VAL . 3.2 mt-30 -147.33 162.1 39.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.22 0.533 . . . . 0.0 111.775 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.565 HD13 HG12 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -152.38 -80.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.772 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -179.72 -67.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.91 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -155.65 -178.9 7.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.88 -40.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.197 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.96 -35.71 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.215 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -64.62 121.09 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 174' ' ' VAL . 10.7 p -172.07 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -102.86 -32.82 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.116 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.1 p -60.8 127.09 29.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.89 -35.51 67.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.03 -22.54 66.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.699 ' CZ ' HD12 ' A' ' 182' ' ' LEU . 14.0 t80 -79.02 -8.67 59.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.9 m -57.71 -40.44 79.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.688 0.28 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.09 -41.77 97.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.738 HD13 ' O ' ' A' ' 182' ' ' LEU . 3.2 tm? -77.69 -22.71 50.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.916 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 174' ' ' VAL . 0.7 OUTLIER -55.68 -26.7 46.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.297 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -34.95 40.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.95 38.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.719 ' C ' HD13 ' A' ' 187' ' ' ILE . 11.4 m-20 57.61 37.4 27.48 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.719 HD13 ' C ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER 9.68 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.267 0.627 . . . . 0.0 112.605 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -106.0 121.9 45.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.765 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.511 ' HA ' HD12 ' A' ' 165' ' ' ILE . 15.9 m -62.69 148.03 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.039 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.34 -11.75 47.59 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.719 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.8 t -70.06 -175.43 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -134.5 124.13 25.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.601 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 163' ' ' VAL . 21.1 m -131.83 172.87 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 0.0 111.461 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.9 138.53 19.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.653 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.682 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 4.0 tt -110.25 158.49 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.15 0.5 . . . . 0.0 111.32 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.473 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 15.4 m -142.07 136.55 29.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.982 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.98 93.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.12 -177.66 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.27 79.16 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 66.99 38.97 93.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.606 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -160.96 150.57 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 0.0 111.017 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.5 tt -95.6 144.74 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -160.08 137.43 9.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.466 HD23 HD22 ' A' ' 213' ' ' LEU . 3.6 mm? -115.55 121.86 43.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.5 m -86.76 138.31 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.534 ' CG ' HG12 ' A' ' 193' ' ' VAL . 3.0 t60 -165.12 172.31 12.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 206' ' ' HIS . 75.5 m-20 -28.17 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.82 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . 135.1 -81.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 23.0 mtmt -158.38 -88.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.614 0.245 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.25 158.34 34.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.01 172.68 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.014 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -79.94 -59.54 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.518 ' HA ' HD11 ' A' ' 217' ' ' LEU . 0.6 OUTLIER 52.72 96.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 3.9 mm? -79.75 178.51 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -76.54 -8.41 57.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.381 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -65.95 0.97 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.116 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -61.14 -36.27 79.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.509 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -89.76 24.48 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.595 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 3.3 t-160 -90.37 -67.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.8 p -103.86 53.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' A' ' 152' ' ' VAL . 31.9 mt -91.57 150.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -92.81 104.07 16.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.999 0.428 . . . . 0.0 111.657 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.562 HD11 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -136.7 -179.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.824 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.528 ' H ' HG22 ' A' ' 223' ' ' ILE . 6.3 tt0 -89.47 165.82 14.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 110.544 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -89.62 102.9 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.601 HD13 ' HA ' ' A' ' 155' ' ' ALA . 2.1 pt? . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.708 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.819 0.342 . . . . 0.0 110.862 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 197' ' ' ASP . 27.6 m -90.07 -43.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.386 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -90.12 -30.37 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.351 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -55.94 -43.2 77.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.336 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -67.46 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.944 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 117' ' ' VAL . 1.9 tt 64.66 130.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.428 ' N ' HD23 ' A' ' 116' ' ' LEU . 7.1 m -147.85 171.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -103.26 -33.85 9.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 m -61.02 140.73 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.394 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.1 tp -89.54 -42.51 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.35 131.04 44.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.04 -63.75 1.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.34 163.97 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.041 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 t -118.0 88.75 2.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -152.96 77.13 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.5 t 59.04 69.56 1.33 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.63 -28.29 80.77 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -106.82 149.64 27.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 155.5 134.45 1.86 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.72 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.433 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 10.4 p30 54.05 157.17 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.275 0 CA-C-O 121.059 0.457 . . . . 0.0 111.939 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.562 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 91.8 Cg_endo -77.78 175.03 11.71 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.896 2.397 . . . . 0.0 112.324 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.591 HG23 ' CD1' ' A' ' 165' ' ' ILE . 1.0 OUTLIER 108.46 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.467 ' HD2' ' C ' ' A' ' 131' ' ' PRO . 72.7 Cg_exo -43.12 118.66 1.36 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.338 2.025 . . . . 0.0 113.125 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.789 ' HA3' HG21 ' A' ' 221' ' ' ILE . . . -90.97 23.5 23.29 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.11 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.459 ' HA ' ' HG ' ' A' ' 217' ' ' LEU . 0.6 OUTLIER -50.24 -36.0 29.25 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.998 0.428 . . . . 0.0 110.478 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD2' HG23 ' A' ' 174' ' ' VAL . 0.3 OUTLIER -90.48 -22.36 21.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -178.28 0.53 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.89 102.33 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.745 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.33 127.05 8.6 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.058 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.9 -79.03 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.779 0.289 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.05 109.74 0.59 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.643 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.11 102.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 0.0 110.422 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.515 ' HA ' HD11 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -81.81 162.05 23.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.268 0.556 . . . . 0.0 111.774 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 p30 49.4 -178.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.804 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.38 179.58 0.77 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.954 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.71 -71.26 0.14 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.988 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -80.27 174.7 5.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.745 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 76.2 Cg_exo -50.69 89.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.567 2.178 . . . . 0.0 112.229 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.406 ' HA2' ' HG2' ' A' ' 224' ' ' GLU . . . -167.78 146.92 11.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.483 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.792 ' O ' HD11 ' A' ' 153' ' ' ILE . 0.4 OUTLIER -140.1 -48.53 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.554 0.216 . . . . 0.0 110.458 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.814 ' O ' HD13 ' A' ' 153' ' ' ILE . 34.9 mtt180 88.24 55.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.766 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.726 HG13 ' CG1' ' A' ' 223' ' ' ILE . 16.0 m 57.38 -47.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.814 HD13 ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -43.99 -30.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 118.636 0.653 . . . . 0.0 112.345 -178.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.13 24.05 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.609 0.243 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -96.51 12.53 31.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.397 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.727 ' HB2' HG12 ' A' ' 195' ' ' ILE . . . -149.84 70.52 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.052 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.512 ' H ' HD21 ' A' ' 226' ' ' LEU . 7.4 m -158.73 -52.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.087 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.503 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.5 OUTLIER -71.4 -79.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.359 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.523 ' H ' HD22 ' A' ' 226' ' ' LEU . 26.5 ttm -155.76 92.09 2.69 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.681 0.276 . . . . 0.0 111.143 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 226' ' ' LEU . 18.7 Cg_endo -60.27 140.33 91.47 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.723 2.282 . . . . 0.0 112.552 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -162.91 -49.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.81 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -168.62 119.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.863 ' HB ' HG22 ' A' ' 223' ' ' ILE . 26.8 m -102.1 134.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 12.4 mtt180 -79.78 126.09 30.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.889 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.742 HD13 HG23 ' A' ' 223' ' ' ILE . 24.4 mm -94.08 96.77 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 165' ' ' ILE . 86.2 t -159.89 92.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.416 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.629 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 170.07 105.54 0.01 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 111.063 179.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 167' ' ' GLN . 22.0 mt 98.25 -31.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.463 ' OD1' HG11 ' A' ' 189' ' ' VAL . 42.8 t-20 37.88 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.12 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.75 179.93 1.62 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.9 0.381 . . . . 0.0 111.446 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.511 HD12 ' HB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -131.04 125.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.085 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -63.82 -45.37 89.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.95 0.405 . . . . 0.0 110.686 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -123.03 143.29 50.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.492 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 174' ' ' VAL . 7.3 p -164.53 94.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -161.69 91.67 0.83 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.849 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.0 p -153.62 135.97 14.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -67.9 -35.08 77.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.91 -32.61 74.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.08 -15.87 51.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.291 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 35.2 m -50.36 -39.36 46.19 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.742 0.306 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.62 -36.03 62.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.748 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -13.27 60.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.032 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -81.02 -2.27 47.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.538 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.09 -43.28 41.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.754 0.311 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.4 -30.15 16.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.029 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.545 ' O ' ' O ' ' A' ' 187' ' ' ILE . 6.5 m-20 73.71 2.86 4.36 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.736 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.545 ' O ' ' O ' ' A' ' 186' ' ' ASP . 41.2 pt 48.62 124.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 112.146 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.61 125.59 54.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.42 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.53 HG23 ' HD2' ' A' ' 222' ' ' ARG . 7.7 p -73.64 146.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.08 1.08 63.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 132' ' ' ILE . 17.4 t -81.31 174.67 11.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.24 131.14 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 132' ' ' ILE . 31.3 m -148.11 -167.92 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -140.38 174.52 10.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.759 0.314 . . . . 0.0 110.827 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.727 HG12 ' HB2' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -160.03 154.76 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 14.8 m -155.1 174.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 112' ' ' VAL . 11.0 m-20 -86.01 160.05 19.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.766 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -163.9 102.08 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.072 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 t70 55.27 43.81 28.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.21 46.05 93.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.547 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -153.2 148.75 27.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.33 . . . . 0.0 110.906 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.663 HG13 HD11 ' A' ' 195' ' ' ILE . 18.4 tt -83.39 147.2 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.206 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.5 t -160.11 122.52 3.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 195' ' ' ILE . 14.5 mt -82.37 113.78 20.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.807 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.7 m -97.08 140.43 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.828 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 207' ' ' ASN . 54.3 t60 -147.92 144.45 28.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.489 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.0 m120 -33.13 -40.56 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.72 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -68.65 -66.31 2.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.1 mtmt -157.69 -176.3 5.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.35 148.84 40.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.415 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -114.39 169.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -79.98 -64.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.401 HD13 HD12 ' A' ' 204' ' ' LEU . 2.7 tp 59.27 167.09 0.06 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 215' ' ' ASP . 0.2 OUTLIER -157.16 152.25 26.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.432 ' H ' HD13 ' A' ' 214' ' ' LEU . 71.6 m-20 -53.31 -26.2 17.76 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.206 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.78 -66.94 0.3 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 135' ' ' LEU . 3.3 mm? -88.36 -20.84 24.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.821 ' HA ' HD11 ' A' ' 221' ' ' ILE . . . -90.14 29.46 1.23 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.859 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 220' ' ' THR . 0.0 OUTLIER -90.12 -33.94 16.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 219' ' ' HIS . 1.4 p -161.91 84.86 0.6 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.334 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.821 HD11 ' HA ' ' A' ' 218' ' ' ALA . 0.0 OUTLIER -120.5 -164.11 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.643 ' HG3' HG23 ' A' ' 165' ' ' ILE . 11.7 ptt180 -86.22 80.38 8.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.263 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.863 HG22 ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -151.43 176.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.574 178.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -120.87 -173.52 2.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.752 0.311 . . . . 0.0 111.019 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.407 ' HA ' HG21 ' A' ' 150' ' ' THR . 1.6 pt-20 -89.84 89.18 7.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.523 HD22 ' H ' ' A' ' 159' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.118 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.76 0.314 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.62 ' HB ' HD13 ' A' ' 202' ' ' ILE . 33.3 m -90.12 -34.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.79 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.949 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -57.66 89.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -90.12 -53.38 4.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.22 160.29 30.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.73 135.1 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.563 ' HB3' HD21 ' A' ' 214' ' ' LEU . 10.9 tptt -159.12 173.47 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.809 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 1.0 OUTLIER -88.25 -45.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.047 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.468 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 12.3 tp -170.69 -51.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.22 142.61 28.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -119.55 -63.0 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 126' ' ' SER . 5.2 m -72.42 176.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.195 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.4 m -71.46 -55.67 7.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.61 -56.55 5.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 123' ' ' VAL . 2.6 m 61.41 86.1 0.16 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.073 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.31 155.23 25.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.618 2.212 . . . . 0.0 112.261 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 60.9 m-85 -142.97 33.97 1.37 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -106.58 -132.23 7.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.758 ' ND2' HG22 ' A' ' 211' ' ' VAL . 0.2 OUTLIER 54.5 -163.86 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.726 ' O ' ' HB1' ' A' ' 185' ' ' ALA . 65.9 Cg_exo -50.68 -74.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.877 1.718 . . . . 0.0 112.591 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.682 HG21 HG23 ' A' ' 187' ' ' ILE . 0.0 OUTLIER 165.2 127.78 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.449 0.166 . . . . 0.0 111.209 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.457 ' HB3' HD12 ' A' ' 213' ' ' LEU . 3.0 Cg_exo -74.17 139.93 27.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.738 2.292 . . . . 0.0 111.969 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.851 ' O ' HD11 ' A' ' 221' ' ' ILE . . . -90.28 93.37 1.86 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.807 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 135' ' ' LEU . 1.3 tt -83.58 -32.36 25.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.02 -10.78 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 169' ' ' ASN . 1.3 mt-10 -61.89 -49.61 75.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.736 0.303 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.496 HD21 ' C ' ' A' ' 216' ' ' ASP . 3.2 mp -29.94 -44.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.981 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -48.73 -44.9 30.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.879 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 105.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.739 0.304 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.76 114.14 0.78 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.544 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.473 ' HB3' HG22 ' A' ' 220' ' ' THR . 6.6 p30 -171.17 142.8 1.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.741 0.305 . . . . 0.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.45 ' HB2' ' HA3' ' A' ' 149' ' ' GLY . 13.8 t -95.9 162.15 13.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -162.41 -45.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.12 -45.0 1.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.84 -179.86 6.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.672 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -74.38 -58.28 1.92 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.518 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 5.9 Cg_exo -33.25 108.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 113.301 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 153' ' ' ILE . . . 115.5 42.0 0.77 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.713 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.904 ' O ' HD13 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -103.53 -142.41 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.803 ' N ' ' HB2' ' A' ' 155' ' ' ALA . 26.0 ttt180 65.13 -69.96 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.748 0.308 . . . . 0.0 111.623 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.618 HG11 HD22 ' A' ' 213' ' ' LEU . 2.5 m -95.68 -38.23 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 149' ' ' GLY . 1.0 OUTLIER -116.55 110.03 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.238 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 157' ' ' THR . 55.7 m-20 99.26 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.705 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.803 ' HB2' ' N ' ' A' ' 151' ' ' ARG . . . -42.93 -34.25 0.93 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.56 61.42 2.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.429 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 154' ' ' ASP . 4.1 t -176.23 -35.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.346 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.7 m -89.3 54.2 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 45.3 mtt 55.0 57.21 11.37 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.391 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 226' ' ' LEU . 7.3 Cg_endo -49.32 129.57 22.86 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.168 2.579 . . . . 0.0 112.559 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -154.97 -47.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.567 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -170.28 91.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 151' ' ' ARG . 20.4 m -70.0 178.42 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.912 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.48 ' HB2' ' CB ' ' A' ' 224' ' ' GLU . 1.5 mpt_? -127.18 107.75 10.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.798 ' HA ' HG23 ' A' ' 223' ' ' ILE . 8.2 tt -70.63 134.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.471 HG13 ' HA2' ' A' ' 190' ' ' GLY . 0.1 OUTLIER -156.39 11.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HB3' ' HB2' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -168.65 100.57 0.4 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.947 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.611 HD11 HD11 ' A' ' 165' ' ' ILE . 3.3 mp -117.65 -4.29 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.949 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 137' ' ' GLU . 25.2 t-20 53.56 -92.76 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.738 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 62.18 -88.14 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 79.4 mt 59.89 -76.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.8 m-85 -62.65 -67.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.871 0.367 . . . . 0.0 111.332 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.92 121.98 12.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.081 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -172.44 -40.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.282 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 176' ' ' THR . 26.5 tt0 -113.58 95.02 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 175' ' ' GLU . 1.5 p -158.27 157.33 32.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.79 -37.31 83.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.61 -31.97 57.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.459 ' CD1' HD22 ' A' ' 182' ' ' LEU . 8.4 t80 -90.08 3.62 52.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.45 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.3 m -59.05 -44.21 91.79 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -72.99 -33.59 65.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.459 HD22 ' CD1' ' A' ' 179' ' ' PHE . 8.1 mp -73.19 -21.8 60.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.4 mt -63.73 -33.32 75.39 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.598 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.68 -28.37 21.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.55 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.726 ' HB1' ' O ' ' A' ' 131' ' ' PRO . . . -51.66 -41.13 61.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.004 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.8 t70 78.85 -8.32 1.66 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.682 HG23 HG21 ' A' ' 132' ' ' ILE . 44.2 mt 61.01 125.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.738 0.304 . . . . 0.0 111.467 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.58 -43.23 3.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.507 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 168' ' ' ILE . 3.3 p 36.94 83.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.471 ' HA2' HG13 ' A' ' 166' ' ' VAL . . . 135.3 2.26 3.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.518 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.62 ' H ' HG23 ' A' ' 165' ' ' ILE . 8.0 t -85.19 -167.44 1.83 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.903 0.382 . . . . 0.0 111.289 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . 0.425 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 45.9 mt-10 -129.62 99.0 5.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.492 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.694 HG12 ' CD2' ' A' ' 206' ' ' HIS . 27.3 m -92.29 169.62 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.625 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.56 135.66 53.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.605 HD12 ' H ' ' A' ' 196' ' ' VAL . 0.7 OUTLIER -90.74 151.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.102 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.605 ' H ' HD12 ' A' ' 195' ' ' ILE . 14.9 p -170.32 151.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.464 ' HB3' HG12 ' A' ' 112' ' ' VAL . 2.0 p30 -131.77 172.16 12.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.749 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.25 118.14 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.334 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.5 t70 66.93 -68.82 0.14 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.56 49.65 0.16 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.304 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -149.06 145.07 27.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 112' ' ' VAL . 9.9 tp -95.14 145.0 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.241 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.505 HG23 HG13 ' A' ' 196' ' ' VAL . 2.2 t -160.05 153.99 23.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 211' ' ' VAL . 3.6 mm? -121.93 103.64 8.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 2.8 m -79.91 122.18 26.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.694 ' CD2' HG12 ' A' ' 193' ' ' VAL . 59.8 t60 -175.73 162.19 2.67 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.4 m120 31.56 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.991 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -54.41 -78.97 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.439 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 22.9 mtmt -160.5 -75.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.495 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -155.48 133.19 11.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.27 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.758 HG22 ' ND2' ' A' ' 130' ' ' ASN . 21.2 t -87.38 141.51 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -79.84 -59.11 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.181 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.618 HD22 HG11 ' A' ' 152' ' ' VAL . 0.2 OUTLIER 48.75 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.609 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 118' ' ' LYS . 6.0 tp -165.95 164.13 18.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -46.75 -31.63 3.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.3 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.496 ' C ' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.62 -58.59 6.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.358 . . . . 0.0 110.591 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.918 ' O ' HD13 ' A' ' 221' ' ' ILE . 7.9 mp -80.39 -12.86 59.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.157 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.428 ' HB2' HD23 ' A' ' 213' ' ' LEU . . . -90.51 -28.02 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -90.43 -19.83 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.907 ' O ' HD12 ' A' ' 221' ' ' ILE . 20.1 p -135.9 78.74 1.73 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.98 HG22 HD11 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -149.01 156.96 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 167' ' ' GLN . 40.4 mtt-85 -101.04 124.25 46.48 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.98 HD11 HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -150.42 178.37 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.815 178.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 223' ' ' ILE . 2.1 tm-20 -95.02 150.07 20.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.493 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.567 ' CB ' ' HB1' ' A' ' 147' ' ' ALA . 3.1 tt0 -89.57 132.88 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 111.259 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.405 ' CD1' ' HA ' ' A' ' 160' ' ' PRO . 4.6 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.322 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.707 0.289 . . . . 0.0 110.849 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.477 HG11 ' HB1' ' A' ' 156' ' ' ALA . 30.2 m -69.55 -42.74 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.196 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -90.38 40.38 1.01 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.155 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -90.13 -51.49 5.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 136.54 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.32 170.14 8.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.62 -43.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.4 tttt 70.37 -66.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.7 m -69.41 143.06 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.218 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tt -86.03 95.26 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -154.78 136.44 14.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.19 140.91 30.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.01 109.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.8 t -159.92 -64.17 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -152.69 -72.35 0.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.822 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.43 ' CB ' ' HD3' ' A' ' 127' ' ' PRO . 0.6 OUTLIER 175.33 -53.44 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 126' ' ' SER . 46.3 Cg_exo -56.6 -171.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.603 2.202 . . . . 0.0 112.557 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -125.13 -175.5 3.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.744 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 211' ' ' VAL . . . -131.19 -158.67 9.27 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.664 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 0.6 OUTLIER -71.51 165.14 51.68 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.545 0.212 . . . . 0.0 110.81 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 38.3 Cg_endo -67.2 126.85 15.7 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.551 2.167 . . . . 0.0 112.787 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.759 ' H ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -172.58 -62.64 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.694 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.737 ' O ' HG21 ' A' ' 187' ' ' ILE . 7.0 Cg_exo -38.92 118.3 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.288 2.658 . . . . 0.0 113.377 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.542 ' HA3' HD12 ' A' ' 221' ' ' ILE . . . -90.81 47.99 3.01 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.536 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.427 ' HA ' ' HG ' ' A' ' 217' ' ' LEU . 2.8 pp -51.02 -32.73 22.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.081 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -89.35 -22.36 22.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -174.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.154 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tt -90.28 102.86 15.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.375 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.701 ' CA ' HD13 ' A' ' 217' ' ' LEU . . . -88.25 128.28 8.99 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.392 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 141' ' ' GLY . 14.1 p -172.91 -43.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 140' ' ' VAL . . . 126.5 107.29 1.52 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.568 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 2.9 m120 -166.79 137.53 3.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.732 ' OG ' HG23 ' A' ' 153' ' ' ILE . 58.0 p -179.08 -34.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.83 -23.21 1.76 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.674 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.66 174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.743 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 147' ' ' ALA . . . -107.46 140.65 40.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 168.38 167.54 0.14 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.561 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 36.9 Cg_exo -56.44 -18.95 26.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.15 1.9 . . . . 0.0 110.973 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 224' ' ' GLU . . . -139.46 153.71 23.15 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.669 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 225' ' ' GLU . 10.8 t -97.2 -142.28 0.29 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.481 ' HB2' ' CB ' ' A' ' 143' ' ' SER . 60.9 mtt180 -150.58 72.16 1.08 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.731 HG23 HD11 ' A' ' 223' ' ' ILE . 44.2 t 64.41 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.159 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.732 HG23 ' OG ' ' A' ' 143' ' ' SER . 1.3 tt -61.47 76.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.5 OUTLIER 162.73 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.598 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.826 ' HA ' HD22 ' A' ' 226' ' ' LEU . . . -89.89 46.0 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.431 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.663 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -145.16 36.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 156' ' ' ALA . 2.8 p -160.07 -43.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.522 ' HB3' HD21 ' A' ' 226' ' ' LEU . 8.4 t -76.81 61.66 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.6 ttt 48.96 86.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.408 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.44 149.41 90.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.644 2.229 . . . . 0.0 112.576 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -156.55 -50.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.688 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.9 mttt -168.11 165.34 13.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 193' ' ' VAL . 3.4 m -155.04 140.41 10.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.626 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.561 ' H ' ' CB ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -79.37 107.63 12.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.571 179.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.809 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -79.5 119.4 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.705 ' HA ' HG13 ' A' ' 189' ' ' VAL . 10.7 t -134.7 38.07 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.395 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.704 ' H ' HD13 ' A' ' 165' ' ' ILE . 0.6 OUTLIER 5.67 -86.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.434 0.694 . . . . 0.0 112.86 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 169' ' ' ASN . 0.4 OUTLIER 159.2 -52.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.471 ' N ' HG22 ' A' ' 168' ' ' ILE . 27.1 p30 -169.48 -172.43 1.45 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.797 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.428 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 36.5 mt-10 -152.13 168.39 25.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.992 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 77.36 -21.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.131 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.29 -51.6 61.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -118.74 178.67 4.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.167 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 174' ' ' VAL . 7.4 p -167.0 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.08 -178.21 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.197 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.7 p -68.42 -173.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.33 -5.05 33.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -57.89 -30.92 66.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.734 0.302 . . . . 0.0 110.986 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.617 ' CD1' HD22 ' A' ' 182' ' ' LEU . 45.7 m-85 -90.13 11.58 20.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.6 m -54.24 -39.39 66.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.733 0.301 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.47 -41.25 69.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.617 HD22 ' CD1' ' A' ' 179' ' ' PHE . 7.7 mp -71.42 -18.19 62.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.958 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -25.14 68.02 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.99 -40.26 57.56 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.04 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 187' ' ' ILE . 6.7 t70 60.89 24.65 14.64 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.282 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.759 HG22 ' H ' ' A' ' 132' ' ' ILE . 1.1 pp 28.51 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.112 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.39 141.19 40.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.098 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 166' ' ' VAL . 25.0 t -69.11 146.9 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.71 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.28 -12.8 26.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.791 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.489 ' N ' HG22 ' A' ' 165' ' ' ILE . 1.3 t -73.67 -165.3 0.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.004 0.431 . . . . 0.0 111.027 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -151.69 145.91 25.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.206 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.675 ' O ' HG22 ' A' ' 163' ' ' VAL . 20.8 m -150.3 179.08 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.012 0.434 . . . . 0.0 111.876 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.99 101.73 1.95 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.38 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.663 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 41.4 pt -79.84 151.46 4.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.558 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.3 m -150.68 152.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.957 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.92 142.03 53.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.05 112.99 1.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.011 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.41 36.43 23.02 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.77 51.41 57.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.594 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -158.28 156.06 29.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.805 0.336 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -94.45 135.42 28.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.763 ' N ' HD13 ' A' ' 202' ' ' ILE . 1.7 t -153.57 133.03 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.653 ' CD2' HD22 ' A' ' 213' ' ' LEU . 2.1 mm? -79.99 159.68 26.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.502 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 9.5 m -152.08 116.65 5.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.213 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.407 ' O ' ' N ' ' A' ' 208' ' ' GLY . 1.7 t-80 179.25 177.98 0.51 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.036 0.446 . . . . 0.0 111.504 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 12.8 m120 42.52 -90.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.783 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -73.08 -67.43 1.81 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.677 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 21.9 mtmt -159.17 -81.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 111.104 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -153.81 175.32 13.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.455 ' CG1' HD12 ' A' ' 213' ' ' LEU . 3.0 t -136.96 159.64 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.836 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -79.89 -61.5 1.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.315 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.838 HD23 ' HB2' ' A' ' 218' ' ' ALA . 3.0 mp 57.12 179.22 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.843 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -151.46 -179.95 7.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.94 13.61 12.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.596 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.623 ' HB2' HD12 ' A' ' 214' ' ' LEU . 12.4 t70 -84.65 -71.76 0.5 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.682 0.277 . . . . 0.0 110.767 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.701 HD13 ' CA ' ' A' ' 139' ' ' GLY . 4.4 mm? -90.2 -40.03 12.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.794 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -56.76 -20.94 24.88 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.497 ' CE1' HD12 ' A' ' 153' ' ' ILE . 13.1 t60 -80.3 7.36 9.69 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.448 HG21 ' H ' ' A' ' 140' ' ' VAL . 12.3 t -163.59 39.91 0.09 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.547 ' HB ' HD11 ' A' ' 223' ' ' ILE . 51.2 mm -89.8 154.57 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 63.5 ttt180 -89.69 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 111.901 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.809 HG23 ' HA ' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -146.8 -178.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.0 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.598 ' HA ' ' HA3' ' A' ' 149' ' ' GLY . 12.1 tm-20 -89.82 165.25 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.82 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.698 ' C ' HD23 ' A' ' 226' ' ' LEU . 33.8 tt0 -99.26 80.54 2.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.826 HD22 ' HA ' ' A' ' 155' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.712 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.773 0.321 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.99 -38.44 11.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.14 55.95 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.89 -33.14 17.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -70.24 158.75 35.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.9 mt -137.11 -52.28 0.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.71 127.05 50.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.261 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . 0.625 ' HB3' HD21 ' A' ' 214' ' ' LEU . 4.8 mmtm -173.19 -173.66 0.95 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -76.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.092 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.719 ' HG ' HD21 ' A' ' 217' ' ' LEU . 6.6 tt -165.46 -46.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -72.27 140.47 48.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.88 158.92 43.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.62 139.67 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.283 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -163.64 178.73 7.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -86.26 -40.31 15.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.71 93.47 37.45 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 112.72 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.639 2.226 . . . . 0.0 112.393 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 57.06 96.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.2 9.54 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.306 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.625 ' CB ' ' HD2' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 53.71 178.53 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.537 0.168 . . . . 0.0 110.648 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.625 ' HD2' ' CB ' ' A' ' 130' ' ' ASN . 2.6 Cg_endo -39.6 141.84 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.922 2.415 . . . . 0.0 112.898 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.782 ' N ' HD13 ' A' ' 187' ' ' ILE . 16.1 tt -37.6 96.0 0.1 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.526 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.516 ' HD2' HD23 ' A' ' 182' ' ' LEU . 4.2 Cg_endo -82.44 78.26 3.46 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.272 2.648 . . . . 0.0 111.243 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.563 ' HA3' ' HG2' ' A' ' 137' ' ' GLU . . . -70.3 111.68 3.92 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.616 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.846 ' CB ' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -90.46 -40.53 11.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 178.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -91.11 -4.62 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.272 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.563 ' HG2' ' HA3' ' A' ' 134' ' ' GLY . 0.0 OUTLIER -90.08 -35.94 15.16 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.401 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 221' ' ' ILE . 3.5 pp -39.93 -34.99 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.933 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.43 82.77 0.01 OUTLIER Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.013 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 138' ' ' LEU . 59.9 t -154.73 -55.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 110.726 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.18 104.1 0.18 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.388 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -57.16 108.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 111.054 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.435 ' N ' ' HB3' ' A' ' 151' ' ' ARG . 14.1 m -90.73 99.3 12.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -106.97 24.16 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.756 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.13 -167.07 1.16 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.43 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 67.58 164.34 0.13 Allowed Pre-proline 0 C--O 1.231 0.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.341 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 51.4 Cg_exo -53.49 145.22 47.8 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.758 2.305 . . . . 0.0 112.487 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 143' ' ' SER . . . 90.94 101.85 1.23 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.609 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 224' ' ' GLU . 10.3 t -118.46 -161.07 0.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.283 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.577 ' C ' HG23 ' A' ' 152' ' ' VAL . 22.3 ptt180 -125.93 33.11 5.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.96 HG22 HG12 ' A' ' 221' ' ' ILE . 0.4 OUTLIER 66.67 -59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 218' ' ' ALA . 1.7 pt -69.57 62.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.4 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.616 ' HB1' HG21 ' A' ' 195' ' ' ILE . . . -40.17 -36.1 0.47 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.781 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.32 76.62 1.71 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.05 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.5 m -159.51 -45.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.6 m -78.61 -78.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.7 ptm -146.59 54.74 2.22 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.416 ' HA ' HD11 ' A' ' 226' ' ' LEU . 2.0 Cg_endo -44.55 106.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.419 2.746 . . . . 0.0 112.701 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -135.47 -40.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.844 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -161.77 96.14 1.01 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.624 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 0.0 OUTLIER -70.0 176.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 6.2 mtt180 -152.02 115.43 4.77 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.711 ' CG1' HG23 ' A' ' 189' ' ' VAL . 8.3 tt -84.76 126.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.983 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.662 ' O ' HG22 ' A' ' 189' ' ' VAL . 32.1 t -133.68 -72.73 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.02 122.45 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.032 0.444 . . . . 0.0 112.171 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.539 ' HB ' HG21 ' A' ' 189' ' ' VAL . 34.1 mm -153.55 -74.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 44.97 -171.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.804 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 172' ' ' PHE . 47.1 tt0 -156.28 -71.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.8 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.3 mt 63.26 -70.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.886 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.2 m-85 -51.87 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 111.49 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.77 120.72 11.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.13 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 174' ' ' VAL . 11.9 p -175.77 39.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -134.99 -41.68 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.9 p -56.58 126.73 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.27 -33.44 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.59 -28.88 70.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.444 ' CE2' HD21 ' A' ' 135' ' ' LEU . 11.8 t80 -73.92 -19.31 60.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.262 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.0 m -50.86 -48.14 60.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -64.68 -31.53 72.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.516 HD23 ' HD2' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -68.85 -38.7 79.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.0 -12.74 37.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -23.29 8.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.379 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.912 ' HB3' HD11 ' A' ' 187' ' ' ILE . . . -53.9 -34.2 58.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.058 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.9 t70 50.32 73.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.912 HD11 ' HB3' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -117.64 -145.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.336 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.31 104.24 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.77 0.319 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.711 HG23 ' CG1' ' A' ' 165' ' ' ILE . 10.7 p -60.44 115.57 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.59 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 142.56 1.76 1.18 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.412 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.532 ' O ' HG22 ' A' ' 165' ' ' ILE . 12.0 t -103.31 -165.15 1.14 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.073 0.437 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -104.5 145.94 29.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.522 HG12 ' ND1' ' A' ' 206' ' ' HIS . 13.0 m -146.48 -163.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.228 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.562 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 9.5 pt-20 -150.38 163.24 38.85 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.643 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.616 HG21 ' HB1' ' A' ' 155' ' ' ALA . 4.2 tt -141.96 160.19 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.179 0.514 . . . . 0.0 111.408 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.499 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 18.3 m -146.64 113.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.01 175.42 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -153.94 172.69 17.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.03 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.49 51.97 50.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -165.78 136.35 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.749 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.91 131.55 57.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.841 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.749 ' N ' HD13 ' A' ' 202' ' ' ILE . 1.6 t -160.02 135.31 8.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.031 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.476 HD23 ' HB ' ' A' ' 195' ' ' ILE . 54.9 mt -79.81 -176.18 5.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.561 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.428 ' OG ' HG22 ' A' ' 196' ' ' VAL . 3.4 m -154.49 109.44 3.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.522 ' ND1' HG12 ' A' ' 193' ' ' VAL . 0.6 OUTLIER 179.8 -178.52 0.41 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.533 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.408 ' HB2' ' HD3' ' A' ' 131' ' ' PRO . 1.6 m-80 42.92 -88.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.48 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -78.48 -68.11 1.54 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.6 mtmt -160.32 -69.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.672 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.14 161.47 41.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.671 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.608 HG22 ' OD1' ' A' ' 130' ' ' ASN . 42.6 t -105.66 157.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.889 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.453 ' N ' HG12 ' A' ' 211' ' ' VAL . 28.1 mt-10 -79.61 -63.49 1.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.707 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.755 ' HB3' ' HB2' ' A' ' 218' ' ' ALA . 41.9 mt 56.26 174.61 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.452 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -171.0 174.16 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.685 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.92 -30.11 9.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.299 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.6 -65.02 1.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.846 HD22 ' CB ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -55.8 -44.9 78.23 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.792 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 213' ' ' LEU . . . -90.62 39.31 0.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.495 ' CD2' HG22 ' A' ' 220' ' ' THR . 2.7 t-160 -90.26 -54.0 4.21 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.643 0.258 . . . . 0.0 111.032 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -147.99 80.56 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.96 HG12 HG22 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -124.16 146.77 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -89.67 102.45 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.684 HG12 HD11 ' A' ' 221' ' ' ILE . 0.3 OUTLIER -151.34 31.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.817 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.666 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.1 tt0 -152.88 157.75 41.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.742 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -116.56 -19.73 9.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 160' ' ' PRO . 5.6 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.93 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.778 0.323 . . . . 0.0 110.863 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.917 ' HB ' HG22 ' A' ' 202' ' ' ILE . 89.1 t -64.04 -28.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.398 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -84.78 62.2 7.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.688 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -57.23 85.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 113' ' ' GLU . 66.4 mtp180 -41.33 -40.91 1.81 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.313 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.43 77.91 9.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.664 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.1 m -62.72 163.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.358 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -154.12 -49.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.704 HG22 ' H ' ' A' ' 120' ' ' LEU . 1.1 p -148.94 -166.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.704 ' H ' HG22 ' A' ' 119' ' ' VAL . 4.5 mm? -107.54 115.63 30.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -153.11 133.04 13.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.05 163.78 13.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -101.25 142.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.1 m 60.38 -89.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 176.26 159.44 0.3 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.6 m 60.08 73.24 0.66 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.46 -30.11 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.672 2.248 . . . . 0.0 112.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.71 150.83 45.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 143.42 136.92 3.21 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.498 ' OD1' HG13 ' A' ' 211' ' ' VAL . 2.6 p-10 51.5 158.46 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.62 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.3 Cg_endo -76.41 135.45 16.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.703 2.269 . . . . 0.0 113.019 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.867 HD11 HG21 ' A' ' 221' ' ' ILE . 0.0 OUTLIER 135.77 -32.12 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 124.058 0.849 . . . . 0.0 112.089 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 1.5 Cg_endo -79.92 72.04 6.73 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.427 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.11 118.12 4.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.244 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 138' ' ' LEU . 1.9 tt -73.19 -45.49 56.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.233 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.28 9.25 29.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.514 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.83 ' O ' HG22 ' A' ' 168' ' ' ILE . 0.5 OUTLIER -90.21 -50.77 5.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.638 0.256 . . . . 0.0 111.225 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.816 HD13 ' N ' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -53.97 -14.92 1.15 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.816 ' N ' HD13 ' A' ' 138' ' ' LEU . . . -45.42 -91.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.255 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 168' ' ' ILE . 14.6 t -89.72 153.23 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.53 ' C ' HD12 ' A' ' 168' ' ' ILE . . . 92.01 155.64 32.02 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.428 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.455 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 2.0 p30 -152.47 131.89 12.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.822 0.344 . . . . 0.0 111.405 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -97.85 170.6 8.85 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -158.68 -60.63 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -162.9 -163.06 0.82 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 94.07 108.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 63.87 162.49 0.12 Allowed Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.378 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.613 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 79.3 Cg_exo -39.69 146.71 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.858 2.372 . . . . 0.0 112.048 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.718 ' HA2' ' HB ' ' A' ' 163' ' ' VAL . . . 151.55 -152.35 24.13 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.892 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -152.13 144.59 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.502 ' C ' HG23 ' A' ' 152' ' ' VAL . 53.8 ttt180 -67.12 2.76 1.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.943 HG22 ' CD1' ' A' ' 223' ' ' ILE . 2.4 t 74.03 -62.51 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.918 0.39 . . . . 0.0 110.484 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.9 pt -97.51 44.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.505 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 157' ' ' THR . 5.0 t70 -162.79 -32.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.686 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.829 ' HB1' HD13 ' A' ' 195' ' ' ILE . . . -27.86 -42.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 202' ' ' ILE . . . -76.99 62.0 2.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 0.0 111.319 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 154' ' ' ASP . 3.0 t -173.32 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.409 ' C ' ' HD3' ' A' ' 160' ' ' PRO . 3.1 t -77.5 -158.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 34.1 mtt -124.47 60.3 23.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.021 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 158' ' ' SER . 81.9 Cg_exo -44.85 162.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.928 2.419 . . . . 0.0 113.181 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.2 mtp85 -152.14 -45.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.348 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -161.26 78.66 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.227 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.745 ' HB ' HG22 ' A' ' 223' ' ' ILE . 32.9 m -69.94 143.45 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.849 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.464 ' HG3' ' HB2' ' A' ' 148' ' ' PRO . 8.0 mtp85 -79.05 98.76 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.365 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.785 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -76.41 79.98 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.401 0.62 . . . . 0.0 111.833 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.632 HG13 ' HA2' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -160.88 97.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.696 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.56 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.9 OUTLIER 170.47 133.77 0.02 OUTLIER 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.585 0.707 . . . . 0.0 112.183 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 137' ' ' GLU . 3.0 mm 75.86 -2.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.413 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.595 ' HB2' HG21 ' A' ' 189' ' ' VAL . 22.8 t30 -55.75 159.42 3.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.939 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -151.4 170.12 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.71 -47.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.055 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.44 -40.34 90.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -71.48 132.91 45.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 174' ' ' VAL . 7.5 p -162.59 93.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 176' ' ' THR . 3.6 tt0 -138.64 178.42 7.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 175' ' ' GLU . 8.4 t 47.83 114.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.885 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.3 -2.97 15.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.775 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.53 -34.41 70.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.615 0.245 . . . . 0.0 111.431 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.462 ' HB3' HD13 ' A' ' 135' ' ' LEU . 2.4 p90 -75.44 -10.14 59.19 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.696 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.1 m -48.71 -40.92 30.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -70.69 -35.85 72.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 133' ' ' PRO . 8.5 mp -73.85 -22.88 59.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.024 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -69.63 -20.88 63.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.068 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -38.56 61.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -69.44 -27.6 65.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 187' ' ' ILE . 13.8 m-20 84.06 -36.52 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.558 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.703 HD13 ' NH1' ' A' ' 222' ' ' ARG . 0.6 OUTLIER 62.18 130.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.384 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -126.82 88.79 2.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.862 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.601 ' O ' HG13 ' A' ' 189' ' ' VAL . 7.6 p -70.99 96.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.543 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.734 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 146.38 -1.21 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.375 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.739 ' O ' HG22 ' A' ' 165' ' ' ILE . 4.5 t -97.03 -162.9 0.99 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.053 0.427 . . . . 0.0 110.891 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.4 124.52 43.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.51 HG12 ' CG ' ' A' ' 206' ' ' HIS . 32.5 m -127.98 175.33 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.258 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.98 169.49 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.829 HD13 ' HB1' ' A' ' 155' ' ' ALA . 0.9 OUTLIER -155.85 154.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.023 0.439 . . . . 0.0 111.135 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.431 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 17.6 m -141.5 155.2 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.952 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.94 155.38 40.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 43.1 ttm-85 -146.29 71.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.987 0.423 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.43 60.28 3.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.12 96.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.563 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . 0.482 ' HA ' HG23 ' A' ' 112' ' ' VAL . 89.8 m-70 -152.55 131.71 12.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 110.725 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.917 HG22 ' HB ' ' A' ' 112' ' ' VAL . 13.8 tt -79.99 139.53 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 111.388 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 202' ' ' ILE . 16.7 p -158.41 119.86 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.457 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.697 HD22 HD12 ' A' ' 195' ' ' ILE . 1.0 OUTLIER -79.57 153.19 29.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.743 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 39.0 m -126.78 125.71 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.51 ' CG ' HG12 ' A' ' 193' ' ' VAL . 0.8 OUTLIER -178.61 176.08 1.03 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.989 0.423 . . . . 0.0 111.378 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 46.89 -87.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.782 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -83.65 -62.6 1.76 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.841 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.72 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.593 0.235 . . . . 0.0 111.231 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -138.14 178.87 6.8 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.498 HG13 ' OD1' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -133.16 179.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.63 -48.81 3.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.4 mt 56.99 176.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.35 177.7 8.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.57 -29.92 69.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.316 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.07 -54.77 6.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.155 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.95 -30.78 68.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.289 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.438 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -90.12 15.88 9.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.743 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.734 ' HD2' HG23 ' A' ' 220' ' ' THR . 4.0 t-160 -84.78 -58.83 2.55 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.809 0.337 . . . . 0.0 110.771 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.734 HG23 ' HD2' ' A' ' 219' ' ' HIS . 3.0 p -147.0 88.05 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.444 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.867 HG21 HD11 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -111.58 -172.1 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.564 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.785 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.7 mtm180 -84.28 76.22 10.13 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.943 ' CD1' HG22 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -153.51 134.0 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 148' ' ' PRO . 9.8 mt-10 -89.68 -108.8 0.08 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 145' ' ' ALA . 2.8 tt0 -150.99 112.44 4.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.206 0.457 . . . . 0.0 111.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 149' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.077 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.777 0.322 . . . . 0.0 110.91 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.655 HG13 ' H ' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -54.76 -75.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.655 ' H ' HG13 ' A' ' 112' ' ' VAL . 5.6 pt-20 -87.48 62.52 7.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 110.722 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 77.52 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -51.72 -34.7 40.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.53 92.77 2.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -164.21 148.87 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -146.93 -68.22 0.26 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 m -76.0 165.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.305 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.6 148.22 26.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.798 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -152.1 -51.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.05 -175.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 123' ' ' VAL . 3.3 p 41.12 90.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.663 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 p -140.04 -56.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -107.86 -35.99 6.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.9 m -63.97 164.43 17.49 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.7 -161.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.78 2.32 . . . . 0.0 112.367 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.662 ' O ' HG13 ' A' ' 211' ' ' VAL . 6.7 p90 -111.84 -54.97 2.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.959 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.2 -102.18 1.0 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.078 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.584 ' H ' HG22 ' A' ' 211' ' ' VAL . 3.7 p30 -143.92 163.37 36.0 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.673 0.273 . . . . 0.0 110.976 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.618 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.46 138.42 80.37 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.951 2.434 . . . . 0.0 112.96 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.657 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 138.81 -29.57 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 O-C-N 124.033 0.833 . . . . 0.0 112.314 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.786 ' HB2' HD23 ' A' ' 182' ' ' LEU . 12.3 Cg_exo -68.09 62.46 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.481 2.121 . . . . 0.0 112.842 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.54 129.42 25.18 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.283 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.693 HD22 ' CD2' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -90.03 -44.25 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -90.15 9.0 30.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.437 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.541 ' O ' HD13 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -90.06 -44.65 9.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.754 0.312 . . . . 0.0 110.994 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 216' ' ' ASP . 3.3 pp -41.17 -36.81 0.79 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.833 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.78 65.73 3.87 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.766 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 90.6 t -152.79 -66.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.686 0.279 . . . . 0.0 111.019 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.4 -175.11 13.94 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.445 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 220' ' ' THR . 2.3 p-10 -162.68 160.72 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 m -163.17 133.38 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.7 -45.47 8.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.01 114.64 2.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.322 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -174.03 -168.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.025 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -56.83 -178.78 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.895 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 95.3 Cg_exo -44.68 89.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.674 2.249 . . . . 0.0 112.648 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 154.78 55.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.525 HG21 ' HA ' ' A' ' 225' ' ' GLU . 7.3 t -101.48 -163.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.513 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.781 ' HD2' HD11 ' A' ' 153' ' ' ILE . 34.0 ptt180 -107.4 107.61 18.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.471 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.777 HG13 ' HB1' ' A' ' 218' ' ' ALA . 7.1 p -41.6 -30.55 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.03 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.781 HD11 ' HD2' ' A' ' 151' ' ' ARG . 23.3 pt -53.45 -42.09 47.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.909 0.385 . . . . 0.0 111.128 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.409 ' N ' HG13 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -84.16 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.878 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 195' ' ' ILE . . . -62.72 80.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.155 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 195' ' ' ILE . . . -172.21 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.064 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.4 t -93.85 -3.62 51.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.47 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 226' ' ' LEU . 38.9 m -94.05 37.6 1.09 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.756 0.312 . . . . 0.0 111.327 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 11.2 ttt 57.67 61.45 5.95 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.854 0.359 . . . . 0.0 111.235 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.524 ' HB3' HD22 ' A' ' 226' ' ' LEU . 29.5 Cg_endo -62.73 170.69 6.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.814 2.342 . . . . 0.0 112.414 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.5 mtt85 -152.15 -47.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -170.02 89.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 195' ' ' ILE . 26.8 m -80.59 -172.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 12.2 mtp85 -124.39 -170.95 2.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.076 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -147.69 79.89 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 110.426 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 165' ' ' ILE . 1.3 m -160.48 98.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.085 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.637 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 170.34 110.84 0.01 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.22 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 221' ' ' ILE . 12.7 mt 109.53 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.363 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 168' ' ' ILE . 22.4 t-20 49.9 164.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.88 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 171.32 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.571 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.728 HD11 HG12 ' A' ' 189' ' ' VAL . 66.4 mt 63.5 -64.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.0 m-85 -47.31 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.474 ' O ' HG23 ' A' ' 174' ' ' VAL . 11.7 mm100 -64.98 116.51 6.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.608 HG11 ' CD2' ' A' ' 183' ' ' LEU . 77.1 t -161.17 80.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 176' ' ' THR . 14.0 mt-10 -106.18 98.73 8.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.123 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.656 HG21 HD13 ' A' ' 135' ' ' LEU . 1.0 OUTLIER -166.03 113.27 0.9 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.83 -26.66 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.146 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -72.3 -30.71 65.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.026 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.693 ' CD2' HD22 ' A' ' 135' ' ' LEU . 33.1 m-85 -90.16 20.64 4.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.486 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.9 m -57.36 -33.37 67.71 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.79 0.329 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -72.25 -42.53 65.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.586 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 133' ' ' PRO . 9.5 mp -71.14 -14.83 62.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.942 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.608 ' CD2' HG11 ' A' ' 174' ' ' VAL . 0.3 OUTLIER -74.8 -27.99 60.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.032 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.1 -43.07 51.41 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.503 ' HB1' ' HD3' ' A' ' 131' ' ' PRO . . . -66.6 -31.12 71.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 187' ' ' ILE . 30.5 m-20 67.43 13.67 9.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.545 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.727 HD12 HH22 ' A' ' 222' ' ' ARG . 6.1 pt 33.95 100.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -102.52 90.69 3.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.668 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.728 HG12 HD11 ' A' ' 171' ' ' ILE . 10.6 p -59.83 115.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.641 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 136.59 -8.4 3.97 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.823 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.657 ' O ' HG22 ' A' ' 165' ' ' ILE . 19.7 t -83.66 -169.33 2.51 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.788 0.328 . . . . 0.0 111.061 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -135.54 122.27 20.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.804 HG12 ' CG ' ' A' ' 206' ' ' HIS . 33.5 m -120.56 -179.11 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . 0.449 ' HA ' HG22 ' A' ' 163' ' ' VAL . 10.3 pt-20 -144.45 164.65 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 156' ' ' ALA . 1.1 mp -128.97 153.27 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.182 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 196' ' ' VAL . 8.8 m -154.26 110.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.96 157.79 37.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.98 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -159.21 118.5 2.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 6.5 t70 69.73 -66.86 0.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -179.64 49.86 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -156.45 149.73 24.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.754 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -102.19 133.59 45.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.754 ' N ' HD13 ' A' ' 202' ' ' ILE . 30.4 p -142.83 129.37 20.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 211' ' ' VAL . 4.2 mm? -79.98 105.01 10.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 209' ' ' LYS . 2.4 m -86.09 120.23 27.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.804 ' CG ' HG12 ' A' ' 193' ' ' VAL . 21.9 t-80 -176.01 166.49 2.98 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 111.644 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.0 m120 40.69 -90.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.852 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -67.9 -71.3 0.97 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.606 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 205' ' ' SER . 2.4 ptpt -161.76 -63.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -152.93 174.28 14.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.543 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.738 HG11 ' HG3' ' A' ' 133' ' ' PRO . 12.3 t -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.928 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -112.04 55.73 0.67 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 111.226 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 218' ' ' ALA . 4.2 pp -83.25 173.05 11.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.609 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.473 HD12 ' CB ' ' A' ' 216' ' ' ASP . 0.3 OUTLIER -97.04 164.79 12.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.954 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.17 -37.95 75.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.515 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.511 ' O ' HD22 ' A' ' 138' ' ' LEU . 0.8 OUTLIER -62.01 -45.1 95.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.544 HD21 ' CE1' ' A' ' 179' ' ' PHE . 3.0 mp -60.34 -37.78 81.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 153' ' ' ILE . . . -90.72 14.12 14.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.755 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -67.85 70.57 0.14 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.964 0.411 . . . . 0.0 111.047 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.769 HG22 ' CB ' ' A' ' 151' ' ' ARG . 6.5 p 59.13 85.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.289 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.639 ' HA ' HD12 ' A' ' 168' ' ' ILE . 0.8 OUTLIER -118.94 -147.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.727 HH22 HD12 ' A' ' 187' ' ' ILE . 6.3 ptt180 -84.95 88.41 7.44 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 222' ' ' ARG . 3.3 mp -151.42 151.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.256 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 2.3 tm-20 -89.85 159.03 17.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.633 0.254 . . . . 0.0 110.363 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.525 ' HA ' HG21 ' A' ' 150' ' ' THR . 0.5 OUTLIER -89.25 104.55 17.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.955 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 160' ' ' PRO . 3.1 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.312 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.573 0.225 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 113' ' ' GLU . 14.7 p -90.35 -45.52 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.699 0.285 . . . . 0.0 111.409 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.47 ' N ' HG13 ' A' ' 112' ' ' VAL . 33.1 mt-10 -84.18 100.26 11.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -80.95 76.81 7.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -88.54 66.16 8.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -143.62 -51.59 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.3 m -69.81 148.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -112.99 -40.03 4.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.49 163.23 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.26 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.8 tt -94.53 118.4 31.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -147.08 173.91 12.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -152.57 152.33 31.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 123' ' ' VAL . 7.3 p -151.98 101.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -167.01 -179.03 4.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -71.81 -37.9 70.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.3 p -164.33 79.45 1.43 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.22 -162.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.748 2.299 . . . . 0.0 112.18 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.0 p90 42.0 91.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.76 161.21 34.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.76 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER 61.91 144.61 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 120.611 0.243 . . . . 0.0 110.953 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.509 ' CB ' ' HA ' ' A' ' 187' ' ' ILE . 1.9 Cg_endo -86.33 105.01 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.116 2.544 . . . . 0.0 112.658 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.723 HG21 HG21 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -164.83 -57.77 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.508 ' HB3' HD21 ' A' ' 213' ' ' LEU . 5.1 Cg_endo -85.08 121.82 2.44 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.727 2.284 . . . . 0.0 113.98 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.499 ' HA2' HD12 ' A' ' 187' ' ' ILE . . . -91.86 170.99 33.95 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.193 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.826 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -69.66 128.62 37.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -26.78 66.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.552 1.158 . . . . 0.0 113.03 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 135' ' ' LEU . 26.5 tt0 -90.63 -55.35 3.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 145' ' ' ALA . 3.9 mm? -90.6 -16.91 27.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.59 -1.187 . . . . 0.0 109.744 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 116.08 8.67 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.792 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.546 ' H ' HG22 ' A' ' 220' ' ' THR . 8.1 p -150.44 -41.73 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.605 0.24 . . . . 0.0 111.249 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.19 86.74 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.655 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.34 -178.23 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.704 0.287 . . . . 0.0 110.787 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.9 p -76.6 -43.78 37.17 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.577 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.94 -178.01 1.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.441 ' HB2' HD12 ' A' ' 138' ' ' LEU . . . -110.07 -86.6 0.53 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.617 ' HB3' ' NE ' ' A' ' 222' ' ' ARG . . . -91.98 138.81 31.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.63 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 57.54 -179.6 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.325 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 53.8 Cg_exo -52.33 -176.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.244 1.963 . . . . 0.0 112.001 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.442 ' HA2' ' C ' ' A' ' 223' ' ' ILE . . . 162.77 140.32 2.84 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.382 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.803 HG21 HD22 ' A' ' 226' ' ' LEU . 6.2 t -176.66 -33.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.848 ' CB ' HG21 ' A' ' 223' ' ' ILE . 4.7 tmm_? -20.08 -55.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -94.22 -44.78 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.658 0.266 . . . . 0.0 111.658 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.793 HD13 ' O ' ' A' ' 219' ' ' HIS . 0.2 OUTLIER -109.41 109.45 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.318 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' ILE . 58.3 m-20 98.58 -38.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.067 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.629 ' HB2' ' C ' ' A' ' 150' ' ' THR . . . -36.74 -46.88 0.63 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 195' ' ' ILE . . . -78.11 65.56 3.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.15 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 m -162.9 -45.99 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.503 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -95.5 43.07 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.9 mtt 53.02 74.31 0.79 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.288 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.593 ' HA ' HD12 ' A' ' 226' ' ' LEU . 18.8 Cg_endo -58.73 139.88 92.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.874 2.383 . . . . 0.0 112.663 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.26 -43.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -162.19 120.79 2.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.52 HG21 ' CG ' ' A' ' 151' ' ' ARG . 1.0 OUTLIER -122.69 128.68 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.452 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 12.3 mtt180 -80.02 123.21 27.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.489 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -90.34 124.27 42.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.327 . . . . 0.0 110.262 178.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.728 ' N ' HD13 ' A' ' 165' ' ' ILE . 21.4 t -144.61 87.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.966 0.412 . . . . 0.0 111.621 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.621 ' HA ' HG11 ' A' ' 189' ' ' VAL . 4.6 tt0 91.91 105.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.335 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.794 HG22 HG21 ' A' ' 221' ' ' ILE . 2.4 pp -142.1 -45.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.656 ' OD1' HD11 ' A' ' 187' ' ' ILE . 52.3 t30 -74.27 159.74 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 5.0 tt0 -104.48 -42.38 5.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.679 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 94.0 mt 69.12 -64.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.596 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -54.46 -34.79 62.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.248 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -99.16 127.4 45.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 174' ' ' VAL . 7.9 p -168.12 96.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -138.01 -43.52 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.504 ' HG1' ' HD2' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -57.67 122.34 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.67 -25.66 59.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.15 -26.98 68.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.504 ' HD2' ' HG1' ' A' ' 176' ' ' THR . 19.1 m-85 -82.6 -6.2 59.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.424 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.3 m -56.34 -41.25 75.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.76 0.314 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.2 -35.82 81.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.49 -26.73 46.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.445 ' O ' HD23 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -69.55 -23.72 63.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.1 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -32.98 61.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -68.01 -31.76 71.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' ILE . 13.9 m-20 83.83 -29.14 0.09 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.631 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.656 HD11 ' OD1' ' A' ' 169' ' ' ASN . 7.4 pt 39.89 103.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.315 0.579 . . . . 0.0 111.946 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -114.6 108.96 17.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.779 ' HA ' HD12 ' A' ' 165' ' ' ILE . 35.2 m -52.69 157.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.251 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.706 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 101.99 -15.96 56.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.302 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.735 ' O ' HG22 ' A' ' 165' ' ' ILE . 7.7 t -74.55 -166.99 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.01 0.433 . . . . 0.0 111.301 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.29 136.86 20.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.786 HG12 ' CG ' ' A' ' 206' ' ' HIS . 29.8 m -141.61 175.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.967 0.413 . . . . 0.0 111.801 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -125.7 162.85 24.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.798 HD12 ' N ' ' A' ' 196' ' ' VAL . 0.1 OUTLIER -136.84 140.97 41.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.389 . . . . 0.0 110.856 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.798 ' N ' HD12 ' A' ' 195' ' ' ILE . 11.0 m -154.25 118.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.023 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -70.0 159.25 34.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -168.91 143.18 3.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.0 t70 68.08 -70.53 0.12 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 175.19 43.03 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.05 165.71 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.441 ' HB ' HG22 ' A' ' 112' ' ' VAL . 19.9 tt -87.24 150.3 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.136 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.0 t -160.05 116.96 2.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.0 106.22 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.676 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.0 m -85.73 129.41 34.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.786 ' CG ' HG12 ' A' ' 193' ' ' VAL . 10.9 t60 -143.94 145.55 32.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -33.39 -40.02 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -62.65 -70.58 1.01 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.26 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.8 mtmt -158.87 -174.66 4.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.44 133.51 53.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.175 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.75 159.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.481 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -83.18 -58.3 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.512 HD13 HG12 ' A' ' 152' ' ' VAL . 1.7 mt 64.2 151.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.205 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 0.4 OUTLIER -140.42 -175.59 4.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.716 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -28.95 67.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.394 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -67.61 0.24 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.597 ' O ' HD11 ' A' ' 221' ' ' ILE . 6.4 mp -78.82 -34.29 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.063 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -90.73 33.94 0.91 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.602 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.793 ' O ' HD13 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -81.71 -56.43 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.723 ' HA ' HG21 ' A' ' 153' ' ' ILE . 13.5 t -174.67 72.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.021 0.439 . . . . 0.0 111.162 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.794 HG21 HG22 ' A' ' 168' ' ' ILE . 4.9 mm -89.55 171.72 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.617 ' NE ' ' HB3' ' A' ' 146' ' ' ALA . 53.6 ttt180 -89.71 99.64 12.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 111.612 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.848 HG21 ' CB ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -129.79 -149.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.587 ' O ' HG22 ' A' ' 150' ' ' THR . 0.0 OUTLIER -118.85 -179.52 3.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 110.803 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 226' ' ' LEU . 30.3 tt0 -111.78 96.21 5.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.803 HD22 HG21 ' A' ' 150' ' ' THR . 1.7 pt? . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.77 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.761 0.315 . . . . 0.0 110.826 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 156' ' ' ALA . 35.2 m -76.16 -41.75 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.419 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.4 OUTLIER -90.27 18.37 6.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -90.05 -51.94 5.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.44 147.96 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.5 mt -147.87 113.24 5.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -112.77 -37.48 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.307 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -109.3 172.37 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 m -89.63 -37.68 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.24 -58.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -78.1 157.8 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.975 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.66 -46.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.1 t 61.42 105.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.0 m -138.81 90.11 2.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.48 80.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m 59.27 86.12 0.17 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.495 ' O ' HG12 ' A' ' 211' ' ' VAL . 60.0 Cg_endo -72.37 -25.57 18.21 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.594 2.196 . . . . 0.0 112.338 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.423 ' CG ' ' HB3' ' A' ' 181' ' ' GLN . 3.9 p90 -114.02 144.0 43.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.732 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.17 -98.83 0.16 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.811 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -56.31 153.75 18.43 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.758 0.313 . . . . 0.0 111.234 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.599 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 89.1 Cg_endo -81.83 137.57 10.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.892 2.395 . . . . 0.0 112.87 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.741 ' H ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER 143.1 -30.99 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 O-C-N 123.922 0.763 . . . . 0.0 111.859 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 2.7 Cg_exo -73.53 63.34 4.59 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.362 2.042 . . . . 0.0 112.326 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.55 81.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.493 HD23 ' CZ ' ' A' ' 179' ' ' PHE . 14.4 tp -70.86 -39.39 72.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.348 . . . . 0.0 110.803 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.11 8.63 31.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.409 ' HG2' ' HB ' ' A' ' 168' ' ' ILE . 2.5 mp0 -88.94 -170.99 3.12 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.792 ' O ' HG23 ' A' ' 220' ' ' THR . 1.0 OUTLIER -62.09 84.6 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.845 0.355 . . . . 0.0 111.126 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.49 32.26 5.09 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.913 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.696 ' C ' HG21 ' A' ' 220' ' ' THR . 18.1 t -128.82 116.5 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.689 0.281 . . . . 0.0 111.179 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.69 -172.33 16.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -175.4 166.43 3.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.728 0.299 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -137.35 -174.34 3.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.059 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.13 -43.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.119 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -158.6 -157.93 0.66 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 85.77 -179.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.967 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -56.71 -176.66 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.967 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 68.4 Cg_exo -41.31 98.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.757 2.305 . . . . 0.0 112.928 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.74 41.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.079 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 152' ' ' VAL . 13.6 t -80.6 -7.19 59.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 4.4 mpt_? 60.56 25.96 15.63 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.012 HG11 ' HB1' ' A' ' 218' ' ' ALA . 21.4 t 70.68 -58.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.535 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 153' ' ' ILE . 5.4 tt -55.41 79.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.999 0.428 . . . . 0.0 111.39 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 167.7 -35.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.382 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 226' ' ' LEU . . . -52.27 -25.28 9.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.598 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 112' ' ' VAL . . . -98.73 32.9 2.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.372 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.0 t -170.96 32.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.352 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.448 ' HB3' HD12 ' A' ' 226' ' ' LEU . 7.4 t -153.06 34.46 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.195 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . 0.402 ' C ' HD13 ' A' ' 226' ' ' LEU . 41.2 ttm 66.44 75.29 0.33 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.008 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.651 ' HA ' HD22 ' A' ' 226' ' ' LEU . 29.0 Cg_endo -62.83 152.85 76.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.843 2.362 . . . . 0.0 112.799 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 -45.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -170.2 124.97 0.75 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 193' ' ' VAL . 6.4 m -110.28 123.0 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 111.488 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -84.22 102.09 12.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.681 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -79.47 122.25 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.649 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.606 ' N ' HD13 ' A' ' 165' ' ' ILE . 20.4 t -144.39 85.86 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.596 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 33.4 tt0 103.54 147.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.074 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.881 HG22 HG23 ' A' ' 221' ' ' ILE . 0.4 OUTLIER -149.59 -66.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.08 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -177.96 -168.52 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.543 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.03 -77.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.87 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.105 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -163.7 -55.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.862 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -163.85 -65.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.541 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 0.4 OUTLIER 72.0 107.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.292 0.568 . . . . 0.0 110.784 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 55.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.954 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 t -161.75 130.12 4.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -22.43 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -60.96 -31.49 71.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.493 ' CZ ' HD23 ' A' ' 135' ' ' LEU . 5.4 m-85 -76.09 -17.17 59.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.322 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 84.8 m -51.85 -43.84 63.39 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . 0.423 ' HB3' ' CG ' ' A' ' 128' ' ' PHE . 55.4 mt-30 -70.83 -33.02 70.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.58 -25.05 59.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.3 tp -84.48 -2.71 57.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.573 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.25 -50.25 30.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.057 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -82.9 -23.37 33.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.129 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 187' ' ' ILE . 9.3 m-20 65.89 16.2 10.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.741 HG22 ' H ' ' A' ' 132' ' ' ILE . 24.0 pt 38.15 99.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.1 0.476 . . . . 0.0 111.988 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 134.49 42.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.93 141.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.543 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 104.54 -8.65 47.83 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 165' ' ' ILE . 16.4 t -70.23 174.92 5.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -132.33 111.88 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.676 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.744 HG12 ' CD2' ' A' ' 206' ' ' HIS . 27.2 m -121.59 176.94 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.362 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -142.13 160.76 39.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.448 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 1.8 tt -134.62 155.7 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 111.152 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.448 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 7.1 m -156.92 132.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.27 145.55 35.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -157.35 116.6 3.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.143 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 51.99 40.76 28.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.88 62.15 6.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.459 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -159.48 158.47 32.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.77 0.319 . . . . 0.0 110.82 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.42 141.79 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 203' ' ' THR . 6.3 t -159.9 111.42 2.0 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.875 HD23 HD22 ' A' ' 213' ' ' LEU . 3.6 mm? -81.19 98.4 8.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.7 m -77.07 110.15 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.744 ' CD2' HG12 ' A' ' 193' ' ' VAL . 24.6 t-80 -107.62 147.21 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.511 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -41.33 -34.4 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.296 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -77.25 -57.49 3.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.496 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -160.68 -175.19 4.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.687 0.279 . . . . 0.0 110.875 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.6 149.0 31.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -116.71 175.64 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.44 ' OE1' HD23 ' A' ' 214' ' ' LEU . 1.4 tm-20 -90.7 -66.56 0.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.875 HD22 HD23 ' A' ' 204' ' ' LEU . 7.8 mp 60.55 155.63 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 111.36 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 213' ' ' LEU . 0.5 OUTLIER -144.69 -175.45 4.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.65 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.68 -29.13 70.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.998 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -45.58 11.84 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.808 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.447 HD22 ' HG ' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -55.61 -69.74 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 1.012 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.52 49.78 1.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -84.65 -38.78 19.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.792 HG23 ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -156.55 90.37 1.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.891 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.881 HG23 HG22 ' A' ' 168' ' ' ILE . 23.8 mm -118.96 162.15 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.011 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -89.66 90.35 8.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 111.268 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.681 HG23 ' HA ' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -137.62 175.16 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.124 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -89.64 162.78 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 110.824 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -89.66 56.04 3.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 155' ' ' ALA . 6.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 . . . . . 0 C--O 1.232 0.157 0 CA-C-O 120.746 0.307 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 156' ' ' ALA . 14.6 p -88.81 -46.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.476 ' N ' HG13 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -90.34 48.86 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.13 -41.24 11.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.054 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -85.54 144.0 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mp -145.08 112.71 6.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.842 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -150.38 168.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.15 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -133.48 100.29 4.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.7 t -144.34 -44.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tt 65.39 46.41 2.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -100.08 -46.46 5.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.27 147.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 123' ' ' VAL . 11.1 p -168.26 125.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.4 t -169.71 157.68 7.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -86.09 83.71 7.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.65 7.97 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.82 -19.26 8.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.705 2.27 . . . . 0.0 112.644 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 62.51 110.62 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -166.37 -150.78 6.49 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.701 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 8.1 p30 53.95 159.18 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.301 0 CA-C-O 120.966 0.412 . . . . 0.0 111.843 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.647 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 83.2 Cg_endo -78.84 137.12 13.83 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.824 2.349 . . . . 0.0 111.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 160.44 -31.03 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 23.8 Cg_exo -63.65 118.54 5.46 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.634 1.556 . . . . 0.0 112.986 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.23 -32.77 8.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.448 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.808 ' CB ' HD12 ' A' ' 217' ' ' LEU . 2.2 pp -36.59 -37.31 0.13 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.51 -50.76 71.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.207 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.679 ' HG2' HD11 ' A' ' 168' ' ' ILE . 2.1 pm0 -90.67 -21.3 21.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.634 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.742 HD12 HD11 ' A' ' 221' ' ' ILE . 6.5 tt -29.57 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.443 . . . . 0.0 112.018 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.35 -93.15 1.23 Allowed Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.427 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.8 t -145.46 42.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 111.181 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.36 -149.23 1.22 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.236 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 0.9 OUTLIER 179.48 177.84 0.56 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.6 p -156.86 -173.47 4.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.778 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.91 74.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.48 -69.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.37 -62.4 1.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -176.18 -63.01 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.073 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 7.1 Cg_exo -33.94 97.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.219 2.613 . . . . 0.0 113.188 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 97.82 112.41 3.07 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.797 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 149' ' ' GLY . 2.8 t 175.92 78.3 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.667 ' HB2' ' HB ' ' A' ' 221' ' ' ILE . 11.0 tpp180 -78.84 92.61 4.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.947 HG13 HD11 ' A' ' 202' ' ' ILE . 8.1 p 48.91 20.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 219' ' ' HIS . 2.9 tt -106.32 10.55 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 121.221 0.534 . . . . 0.0 110.312 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.9 -35.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.572 ' HA ' HD11 ' A' ' 226' ' ' LEU . . . -88.41 43.72 1.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.502 ' HB3' HG11 ' A' ' 112' ' ' VAL . . . -140.76 33.54 1.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.15 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.48 ' H ' HD21 ' A' ' 226' ' ' LEU . 12.6 p -158.08 -41.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.647 ' HB3' HD13 ' A' ' 226' ' ' LEU . 0.4 OUTLIER -76.2 84.85 3.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.407 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.2 mtt 57.36 61.31 6.35 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.645 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.617 ' HA ' HD23 ' A' ' 226' ' ' LEU . 30.8 Cg_endo -63.2 124.74 14.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.848 2.365 . . . . 0.0 112.407 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -157.0 -47.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -159.98 148.82 17.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.43 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 193' ' ' VAL . 15.4 m -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.444 . . . . 0.0 111.792 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 13.3 mtp85 -82.2 109.37 16.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 191' ' ' SER . 0.4 OUTLIER -84.13 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.978 0.418 . . . . 0.0 111.737 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.421 ' N ' HD13 ' A' ' 165' ' ' ILE . 3.9 t -138.45 42.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.867 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.777 ' O ' HD13 ' A' ' 168' ' ' ILE . 59.0 mt-30 39.56 -108.9 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.482 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.777 HD13 ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -172.36 -64.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.853 0.358 . . . . 0.0 110.527 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -138.15 -62.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -171.68 -75.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.011 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -176.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.1 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -163.94 -64.49 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . 0.619 ' O ' HG12 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -117.98 -83.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.776 HG22 HD11 ' A' ' 183' ' ' LEU . 0.4 OUTLIER 68.95 13.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 176' ' ' THR . 0.0 OUTLIER -106.06 94.41 5.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.797 0.332 . . . . 0.0 111.077 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -166.67 115.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.91 -41.25 95.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.1 -33.82 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -90.14 5.94 44.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.278 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.2 m -57.47 -26.79 61.77 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.45 -36.88 85.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.7 mm? -73.74 -33.27 64.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . 0.776 HD11 HG22 ' A' ' 174' ' ' VAL . 7.0 mt -78.0 -28.76 49.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.52 -34.48 61.79 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -76.4 -14.66 60.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.283 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.543 ' O ' HG12 ' A' ' 187' ' ' ILE . 11.4 m-20 81.09 -47.48 0.25 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 186' ' ' ASP . 2.3 pt 53.76 125.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 174.95 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 167' ' ' GLN . 11.0 p -101.43 147.21 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.95 65.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.536 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.532 ' N ' HG22 ' A' ' 165' ' ' ILE . 6.1 t -66.75 -169.1 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.035 0.445 . . . . 0.0 111.203 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.4 97.06 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.686 HG12 ' CD2' ' A' ' 206' ' ' HIS . 33.4 m -110.91 -178.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.84 177.98 9.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.6 ' CG2' HD13 ' A' ' 204' ' ' LEU . 1.4 pp -136.12 169.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 196' ' ' VAL . 12.5 m -150.14 98.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -71.64 98.37 1.89 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -70.01 -177.65 1.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.27 -26.44 66.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.32 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.517 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -158.96 139.8 12.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.992 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.947 HD11 HG13 ' A' ' 152' ' ' VAL . 15.0 tt -97.81 130.93 45.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.2 t -160.01 145.98 15.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.914 0.387 . . . . 0.0 111.234 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.6 HD13 ' CG2' ' A' ' 195' ' ' ILE . 3.4 mm? -95.98 169.58 9.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.656 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.9 m -148.96 136.7 20.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.686 ' CD2' HG12 ' A' ' 193' ' ' VAL . 54.3 t-80 -153.12 157.24 40.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -51.04 97.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 141.37 -64.71 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.32 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -160.04 173.2 16.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 111.061 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.52 153.28 26.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.22 161.63 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.94 -63.03 1.5 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.732 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.7 mp 53.81 93.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.369 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.66 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -69.64 -33.48 72.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.412 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.42 ' HB3' HD13 ' A' ' 217' ' ' LEU . 0.4 OUTLIER -50.75 -56.42 12.12 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.729 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.808 HD12 ' CB ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.65 -39.16 77.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.417 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.431 ' O ' ' HB ' ' A' ' 153' ' ' ILE . . . -90.5 33.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.313 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.828 ' O ' HD13 ' A' ' 153' ' ' ILE . 3.6 t-160 -90.57 -58.69 2.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.623 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 219' ' ' HIS . 71.5 p -149.25 71.23 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.481 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.742 HD11 HD12 ' A' ' 138' ' ' LEU . 30.1 mm -98.8 166.26 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.385 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.624 ' HA ' ' HA2' ' A' ' 149' ' ' GLY . 13.8 ttt180 -100.97 101.04 11.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' A' ' 221' ' ' ILE . 1.9 mp -147.23 171.87 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 1.5 tm-20 -89.12 167.82 12.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.332 . . . . 0.0 110.728 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.628 ' C ' HD12 ' A' ' 226' ' ' LEU . 33.3 tt0 -89.55 81.53 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.647 HD13 ' HB3' ' A' ' 158' ' ' SER . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.352 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.791 0.329 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.554 HG21 HG12 ' A' ' 202' ' ' ILE . 24.1 m -65.23 -49.09 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.268 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.497 ' N ' HG23 ' A' ' 112' ' ' VAL . 22.3 mt-10 -90.45 52.8 2.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -89.94 -36.94 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -84.31 140.03 31.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.2 mt -111.75 151.32 29.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -155.07 146.85 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.72 -49.35 7.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.89 172.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.52 92.2 2.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -130.26 123.76 30.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.71 163.88 23.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 m -69.84 161.53 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -83.38 73.76 10.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -154.23 -51.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 m -143.4 108.55 5.25 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.62 -29.8 62.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.552 2.168 . . . . 0.0 112.513 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . 0.611 ' HB3' HD12 ' A' ' 182' ' ' LEU . 4.2 p90 -125.96 169.22 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.584 ' HA3' HG13 ' A' ' 211' ' ' VAL . . . -92.0 -134.42 6.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.459 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.628 ' CB ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER -123.52 -60.97 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.547 0.213 . . . . 0.0 111.513 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.813 ' HA ' HG21 ' A' ' 187' ' ' ILE . 3.3 Cg_exo -84.82 56.34 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.495 2.797 . . . . 0.0 112.072 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.801 ' O ' HG23 ' A' ' 132' ' ' ILE . 0.1 OUTLIER 36.81 68.72 1.44 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.886 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.94 138.49 42.79 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.998 2.466 . . . . 0.0 112.639 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' CG2' ' A' ' 168' ' ' ILE . . . -90.83 78.53 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.051 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.552 HD23 ' CD2' ' A' ' 182' ' ' LEU . 2.9 pp -76.88 -46.16 25.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.929 0.395 . . . . 0.0 110.44 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.53 ' N ' HD12 ' A' ' 135' ' ' LEU . 12.4 m-20 -90.56 4.09 52.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.051 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.7 -167.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 171' ' ' ILE . 2.2 tt -80.44 59.73 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.785 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.32 95.91 1.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.611 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.53 -59.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.093 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.78 -178.87 40.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.594 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.14 168.82 23.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.8 m -120.48 148.73 43.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.998 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.18 -44.77 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.785 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -118.59 -164.78 1.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 69.75 132.07 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -74.59 -46.92 5.53 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 12.5 Cg_exo -35.65 -38.81 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.976 2.451 . . . . 0.0 113.367 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -153.08 132.79 3.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.821 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.696 HG21 ' HB2' ' A' ' 155' ' ' ALA . 8.8 t -104.66 -26.44 12.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 153' ' ' ILE . 3.7 tpp180 66.95 63.54 0.47 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.538 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.784 HG11 HD12 ' A' ' 221' ' ' ILE . 0.0 OUTLIER 43.62 -82.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.178 179.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.672 HD13 ' CE1' ' A' ' 219' ' ' HIS . 3.1 tt -51.29 82.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.949 0.404 . . . . 0.0 111.285 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 158.84 -40.51 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.026 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.696 ' HB2' HG21 ' A' ' 150' ' ' THR . . . -68.63 -18.49 64.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.247 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.868 ' HB2' HG21 ' A' ' 195' ' ' ILE . . . -106.21 32.22 4.59 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.468 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.0 t -154.02 19.47 0.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.463 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -134.2 -66.85 0.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.739 0.304 . . . . 0.0 110.836 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 25.2 ttm -167.48 56.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.634 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.491 ' HB3' HD13 ' A' ' 195' ' ' ILE . 10.0 Cg_endo -51.83 146.26 28.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.172 2.581 . . . . 0.0 112.818 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -161.77 -50.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.487 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -170.33 84.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 1.15 HG13 HD11 ' A' ' 195' ' ' ILE . 19.3 m -70.16 143.52 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.449 ' HB2' ' CB ' ' A' ' 224' ' ' GLU . 6.3 mtt85 -90.36 106.94 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.76 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.981 HD11 HG12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -77.4 143.24 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.455 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.839 ' N ' HD13 ' A' ' 165' ' ' ILE . 11.4 t -142.79 -40.05 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.658 ' O ' HD13 ' A' ' 168' ' ' ILE . 1.6 mt-30 -131.46 129.28 40.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.828 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.981 HG12 HD11 ' A' ' 165' ' ' ILE . 15.1 mm -146.52 -42.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.05 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -51.7 167.11 0.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -93.64 -175.27 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -131.66 -56.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.17 -66.48 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -88.91 170.36 10.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.7 p -168.77 -40.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.263 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.8 98.38 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.5 p -153.87 138.65 17.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.18 73.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -62.36 -26.19 68.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.189 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -90.07 -31.92 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -54.22 -38.21 65.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.975 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -28.12 69.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 128' ' ' PHE . 7.2 mp -76.87 -34.24 57.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.901 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.48 -32.25 73.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.0 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -25.07 20.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.06 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 130' ' ' ASN . . . -57.39 -21.01 33.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.608 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 7.3 t70 65.42 85.19 0.14 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.761 0.315 . . . . 0.0 110.759 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.813 HG21 ' HA ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 166.39 144.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.577 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . 0.508 ' N ' HD13 ' A' ' 187' ' ' ILE . 11.2 mpt_? -115.53 -87.82 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.962 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 165' ' ' ILE . 33.8 m -155.43 169.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . 0.667 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 98.75 -13.44 62.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.179 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . 0.442 ' O ' HG22 ' A' ' 165' ' ' ILE . 5.4 t -68.56 -167.44 0.09 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.278 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -141.11 92.07 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 206' ' ' HIS . 31.0 m -100.06 148.03 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.628 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -95.48 161.31 14.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.652 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 1.15 HD11 HG13 ' A' ' 163' ' ' VAL . 0.6 OUTLIER -113.9 156.35 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.138 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.42 133.07 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.35 95.21 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.025 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -74.21 178.91 4.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.44 86.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 65.96 44.7 91.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.642 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -161.78 139.33 8.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.929 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -97.27 126.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.697 ' N ' HD13 ' A' ' 202' ' ' ILE . 0.6 OUTLIER -160.07 137.72 9.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.443 HD13 HG21 ' A' ' 193' ' ' VAL . 17.8 mt -80.0 178.7 8.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -150.4 93.46 1.99 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.769 0.319 . . . . 0.0 111.259 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 193' ' ' VAL . 2.1 t60 178.66 -169.64 0.1 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 60.51 -72.2 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -118.62 -52.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.959 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -160.59 -77.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.756 0.312 . . . . 0.0 110.428 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -142.21 160.76 39.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.584 HG13 ' HA3' ' A' ' 129' ' ' GLY . 10.8 t -114.69 142.97 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 213' ' ' LEU . 7.0 mm-40 -79.73 -51.86 8.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' A' ' 203' ' ' THR . 0.5 OUTLIER 23.14 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.164 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.14 161.72 10.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 1.8 m-20 -53.87 -30.67 46.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.322 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -54.29 -53.92 47.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.972 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -40.99 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.038 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.527 ' HA ' HD11 ' A' ' 221' ' ' ILE . . . -55.41 -21.44 15.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.026 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.672 ' CE1' HD13 ' A' ' 153' ' ' ILE . 7.3 t60 -82.65 -16.65 47.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.301 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.2 t -141.7 80.82 1.74 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.784 HD12 HG11 ' A' ' 152' ' ' VAL . 36.9 mt -126.51 159.62 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -97.86 107.6 20.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 112.161 -179.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -148.04 168.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.678 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.571 ' O ' HG22 ' A' ' 150' ' ' THR . 3.4 tt0 -89.73 169.55 11.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.645 0.259 . . . . 0.0 110.452 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 22.8 tt0 -89.53 125.45 35.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 155' ' ' ALA . 3.7 pp . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.316 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.752 0.311 . . . . 0.0 110.9 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 113' ' ' GLU . 28.8 m -69.53 -42.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -78.91 70.68 5.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.887 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 52.2 2.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -70.9 132.9 45.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 tp -157.61 -51.7 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 m -90.75 157.48 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.216 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -88.13 -38.68 15.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.38 140.04 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.53 125.68 39.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -131.73 155.51 47.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -148.01 130.45 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.91 140.76 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.7 t 61.37 173.51 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -158.0 103.46 1.86 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.47 -61.92 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.46 106.83 2.35 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.474 2.116 . . . . 0.0 112.567 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -139.99 44.38 1.91 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.19 120.38 2.33 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.247 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.468 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 2.0 p-10 -175.15 163.31 2.28 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.51 ' HG2' HG11 ' A' ' 193' ' ' VAL . 5.3 Cg_endo -47.15 140.79 13.83 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.97 2.447 . . . . 0.0 112.908 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.789 HD12 ' HD2' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -6.86 84.01 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.064 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.31 142.75 74.24 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.04 2.493 . . . . 0.0 111.729 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.582 ' HA3' HG21 ' A' ' 221' ' ' ILE . . . -90.45 29.47 6.66 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.873 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.7 tt -79.03 -56.3 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.104 0.478 . . . . 0.0 110.198 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.19 12.02 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.229 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.41 ' HB2' ' HA2' ' A' ' 134' ' ' GLY . 3.9 tp10 -87.04 -149.28 0.15 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.95 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.09 84.61 6.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.574 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 217' ' ' LEU . . . -90.33 111.42 3.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.248 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 141' ' ' GLY . 8.7 p -146.76 -46.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.621 0.248 . . . . 0.0 111.477 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 140' ' ' VAL . . . 134.26 115.45 1.56 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.549 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.49 -173.06 0.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.825 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.76 122.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.07 -46.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.543 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.96 -173.99 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 62.05 -83.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.685 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -179.15 -59.55 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.49 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 5.1 Cg_exo -31.36 133.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.363 2.709 . . . . 0.0 113.546 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.82 125.94 0.04 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.688 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 225' ' ' GLU . 0.2 OUTLIER -167.97 -151.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.462 0.172 . . . . 0.0 110.876 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.94 ' HB2' HG21 ' A' ' 223' ' ' ILE . 36.4 ttp180 69.02 -70.15 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.264 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.732 HG21 ' HB1' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -95.25 -17.79 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.413 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.647 ' N ' HD13 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -133.54 107.09 10.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.642 0.258 . . . . 0.0 111.419 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . 0.603 ' O ' HG22 ' A' ' 157' ' ' THR . 15.7 t70 99.12 -37.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.82 ' HB2' ' H ' ' A' ' 151' ' ' ARG . . . -48.33 -32.18 7.07 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.03 -54.71 41.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.546 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 154' ' ' ASP . 7.9 t -63.23 -28.73 70.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.573 ' HB2' HD12 ' A' ' 226' ' ' LEU . 3.0 m -71.99 -155.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.09 71.12 1.35 Allowed Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.712 0.291 . . . . 0.0 111.147 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . 0.404 ' N ' HD13 ' A' ' 226' ' ' LEU . 78.7 Cg_exo -38.32 132.48 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.261 2.641 . . . . 0.0 113.148 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -170.0 -49.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -170.17 84.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.651 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 193' ' ' VAL . 31.3 m -69.95 -178.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.133 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.723 ' O ' HG23 ' A' ' 223' ' ' ILE . 8.9 mtp85 -124.31 -167.7 1.69 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.529 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.716 HG23 ' HG3' ' A' ' 222' ' ' ARG . 28.4 mm -142.37 124.83 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.796 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 t -152.11 68.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.668 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . 14.5 tt0 44.77 -94.13 0.02 OUTLIER 'General case' 0 C--O 1.246 0.888 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 168' ' ' ILE . 48.6 mm 77.59 -5.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 36.2 p30 -157.9 -178.81 7.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.744 0.306 . . . . 0.0 111.139 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.09 -88.71 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.164 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.14 -55.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.683 0.278 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.5 t80 63.55 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -104.63 171.74 7.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.829 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 174' ' ' VAL . 9.4 p -172.55 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.969 0.414 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.43 -173.33 4.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.645 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.4 p -128.0 -81.72 0.59 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.191 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.03 -43.78 86.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.453 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -67.86 -36.73 80.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.14 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.419 ' CD1' HD22 ' A' ' 182' ' ' LEU . 6.6 t80 -90.21 7.54 37.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.6 m -65.59 -48.4 72.44 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.43 -34.41 65.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.419 HD22 ' CD1' ' A' ' 179' ' ' PHE . 11.0 mp -62.8 -23.96 67.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.088 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.2 mt -90.06 -32.09 16.87 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -19.27 10.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.526 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.434 ' CB ' ' N ' ' A' ' 130' ' ' ASN . . . -81.6 11.9 4.29 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 62.35 100.93 0.03 OUTLIER 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.56 HG22 ' HA ' ' A' ' 132' ' ' ILE . 2.7 pt -83.51 87.14 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.401 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -125.0 107.81 11.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.691 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.58 ' N ' HD11 ' A' ' 132' ' ' ILE . 18.3 m -56.77 156.91 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.05 -6.9 66.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.087 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.5 t -66.25 -170.43 0.09 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.038 0.446 . . . . 0.0 111.525 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.34 136.21 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.716 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.793 HG12 ' CD2' ' A' ' 206' ' ' HIS . 35.5 m -138.92 -174.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.045 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.11 161.34 33.53 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.835 0.35 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 196' ' ' VAL . 0.3 OUTLIER -121.19 153.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.786 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.576 ' H ' HD12 ' A' ' 195' ' ' ILE . 13.5 p -141.89 141.4 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.36 91.6 8.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.432 ' HB2' HG22 ' A' ' 203' ' ' THR . 6.3 ttt180 -70.12 -179.71 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.78 92.92 3.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.17 35.0 91.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.673 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -163.45 143.31 8.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.763 0.315 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.651 HD13 HG12 ' A' ' 152' ' ' VAL . 20.9 tt -98.48 111.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.45 HG23 ' CG1' ' A' ' 196' ' ' VAL . 9.6 t -120.69 133.97 55.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.656 HD11 HG22 ' A' ' 152' ' ' VAL . 1.3 mm? -90.32 120.9 31.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.7 m -102.44 140.28 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . 0.793 ' CD2' HG12 ' A' ' 193' ' ' VAL . 26.3 t-80 -158.71 145.0 16.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' HIS . 21.2 m120 -28.56 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.441 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -56.99 -76.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.093 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.1 mtmt -160.2 -174.51 4.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.91 133.93 48.05 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.441 HG21 ' ND2' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -112.86 148.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 111.588 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.39 -9.23 59.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.973 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.425 ' HB2' HD23 ' A' ' 204' ' ' LEU . 5.5 mp -36.99 106.92 0.05 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.784 0.326 . . . . 0.0 111.439 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 4.1 mp -93.34 -176.52 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 0.7 OUTLIER -63.08 -14.54 49.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.291 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.39 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 111.227 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . 0.478 ' HA ' ' HA3' ' A' ' 139' ' ' GLY . 2.5 mm? -86.28 -24.06 26.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.343 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 152' ' ' VAL . . . -90.41 35.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.538 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.465 ' HA ' HG21 ' A' ' 153' ' ' ILE . 0.9 OUTLIER -85.86 -7.22 58.85 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.358 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.472 ' O ' HG23 ' A' ' 220' ' ' THR . 4.6 t -179.09 90.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.196 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.582 HG21 ' HA3' ' A' ' 134' ' ' GLY . 0.1 OUTLIER -126.42 -163.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.789 ' HD2' HD12 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -84.39 88.95 7.3 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.94 HG21 ' HB2' ' A' ' 151' ' ' ARG . 1.7 mp -151.76 144.41 16.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.48 ' CB ' ' HB2' ' A' ' 164' ' ' ARG . 15.4 tt0 -89.86 161.15 16.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.662 ' HA ' HG21 ' A' ' 150' ' ' THR . 35.7 tt0 -89.3 118.61 29.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.086 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 158' ' ' SER . 2.1 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.288 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.749 0.309 . . . . 0.0 110.895 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 156' ' ' ALA . 14.7 p -75.66 -41.98 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.416 ' N ' HG13 ' A' ' 112' ' ' VAL . 35.2 mt-10 -66.07 93.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -73.23 73.83 1.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.07 92.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.014 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mt -166.71 166.02 16.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -151.04 146.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -149.65 -48.38 0.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.9 t -146.76 -68.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.039 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 tp -172.75 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.24 176.07 5.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -139.21 -58.04 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 123' ' ' VAL . 10.6 p -164.53 123.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t -166.7 164.8 16.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -114.91 -42.02 3.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.0 p -145.08 64.6 11.19 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.47 70.2 6.37 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.719 2.28 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -164.09 38.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -131.17 -175.24 13.93 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.66 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 1.8 p-10 50.62 166.51 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 122.273 0.229 . . . . 0.0 111.148 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PRO . . . . . 0.66 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 43.5 Cg_exo -23.07 139.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.31 3.34 . . . . 0.0 113.856 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.87 ' N ' HD13 ' A' ' 187' ' ' ILE . 18.7 tt -46.45 121.99 6.58 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.17 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.561 ' HB3' HD11 ' A' ' 213' ' ' LEU . 83.6 Cg_endo -81.2 140.16 12.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.771 2.314 . . . . 0.0 111.828 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . 0.697 ' O ' HD11 ' A' ' 221' ' ' ILE . . . -90.52 68.66 2.36 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.306 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 135' ' ' LEU . 9.9 tt -70.6 -65.77 0.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.98 3.43 54.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.168 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.503 ' CD ' HD13 ' A' ' 168' ' ' ILE . 2.6 mt-10 -77.71 -47.46 19.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.52 0.2 . . . . 0.0 111.331 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.612 ' HB3' HD12 ' A' ' 221' ' ' ILE . 1.7 pp -41.91 -31.8 0.37 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.805 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -40.81 -34.56 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.153 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.68 103.36 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 111.003 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 128.15 172.92 13.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.4 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 9.6 p30 -156.9 150.35 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -138.72 98.64 3.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.02 -53.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.45 153.0 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 61.17 174.73 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.119 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ALA . . . . . 0.677 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -73.39 -57.49 2.71 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 7.6 Cg_exo -33.68 109.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.175 2.583 . . . . 0.0 113.216 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 95.52 137.6 9.22 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.598 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' THR . . . . . 0.84 HG23 ' HB ' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -179.14 -80.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.535 0.207 . . . . 0.0 111.431 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ARG . . . . . 0.689 ' O ' HG12 ' A' ' 152' ' ' VAL . 5.0 tpt180 70.08 38.98 1.42 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.958 0.409 . . . . 0.0 110.609 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 195' ' ' ILE . 0.3 OUTLIER 82.68 2.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.903 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 150' ' ' THR . 2.9 tp -92.78 25.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 120.749 0.309 . . . . 0.0 111.369 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 170.46 -36.43 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.797 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 225' ' ' GLU . . . -67.4 -21.16 65.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . 0.637 ' O ' HG23 ' A' ' 157' ' ' THR . . . -86.73 56.31 3.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -166.34 -43.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 83.91 5.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 66.8 mtt 59.49 62.59 3.79 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.285 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 124.61 11.05 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.697 2.265 . . . . 0.0 112.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -153.08 -48.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -164.61 113.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 m -89.54 132.66 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.236 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ARG . . . . . 0.453 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 13.8 mtt180 -79.88 98.24 7.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.283 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.974 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.3 OUTLIER -70.72 124.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.698 0.285 . . . . 0.0 110.888 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' VAL . . . . . 0.595 ' N ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -160.87 98.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.404 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 16.9 mt-30 93.15 137.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.872 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 169' ' ' ASN . 0.6 OUTLIER -143.74 -48.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.835 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 168' ' ' ILE . 5.8 t-20 172.69 -85.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.512 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.63 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.701 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.16 -60.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.9 t80 61.49 -81.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -116.63 134.89 54.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.972 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 174' ' ' VAL . 7.3 p -163.26 94.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.04 -42.72 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.267 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.7 t -59.79 144.02 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.35 -33.33 71.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -31.73 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.391 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PHE . . . . . 0.482 ' CD1' HD22 ' A' ' 182' ' ' LEU . 82.0 t80 -90.06 -29.24 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.068 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.3 m -54.45 -32.01 56.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -71.37 -35.59 71.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LEU . . . . . 0.521 HD23 ' HG2' ' A' ' 133' ' ' PRO . 9.1 mp -55.78 -30.33 61.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.72 -31.88 46.6 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.824 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -23.78 3.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.103 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ALA . . . . . 0.795 ' HB3' HD11 ' A' ' 187' ' ' ILE . . . -51.9 -26.1 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.186 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 187' ' ' ILE . 7.8 t70 57.84 78.47 0.24 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.267 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ILE . . . . . 0.87 HD13 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER 178.98 160.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -144.61 172.58 12.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 165' ' ' ILE . 24.6 m -54.21 174.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.839 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.69 -15.13 61.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.6 t -86.95 -164.7 1.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.394 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -132.2 86.62 2.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.397 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' VAL . . . . . 0.476 HG12 ' CG ' ' A' ' 131' ' ' PRO . 8.4 m -84.23 175.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.89 168.17 20.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ILE . . . . . 0.723 ' CG2' HD23 ' A' ' 204' ' ' LEU . 2.9 pp -139.96 167.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.333 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 m -154.94 142.19 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.005 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -70.08 85.02 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ARG . . . . . 0.543 ' HB2' HG21 ' A' ' 203' ' ' THR . 20.4 tpt180 -78.89 88.91 4.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.209 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.26 54.77 9.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.339 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.41 39.07 96.77 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.654 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.19 145.0 31.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.736 0.303 . . . . 0.0 110.739 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . 0.694 HD11 ' C ' ' A' ' 214' ' ' LEU . 30.3 pt -80.0 139.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.241 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 198' ' ' ARG . 2.6 t -160.17 129.95 5.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.822 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . 0.871 HD12 HD22 ' A' ' 213' ' ' LEU . 25.7 mt -86.02 151.38 23.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.616 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 43.5 m -143.44 123.08 13.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -174.87 168.79 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.6 t30 67.4 -69.92 0.13 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.449 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 172.76 29.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.231 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.7 165.5 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.47 146.46 39.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.522 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -117.85 163.57 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.94 -65.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.381 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' LEU . . . . . 0.871 HD22 HD12 ' A' ' 204' ' ' LEU . 6.6 mp 36.0 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.778 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.694 ' C ' HD11 ' A' ' 202' ' ' ILE . 1.1 tp -75.95 -169.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.391 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASP . . . . . 0.401 ' N ' HD11 ' A' ' 202' ' ' ILE . 13.7 t70 -55.22 -25.09 30.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.998 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . 0.588 ' O ' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -68.4 -57.26 6.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.963 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.36 -49.98 67.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.191 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ALA . . . . . 0.514 ' O ' HD13 ' A' ' 153' ' ' ILE . . . -90.21 47.2 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.65 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 220' ' ' THR . 3.2 t-160 -90.16 -43.09 10.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.708 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' THR . . . . . 0.443 ' HB ' ' HA ' ' A' ' 142' ' ' ASN . 3.0 p -155.39 70.13 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ILE . . . . . 0.697 HD11 ' O ' ' A' ' 134' ' ' GLY . 0.7 OUTLIER -106.94 165.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' ARG . . . . . 0.672 ' C ' HD13 ' A' ' 223' ' ' ILE . 33.6 mtt-85 -101.8 92.57 4.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ILE . . . . . 0.974 HG23 ' HA ' ' A' ' 165' ' ' ILE . 3.8 mm -124.21 -162.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' GLU . . . . . 0.801 ' H ' HG22 ' A' ' 223' ' ' ILE . 12.8 tm-20 -112.14 133.22 54.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.943 0.338 . . . . 0.0 110.511 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 0.8 OUTLIER -89.67 109.31 20.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.244 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.471 -0.252 . . . . 8.39 112.471 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.2 m -129.77 60.68 1.58 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.783 0.325 . . . . 7.24 110.834 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 63.6 m80 59.61 -88.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.209 -0.45 . . . . 8.39 110.903 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 13.4 mtt 48.33 86.31 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.328 -0.396 . . . . 7.44 110.999 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -87.91 108.2 19.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 5.35 110.932 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 15.0 mt-10 -72.71 178.09 4.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.203 -0.453 . . . . 3.42 110.832 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.597 ' HB ' HD12 ' A' ' 202' ' ' ILE . 27.3 m -68.01 -49.52 67.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.268 -0.423 . . . . 2.29 111.143 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.522 ' N ' HG23 ' A' ' 112' ' ' VAL . 1.7 pt-20 -80.53 -8.34 59.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 3.04 111.113 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 3.3 tmt_? -54.96 -35.12 63.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.394 -0.367 . . . . 7.14 110.989 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -78.15 127.61 32.55 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.137 -0.483 . . . . 7.66 110.941 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.6 mp -112.57 113.04 25.0 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 4.53 110.809 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.467 HG21 HD21 ' A' ' 214' ' ' LEU . 13.0 m -128.06 171.51 16.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.244 -0.435 . . . . 4.14 111.159 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 44.0 mttt -127.13 -43.45 1.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 7.37 110.933 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.441 ' H ' HG22 ' A' ' 119' ' ' VAL . 0.4 OUTLIER -63.66 171.06 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.429 . . . . 2.55 111.203 -179.995 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.592 HD21 HD11 ' A' ' 135' ' ' LEU . 7.3 tp -110.81 72.7 0.79 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.204 -0.453 . . . . 2.62 110.902 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.403 ' O ' HD22 ' A' ' 214' ' ' LEU . 74.9 mttt -153.09 160.97 42.99 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 5.81 110.855 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -151.0 -166.04 2.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.237 -0.438 . . . . 4.19 110.94 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.94 -166.36 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 3.64 110.998 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 6.8 t 75.13 172.96 0.26 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.331 -0.395 . . . . 4.28 110.888 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 26.3 mtt85 -102.34 -29.08 11.87 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.147 -0.478 . . . . 6.64 110.974 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.7 m -111.56 76.2 1.49 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 3.9 110.997 -179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -72.5 -20.04 24.19 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.732 2.288 . . . . 3.79 112.345 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -107.78 150.42 27.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.157 -0.474 . . . . 4.12 110.938 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.646 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 147.31 157.22 7.31 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.772 -0.728 . . . . 1.87 112.508 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.646 ' O ' ' O ' ' A' ' 129' ' ' GLY . 2.3 p30 49.2 141.77 0.01 OUTLIER Pre-proline 0 C--N 1.332 -0.185 0 CA-C-O 121.111 0.482 . . . . 2.37 111.405 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.708 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 73.8 Cg_endo -75.92 141.02 23.64 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.934 2.423 . . . . 1.86 112.763 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.735 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 136.92 -27.46 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.254 0 CA-C-N 116.0 -0.546 . . . . 4.82 111.765 179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.735 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 17.1 Cg_exo -66.47 53.66 0.38 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.764 2.31 . . . . 1.57 112.784 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.475 ' HA3' HG21 ' A' ' 168' ' ' ILE . . . -67.21 90.3 0.18 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.818 -0.706 . . . . 1.25 112.232 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.592 HD11 HD21 ' A' ' 120' ' ' LEU . 6.3 tt -67.47 -56.47 9.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.895 0.379 . . . . 2.97 111.282 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -89.97 8.97 29.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.075 -0.512 . . . . 3.87 111.374 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.432 ' O ' ' HB2' ' A' ' 169' ' ' ASN . 0.5 OUTLIER -90.13 -50.05 6.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.757 0.313 . . . . 2.87 111.04 -179.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.571 HD22 ' O ' ' A' ' 217' ' ' LEU . 1.3 pp -45.29 -38.36 5.56 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.207 -0.452 . . . . 4.4 111.429 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.727 ' O ' HG23 ' A' ' 140' ' ' VAL . . . -45.87 86.67 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.849 -0.691 . . . . 2.74 112.92 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.727 HG23 ' O ' ' A' ' 139' ' ' GLY . 1.9 t 145.3 -61.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-O 120.727 0.299 . . . . 4.35 111.211 179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.55 ' N ' HG12 ' A' ' 140' ' ' VAL . . . -66.56 173.97 24.64 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.881 -0.676 . . . . 3.37 113.05 -179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 141' ' ' GLY . 3.2 p-10 169.25 122.47 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.669 0.271 . . . . 2.71 110.67 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.441 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 66.2 m -122.4 -179.1 4.08 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.911 0.386 . . . . 3.25 111.212 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -164.61 -40.94 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.983 -0.553 . . . . 3.13 110.883 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -133.86 -172.18 2.92 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.272 -0.422 . . . . 4.03 111.169 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 65.7 154.07 0.07 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 3.45 111.098 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.649 ' O ' ' N ' ' A' ' 149' ' ' GLY . . . -64.0 -56.65 22.94 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.352 -0.386 . . . . 2.73 111.16 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 10.4 Cg_exo -32.31 79.15 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 123.162 2.575 . . . . 3.55 112.763 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.649 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 62.16 125.36 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.693 -0.765 . . . . 2.73 112.331 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.733 ' CG2' ' HB2' ' A' ' 155' ' ' ALA . 13.9 t -102.93 -5.48 23.44 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 2.61 110.696 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.605 ' CG ' ' HA ' ' A' ' 220' ' ' THR . 0.0 OUTLIER 69.54 118.45 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.111 -0.495 . . . . 8.22 110.773 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.659 ' HA ' ' HB3' ' A' ' 155' ' ' ALA . 29.3 t -31.85 -46.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.098 -0.501 . . . . 2.74 111.499 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.537 ' CG2' ' HB3' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -43.29 -35.55 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.96 0.41 . . . . 2.41 110.993 179.897 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -109.32 -25.38 10.6 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.947 -0.57 . . . . 1.93 110.809 179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.733 ' HB2' ' CG2' ' A' ' 150' ' ' THR . . . -71.22 58.96 0.25 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.291 -0.413 . . . . 1.51 111.113 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.495 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -175.43 34.94 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 2.02 111.027 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.0 t -157.3 -33.39 0.08 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 2.51 111.293 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.92 48.27 1.33 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.459 -0.337 . . . . 2.05 111.115 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 4.1 ttm 62.95 61.62 1.95 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.238 -0.437 . . . . 2.84 111.063 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.742 ' HB3' HD22 ' A' ' 226' ' ' LEU . 18.0 Cg_endo -59.3 149.26 82.06 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.839 2.359 . . . . 1.58 112.304 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 33.4 mtt180 -146.12 -47.48 0.2 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 2.99 110.84 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.9 tttt -170.04 95.02 0.26 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 2.49 110.835 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.553 HG23 HG23 ' A' ' 193' ' ' VAL . 8.1 m -73.06 116.55 15.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 1.08 111.109 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.459 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 2.2 mtp180 -80.44 118.15 21.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.12 -0.491 . . . . 3.3 111.069 -179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.632 HD11 HD13 ' A' ' 168' ' ' ILE . 0.1 OUTLIER -84.08 120.27 34.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.359 -0.382 . . . . 1.4 110.66 179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.455 ' O ' ' HB ' ' A' ' 189' ' ' VAL . 20.3 t -110.25 -23.0 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.353 -0.385 . . . . 1.87 111.58 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.712 ' C ' HD13 ' A' ' 168' ' ' ILE . 1.8 mt-30 -178.63 -175.65 0.44 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.984 0.421 . . . . 4.75 111.22 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.759 HG13 HD12 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -136.1 -60.83 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.932 -0.576 . . . . 4.51 110.868 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.432 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 15.2 t-20 178.32 -71.19 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.181 -0.463 . . . . 4.32 110.909 179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -173.62 -163.05 0.16 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.213 -0.448 . . . . 5.35 110.873 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.508 ' O ' ' C ' ' A' ' 172' ' ' PHE . 0.0 OUTLIER -121.69 -12.39 8.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.258 -0.428 . . . . 4.19 111.254 179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.508 ' C ' ' O ' ' A' ' 171' ' ' ILE . 2.8 t80 -26.86 -58.53 0.09 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.18 -0.463 . . . . 6.41 111.315 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -90.09 122.28 32.92 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.957 -0.565 . . . . 4.21 110.894 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.578 HG22 ' O ' ' A' ' 174' ' ' VAL . 12.4 p -168.71 37.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 2.74 111.164 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 176' ' ' THR . 22.8 tt0 -112.95 77.31 1.04 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 5.08 110.882 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 175' ' ' GLU . 1.4 p -157.35 124.92 5.3 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 2.95 110.864 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.53 -33.11 73.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.157 -0.474 . . . . 2.26 111.057 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -70.43 -33.13 70.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.261 -0.427 . . . . 3.08 110.944 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -76.97 -13.06 60.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.199 -0.455 . . . . 3.8 111.009 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 88.1 m -56.52 -41.88 77.48 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.329 -0.396 . . . . 1.9 110.962 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 65.8 mt-30 -72.4 -35.11 68.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.216 -0.447 . . . . 3.22 110.931 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 3.7 mp -73.04 -20.6 60.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 2.17 110.949 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.12 -8.43 59.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 2.12 111.078 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -54.51 -31.64 56.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.411 -0.359 . . . . 2.26 110.955 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.3 -30.24 38.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.289 -0.414 . . . . 1.95 111.168 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.427 ' O ' ' C ' ' A' ' 187' ' ' ILE . 3.1 t0 69.33 15.28 8.49 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.269 -0.423 . . . . 3.66 110.953 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.759 HD12 HG13 ' A' ' 168' ' ' ILE . 7.8 pt 32.93 90.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 3.28 111.531 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -84.37 93.39 8.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 2.93 110.759 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 189' ' ' VAL . 8.5 m -57.66 122.39 7.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.012 -0.54 . . . . 1.84 111.073 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.503 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 116.26 -5.27 19.73 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.689 -0.767 . . . . 1.3 112.55 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.435 ' C ' HG22 ' A' ' 165' ' ' ILE . 2.0 t -72.19 -161.45 0.08 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.807 0.336 . . . . 1.56 110.958 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -147.38 115.08 6.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 2.76 110.725 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.896 HG12 ' CD2' ' A' ' 206' ' ' HIS . 29.4 m -128.67 176.48 7.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 1.05 111.187 -179.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -139.95 152.48 46.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.112 -0.495 . . . . 2.3 110.784 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 0.4 OUTLIER -128.41 153.96 38.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.242 -0.436 . . . . 2.54 111.172 -179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.491 HG13 ' O ' ' A' ' 195' ' ' ILE . 5.6 m -157.83 145.92 9.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.032 -0.531 . . . . 2.28 111.113 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -77.85 170.39 16.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.227 -0.442 . . . . 2.36 110.893 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 55.1 ttt180 -169.98 105.39 0.32 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.309 -0.405 . . . . 3.73 110.968 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 34.5 m-20 49.41 51.0 17.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 3.14 110.996 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 60.74 68.04 1.86 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.792 -0.718 . . . . 2.0 112.417 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 2.9 m-70 -170.07 155.58 5.58 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.804 0.335 . . . . 2.77 110.864 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.603 HD11 ' CG1' ' A' ' 152' ' ' VAL . 19.4 tt -105.3 140.14 24.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.224 -0.444 . . . . 1.86 111.128 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 2.1 t -160.03 122.21 3.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 1.58 110.959 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.414 HD13 ' HB ' ' A' ' 195' ' ' ILE . 3.1 mm? -84.86 119.23 25.1 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 1.71 110.776 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -96.9 117.63 31.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 1.27 111.012 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.896 ' CD2' HG12 ' A' ' 193' ' ' VAL . 10.6 t-80 -129.66 146.73 51.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 2.2 110.746 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.564 ' C ' ' O ' ' A' ' 206' ' ' HIS . 7.0 m120 -19.4 -55.49 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.12 -0.491 . . . . 3.91 111.303 -179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -54.36 -76.93 0.17 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.718 -0.754 . . . . 1.41 112.42 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 18.5 mtmt -159.72 -174.44 4.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.767 0.317 . . . . 3.49 110.763 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -93.17 149.24 21.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.291 -0.413 . . . . 2.07 110.635 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.418 HG21 ' OD1' ' A' ' 130' ' ' ASN . 0.0 OUTLIER -122.41 178.04 3.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 1.5 111.213 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 18.4 mm-40 -93.77 -66.46 0.92 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.085 -0.507 . . . . 3.28 110.693 179.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.581 HD23 ' HB2' ' A' ' 218' ' ' ALA . 3.4 mp 57.03 77.18 0.28 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.095 -0.502 . . . . 2.14 110.949 179.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.467 HD21 HG21 ' A' ' 117' ' ' VAL . 17.9 tp -54.85 163.42 0.99 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.183 -0.462 . . . . 2.53 110.77 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.41 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 6.7 m-20 -54.59 -22.79 14.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 2.15 110.998 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.565 ' O ' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -81.89 -20.1 39.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.239 -0.437 . . . . 1.96 111.072 -179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.571 ' O ' HD22 ' A' ' 138' ' ' LEU . 10.5 mp -89.97 -56.41 3.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.336 -0.393 . . . . 2.65 111.045 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.628 ' HB1' ' CB ' ' A' ' 152' ' ' VAL . . . -90.22 46.1 1.32 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.23 -0.441 . . . . 1.22 111.114 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.506 ' HB3' HD13 ' A' ' 138' ' ' LEU . 3.6 t-160 -90.06 -45.06 9.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.237 -0.438 . . . . 2.17 111.013 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.605 ' HA ' ' CG ' ' A' ' 151' ' ' ARG . 6.0 p -142.25 65.31 1.36 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.411 -0.359 . . . . 2.02 111.633 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.936 ' HB ' HD11 ' A' ' 223' ' ' ILE . 33.0 mm -89.76 158.04 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 116.33 -0.395 . . . . 1.91 110.614 179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.47 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 2.6 mtt-85 -95.2 86.18 4.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.973 0.416 . . . . 6.53 111.198 -179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.936 HD11 ' HB ' ' A' ' 221' ' ' ILE . 0.2 OUTLIER -123.43 -154.01 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.976 -0.556 . . . . 1.85 110.497 179.71 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.459 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.0 OUTLIER -117.94 162.44 18.14 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.83 0.348 . . . . 3.25 111.003 -179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.446 ' CB ' ' HB ' ' A' ' 150' ' ' THR . 16.9 tt0 -89.9 99.67 12.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.065 -0.516 . . . . 2.8 110.849 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.742 HD22 ' HB3' ' A' ' 160' ' ' PRO . 0.3 OUTLIER . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.228 -0.891 . . . . 2.48 111.008 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.492 -0.243 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 3.2 m 69.74 -67.82 0.22 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.655 0.264 . . . . 0.0 111.099 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 27.3 p80 -95.29 146.71 24.16 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.867 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 29.1 mtt 58.86 94.16 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.035 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.99 166.81 13.24 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.931 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 -81.72 139.16 35.04 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.883 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.401 HG23 ' N ' ' A' ' 113' ' ' GLU . 34.1 m -76.42 -41.03 35.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.251 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.401 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.0 OUTLIER -70.77 -34.6 71.97 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.16 -179.948 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 20.0 ttm180 -72.14 -38.52 69.19 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.372 -0.377 . . . . 0.0 111.088 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -71.35 -37.75 71.66 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 15.4 tp -71.91 148.58 45.93 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.001 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 119' ' ' VAL . 10.3 m -99.89 169.99 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.134 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 80.5 tttt -77.25 84.08 3.71 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.004 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.621 HG23 HG23 ' A' ' 117' ' ' VAL . 7.7 t -145.97 158.33 12.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.901 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.403 ' N ' HG12 ' A' ' 119' ' ' VAL . 14.0 tp -91.86 -42.67 9.94 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.03 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -109.89 111.91 23.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.945 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.36 -71.49 0.74 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.866 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.37 138.49 50.74 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.965 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 63.1 p -129.79 111.78 12.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 2.9 ppt_? -162.34 -43.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.413 ' HA ' ' HD3' ' A' ' 127' ' ' PRO . 42.0 m -85.52 132.93 43.19 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.848 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 126' ' ' SER . 45.7 Cg_exo -56.39 176.19 0.22 Allowed 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 122.566 2.177 . . . . 0.0 112.432 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 18.1 m-85 -133.52 98.03 4.1 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.768 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -149.66 25.15 1.19 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.954 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 12.3 p30 -125.16 139.02 32.74 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.618 0.247 . . . . 0.0 110.796 179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.582 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.2 Cg_endo -75.74 135.35 17.65 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.761 2.307 . . . . 0.0 112.676 -179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.61 HG13 HG21 ' A' ' 193' ' ' VAL . 0.0 OUTLIER 148.91 -32.05 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.436 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.117 179.413 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.594 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 7.4 Cg_endo -86.68 83.82 1.09 Allowed 'Trans proline' 0 C--N 1.352 0.755 0 C-N-CA 122.491 2.127 . . . . 0.0 112.434 -179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -90.1 117.19 4.97 Favored Glycine 0 N--CA 1.452 -0.272 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.48 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.445 ' HA ' ' HB3' ' A' ' 217' ' ' LEU . 3.5 tt -81.08 -59.51 2.63 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.879 0.371 . . . . 0.0 110.911 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -89.51 11.89 18.17 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.902 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.472 ' CG ' ' HB ' ' A' ' 168' ' ' ILE . 0.6 OUTLIER -90.11 -38.61 13.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.02 -179.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.4 HD23 ' O ' ' A' ' 135' ' ' LEU . 2.2 pp -42.62 -35.47 1.11 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.536 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -51.84 151.39 7.0 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.714 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.0 t 58.6 101.71 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.755 0.312 . . . . 0.0 111.237 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 121.97 141.64 6.1 Favored Glycine 0 C--N 1.331 0.304 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.425 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -164.57 96.13 0.75 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.817 0.342 . . . . 0.0 110.892 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.443 ' N ' ' HD3' ' A' ' 151' ' ' ARG . 1.1 m -101.85 -175.89 2.98 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.52 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -154.85 -48.66 0.09 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.754 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -153.72 89.56 1.33 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.22 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -173.71 155.0 2.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.932 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -64.06 -61.61 6.53 Favored Pre-proline 0 C--N 1.332 -0.166 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.09 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 8.2 Cg_exo -34.44 -43.99 0.38 Allowed 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.014 2.476 . . . . 0.0 112.627 179.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -161.71 140.25 6.5 Favored Glycine 0 N--CA 1.45 -0.401 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.857 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . . . . . . . . . 4.8 t -112.41 -20.88 11.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.655 0.227 . . . . 0.0 111.488 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.793 ' O ' HG22 ' A' ' 153' ' ' ILE . 18.5 ttp180 74.6 30.56 1.04 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.544 -0.298 . . . . 0.0 110.945 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.597 HG22 ' HB ' ' A' ' 221' ' ' ILE . 0.0 OUTLIER 52.51 -70.75 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.624 -179.967 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.793 HG22 ' O ' ' A' ' 151' ' ' ARG . 3.4 tt -44.04 85.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.296 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 152' ' ' VAL . 1.7 p30 168.06 -45.54 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.38 -179.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.601 ' HA ' HD13 ' A' ' 226' ' ' LEU . . . -49.63 -29.39 7.14 Favored 'General case' 0 CA--C 1.528 0.101 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.474 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.682 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -95.32 33.06 1.63 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.417 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.9 t -170.59 33.61 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.175 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.576 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.1 OUTLIER -158.52 35.54 0.23 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.038 179.881 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.1 mtp 58.43 67.87 1.99 Allowed Pre-proline 0 C--N 1.332 -0.157 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.113 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.48 ' HA ' HD12 ' A' ' 226' ' ' LEU . 18.3 Cg_endo -60.14 155.67 44.11 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.81 2.34 . . . . 0.0 112.605 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.3 mtt180 -143.49 -55.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.504 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 80.2 tttt -170.26 91.84 0.19 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.062 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 193' ' ' VAL . 15.9 m -69.99 170.24 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.565 179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.458 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -139.81 116.53 10.85 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.707 HD13 ' N ' ' A' ' 166' ' ' VAL . 0.2 OUTLIER -77.53 129.6 37.23 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.199 179.189 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.707 ' N ' HD13 ' A' ' 165' ' ' ILE . 17.7 t -133.93 -25.43 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 112.577 0.584 . . . . 0.0 112.577 -179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.472 ' HA ' HG11 ' A' ' 189' ' ' VAL . 3.2 mt-30 -147.33 162.1 39.65 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-O 121.22 0.533 . . . . 0.0 111.775 -179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.565 HD13 HG12 ' A' ' 187' ' ' ILE . 0.1 OUTLIER -152.38 -80.17 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.772 179.806 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -179.72 -67.34 0.01 OUTLIER 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.91 179.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -155.65 -178.9 7.62 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.919 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -128.88 -40.99 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.197 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -58.96 -35.71 73.6 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.215 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 21.6 mt-30 -64.62 121.09 13.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.039 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.633 ' O ' HG13 ' A' ' 174' ' ' VAL . 10.7 p -172.07 98.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.114 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 15.6 mt-10 -102.86 -32.82 9.59 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.116 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 2.1 p -60.8 127.09 29.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.078 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -72.89 -35.51 67.13 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.021 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -66.03 -22.54 66.45 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.128 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.699 ' CZ ' HD12 ' A' ' 182' ' ' LEU . 14.0 t80 -79.02 -8.67 59.13 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.379 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 26.9 m -57.71 -40.44 79.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.688 0.28 . . . . 0.0 111.004 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -64.09 -41.77 97.16 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.901 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.738 HD13 ' O ' ' A' ' 182' ' ' LEU . 3.2 tm? -77.69 -22.71 50.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.916 179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.596 HD11 HG11 ' A' ' 174' ' ' VAL . 0.7 OUTLIER -55.68 -26.7 46.26 Favored 'General case' 0 CA--C 1.528 0.133 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.297 179.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -51.7 -34.95 40.93 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.081 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -80.24 -32.95 38.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.719 ' C ' HD13 ' A' ' 187' ' ' ILE . 11.4 m-20 57.61 37.4 27.48 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.719 HD13 ' C ' ' A' ' 186' ' ' ASP . 0.1 OUTLIER 9.68 103.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 C-N-CA 123.267 0.627 . . . . 0.0 112.605 -179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.5 mpt_? -106.0 121.9 45.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.765 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.511 ' HA ' HD12 ' A' ' 165' ' ' ILE . 15.9 m -62.69 148.03 11.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.039 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 105.34 -11.75 47.59 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.719 179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 33.8 t -70.06 -175.43 0.95 Allowed 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.931 0.396 . . . . 0.0 111.188 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -134.5 124.13 25.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.601 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.737 HG23 HG23 ' A' ' 163' ' ' VAL . 21.1 m -131.83 172.87 15.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.881 0.372 . . . . 0.0 111.461 -179.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -150.9 138.53 19.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.653 179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.682 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 4.0 tt -110.25 158.49 10.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.15 0.5 . . . . 0.0 111.32 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.473 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 15.4 m -142.07 136.55 29.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.982 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.98 93.57 0.79 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.951 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.12 -177.66 2.16 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.853 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 13.9 m-20 -71.27 79.16 0.72 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.75 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 66.99 38.97 93.14 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.606 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 46.2 m-70 -160.96 150.57 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.853 0.359 . . . . 0.0 111.017 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 17.5 tt -95.6 144.74 9.49 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.016 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 1.2 t -160.08 137.43 9.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.88 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.466 HD23 HD22 ' A' ' 213' ' ' LEU . 3.6 mm? -115.55 121.86 43.94 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.883 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 14.5 m -86.76 138.31 31.72 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.838 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.534 ' CG ' HG12 ' A' ' 193' ' ' VAL . 3.0 t60 -165.12 172.31 12.73 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.14 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.427 ' C ' ' O ' ' A' ' 206' ' ' HIS . 75.5 m-20 -28.17 95.56 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.82 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.43 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . 135.1 -81.07 0.3 Allowed Glycine 0 N--CA 1.449 -0.499 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.893 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.43 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 23.0 mtmt -158.38 -88.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.614 0.245 . . . . 0.0 110.8 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -158.25 158.34 34.28 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.514 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.01 172.68 4.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.014 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -79.94 -59.54 2.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.81 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.518 ' HA ' HD11 ' A' ' 217' ' ' LEU . 0.6 OUTLIER 52.72 96.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.209 179.931 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.471 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 3.9 mm? -79.75 178.51 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.814 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -76.54 -8.41 57.14 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.381 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.02 -65.95 0.97 Allowed 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.737 0.303 . . . . 0.0 111.116 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 213' ' ' LEU . 0.2 OUTLIER -61.14 -36.27 79.32 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.509 -179.688 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -89.76 24.48 2.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.703 -179.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.595 ' O ' ' HG2' ' A' ' 151' ' ' ARG . 3.3 t-160 -90.37 -67.83 0.82 Allowed 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 111.723 0.268 . . . . 0.0 111.723 -179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.8 p -103.86 53.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -178.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.597 ' HB ' HG22 ' A' ' 152' ' ' VAL . 31.9 mt -91.57 150.03 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.356 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.401 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -92.81 104.07 16.36 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.999 0.428 . . . . 0.0 111.657 -179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.562 HD11 HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -136.7 -179.81 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.824 179.238 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.528 ' H ' HG22 ' A' ' 223' ' ' ILE . 6.3 tt0 -89.47 165.82 14.08 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.68 0.276 . . . . 0.0 110.544 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 18.1 tt0 -89.62 102.9 15.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.098 -179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.601 HD13 ' HA ' ' A' ' 155' ' ' ALA . 2.1 pt? . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.708 179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.465 -0.254 . . . . 0.0 112.465 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 54.1 m -102.85 45.57 0.96 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.834 0.349 . . . . 0.0 110.914 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 65.1 m80 -149.69 122.5 8.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.919 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 71.1 mtp 58.17 79.89 0.19 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.012 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -89.96 159.27 16.99 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.977 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -85.46 176.67 8.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 197' ' ' ASP . 27.6 m -90.07 -43.63 14.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.386 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.429 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -90.12 -30.37 17.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.351 -179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -55.94 -43.2 77.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.336 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 8.8 ttt180 -67.46 -64.52 0.84 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.944 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.428 HD23 ' N ' ' A' ' 117' ' ' VAL . 1.9 tt 64.66 130.7 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.062 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.428 ' N ' HD23 ' A' ' 116' ' ' LEU . 7.1 m -147.85 171.57 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.107 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 55.2 pttt -103.26 -33.85 9.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.159 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.9 m -61.02 140.73 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.394 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 16.1 tp -89.54 -42.51 11.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.943 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -97.35 131.04 44.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.04 -63.75 1.19 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.882 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.34 163.97 11.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.041 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.5 t -118.0 88.75 2.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.914 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 -152.96 77.13 1.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.841 179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 12.5 t 59.04 69.56 1.33 Allowed Pre-proline 0 C--N 1.331 -0.201 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.98 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_exo -57.63 -28.29 80.77 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.721 2.281 . . . . 0.0 112.427 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -106.82 149.64 27.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.845 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 155.5 134.45 1.86 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.72 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.433 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 10.4 p30 54.05 157.17 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.275 0 CA-C-O 121.059 0.457 . . . . 0.0 111.939 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.562 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 91.8 Cg_endo -77.78 175.03 11.71 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.896 2.397 . . . . 0.0 112.324 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.591 HG23 ' CD1' ' A' ' 165' ' ' ILE . 1.0 OUTLIER 108.46 -47.18 0.0 OUTLIER Pre-proline 0 N--CA 1.472 0.638 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 178.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.467 ' HD2' ' C ' ' A' ' 131' ' ' PRO . 72.7 Cg_exo -43.12 118.66 1.36 Allowed 'Trans proline' 0 C--N 1.35 0.63 0 C-N-CA 122.338 2.025 . . . . 0.0 113.125 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.789 ' HA3' HG21 ' A' ' 221' ' ' ILE . . . -90.97 23.5 23.29 Favored Glycine 0 CA--C 1.518 0.27 0 CA-C-N 114.92 -1.036 . . . . 0.0 113.11 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.459 ' HA ' ' HG ' ' A' ' 217' ' ' LEU . 0.6 OUTLIER -50.24 -36.0 29.25 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.998 0.428 . . . . 0.0 110.478 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.444 ' OD2' HG23 ' A' ' 174' ' ' VAL . 0.3 OUTLIER -90.48 -22.36 21.41 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.544 179.337 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -65.67 -178.28 0.53 Allowed 'General case' 0 C--O 1.232 0.134 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.293 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 14.2 tp -90.89 102.33 15.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.745 -179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.33 127.05 8.6 Favored Glycine 0 CA--C 1.518 0.267 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.058 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.0 t -131.9 -79.03 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.779 0.289 . . . . 0.0 111.474 -179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.05 109.74 0.59 Allowed Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.643 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 177.11 102.29 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.618 0.247 . . . . 0.0 110.422 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.515 ' HA ' HD11 ' A' ' 153' ' ' ILE . 0.8 OUTLIER -81.81 162.05 23.01 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 121.268 0.556 . . . . 0.0 111.774 -179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.2 p30 49.4 -178.13 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.804 179.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -178.38 179.58 0.77 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.954 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -60.71 -71.26 0.14 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.988 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -80.27 174.7 5.72 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.664 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.745 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 76.2 Cg_exo -50.69 89.18 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.567 2.178 . . . . 0.0 112.229 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.406 ' HA2' ' HG2' ' A' ' 224' ' ' GLU . . . -167.78 146.92 11.02 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.483 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.792 ' O ' HD11 ' A' ' 153' ' ' ILE . 0.4 OUTLIER -140.1 -48.53 0.45 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.554 0.216 . . . . 0.0 110.458 179.847 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.814 ' O ' HD13 ' A' ' 153' ' ' ILE . 34.9 mtt180 88.24 55.19 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.766 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.726 HG13 ' CG1' ' A' ' 223' ' ' ILE . 16.0 m 57.38 -47.3 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.814 HD13 ' O ' ' A' ' 151' ' ' ARG . 0.2 OUTLIER -43.99 -30.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-N 118.636 0.653 . . . . 0.0 112.345 -178.165 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -124.13 24.05 8.27 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.609 0.243 . . . . 0.0 111.177 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.461 ' HB1' HG11 ' A' ' 163' ' ' VAL . . . -96.51 12.53 31.19 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.397 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.727 ' HB2' HG12 ' A' ' 195' ' ' ILE . . . -149.84 70.52 1.06 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.951 0.405 . . . . 0.0 111.052 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.512 ' H ' HD21 ' A' ' 226' ' ' LEU . 7.4 m -158.73 -52.04 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.087 179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.503 ' HB2' HD11 ' A' ' 226' ' ' LEU . 0.5 OUTLIER -71.4 -79.79 0.06 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.359 -179.747 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.523 ' H ' HD22 ' A' ' 226' ' ' LEU . 26.5 ttm -155.76 92.09 2.69 Favored Pre-proline 0 CA--C 1.53 0.185 0 CA-C-O 120.681 0.276 . . . . 0.0 111.143 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.488 ' HA ' ' HB3' ' A' ' 226' ' ' LEU . 18.7 Cg_endo -60.27 140.33 91.47 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.723 2.282 . . . . 0.0 112.552 -179.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.6 ttt-85 -162.91 -49.15 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.81 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.5 tttt -168.62 119.48 0.76 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.723 179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.863 ' HB ' HG22 ' A' ' 223' ' ' ILE . 26.8 m -102.1 134.47 42.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.018 0.437 . . . . 0.0 111.692 -179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.657 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 12.4 mtt180 -79.78 126.09 30.52 Favored 'General case' 0 C--O 1.224 -0.287 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.889 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.742 HD13 HG23 ' A' ' 223' ' ' ILE . 24.4 mm -94.08 96.77 6.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 111.688 0.255 . . . . 0.0 111.688 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 165' ' ' ILE . 86.2 t -159.89 92.88 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.366 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.416 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.629 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER 170.07 105.54 0.01 OUTLIER 'General case' 0 C--O 1.24 0.597 0 CA-C-O 120.979 0.419 . . . . 0.0 111.063 179.224 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.545 ' HB ' ' O ' ' A' ' 167' ' ' GLN . 22.0 mt 98.25 -31.28 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-N 115.211 -0.904 . . . . 0.0 110.615 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.463 ' OD1' HG11 ' A' ' 189' ' ' VAL . 42.8 t-20 37.88 -92.71 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 116.022 -0.535 . . . . 0.0 112.12 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -68.75 179.93 1.62 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-O 120.9 0.381 . . . . 0.0 111.446 -179.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.511 HD12 ' HB ' ' A' ' 174' ' ' VAL . 0.0 OUTLIER -131.04 125.26 57.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.184 0 CA-C-N 115.971 -0.559 . . . . 0.0 111.085 -179.903 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -63.82 -45.37 89.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.95 0.405 . . . . 0.0 110.686 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -123.03 143.29 50.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.492 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 174' ' ' VAL . 7.3 p -164.53 94.63 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.945 0.402 . . . . 0.0 111.216 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -161.69 91.67 0.83 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.849 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.0 p -153.62 135.97 14.96 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.924 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -67.9 -35.08 77.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.037 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -64.91 -32.61 74.4 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.12 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -82.08 -15.87 51.99 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.291 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 35.2 m -50.36 -39.36 46.19 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 120.742 0.306 . . . . 0.0 110.98 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -74.62 -36.03 62.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.748 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -75.81 -13.27 60.28 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.032 179.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.4 tt -81.02 -2.27 47.34 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.538 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -49.09 -43.28 41.1 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.754 0.311 . . . . 0.0 111.04 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -91.4 -30.15 16.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.029 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.545 ' O ' ' O ' ' A' ' 187' ' ' ILE . 6.5 m-20 73.71 2.86 4.36 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.736 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.545 ' O ' ' O ' ' A' ' 186' ' ' ASP . 41.2 pt 48.62 124.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-O 121.256 0.551 . . . . 0.0 112.146 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.61 125.59 54.44 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.42 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.53 HG23 ' HD2' ' A' ' 222' ' ' ARG . 7.7 p -73.64 146.25 10.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.156 -179.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 95.08 1.08 63.15 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.435 ' HB3' HD11 ' A' ' 132' ' ' ILE . 17.4 t -81.31 174.67 11.29 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.813 0.34 . . . . 0.0 111.035 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.24 131.14 52.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.845 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.528 HG11 HG12 ' A' ' 132' ' ' ILE . 31.3 m -148.11 -167.92 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.874 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -140.38 174.52 10.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.759 0.314 . . . . 0.0 110.827 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.727 HG12 ' HB2' ' A' ' 156' ' ' ALA . 1.0 OUTLIER -160.03 154.76 4.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 121.06 0.457 . . . . 0.0 111.115 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.419 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 14.8 m -155.1 174.27 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.093 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.467 ' OD1' HG13 ' A' ' 112' ' ' VAL . 11.0 m-20 -86.01 160.05 19.43 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.766 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 51.9 ttt180 -163.9 102.08 0.89 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.072 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 t70 55.27 43.81 28.52 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.21 46.05 93.93 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.547 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -153.2 148.75 27.24 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.794 0.33 . . . . 0.0 110.906 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.663 HG13 HD11 ' A' ' 195' ' ' ILE . 18.4 tt -83.39 147.2 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.206 -179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 4.5 t -160.11 122.52 3.34 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.846 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.439 HD23 ' HB ' ' A' ' 195' ' ' ILE . 14.5 mt -82.37 113.78 20.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.807 179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 5.7 m -97.08 140.43 31.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.828 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.401 ' O ' ' C ' ' A' ' 207' ' ' ASN . 54.3 t60 -147.92 144.45 28.06 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.489 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.401 ' C ' ' O ' ' A' ' 206' ' ' HIS . 4.0 m120 -33.13 -40.56 0.06 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.72 -179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.417 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -68.65 -66.31 2.33 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.492 179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.1 mtmt -157.69 -176.3 5.86 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.816 0.341 . . . . 0.0 110.942 -179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -116.35 148.84 40.2 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.415 179.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 204' ' ' LEU . 0.0 OUTLIER -114.39 169.88 5.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.157 -179.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -79.98 -64.52 1.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.821 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.401 HD13 HD12 ' A' ' 204' ' ' LEU . 2.7 tp 59.27 167.09 0.06 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.2 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.432 HD13 ' H ' ' A' ' 215' ' ' ASP . 0.2 OUTLIER -157.16 152.25 26.05 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.686 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.432 ' H ' HD13 ' A' ' 214' ' ' LEU . 71.6 m-20 -53.31 -26.2 17.76 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.206 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -51.78 -66.94 0.3 Allowed 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.863 0.363 . . . . 0.0 111.104 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.459 ' HG ' ' HA ' ' A' ' 135' ' ' LEU . 3.3 mm? -88.36 -20.84 24.79 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.983 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.821 ' HA ' HD11 ' A' ' 221' ' ' ILE . . . -90.14 29.46 1.23 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.859 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.557 ' O ' HG23 ' A' ' 220' ' ' THR . 0.0 OUTLIER -90.12 -33.94 16.07 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.23 -179.726 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.557 HG23 ' O ' ' A' ' 219' ' ' HIS . 1.4 p -161.91 84.86 0.6 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.334 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.821 HD11 ' HA ' ' A' ' 218' ' ' ALA . 0.0 OUTLIER -120.5 -164.11 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.781 0.324 . . . . 0.0 111.72 179.79 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.643 ' HG3' HG23 ' A' ' 165' ' ' ILE . 11.7 ptt180 -86.22 80.38 8.78 Favored 'General case' 0 C--N 1.334 -0.08 0 CA-C-N 116.077 -0.511 . . . . 0.0 112.263 -178.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.863 HG22 ' HB ' ' A' ' 163' ' ' VAL . 0.1 OUTLIER -151.43 176.66 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.574 178.048 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.593 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 0.2 OUTLIER -120.87 -173.52 2.62 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.752 0.311 . . . . 0.0 111.019 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.407 ' HA ' HG21 ' A' ' 150' ' ' THR . 1.6 pt-20 -89.84 89.18 7.64 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.934 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.523 HD22 ' H ' ' A' ' 159' ' ' MET . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.205 -0.902 . . . . 0.0 111.118 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.517 -0.233 . . . . 0.0 112.517 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 47.7 m -155.23 145.0 21.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.804 0.335 . . . . 0.0 110.903 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 5.4 t60 66.02 134.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.089 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 62.5 mtt -150.48 130.36 13.33 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.908 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -88.24 108.35 19.26 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.92 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -90.1 122.22 32.87 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.62 ' HB ' HD13 ' A' ' 202' ' ' ILE . 33.3 m -90.12 -34.49 6.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.164 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -63.79 -162.16 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.949 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 81.0 mtt180 -57.66 89.12 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.191 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 2.3 tmt_? -90.12 -53.38 4.5 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.825 179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.4 mp -126.22 160.29 30.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -93.73 135.1 29.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.563 ' HB3' HD21 ' A' ' 214' ' ' LEU . 10.9 tptt -159.12 173.47 16.37 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.809 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 120' ' ' LEU . 1.0 OUTLIER -88.25 -45.22 15.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 120.988 0.423 . . . . 0.0 111.047 -179.924 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.468 ' N ' ' CG1' ' A' ' 119' ' ' VAL . 12.3 tp -170.69 -51.62 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.897 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.0 mttt -86.22 142.61 28.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.87 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -119.55 -63.0 1.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.872 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.423 HG23 ' N ' ' A' ' 126' ' ' SER . 5.2 m -72.42 176.44 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.195 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 48.4 m -71.46 -55.67 7.44 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.078 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.5 ttt180 -71.61 -56.55 5.65 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.923 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.423 ' N ' HG23 ' A' ' 123' ' ' VAL . 2.6 m 61.41 86.1 0.16 Allowed Pre-proline 0 C--N 1.332 -0.184 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.073 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -56.31 155.23 25.7 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.618 2.212 . . . . 0.0 112.261 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.417 ' HB3' ' HA ' ' A' ' 182' ' ' LEU . 60.9 m-85 -142.97 33.97 1.37 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.026 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -106.58 -132.23 7.02 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.121 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.758 ' ND2' HG22 ' A' ' 211' ' ' VAL . 0.2 OUTLIER 54.5 -163.86 0.01 OUTLIER Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.726 ' O ' ' HB1' ' A' ' 185' ' ' ALA . 65.9 Cg_exo -50.68 -74.92 0.03 OUTLIER 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 121.877 1.718 . . . . 0.0 112.591 -179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.682 HG21 HG23 ' A' ' 187' ' ' ILE . 0.0 OUTLIER 165.2 127.78 0.02 OUTLIER Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.449 0.166 . . . . 0.0 111.209 179.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.457 ' HB3' HD12 ' A' ' 213' ' ' LEU . 3.0 Cg_exo -74.17 139.93 27.27 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.738 2.292 . . . . 0.0 111.969 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.851 ' O ' HD11 ' A' ' 221' ' ' ILE . . . -90.28 93.37 1.86 Allowed Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.807 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 135' ' ' LEU . 1.3 tt -83.58 -32.36 25.83 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.757 0.313 . . . . 0.0 110.837 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -90.02 -10.78 43.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.15 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' HG2' ' HB3' ' A' ' 169' ' ' ASN . 1.3 mt-10 -61.89 -49.61 75.52 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.736 0.303 . . . . 0.0 110.928 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.496 HD21 ' C ' ' A' ' 216' ' ' ASP . 3.2 mp -29.94 -44.62 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.981 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -48.73 -44.9 30.89 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.879 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.94 105.41 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.739 0.304 . . . . 0.0 110.969 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.76 114.14 0.78 Allowed Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.544 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.473 ' HB3' HG22 ' A' ' 220' ' ' THR . 6.6 p30 -171.17 142.8 1.82 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.741 0.305 . . . . 0.0 110.902 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.45 ' HB2' ' HA3' ' A' ' 149' ' ' GLY . 13.8 t -95.9 162.15 13.7 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -162.41 -45.82 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.513 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -129.12 -45.0 1.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.989 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -78.84 -179.86 6.82 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.102 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.672 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -74.38 -58.28 1.92 Allowed Pre-proline 0 C--N 1.332 -0.183 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.518 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.672 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 5.9 Cg_exo -33.25 108.01 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.333 0 C-N-CA 123.291 2.661 . . . . 0.0 113.301 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.667 ' O ' HG23 ' A' ' 153' ' ' ILE . . . 115.5 42.0 0.77 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.873 -0.679 . . . . 0.0 112.713 179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.904 ' O ' HD13 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -103.53 -142.41 0.36 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.649 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.803 ' N ' ' HB2' ' A' ' 155' ' ' ALA . 26.0 ttt180 65.13 -69.96 0.09 Allowed 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 120.748 0.308 . . . . 0.0 111.623 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.618 HG11 HD22 ' A' ' 213' ' ' LEU . 2.5 m -95.68 -38.23 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.795 -179.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.667 HG23 ' O ' ' A' ' 149' ' ' GLY . 1.0 OUTLIER -116.55 110.03 30.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.238 -179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.766 ' O ' HG22 ' A' ' 157' ' ' THR . 55.7 m-20 99.26 -36.55 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.705 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.803 ' HB2' ' N ' ' A' ' 151' ' ' ARG . . . -42.93 -34.25 0.93 Allowed 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -78.56 61.42 2.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.787 0.327 . . . . 0.0 111.429 -179.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.766 HG22 ' O ' ' A' ' 154' ' ' ASP . 4.1 t -176.23 -35.77 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.346 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 24.7 m -89.3 54.2 2.87 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.313 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 45.3 mtt 55.0 57.21 11.37 Favored Pre-proline 0 C--N 1.332 -0.177 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.391 179.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.405 ' HA ' ' CD1' ' A' ' 226' ' ' LEU . 7.3 Cg_endo -49.32 129.57 22.86 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 123.168 2.579 . . . . 0.0 112.559 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -154.97 -47.98 0.08 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.567 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 9.5 mttt -170.28 91.74 0.19 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.921 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.724 HG11 ' HA ' ' A' ' 151' ' ' ARG . 20.4 m -70.0 178.42 0.41 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.912 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.48 ' HB2' ' CB ' ' A' ' 224' ' ' GLU . 1.5 mpt_? -127.18 107.75 10.29 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.798 ' HA ' HG23 ' A' ' 223' ' ' ILE . 8.2 tt -70.63 134.2 30.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.471 HG13 ' HA2' ' A' ' 190' ' ' GLY . 0.1 OUTLIER -156.39 11.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 N-CA-C 112.98 0.733 . . . . 0.0 112.98 -179.167 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.482 ' HB3' ' HB2' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -168.65 100.57 0.4 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 121.078 0.466 . . . . 0.0 111.947 179.846 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.611 HD11 HD11 ' A' ' 165' ' ' ILE . 3.3 mp -117.65 -4.29 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.949 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.428 ' HB3' ' HG2' ' A' ' 137' ' ' GLU . 25.2 t-20 53.56 -92.76 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.738 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.445 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.6 OUTLIER 62.18 -88.14 0.02 OUTLIER 'General case' 0 CA--C 1.53 0.179 0 CA-C-O 120.505 0.193 . . . . 0.0 110.827 -179.554 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 79.4 mt 59.89 -76.38 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 111.813 0.301 . . . . 0.0 111.813 179.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.445 ' N ' ' O ' ' A' ' 170' ' ' GLU . 18.8 m-85 -62.65 -67.01 0.46 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.871 0.367 . . . . 0.0 111.332 -179.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -58.92 121.98 12.53 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.081 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 15.0 p -172.44 -40.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.282 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.444 ' O ' HG23 ' A' ' 176' ' ' THR . 26.5 tt0 -113.58 95.02 5.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.935 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.444 HG23 ' O ' ' A' ' 175' ' ' GLU . 1.5 p -158.27 157.33 32.32 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.883 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -61.79 -37.31 83.86 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.137 -179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 30.6 mt-30 -76.61 -31.97 57.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.152 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.459 ' CD1' HD22 ' A' ' 182' ' ' LEU . 8.4 t80 -90.08 3.62 52.76 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.45 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.3 m -59.05 -44.21 91.79 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.859 0.362 . . . . 0.0 110.509 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 58.9 mt-30 -72.99 -33.59 65.89 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.537 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.459 HD22 ' CD1' ' A' ' 179' ' ' PHE . 8.1 mp -73.19 -21.8 60.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.913 179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.4 mt -63.73 -33.32 75.39 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.598 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -52.68 -28.37 21.44 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.55 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.726 ' HB1' ' O ' ' A' ' 131' ' ' PRO . . . -51.66 -41.13 61.14 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.004 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 3.8 t70 78.85 -8.32 1.66 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.893 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.682 HG23 HG21 ' A' ' 132' ' ' ILE . 44.2 mt 61.01 125.86 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.528 0.125 0 CA-C-O 120.738 0.304 . . . . 0.0 111.467 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.58 -43.23 3.05 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.507 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.582 ' HB ' HD13 ' A' ' 168' ' ' ILE . 3.3 p 36.94 83.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.145 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.471 ' HA2' HG13 ' A' ' 166' ' ' VAL . . . 135.3 2.26 3.0 Favored Glycine 0 CA--C 1.52 0.345 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.518 -179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.62 ' H ' HG23 ' A' ' 165' ' ' ILE . 8.0 t -85.19 -167.44 1.83 Allowed 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.903 0.382 . . . . 0.0 111.289 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . 0.425 ' O ' ' CE1' ' A' ' 206' ' ' HIS . 45.9 mt-10 -129.62 99.0 5.0 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.492 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.694 HG12 ' CD2' ' A' ' 206' ' ' HIS . 27.3 m -92.29 169.62 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.625 -179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -124.56 135.66 53.33 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.598 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.605 HD12 ' H ' ' A' ' 196' ' ' VAL . 0.7 OUTLIER -90.74 151.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-O 121.171 0.51 . . . . 0.0 111.102 179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.605 ' H ' HD12 ' A' ' 195' ' ' ILE . 14.9 p -170.32 151.95 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.325 -0.852 . . . . 0.0 111.154 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.464 ' HB3' HG12 ' A' ' 112' ' ' VAL . 2.0 p30 -131.77 172.16 12.63 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.749 179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -163.25 118.14 1.68 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.334 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.5 t70 66.93 -68.82 0.14 Allowed 'General case' 0 C--O 1.232 0.149 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.299 179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -173.56 49.65 0.16 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.304 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -149.06 145.07 27.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.814 0.34 . . . . 0.0 110.821 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.62 HD13 ' HB ' ' A' ' 112' ' ' VAL . 9.9 tp -95.14 145.0 8.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.241 -179.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.505 HG23 HG13 ' A' ' 196' ' ' VAL . 2.2 t -160.05 153.99 23.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.694 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.438 ' O ' HG23 ' A' ' 211' ' ' VAL . 3.6 mm? -121.93 103.64 8.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.016 -179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 2.8 m -79.91 122.18 26.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.694 ' CD2' HG12 ' A' ' 193' ' ' VAL . 59.8 t60 -175.73 162.19 2.67 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.575 179.779 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.4 m120 31.56 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.991 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -54.41 -78.97 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.439 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.473 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 22.9 mtmt -160.5 -75.54 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.969 0.414 . . . . 0.0 110.495 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -155.48 133.19 11.23 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.27 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.758 HG22 ' ND2' ' A' ' 130' ' ' ASN . 21.2 t -87.38 141.51 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.016 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 3.7 tm-20 -79.84 -59.11 2.86 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.181 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.618 HD22 HG11 ' A' ' 152' ' ' VAL . 0.2 OUTLIER 48.75 -168.66 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.609 179.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.563 HD21 ' HB3' ' A' ' 118' ' ' LYS . 6.0 tp -165.95 164.13 18.42 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -46.75 -31.63 3.1 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.674 0.273 . . . . 0.0 111.3 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.496 ' C ' HD21 ' A' ' 138' ' ' LEU . 0.1 OUTLIER -62.62 -58.59 6.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.853 0.358 . . . . 0.0 110.591 179.642 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.918 ' O ' HD13 ' A' ' 221' ' ' ILE . 7.9 mp -80.39 -12.86 59.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.157 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.428 ' HB2' HD23 ' A' ' 213' ' ' LEU . . . -90.51 -28.02 18.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.666 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -90.43 -19.83 23.46 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 -179.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.907 ' O ' HD12 ' A' ' 221' ' ' ILE . 20.1 p -135.9 78.74 1.73 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 112.511 0.56 . . . . 0.0 112.511 -178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.98 HG22 HD11 ' A' ' 223' ' ' ILE . 0.9 OUTLIER -149.01 156.96 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 109.333 -0.618 . . . . 0.0 109.333 178.414 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 167' ' ' GLN . 40.4 mtt-85 -101.04 124.25 46.48 Favored 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.773 0.657 . . . . 0.0 112.773 -178.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.98 HD11 HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -150.42 178.37 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.815 178.998 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.545 ' H ' HG22 ' A' ' 223' ' ' ILE . 2.1 tm-20 -95.02 150.07 20.57 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.724 0.297 . . . . 0.0 110.493 179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.567 ' CB ' ' HB1' ' A' ' 147' ' ' ALA . 3.1 tt0 -89.57 132.88 34.87 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.967 0.413 . . . . 0.0 111.259 -179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.405 ' CD1' ' HA ' ' A' ' 160' ' ' PRO . 4.6 mt . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.265 -0.874 . . . . 0.0 111.322 179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 23.3 t -88.26 -50.87 6.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.823 0.344 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 58.5 m80 -124.12 -57.54 1.59 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.884 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.0 mtt -112.5 108.87 18.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.891 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.82 129.09 36.25 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.885 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -90.0 148.01 23.34 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.849 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.477 HG11 ' HB1' ' A' ' 156' ' ' ALA . 30.2 m -69.55 -42.74 80.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.196 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.413 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.5 OUTLIER -90.38 40.38 1.01 Allowed 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.155 179.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 58.8 ttt-85 -90.13 -51.49 5.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.928 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.34 136.54 35.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.909 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 8.1 mp -99.32 170.14 8.86 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.883 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.7 m -141.62 -43.82 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.299 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 61.4 tttt 70.37 -66.93 0.26 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.045 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.7 m -69.41 143.06 15.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.218 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 2.4 tt -86.03 95.26 9.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.922 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 89.1 mttt -154.78 136.44 14.36 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.882 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -97.19 140.91 30.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.855 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 18.2 t -142.01 109.54 2.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.084 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 42.8 t -159.92 -64.17 0.07 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.849 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -152.69 -72.35 0.14 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.822 179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.43 ' CB ' ' HD3' ' A' ' 127' ' ' PRO . 0.6 OUTLIER 175.33 -53.44 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.183 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.031 179.925 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.43 ' HD3' ' CB ' ' A' ' 126' ' ' SER . 46.3 Cg_exo -56.6 -171.77 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.603 2.202 . . . . 0.0 112.557 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 10.8 p90 -125.13 -175.5 3.32 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.744 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.448 ' HA3' HG22 ' A' ' 211' ' ' VAL . . . -131.19 -158.67 9.27 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.664 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.492 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 0.6 OUTLIER -71.51 165.14 51.68 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 120.545 0.212 . . . . 0.0 110.81 -179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 38.3 Cg_endo -67.2 126.85 15.7 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.551 2.167 . . . . 0.0 112.787 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.759 ' H ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER -172.58 -62.64 0.0 OUTLIER Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.694 179.59 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.737 ' O ' HG21 ' A' ' 187' ' ' ILE . 7.0 Cg_exo -38.92 118.3 0.36 Allowed 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.288 2.658 . . . . 0.0 113.377 -178.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.542 ' HA3' HD12 ' A' ' 221' ' ' ILE . . . -90.81 47.99 3.01 Favored Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.536 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.427 ' HA ' ' HG ' ' A' ' 217' ' ' LEU . 2.8 pp -51.02 -32.73 22.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.789 0.328 . . . . 0.0 111.081 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -89.35 -22.36 22.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.888 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.29 -174.86 0.06 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.154 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.6 tt -90.28 102.86 15.58 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.375 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.701 ' CA ' HD13 ' A' ' 217' ' ' LEU . . . -88.25 128.28 8.99 Favored Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.392 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 141' ' ' GLY . 14.1 p -172.91 -43.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 120.656 0.265 . . . . 0.0 111.309 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.45 ' N ' HG13 ' A' ' 140' ' ' VAL . . . 126.5 107.29 1.52 Allowed Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.568 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 151' ' ' ARG . 2.9 m120 -166.79 137.53 3.24 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.681 0.277 . . . . 0.0 110.885 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.732 ' OG ' HG23 ' A' ' 153' ' ' ILE . 58.0 p -179.08 -34.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.068 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -49.83 -23.21 1.76 Allowed 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.674 -179.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -49.66 174.58 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 111.743 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 147' ' ' ALA . . . -107.46 140.65 40.09 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.671 -179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 168.38 167.54 0.14 Allowed Pre-proline 0 N--CA 1.463 0.195 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.561 179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.544 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 36.9 Cg_exo -56.44 -18.95 26.98 Favored 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.15 1.9 . . . . 0.0 110.973 178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.598 ' HA3' ' HA ' ' A' ' 224' ' ' GLU . . . -139.46 153.71 23.15 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.669 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.535 HG22 ' HA ' ' A' ' 225' ' ' GLU . 10.8 t -97.2 -142.28 0.29 Allowed 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.481 ' HB2' ' CB ' ' A' ' 143' ' ' SER . 60.9 mtt180 -150.58 72.16 1.08 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 120.783 0.325 . . . . 0.0 111.301 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.731 HG23 HD11 ' A' ' 223' ' ' ILE . 44.2 t 64.41 -72.03 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.159 180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.732 HG23 ' OG ' ' A' ' 143' ' ' SER . 1.3 tt -61.47 76.76 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.5 OUTLIER 162.73 -37.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.598 -179.621 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.826 ' HA ' HD22 ' A' ' 226' ' ' LEU . . . -89.89 46.0 1.32 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.431 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.663 ' HB2' ' CD1' ' A' ' 195' ' ' ILE . . . -145.16 36.26 1.11 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.069 179.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 156' ' ' ALA . 2.8 p -160.07 -43.18 0.05 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.191 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.522 ' HB3' HD21 ' A' ' 226' ' ' LEU . 8.4 t -76.81 61.66 1.92 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.379 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 6.6 ttt 48.96 86.28 0.16 Allowed Pre-proline 0 N--CA 1.463 0.198 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.408 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -64.44 149.41 90.09 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.644 2.229 . . . . 0.0 112.576 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 16.6 ttt180 -156.55 -50.96 0.08 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.688 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . 0.423 ' O ' HG13 ' A' ' 163' ' ' VAL . 2.9 mttt -168.11 165.34 13.38 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.696 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.675 HG22 ' O ' ' A' ' 193' ' ' VAL . 3.4 m -155.04 140.41 10.57 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.626 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.561 ' H ' ' CB ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -79.37 107.63 12.28 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.571 179.069 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.809 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.1 OUTLIER -79.5 119.4 28.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -179.434 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.705 ' HA ' HG13 ' A' ' 189' ' ' VAL . 10.7 t -134.7 38.07 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.395 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.704 ' H ' HD13 ' A' ' 165' ' ' ILE . 0.6 OUTLIER 5.67 -86.76 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 123.434 0.694 . . . . 0.0 112.86 179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 169' ' ' ASN . 0.4 OUTLIER 159.2 -52.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.471 ' N ' HG22 ' A' ' 168' ' ' ILE . 27.1 p30 -169.48 -172.43 1.45 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.797 179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.428 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 36.5 mt-10 -152.13 168.39 25.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.992 179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.428 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 0.1 OUTLIER 77.36 -21.97 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 112.131 179.834 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.29 -51.6 61.78 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.765 0.317 . . . . 0.0 111.418 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.5 mm100 -118.74 178.67 4.39 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.167 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.612 ' O ' HG13 ' A' ' 174' ' ' VAL . 7.4 p -167.0 96.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.933 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -64.08 -178.21 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.197 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 19.7 p -68.42 -173.26 0.41 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.073 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -72.33 -5.05 33.51 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.66 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -57.89 -30.92 66.26 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.734 0.302 . . . . 0.0 110.986 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.617 ' CD1' HD22 ' A' ' 182' ' ' LEU . 45.7 m-85 -90.13 11.58 20.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.487 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 25.6 m -54.24 -39.39 66.75 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-O 120.733 0.301 . . . . 0.0 110.65 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -71.47 -41.25 69.62 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.462 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.617 HD22 ' CD1' ' A' ' 179' ' ' PHE . 7.7 mp -71.42 -18.19 62.35 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.958 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.88 -25.14 68.02 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.211 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.99 -40.26 57.56 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.897 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -85.34 -34.04 21.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.859 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.423 ' O ' ' C ' ' A' ' 187' ' ' ILE . 6.7 t70 60.89 24.65 14.64 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.282 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.759 HG22 ' H ' ' A' ' 132' ' ' ILE . 1.1 pp 28.51 94.37 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.112 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.39 141.19 40.6 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.098 -179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.705 HG13 ' HA ' ' A' ' 166' ' ' VAL . 25.0 t -69.11 146.9 12.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.71 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 112.28 -12.8 26.13 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.791 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.489 ' N ' HG22 ' A' ' 165' ' ' ILE . 1.3 t -73.67 -165.3 0.26 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.004 0.431 . . . . 0.0 111.027 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -151.69 145.91 25.39 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.206 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.675 ' O ' HG22 ' A' ' 163' ' ' VAL . 20.8 m -150.3 179.08 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.012 0.434 . . . . 0.0 111.876 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -156.99 101.73 1.95 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.38 179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.663 ' CD1' ' HB2' ' A' ' 156' ' ' ALA . 41.4 pt -79.84 151.46 4.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.558 -179.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 14.3 m -150.68 152.4 11.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.957 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.92 142.03 53.0 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.902 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.05 112.99 1.86 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.011 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.41 36.43 23.02 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.282 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.77 51.41 57.56 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.594 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 55.4 m-70 -158.28 156.06 29.97 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.805 0.336 . . . . 0.0 110.942 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.763 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -94.45 135.42 28.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.033 -179.917 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.763 ' N ' HD13 ' A' ' 202' ' ' ILE . 1.7 t -153.57 133.03 12.85 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.833 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.653 ' CD2' HD22 ' A' ' 213' ' ' LEU . 2.1 mm? -79.99 159.68 26.16 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.502 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.514 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 9.5 m -152.08 116.65 5.06 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.499 -0.319 . . . . 0.0 111.213 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.407 ' O ' ' N ' ' A' ' 208' ' ' GLY . 1.7 t-80 179.25 177.98 0.51 Allowed 'General case' 0 C--O 1.237 0.407 0 CA-C-O 121.036 0.446 . . . . 0.0 111.504 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 12.8 m120 42.52 -90.94 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.783 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.451 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -73.08 -67.43 1.81 Allowed Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.677 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 21.9 mtmt -159.17 -81.8 0.05 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.691 0.281 . . . . 0.0 111.104 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.514 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.0 OUTLIER -153.81 175.32 13.45 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.923 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.455 ' CG1' HD12 ' A' ' 213' ' ' LEU . 3.0 t -136.96 159.64 36.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.836 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -79.89 -61.5 1.97 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.315 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.838 HD23 ' HB2' ' A' ' 218' ' ' ALA . 3.0 mp 57.12 179.22 0.05 OUTLIER 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.029 -179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.843 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -151.46 -179.95 7.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.938 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -88.94 13.61 12.4 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.596 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.623 ' HB2' HD12 ' A' ' 214' ' ' LEU . 12.4 t70 -84.65 -71.76 0.5 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.682 0.277 . . . . 0.0 110.767 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.701 HD13 ' CA ' ' A' ' 139' ' ' GLY . 4.4 mm? -90.2 -40.03 12.45 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.794 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.843 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -56.76 -20.94 24.88 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.538 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.497 ' CE1' HD12 ' A' ' 153' ' ' ILE . 13.1 t60 -80.3 7.36 9.69 Favored 'General case' 0 CA--C 1.531 0.219 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.448 HG21 ' H ' ' A' ' 140' ' ' VAL . 12.3 t -163.59 39.91 0.09 Allowed 'General case' 0 C--O 1.232 0.172 0 N-CA-C 111.87 0.322 . . . . 0.0 111.87 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.547 ' HB ' HD11 ' A' ' 223' ' ' ILE . 51.2 mm -89.8 154.57 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 110.27 -0.27 . . . . 0.0 110.27 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.417 ' CB ' ' O ' ' A' ' 167' ' ' GLN . 63.5 ttt180 -89.69 105.07 17.56 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.141 0.496 . . . . 0.0 111.901 -179.097 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.809 HG23 ' HA ' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -146.8 -178.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.0 178.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.598 ' HA ' ' HA3' ' A' ' 149' ' ' GLY . 12.1 tm-20 -89.82 165.25 14.25 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.736 -0.386 . . . . 0.0 110.82 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.698 ' C ' HD23 ' A' ' 226' ' ' LEU . 33.8 tt0 -99.26 80.54 2.44 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.0 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.826 HD22 ' HA ' ' A' ' 155' ' ' ALA . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.616 -0.707 . . . . 0.0 112.712 179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.207 0 N-CA-C 112.521 -0.231 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 65.5 p -153.54 -53.54 0.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.682 0.277 . . . . 0.0 110.901 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 4.4 t60 70.07 -67.71 0.23 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.057 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.9 mtt -105.24 126.35 52.0 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.921 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -87.05 101.95 13.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.886 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -89.97 -60.0 2.05 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 24.0 m -89.99 -38.44 11.02 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.214 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -90.14 55.95 3.26 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.901 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.0 ttp180 -88.89 -33.14 17.42 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.951 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -70.24 158.75 35.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.9 mt -137.11 -52.28 0.67 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.995 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.7 m -97.71 127.05 50.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.261 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . 0.625 ' HB3' HD21 ' A' ' 214' ' ' LEU . 4.8 mmtm -173.19 -173.66 0.95 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.774 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.06 -76.23 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.092 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.719 ' HG ' HD21 ' A' ' 217' ' ' LEU . 6.6 tt -165.46 -46.27 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.952 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 50.8 tttm -72.27 140.47 48.63 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.897 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -140.88 158.92 43.27 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.899 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.0 m -70.62 139.67 19.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.283 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 13.4 t -163.64 178.73 7.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -86.26 -40.31 15.66 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -115.71 93.47 37.45 Favored Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.899 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -56.28 112.72 1.16 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.639 2.226 . . . . 0.0 112.393 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 20.8 m-85 57.06 96.22 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.086 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 176.55 -149.2 9.54 Favored Glycine 0 C--N 1.33 0.243 0 C-N-CA 120.982 -0.627 . . . . 0.0 112.306 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.625 ' CB ' ' HD2' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 53.71 178.53 0.03 OUTLIER Pre-proline 0 CA--C 1.535 0.401 0 CA-C-N 116.537 0.168 . . . . 0.0 110.648 179.784 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.625 ' HD2' ' CB ' ' A' ' 130' ' ' ASN . 2.6 Cg_endo -39.6 141.84 0.51 Allowed 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.922 2.415 . . . . 0.0 112.898 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.782 ' N ' HD13 ' A' ' 187' ' ' ILE . 16.1 tt -37.6 96.0 0.1 Allowed Pre-proline 0 CA--C 1.531 0.244 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.526 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.516 ' HD2' HD23 ' A' ' 182' ' ' LEU . 4.2 Cg_endo -82.44 78.26 3.46 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.272 2.648 . . . . 0.0 111.243 179.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.563 ' HA3' ' HG2' ' A' ' 137' ' ' GLU . . . -70.3 111.68 3.92 Favored Glycine 0 N--CA 1.445 -0.734 0 CA-C-N 115.634 -0.712 . . . . 0.0 113.616 -178.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.846 ' CB ' HD22 ' A' ' 217' ' ' LEU . 0.1 OUTLIER -90.46 -40.53 11.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.049 0.452 . . . . 0.0 110.316 178.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -91.11 -4.62 56.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.272 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.563 ' HG2' ' HA3' ' A' ' 134' ' ' GLY . 0.0 OUTLIER -90.08 -35.94 15.16 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.401 -179.52 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.783 ' HB3' HG22 ' A' ' 221' ' ' ILE . 3.5 pp -39.93 -34.99 0.31 Allowed 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.933 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.498 ' N ' HD12 ' A' ' 138' ' ' LEU . . . -56.43 82.77 0.01 OUTLIER Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.958 -0.639 . . . . 0.0 113.013 -179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.436 ' N ' ' O ' ' A' ' 138' ' ' LEU . 59.9 t -154.73 -55.89 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.84 0.352 . . . . 0.0 110.726 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -179.18 104.1 0.18 Allowed Glycine 0 C--N 1.331 0.272 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.388 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -57.16 108.99 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.662 0.268 . . . . 0.0 111.054 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.435 ' N ' ' HB3' ' A' ' 151' ' ' ARG . 14.1 m -90.73 99.3 12.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.193 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -106.97 24.16 13.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.756 179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -114.13 -167.07 1.16 Allowed 'General case' 0 C--O 1.231 0.118 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.321 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -82.71 -173.43 4.64 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.426 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.479 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 67.58 164.34 0.13 Allowed Pre-proline 0 C--O 1.231 0.097 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.341 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 51.4 Cg_exo -53.49 145.22 47.8 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.758 2.305 . . . . 0.0 112.487 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 143' ' ' SER . . . 90.94 101.85 1.23 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.609 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.666 HG21 ' HB2' ' A' ' 224' ' ' GLU . 10.3 t -118.46 -161.07 0.82 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.693 0.283 . . . . 0.0 110.786 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.577 ' C ' HG23 ' A' ' 152' ' ' VAL . 22.3 ptt180 -125.93 33.11 5.13 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.709 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.96 HG22 HG12 ' A' ' 221' ' ' ILE . 0.4 OUTLIER 66.67 -59.7 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.987 -179.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.618 HG23 ' O ' ' A' ' 218' ' ' ALA . 1.7 pt -69.57 62.64 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 CA-C-O 121.102 0.477 . . . . 0.0 111.071 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.4 -32.88 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.093 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.616 ' HB1' HG21 ' A' ' 195' ' ' ILE . . . -40.17 -36.1 0.47 Allowed 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.781 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -128.32 76.62 1.71 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.05 179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.5 m -159.51 -45.88 0.05 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.218 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.6 m -78.61 -78.17 0.15 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.111 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 17.7 ptm -146.59 54.74 2.22 Favored Pre-proline 0 C--N 1.332 -0.188 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.889 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.416 ' HA ' HD11 ' A' ' 226' ' ' LEU . 2.0 Cg_endo -44.55 106.39 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.419 2.746 . . . . 0.0 112.701 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -135.47 -40.02 0.72 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.844 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -161.77 96.14 1.01 Allowed 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.906 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.624 ' HB ' ' O ' ' A' ' 223' ' ' ILE . 0.0 OUTLIER -70.0 176.42 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.941 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.615 ' O ' ' HA ' ' A' ' 223' ' ' ILE . 6.2 mtt180 -152.02 115.43 4.77 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.711 ' CG1' HG23 ' A' ' 189' ' ' VAL . 8.3 tt -84.76 126.79 40.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.983 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.662 ' O ' HG22 ' A' ' 189' ' ' VAL . 32.1 t -133.68 -72.73 0.26 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.17 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . . . . . . . . . 27.0 tt0 -99.02 122.45 42.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.032 0.444 . . . . 0.0 112.171 -178.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.539 ' HB ' HG21 ' A' ' 189' ' ' VAL . 34.1 mm -153.55 -74.25 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.229 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 44.97 -171.12 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.804 179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.436 ' O ' ' N ' ' A' ' 172' ' ' PHE . 47.1 tt0 -156.28 -71.52 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.8 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 73.3 mt 63.26 -70.12 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.886 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.436 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.2 m-85 -51.87 -71.14 0.07 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.808 0.337 . . . . 0.0 111.49 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -62.77 120.72 11.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.13 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 174' ' ' VAL . 11.9 p -175.77 39.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.09 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -134.99 -41.68 0.74 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.146 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 11.9 p -56.58 126.73 27.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -71.27 -33.44 69.77 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.046 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.6 mp0 -62.59 -28.88 70.19 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.124 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.444 ' CE2' HD21 ' A' ' 135' ' ' LEU . 11.8 t80 -73.92 -19.31 60.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.262 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 28.0 m -50.86 -48.14 60.2 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.549 -0.296 . . . . 0.0 110.94 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -64.68 -31.53 72.79 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.876 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.516 HD23 ' HD2' ' A' ' 133' ' ' PRO . 0.6 OUTLIER -68.85 -38.7 79.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.828 179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.0 -12.74 37.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.162 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.33 -23.29 8.91 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.379 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.912 ' HB3' HD11 ' A' ' 187' ' ' ILE . . . -53.9 -34.2 58.8 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.747 0.308 . . . . 0.0 111.058 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 7.9 t70 50.32 73.79 0.25 Allowed 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.071 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.912 HD11 ' HB3' ' A' ' 185' ' ' ALA . 0.1 OUTLIER -117.64 -145.78 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.336 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -162.31 104.24 1.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.77 0.319 . . . . 0.0 111.157 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.711 HG23 ' CG1' ' A' ' 165' ' ' ILE . 10.7 p -60.44 115.57 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.567 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.59 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 142.56 1.76 1.18 Allowed Glycine 0 CA--C 1.521 0.458 0 C-N-CA 120.593 -0.813 . . . . 0.0 113.412 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.532 ' O ' HG22 ' A' ' 165' ' ' ILE . 12.0 t -103.31 -165.15 1.14 Allowed 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 117.073 0.437 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 58.1 mt-10 -104.5 145.94 29.59 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.431 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.522 HG12 ' ND1' ' A' ' 206' ' ' HIS . 13.0 m -146.48 -163.38 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.228 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.562 ' HA ' ' CG2' ' A' ' 163' ' ' VAL . 9.5 pt-20 -150.38 163.24 38.85 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.643 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.616 HG21 ' HB1' ' A' ' 155' ' ' ALA . 4.2 tt -141.96 160.19 20.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 121.179 0.514 . . . . 0.0 111.408 -179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.499 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 18.3 m -146.64 113.6 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.882 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -70.01 175.42 4.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.084 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 18.6 ttt180 -153.94 172.69 17.03 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.793 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -60.77 91.28 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.03 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 63.49 51.97 50.14 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.589 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -165.78 136.35 3.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.86 0.362 . . . . 0.0 111.012 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.749 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -107.91 131.55 57.94 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.192 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.841 179.87 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.749 ' N ' HD13 ' A' ' 202' ' ' ILE . 1.6 t -160.02 135.31 8.11 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.031 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.476 HD23 ' HB ' ' A' ' 195' ' ' ILE . 54.9 mt -79.81 -176.18 5.28 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.561 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.428 ' OG ' HG22 ' A' ' 196' ' ' VAL . 3.4 m -154.49 109.44 3.07 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.665 0.269 . . . . 0.0 111.421 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.522 ' ND1' HG12 ' A' ' 193' ' ' VAL . 0.6 OUTLIER 179.8 -178.52 0.41 Allowed 'General case' 0 C--O 1.237 0.419 0 CA-C-O 121.008 0.432 . . . . 0.0 111.533 179.572 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.408 ' HB2' ' HD3' ' A' ' 131' ' ' PRO . 1.6 m-80 42.92 -88.66 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 115.437 -0.801 . . . . 0.0 111.48 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.485 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -78.48 -68.11 1.54 Allowed Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.339 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.485 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.6 mtmt -160.32 -69.72 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.86 0.362 . . . . 0.0 110.672 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -148.14 161.47 41.38 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.671 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.608 HG22 ' OD1' ' A' ' 130' ' ' ASN . 42.6 t -105.66 157.15 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.889 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.453 ' N ' HG12 ' A' ' 211' ' ' VAL . 28.1 mt-10 -79.61 -63.49 1.4 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.707 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.755 ' HB3' ' HB2' ' A' ' 218' ' ' ALA . 41.9 mt 56.26 174.61 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.452 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.625 HD21 ' HB3' ' A' ' 118' ' ' LYS . 0.3 OUTLIER -171.0 174.16 4.82 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.685 179.914 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -49.92 -30.11 9.59 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.299 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.6 -65.02 1.06 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.973 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.846 HD22 ' CB ' ' A' ' 135' ' ' LEU . 0.3 OUTLIER -55.8 -44.9 78.23 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.792 179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.755 ' HB2' ' HB3' ' A' ' 213' ' ' LEU . . . -90.62 39.31 0.97 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.35 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.495 ' CD2' HG22 ' A' ' 220' ' ' THR . 2.7 t-160 -90.26 -54.0 4.21 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.643 0.258 . . . . 0.0 111.032 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.558 HG23 ' HB2' ' A' ' 138' ' ' LEU . 0.0 OUTLIER -147.99 80.56 1.48 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 -178.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.96 HG12 HG22 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -124.16 146.77 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 177.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . . . . . . . . . 27.3 mtt85 -89.67 102.45 15.13 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -177.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.684 HG12 HD11 ' A' ' 221' ' ' ILE . 0.3 OUTLIER -151.34 31.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.817 178.102 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.666 ' HB2' HG21 ' A' ' 150' ' ' THR . 2.1 tt0 -152.88 157.75 41.14 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.733 -0.387 . . . . 0.0 111.742 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -116.56 -19.73 9.91 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.986 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.416 HD11 ' HA ' ' A' ' 160' ' ' PRO . 5.6 mt . . . . . 0 C--O 1.249 1.041 0 CA-C-O 118.253 -0.88 . . . . 0.0 110.93 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.515 -0.234 . . . . 0.0 112.515 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 44.8 m -84.77 139.31 32.05 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.767 0.318 . . . . 0.0 110.9 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -150.35 -51.97 0.14 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.869 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 47.3 mtt 60.83 104.52 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.019 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.15 147.01 34.74 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -87.38 -178.35 6.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.917 ' HB ' HG22 ' A' ' 202' ' ' ILE . 89.1 t -64.04 -28.55 45.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.398 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.409 ' O ' ' N ' ' A' ' 115' ' ' ARG . 0.0 OUTLIER -84.78 62.2 7.26 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.884 0.373 . . . . 0.0 110.688 179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 23.9 ttt180 -57.23 85.56 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.947 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . 0.409 ' N ' ' O ' ' A' ' 113' ' ' GLU . 66.4 mtp180 -41.33 -40.91 1.81 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.313 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.43 77.91 9.36 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.664 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 18.1 m -62.72 163.05 1.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.358 -179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -154.12 -49.51 0.09 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.871 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.704 HG22 ' H ' ' A' ' 120' ' ' LEU . 1.1 p -148.94 -166.43 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.874 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.704 ' H ' HG22 ' A' ' 119' ' ' VAL . 4.5 mm? -107.54 115.63 30.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.859 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -153.11 133.04 13.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.988 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -94.05 163.78 13.34 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.847 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 14.7 p -101.25 142.78 15.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.123 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 10.1 m 60.38 -89.26 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.108 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 176.26 159.44 0.3 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.917 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.6 m 60.08 73.24 0.66 Allowed Pre-proline 0 C--N 1.332 -0.194 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.152 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -75.46 -30.11 6.86 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.672 2.248 . . . . 0.0 112.477 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.71 150.83 45.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.117 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . 143.42 136.92 3.21 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.95 -0.643 . . . . 0.0 112.507 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.498 ' OD1' HG13 ' A' ' 211' ' ' VAL . 2.6 p-10 51.5 158.46 0.04 OUTLIER Pre-proline 0 N--CA 1.467 0.375 0 CA-C-O 120.927 0.394 . . . . 0.0 111.768 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.62 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 72.3 Cg_endo -76.41 135.45 16.57 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.703 2.269 . . . . 0.0 113.019 -179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.867 HD11 HG21 ' A' ' 221' ' ' ILE . 0.0 OUTLIER 135.77 -32.12 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.608 0 O-C-N 124.058 0.849 . . . . 0.0 112.089 179.234 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 1.5 Cg_endo -79.92 72.04 6.73 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.233 1.955 . . . . 0.0 112.427 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -88.11 118.12 4.98 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.244 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.557 ' O ' HD12 ' A' ' 138' ' ' LEU . 1.9 tt -73.19 -45.49 56.06 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.776 0.322 . . . . 0.0 111.233 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -90.28 9.25 29.45 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.514 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.83 ' O ' HG22 ' A' ' 168' ' ' ILE . 0.5 OUTLIER -90.21 -50.77 5.8 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.638 0.256 . . . . 0.0 111.225 -179.768 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.816 HD13 ' N ' ' A' ' 139' ' ' GLY . 0.0 OUTLIER -53.97 -14.92 1.15 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 112.316 0.488 . . . . 0.0 112.316 -179.602 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.816 ' N ' HD13 ' A' ' 138' ' ' LEU . . . -45.42 -91.9 0.01 OUTLIER Glycine 0 C--N 1.334 0.425 0 C-N-CA 121.109 -0.567 . . . . 0.0 113.255 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.512 ' O ' HG23 ' A' ' 168' ' ' ILE . 14.6 t -89.72 153.23 3.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.757 0.313 . . . . 0.0 111.362 -179.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.53 ' C ' HD12 ' A' ' 168' ' ' ILE . . . 92.01 155.64 32.02 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.951 -0.643 . . . . 0.0 112.428 179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.455 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 2.0 p30 -152.47 131.89 12.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.822 0.344 . . . . 0.0 111.405 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 1.2 m -97.85 170.6 8.85 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.945 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -158.68 -60.63 0.08 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.021 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.639 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -162.9 -163.06 0.82 Allowed 'General case' 0 CA--C 1.53 0.188 0 N-CA-C 111.829 0.307 . . . . 0.0 111.829 -179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.639 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 94.07 108.37 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.485 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.544 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 63.87 162.49 0.12 Allowed Pre-proline 0 N--CA 1.464 0.227 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.378 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.613 ' O ' ' HB2' ' A' ' 224' ' ' GLU . 79.3 Cg_exo -39.69 146.71 0.21 Allowed 'Trans proline' 0 C--N 1.351 0.686 0 C-N-CA 122.858 2.372 . . . . 0.0 112.048 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.718 ' HA2' ' HB ' ' A' ' 163' ' ' VAL . . . 151.55 -152.35 24.13 Favored Glycine 0 CA--C 1.519 0.295 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.892 -178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 224' ' ' GLU . 0.2 OUTLIER -152.13 144.59 24.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 110.227 -0.286 . . . . 0.0 110.227 178.724 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.502 ' C ' HG23 ' A' ' 152' ' ' VAL . 53.8 ttt180 -67.12 2.76 1.39 Allowed 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.943 HG22 ' CD1' ' A' ' 223' ' ' ILE . 2.4 t 74.03 -62.51 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 CA-C-O 120.918 0.39 . . . . 0.0 110.484 -179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . . . . . . . . . 44.9 pt -97.51 44.05 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.505 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.617 ' O ' HG22 ' A' ' 157' ' ' THR . 5.0 t70 -162.79 -32.93 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.686 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.829 ' HB1' HD13 ' A' ' 195' ' ' ILE . . . -27.86 -42.51 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 112.378 0.51 . . . . 0.0 112.378 -179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.831 ' HB2' ' HA ' ' A' ' 202' ' ' ILE . . . -76.99 62.0 2.06 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.855 0.36 . . . . 0.0 111.319 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 154' ' ' ASP . 3.0 t -173.32 -40.91 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.966 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.409 ' C ' ' HD3' ' A' ' 160' ' ' PRO . 3.1 t -77.5 -158.84 0.12 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.728 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 34.1 mtt -124.47 60.3 23.89 Favored Pre-proline 0 CA--C 1.53 0.183 0 CA-C-O 120.742 0.306 . . . . 0.0 111.021 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.409 ' HD3' ' C ' ' A' ' 158' ' ' SER . 81.9 Cg_exo -44.85 162.7 0.07 OUTLIER 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.928 2.419 . . . . 0.0 113.181 -179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 50.2 mtp85 -152.14 -45.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.348 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -161.26 78.66 0.58 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.227 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.745 ' HB ' HG22 ' A' ' 223' ' ' ILE . 32.9 m -69.94 143.45 14.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.849 -179.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.464 ' HG3' ' HB2' ' A' ' 148' ' ' PRO . 8.0 mtp85 -79.05 98.76 6.61 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.365 178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.785 ' HA ' ' O ' ' A' ' 222' ' ' ARG . 0.0 OUTLIER -76.41 79.98 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-O 121.401 0.62 . . . . 0.0 111.833 -178.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.632 HG13 ' HA2' ' A' ' 190' ' ' GLY . 0.0 OUTLIER -160.88 97.32 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.696 179.955 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.56 ' O ' ' CG ' ' A' ' 222' ' ' ARG . 0.9 OUTLIER 170.47 133.77 0.02 OUTLIER 'General case' 0 C--O 1.242 0.709 0 CA-C-O 121.585 0.707 . . . . 0.0 112.183 179.968 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.83 HG22 ' O ' ' A' ' 137' ' ' GLU . 3.0 mm 75.86 -2.44 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 CA-C-N 115.293 -0.867 . . . . 0.0 112.413 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.595 ' HB2' HG21 ' A' ' 189' ' ' VAL . 22.8 t30 -55.75 159.42 3.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.818 0.342 . . . . 0.0 110.939 179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -151.4 170.12 20.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.96 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -147.71 -47.0 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.055 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -60.44 -40.34 90.75 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -71.48 132.91 45.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.881 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.587 ' O ' HG13 ' A' ' 174' ' ' VAL . 7.5 p -162.59 93.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.127 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 176' ' ' THR . 3.6 tt0 -138.64 178.42 7.16 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.788 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.493 ' O ' ' O ' ' A' ' 175' ' ' GLU . 8.4 t 47.83 114.9 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.885 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.3 -2.97 15.07 Favored 'General case' 0 CA--C 1.531 0.244 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.775 179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 11.9 tp60 -58.53 -34.41 70.95 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.615 0.245 . . . . 0.0 111.431 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.462 ' HB3' HD13 ' A' ' 135' ' ' LEU . 2.4 p90 -75.44 -10.14 59.19 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.696 -179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 94.1 m -48.71 -40.92 30.17 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.802 0.334 . . . . 0.0 110.973 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -70.69 -35.85 72.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.663 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.49 HD23 ' O ' ' A' ' 133' ' ' PRO . 8.5 mp -73.85 -22.88 59.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.024 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER -69.63 -20.88 63.6 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.068 179.932 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.8 -38.56 61.35 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.799 0.333 . . . . 0.0 110.899 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.429 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -69.44 -27.6 65.4 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.162 179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.547 ' O ' HG13 ' A' ' 187' ' ' ILE . 13.8 m-20 84.06 -36.52 0.07 Allowed 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.558 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.703 HD13 ' NH1' ' A' ' 222' ' ' ARG . 0.6 OUTLIER 62.18 130.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.191 0 CA-C-O 121.012 0.434 . . . . 0.0 111.384 -179.787 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 6.3 mpt_? -126.82 88.79 2.88 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.862 -179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.601 ' O ' HG13 ' A' ' 189' ' ' VAL . 7.6 p -70.99 96.31 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.543 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.734 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 146.38 -1.21 0.85 Allowed Glycine 0 CA--C 1.521 0.461 0 C-N-CA 120.904 -0.665 . . . . 0.0 113.375 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.739 ' O ' HG22 ' A' ' 165' ' ' ILE . 4.5 t -97.03 -162.9 0.99 Allowed 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 117.053 0.427 . . . . 0.0 110.891 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -122.4 124.52 43.85 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.645 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.51 HG12 ' CG ' ' A' ' 206' ' ' HIS . 32.5 m -127.98 175.33 9.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.258 -179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -133.98 169.49 17.04 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.838 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.829 HD13 ' HB1' ' A' ' 155' ' ' ALA . 0.9 OUTLIER -155.85 154.62 6.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 121.023 0.439 . . . . 0.0 111.135 -179.98 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.431 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 17.6 m -141.5 155.2 20.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.952 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -69.94 155.38 40.66 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.89 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 43.1 ttm-85 -146.29 71.07 1.24 Allowed 'General case' 0 N--CA 1.453 -0.282 0 CA-C-O 120.987 0.423 . . . . 0.0 111.135 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 8.9 t70 54.43 60.28 3.65 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.224 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.01 44.12 96.38 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.563 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . 0.482 ' HA ' HG23 ' A' ' 112' ' ' VAL . 89.8 m-70 -152.55 131.71 12.72 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.723 0.297 . . . . 0.0 110.725 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.917 HG22 ' HB ' ' A' ' 112' ' ' VAL . 13.8 tt -79.99 139.53 18.1 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-O 120.9 0.381 . . . . 0.0 111.388 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.46 HG23 ' O ' ' A' ' 202' ' ' ILE . 16.7 p -158.41 119.86 3.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.457 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.697 HD22 HD12 ' A' ' 195' ' ' ILE . 1.0 OUTLIER -79.57 153.19 29.65 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.743 -179.707 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.428 ' HA ' ' HA ' ' A' ' 210' ' ' ASP . 39.0 m -126.78 125.71 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.324 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.51 ' CG ' HG12 ' A' ' 193' ' ' VAL . 0.8 OUTLIER -178.61 176.08 1.03 Allowed 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.989 0.423 . . . . 0.0 111.378 179.721 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 46.89 -87.81 0.01 OUTLIER 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.782 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -83.65 -62.6 1.76 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.841 -179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -160.72 -84.9 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.593 0.235 . . . . 0.0 111.231 -179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -138.14 178.87 6.8 Favored 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.835 0.35 . . . . 0.0 110.898 -179.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.498 HG13 ' OD1' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -133.16 179.08 4.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.791 179.785 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -108.63 -48.81 3.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.885 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . . . . . . . . . 87.4 mt 56.99 176.89 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.152 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.35 177.7 8.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.867 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -60.57 -29.92 69.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.316 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -75.07 -54.77 6.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.155 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.95 -30.78 68.25 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.289 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.438 ' O ' HG12 ' A' ' 152' ' ' VAL . . . -90.12 15.88 9.44 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.743 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.734 ' HD2' HG23 ' A' ' 220' ' ' THR . 4.0 t-160 -84.78 -58.83 2.55 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-O 120.809 0.337 . . . . 0.0 110.771 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.734 HG23 ' HD2' ' A' ' 219' ' ' HIS . 3.0 p -147.0 88.05 1.72 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.444 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.867 HG21 HD11 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -111.58 -172.1 0.48 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.687 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.564 -178.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.785 ' O ' ' HA ' ' A' ' 165' ' ' ILE . 1.7 mtm180 -84.28 76.22 10.13 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.439 0.903 . . . . 0.0 113.439 -176.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.943 ' CD1' HG22 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -153.51 134.0 4.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 176.563 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.613 ' HB2' ' O ' ' A' ' 148' ' ' PRO . 9.8 mt-10 -89.68 -108.8 0.08 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 145' ' ' ALA . 2.8 tt0 -150.99 112.44 4.41 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.206 0.457 . . . . 0.0 111.814 -179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 149' ' ' GLY . 0.6 OUTLIER . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.233 -0.889 . . . . 0.0 111.077 179.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.502 -0.239 . . . . 0.0 112.502 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 50.4 m -84.87 158.0 20.74 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.797 0.332 . . . . 0.0 110.915 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 80.1 m80 -148.6 -52.98 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 28.8 mtt -82.97 119.2 24.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.914 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -84.36 136.95 33.68 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.883 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -80.72 173.31 12.73 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.655 HG13 ' H ' ' A' ' 113' ' ' GLU . 0.6 OUTLIER -54.76 -75.05 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.241 -179.896 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.655 ' H ' HG13 ' A' ' 112' ' ' VAL . 5.6 pt-20 -87.48 62.52 7.17 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 120.888 0.375 . . . . 0.0 110.722 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.6 77.52 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.757 179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -51.72 -34.7 40.07 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.267 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 66.6 mt -74.53 92.77 2.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.919 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.8 p -164.21 148.87 2.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.064 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.0 mttt -146.93 -68.22 0.26 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.977 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 7.4 m -76.0 165.15 3.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.305 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -85.6 148.22 26.03 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.798 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 81.6 mttt -152.1 -51.3 0.11 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.962 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -68.05 -175.83 0.63 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.923 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 123' ' ' VAL . 3.3 p 41.12 90.61 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.663 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 60.4 p -140.04 -56.67 0.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.996 179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 35.2 ptt180 -107.86 -35.99 6.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.083 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 2.9 m -63.97 164.43 17.49 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.004 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.7 -161.27 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.78 2.32 . . . . 0.0 112.367 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.662 ' O ' HG13 ' A' ' 211' ' ' VAL . 6.7 p90 -111.84 -54.97 2.56 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.959 179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 117.2 -102.18 1.0 Allowed Glycine 0 C--N 1.331 0.299 0 C-N-CA 120.7 -0.762 . . . . 0.0 113.078 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.584 ' H ' HG22 ' A' ' 211' ' ' VAL . 3.7 p30 -143.92 163.37 36.0 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 120.673 0.273 . . . . 0.0 110.976 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.618 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 19.3 Cg_endo -60.46 138.42 80.37 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 122.951 2.434 . . . . 0.0 112.96 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.657 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.0 OUTLIER 138.81 -29.57 0.0 OUTLIER Pre-proline 0 N--CA 1.473 0.718 0 O-C-N 124.033 0.833 . . . . 0.0 112.314 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.786 ' HB2' HD23 ' A' ' 182' ' ' LEU . 12.3 Cg_exo -68.09 62.46 1.01 Allowed 'Trans proline' 0 C--N 1.352 0.717 0 C-N-CA 122.481 2.121 . . . . 0.0 112.842 -179.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.54 129.42 25.18 Favored Glycine 0 CA--C 1.518 0.281 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.283 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.693 HD22 ' CD2' ' A' ' 179' ' ' PHE . 0.2 OUTLIER -90.03 -44.25 9.97 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.752 0.31 . . . . 0.0 111.373 -179.654 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -90.15 9.0 30.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.437 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.541 ' O ' HD13 ' A' ' 168' ' ' ILE . 0.4 OUTLIER -90.06 -44.65 9.69 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.754 0.312 . . . . 0.0 110.994 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.511 HD22 ' O ' ' A' ' 216' ' ' ASP . 3.3 pp -41.17 -36.81 0.79 Allowed 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.833 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -85.78 65.73 3.87 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.766 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 90.6 t -152.79 -66.87 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.686 0.279 . . . . 0.0 111.019 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -139.4 -175.11 13.94 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.445 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.403 ' HB2' HG21 ' A' ' 220' ' ' THR . 2.3 p-10 -162.68 160.72 25.92 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.789 0.328 . . . . 0.0 111.263 -179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.1 m -163.17 133.38 4.44 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -92.7 -45.47 8.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.121 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -159.01 114.64 2.57 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.322 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -174.03 -168.14 0.39 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.025 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.894 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -56.83 -178.78 0.08 OUTLIER Pre-proline 0 C--N 1.332 -0.155 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.895 179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.894 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 95.3 Cg_exo -44.68 89.47 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 122.674 2.249 . . . . 0.0 112.648 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 147' ' ' ALA . . . 154.78 55.72 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.013 -0.613 . . . . 0.0 112.349 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.525 HG21 ' HA ' ' A' ' 225' ' ' GLU . 7.3 t -101.48 -163.87 1.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.732 0.301 . . . . 0.0 110.513 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.781 ' HD2' HD11 ' A' ' 153' ' ' ILE . 34.0 ptt180 -107.4 107.61 18.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.471 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.777 HG13 ' HB1' ' A' ' 218' ' ' ALA . 7.1 p -41.6 -30.55 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.03 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.781 HD11 ' HD2' ' A' ' 151' ' ' ARG . 23.3 pt -53.45 -42.09 47.63 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.113 0 CA-C-O 120.909 0.385 . . . . 0.0 111.128 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.409 ' N ' HG13 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -84.16 -46.54 11.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.878 179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.433 ' O ' HD13 ' A' ' 195' ' ' ILE . . . -62.72 80.24 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.155 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.547 ' HB2' HG21 ' A' ' 195' ' ' ILE . . . -172.21 -46.12 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.064 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.4 t -93.85 -3.62 51.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.47 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.483 ' O ' HD11 ' A' ' 226' ' ' LEU . 38.9 m -94.05 37.6 1.09 Allowed 'General case' 0 CA--C 1.529 0.139 0 CA-C-O 120.756 0.312 . . . . 0.0 111.327 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 11.2 ttt 57.67 61.45 5.95 Favored Pre-proline 0 C--N 1.332 -0.164 0 CA-C-O 120.854 0.359 . . . . 0.0 111.235 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.524 ' HB3' HD22 ' A' ' 226' ' ' LEU . 29.5 Cg_endo -62.73 170.69 6.76 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.814 2.342 . . . . 0.0 112.414 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 47.5 mtt85 -152.15 -47.9 0.11 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.756 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -170.02 89.04 0.16 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.953 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.507 HG21 HD11 ' A' ' 195' ' ' ILE . 26.8 m -80.59 -172.83 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.945 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.526 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 12.2 mtp85 -124.39 -170.95 2.24 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.076 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.749 HG23 ' O ' ' A' ' 165' ' ' ILE . 0.0 OUTLIER -147.69 79.89 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 CA-C-O 121.163 0.506 . . . . 0.0 110.426 179.483 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 165' ' ' ILE . 1.3 m -160.48 98.41 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.085 -179.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.637 ' CB ' ' HA ' ' A' ' 222' ' ' ARG . 0.2 OUTLIER 170.34 110.84 0.01 OUTLIER 'General case' 0 C--O 1.244 0.788 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.22 179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.639 HD12 ' HA ' ' A' ' 221' ' ' ILE . 12.7 mt 109.53 -39.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 114.663 -1.153 . . . . 0.0 110.363 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.493 ' O ' ' O ' ' A' ' 168' ' ' ILE . 22.4 t-20 49.9 164.53 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.88 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.461 ' O ' ' N ' ' A' ' 172' ' ' PHE . 0.2 OUTLIER 171.32 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.571 179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.728 HD11 HG12 ' A' ' 189' ' ' VAL . 66.4 mt 63.5 -64.5 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 179.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.461 ' N ' ' O ' ' A' ' 170' ' ' GLU . 8.0 m-85 -47.31 -79.27 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 N-CA-C 112.011 0.374 . . . . 0.0 112.011 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.474 ' O ' HG23 ' A' ' 174' ' ' VAL . 11.7 mm100 -64.98 116.51 6.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.938 0.399 . . . . 0.0 111.647 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.608 HG11 ' CD2' ' A' ' 183' ' ' LEU . 77.1 t -161.17 80.73 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.432 179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.644 ' O ' HG23 ' A' ' 176' ' ' THR . 14.0 mt-10 -106.18 98.73 8.37 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.123 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.656 HG21 HD13 ' A' ' 135' ' ' LEU . 1.0 OUTLIER -166.03 113.27 0.9 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.902 179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -70.83 -26.66 63.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.146 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 16.5 mp0 -72.3 -30.71 65.06 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.026 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.693 ' CD2' HD22 ' A' ' 135' ' ' LEU . 33.1 m-85 -90.16 20.64 4.21 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.486 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 55.9 m -57.36 -33.37 67.71 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 120.79 0.329 . . . . 0.0 110.642 179.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 73.2 mt-30 -72.25 -42.53 65.52 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.586 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.786 HD23 ' HB2' ' A' ' 133' ' ' PRO . 9.5 mp -71.14 -14.83 62.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.942 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.608 ' CD2' HG11 ' A' ' 174' ' ' VAL . 0.3 OUTLIER -74.8 -27.99 60.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.032 179.815 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -50.1 -43.07 51.41 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.075 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.503 ' HB1' ' HD3' ' A' ' 131' ' ' PRO . . . -66.6 -31.12 71.62 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.118 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 187' ' ' ILE . 30.5 m-20 67.43 13.67 9.4 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.545 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.727 HD12 HH22 ' A' ' 222' ' ' ARG . 6.1 pt 33.95 100.29 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 N-CA-C 112.298 0.481 . . . . 0.0 112.298 179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 7.1 mtt180 -102.52 90.69 3.94 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.668 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.728 HG12 HD11 ' A' ' 171' ' ' ILE . 10.6 p -59.83 115.81 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.894 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.641 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 136.59 -8.4 3.97 Favored Glycine 0 CA--C 1.519 0.298 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.823 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.657 ' O ' HG22 ' A' ' 165' ' ' ILE . 19.7 t -83.66 -169.33 2.51 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.788 0.328 . . . . 0.0 111.061 -179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -135.54 122.27 20.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.735 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.804 HG12 ' CG ' ' A' ' 206' ' ' HIS . 33.5 m -120.56 -179.11 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.273 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . 0.449 ' HA ' HG22 ' A' ' 163' ' ' VAL . 10.3 pt-20 -144.45 164.65 30.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.717 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.547 HG21 ' HB2' ' A' ' 156' ' ' ALA . 1.1 mp -128.97 153.27 38.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.182 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.401 ' O ' HG23 ' A' ' 196' ' ' VAL . 8.8 m -154.26 110.02 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.028 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -71.96 157.79 37.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.98 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 31.6 mtp180 -159.21 118.5 2.98 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.935 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 6.5 t70 69.73 -66.86 0.25 Allowed 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.115 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -179.64 49.86 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.441 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 81.6 m-70 -156.45 149.73 24.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.784 0.326 . . . . 0.0 111.008 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.754 HD13 ' N ' ' A' ' 203' ' ' THR . 0.0 OUTLIER -102.19 133.59 45.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.916 179.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.754 ' N ' HD13 ' A' ' 202' ' ' ILE . 30.4 p -142.83 129.37 20.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.917 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.551 ' O ' HG23 ' A' ' 211' ' ' VAL . 4.2 mm? -79.98 105.01 10.94 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.811 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.434 ' HA ' ' O ' ' A' ' 209' ' ' LYS . 2.4 m -86.09 120.23 27.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.957 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.804 ' CG ' HG12 ' A' ' 193' ' ' VAL . 21.9 t-80 -176.01 166.49 2.98 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.023 0.44 . . . . 0.0 111.644 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 9.0 m120 40.69 -90.32 0.01 OUTLIER 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.852 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -67.9 -71.3 0.97 Allowed Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.606 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 205' ' ' SER . 2.4 ptpt -161.76 -63.7 0.05 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.829 0.347 . . . . 0.0 110.928 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -152.93 174.28 14.32 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.543 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.738 HG11 ' HG3' ' A' ' 133' ' ' PRO . 12.3 t -125.18 140.05 49.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.928 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -112.04 55.73 0.67 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.97 0.414 . . . . 0.0 111.226 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 218' ' ' ALA . 4.2 pp -83.25 173.05 11.97 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.609 179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.473 HD12 ' CB ' ' A' ' 216' ' ' ASP . 0.3 OUTLIER -97.04 164.79 12.37 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.814 0.34 . . . . 0.0 110.954 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 61.0 m-20 -58.17 -37.95 75.71 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.515 -179.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.511 ' O ' HD22 ' A' ' 138' ' ' LEU . 0.8 OUTLIER -62.01 -45.1 95.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.039 -179.821 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.544 HD21 ' CE1' ' A' ' 179' ' ' PHE . 3.0 mp -60.34 -37.78 81.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.323 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.78 ' O ' HG23 ' A' ' 153' ' ' ILE . . . -90.72 14.12 14.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.755 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 3.4 t-160 -67.85 70.57 0.14 Allowed 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.964 0.411 . . . . 0.0 111.047 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.769 HG22 ' CB ' ' A' ' 151' ' ' ARG . 6.5 p 59.13 85.8 0.09 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.289 179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.639 ' HA ' HD12 ' A' ' 168' ' ' ILE . 0.8 OUTLIER -118.94 -147.87 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.448 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.544 -179.748 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.727 HH22 HD12 ' A' ' 187' ' ' ILE . 6.3 ptt180 -84.95 88.41 7.44 Favored 'General case' 0 CA--C 1.524 -0.053 0 N-CA-C 112.228 0.455 . . . . 0.0 112.228 -178.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.53 HD12 ' C ' ' A' ' 222' ' ' ARG . 3.3 mp -151.42 151.12 12.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.256 178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.526 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 2.3 tm-20 -89.85 159.03 17.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-O 120.633 0.254 . . . . 0.0 110.363 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.525 ' HA ' HG21 ' A' ' 150' ' ' THR . 0.5 OUTLIER -89.25 104.55 17.09 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.955 -179.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.524 HD22 ' HB3' ' A' ' 160' ' ' PRO . 3.1 pp . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.257 -0.877 . . . . 0.0 111.312 -179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.152 0 N-CA-C 112.522 -0.231 . . . . 0.0 112.522 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 33.2 m -83.51 -52.4 6.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.752 0.31 . . . . 0.0 110.939 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 3.3 t60 70.62 -66.73 0.27 Allowed 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.072 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 25.6 mtt -113.25 163.37 14.88 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.944 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -79.05 142.57 36.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.912 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 -90.05 -87.74 0.18 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.061 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.47 HG13 ' N ' ' A' ' 113' ' ' GLU . 14.7 p -90.35 -45.52 14.94 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.133 0 CA-C-O 120.699 0.285 . . . . 0.0 111.409 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.47 ' N ' HG13 ' A' ' 112' ' ' VAL . 33.1 mt-10 -84.18 100.26 11.05 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.908 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -80.95 76.81 7.89 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 22.9 ptt180 -88.54 66.16 8.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 84.9 mt -143.62 -51.59 0.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.3 m -69.81 148.27 11.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.21 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -112.99 -40.03 4.07 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.021 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.5 m -67.49 163.23 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.26 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.8 tt -94.53 118.4 31.61 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.922 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -147.08 173.91 12.05 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.857 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -152.57 152.33 31.72 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.899 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 123' ' ' VAL . 7.3 p -151.98 101.97 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.077 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.5 t -167.01 -179.03 4.45 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.903 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 15.0 ptt180 -71.81 -37.9 70.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.005 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 63.3 p -164.33 79.45 1.43 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.989 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -61.22 -162.28 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.748 2.299 . . . . 0.0 112.18 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 4.0 p90 42.0 91.64 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.328 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.344 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -167.76 161.21 34.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.76 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.474 ' HA ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER 61.91 144.61 0.07 OUTLIER Pre-proline 0 N--CA 1.464 0.234 0 CA-C-O 120.611 0.243 . . . . 0.0 110.953 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.509 ' CB ' ' HA ' ' A' ' 187' ' ' ILE . 1.9 Cg_endo -86.33 105.01 0.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.116 2.544 . . . . 0.0 112.658 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.723 HG21 HG21 ' A' ' 193' ' ' VAL . 0.0 OUTLIER -164.83 -57.77 0.01 OUTLIER Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.508 ' HB3' HD21 ' A' ' 213' ' ' LEU . 5.1 Cg_endo -85.08 121.82 2.44 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.727 2.284 . . . . 0.0 113.98 -177.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.499 ' HA2' HD12 ' A' ' 187' ' ' ILE . . . -91.86 170.99 33.95 Favored Glycine 0 CA--C 1.503 -0.707 0 CA-C-N 115.492 -0.776 . . . . 0.0 112.193 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.826 ' O ' ' N ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER -69.66 128.62 37.1 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -26.78 66.3 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 O-C-N 124.552 1.158 . . . . 0.0 113.03 -177.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.826 ' N ' ' O ' ' A' ' 135' ' ' LEU . 26.5 tt0 -90.63 -55.35 3.61 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 177.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 145' ' ' ALA . 3.9 mm? -90.6 -16.91 27.85 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 114.59 -1.187 . . . . 0.0 109.744 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -64.19 116.08 8.67 Favored Glycine 0 C--N 1.341 0.822 0 C-N-CA 120.473 -0.87 . . . . 0.0 112.792 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.546 ' H ' HG22 ' A' ' 220' ' ' THR . 8.1 p -150.44 -41.73 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-O 120.605 0.24 . . . . 0.0 111.249 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 147.19 86.74 0.06 OUTLIER Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.655 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 173.34 -178.23 0.08 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.704 0.287 . . . . 0.0 110.787 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 4.9 p -76.6 -43.78 37.17 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.577 179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -173.94 -178.01 1.45 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.441 ' HB2' HD12 ' A' ' 138' ' ' LEU . . . -110.07 -86.6 0.53 Allowed 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.617 ' HB3' ' NE ' ' A' ' 222' ' ' ARG . . . -91.98 138.81 31.23 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.63 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.795 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . 57.54 -179.6 0.03 OUTLIER Pre-proline 0 C--N 1.332 -0.163 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.325 -179.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.795 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 53.8 Cg_exo -52.33 -176.57 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.244 1.963 . . . . 0.0 112.001 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.442 ' HA2' ' C ' ' A' ' 223' ' ' ILE . . . 162.77 140.32 2.84 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.382 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.803 HG21 HD22 ' A' ' 226' ' ' LEU . 6.2 t -176.66 -33.08 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.353 0 N-CA-C 111.952 0.352 . . . . 0.0 111.952 -179.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.848 ' CB ' HG21 ' A' ' 223' ' ' ILE . 4.7 tmm_? -20.08 -55.71 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -179.287 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.512 HG12 HD13 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -94.22 -44.78 13.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.658 0.266 . . . . 0.0 111.658 -179.243 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.793 HD13 ' O ' ' A' ' 219' ' ' HIS . 0.2 OUTLIER -109.41 109.45 28.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.318 -179.411 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.535 ' CB ' ' O ' ' A' ' 153' ' ' ILE . 58.3 m-20 98.58 -38.89 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.067 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.629 ' HB2' ' C ' ' A' ' 150' ' ' THR . . . -36.74 -46.88 0.63 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 111.858 0.318 . . . . 0.0 111.858 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.7 ' HB2' HD11 ' A' ' 195' ' ' ILE . . . -78.11 65.56 3.53 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.15 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 7.2 m -162.9 -45.99 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.132 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.503 ' HB3' HD11 ' A' ' 226' ' ' LEU . 0.3 OUTLIER -95.5 43.07 1.09 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.41 -179.651 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 48.9 mtt 53.02 74.31 0.79 Allowed Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.288 179.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.593 ' HA ' HD12 ' A' ' 226' ' ' LEU . 18.8 Cg_endo -58.73 139.88 92.63 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.874 2.383 . . . . 0.0 112.663 -179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -139.26 -43.87 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.595 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -162.19 120.79 2.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.471 179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.52 HG21 ' CG ' ' A' ' 151' ' ' ARG . 1.0 OUTLIER -122.69 128.68 75.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.452 -179.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 12.3 mtt180 -80.02 123.21 27.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.489 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.779 HD12 ' HA ' ' A' ' 189' ' ' VAL . 0.0 OUTLIER -90.34 124.27 42.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.786 0.327 . . . . 0.0 110.262 178.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.728 ' N ' HD13 ' A' ' 165' ' ' ILE . 21.4 t -144.61 87.51 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-O 120.966 0.412 . . . . 0.0 111.621 -179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.621 ' HA ' HG11 ' A' ' 189' ' ' VAL . 4.6 tt0 91.91 105.92 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.335 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.794 HG22 HG21 ' A' ' 221' ' ' ILE . 2.4 pp -142.1 -45.33 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.337 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.656 ' OD1' HD11 ' A' ' 187' ' ' ILE . 52.3 t30 -74.27 159.74 32.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.969 0.414 . . . . 0.0 111.556 -179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.426 ' O ' ' HB ' ' A' ' 171' ' ' ILE . 5.0 tt0 -104.48 -42.38 5.47 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.679 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 170' ' ' GLU . 94.0 mt 69.12 -64.78 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.596 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -54.46 -34.79 62.18 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.248 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -99.16 127.4 45.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.981 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.62 ' O ' HG13 ' A' ' 174' ' ' VAL . 7.9 p -168.12 96.49 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.045 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -138.01 -43.52 0.52 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.11 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.504 ' HG1' ' HD2' ' A' ' 179' ' ' PHE . 1.0 OUTLIER -57.67 122.34 12.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.132 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -74.67 -25.66 59.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.159 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -62.15 -26.98 68.63 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.16 -179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.504 ' HD2' ' HG1' ' A' ' 176' ' ' THR . 19.1 m-85 -82.6 -6.2 59.22 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.424 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 61.3 m -56.34 -41.25 75.79 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.76 0.314 . . . . 0.0 110.889 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 48.1 mt-30 -66.2 -35.82 81.45 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.49 -26.73 46.05 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.898 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.445 ' O ' HD23 ' A' ' 183' ' ' LEU . 0.9 OUTLIER -69.55 -23.72 63.61 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.1 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -54.91 -32.98 61.66 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.948 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.42 ' O ' ' CB ' ' A' ' 186' ' ' ASP . . . -68.01 -31.76 71.67 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.124 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 187' ' ' ILE . 13.9 m-20 83.83 -29.14 0.09 Allowed 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.631 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.656 HD11 ' OD1' ' A' ' 169' ' ' ASN . 7.4 pt 39.89 103.08 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.298 0 CA-C-O 121.315 0.579 . . . . 0.0 111.946 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 3.8 mtp180 -114.6 108.96 17.52 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.562 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.779 ' HA ' HD12 ' A' ' 165' ' ' ILE . 35.2 m -52.69 157.02 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.251 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.706 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 101.99 -15.96 56.21 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.934 -0.651 . . . . 0.0 112.302 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.735 ' O ' HG22 ' A' ' 165' ' ' ILE . 7.7 t -74.55 -166.99 0.49 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.01 0.433 . . . . 0.0 111.301 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -149.29 136.86 20.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.315 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.786 HG12 ' CG ' ' A' ' 206' ' ' HIS . 29.8 m -141.61 175.25 5.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.967 0.413 . . . . 0.0 111.801 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 24.2 tt0 -125.7 162.85 24.12 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.421 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.798 HD12 ' N ' ' A' ' 196' ' ' VAL . 0.1 OUTLIER -136.84 140.97 41.99 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.916 0.389 . . . . 0.0 110.856 -179.82 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.798 ' N ' HD12 ' A' ' 195' ' ' ILE . 11.0 m -154.25 118.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.023 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -70.0 159.25 34.14 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -168.91 143.18 3.07 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.107 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 9.0 t70 68.08 -70.53 0.12 Allowed 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.158 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 175.19 43.03 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.519 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.05 165.71 17.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.856 0.36 . . . . 0.0 111.031 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.441 ' HB ' HG22 ' A' ' 112' ' ' VAL . 19.9 tt -87.24 150.3 3.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.136 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 6.0 t -160.05 116.96 2.51 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.945 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -80.0 106.22 11.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.676 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 7.0 m -85.73 129.41 34.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.192 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.786 ' CG ' HG12 ' A' ' 193' ' ' VAL . 10.9 t60 -143.94 145.55 32.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.614 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -33.39 -40.02 0.06 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.439 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -62.65 -70.58 1.01 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.26 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.8 mtmt -158.87 -174.66 4.87 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.742 0.306 . . . . 0.0 110.672 179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.44 133.51 53.68 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.175 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -114.75 159.19 14.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.481 -179.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -83.18 -58.3 2.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.629 179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.512 HD13 HG12 ' A' ' 152' ' ' VAL . 1.7 mt 64.2 151.69 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.205 179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.527 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 0.4 OUTLIER -140.42 -175.59 4.32 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.716 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -59.67 -28.95 67.71 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.394 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -53.73 -67.61 0.24 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.806 0.336 . . . . 0.0 110.937 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.597 ' O ' HD11 ' A' ' 221' ' ' ILE . 6.4 mp -78.82 -34.29 45.42 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.063 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.527 ' HB3' ' O ' ' A' ' 214' ' ' LEU . . . -90.73 33.94 0.91 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.602 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.793 ' O ' HD13 ' A' ' 153' ' ' ILE . 0.0 OUTLIER -81.71 -56.43 4.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.722 0.296 . . . . 0.0 110.906 179.987 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.723 ' HA ' HG21 ' A' ' 153' ' ' ILE . 13.5 t -174.67 72.77 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.021 0.439 . . . . 0.0 111.162 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.794 HG21 HG22 ' A' ' 168' ' ' ILE . 4.9 mm -89.55 171.72 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.493 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.687 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.617 ' NE ' ' HB3' ' A' ' 146' ' ' ALA . 53.6 ttt180 -89.71 99.64 12.6 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.986 0.422 . . . . 0.0 111.612 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.848 HG21 ' CB ' ' A' ' 151' ' ' ARG . 0.4 OUTLIER -129.79 -149.97 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 179.071 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.587 ' O ' HG22 ' A' ' 150' ' ' THR . 0.0 OUTLIER -118.85 -179.52 3.84 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.707 0.289 . . . . 0.0 110.803 179.353 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.419 ' O ' ' C ' ' A' ' 226' ' ' LEU . 30.3 tt0 -111.78 96.21 5.94 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.031 -179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.803 HD22 HG21 ' A' ' 150' ' ' THR . 1.7 pt? . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.77 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 18.2 t -152.3 -53.94 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.743 0.306 . . . . 0.0 110.908 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -85.14 164.7 17.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 60.9 mtt -146.56 -59.89 0.3 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.868 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -89.91 115.46 27.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.97 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -86.43 167.3 14.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.826 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.421 HG22 ' HB3' ' A' ' 156' ' ' ALA . 35.2 m -76.16 -41.75 37.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.26 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.419 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.4 OUTLIER -90.27 18.37 6.11 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.405 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 1.1 mmt180 -90.05 -51.94 5.21 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.769 0.319 . . . . 0.0 110.917 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 7.3 mmt85 -80.44 147.96 30.73 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.029 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 19.5 mt -147.87 113.24 5.6 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.787 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.5 m -112.77 -37.48 2.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.307 -179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -109.3 172.37 6.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.929 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 m -89.63 -37.68 10.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.483 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -155.24 -58.79 0.1 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.022 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 77.8 tttt -78.1 157.8 29.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.975 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -163.66 -46.48 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.786 179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 99.1 t 61.42 105.97 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.222 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 68.0 m -138.81 90.11 2.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.806 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.48 80.15 0.21 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.097 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.1 m 59.27 86.12 0.17 Allowed Pre-proline 0 C--N 1.331 -0.21 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.18 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.495 ' O ' HG12 ' A' ' 211' ' ' VAL . 60.0 Cg_endo -72.37 -25.57 18.21 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.594 2.196 . . . . 0.0 112.338 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.423 ' CG ' ' HB3' ' A' ' 181' ' ' GLN . 3.9 p90 -114.02 144.0 43.82 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.732 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 164.17 -98.83 0.16 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.811 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -56.31 153.75 18.43 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 120.758 0.313 . . . . 0.0 111.234 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.599 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 89.1 Cg_endo -81.83 137.57 10.01 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.892 2.395 . . . . 0.0 112.87 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.741 ' H ' HG22 ' A' ' 187' ' ' ILE . 0.0 OUTLIER 143.1 -30.99 0.0 OUTLIER Pre-proline 0 N--CA 1.469 0.486 0 O-C-N 123.922 0.763 . . . . 0.0 111.859 179.441 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.643 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 2.7 Cg_exo -73.53 63.34 4.59 Favored 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 122.362 2.042 . . . . 0.0 112.326 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -71.55 81.37 0.51 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.889 -0.672 . . . . 0.0 112.562 179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.493 HD23 ' CZ ' ' A' ' 179' ' ' PHE . 14.4 tp -70.86 -39.39 72.95 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.832 0.348 . . . . 0.0 110.803 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -90.11 8.63 31.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.025 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.409 ' HG2' ' HB ' ' A' ' 168' ' ' ILE . 2.5 mp0 -88.94 -170.99 3.12 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.709 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.792 ' O ' HG23 ' A' ' 220' ' ' THR . 1.0 OUTLIER -62.09 84.6 0.02 OUTLIER 'General case' 0 C--O 1.232 0.14 0 CA-C-O 120.845 0.355 . . . . 0.0 111.126 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.49 32.26 5.09 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.004 -0.617 . . . . 0.0 112.913 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.696 ' C ' HG21 ' A' ' 220' ' ' THR . 18.1 t -128.82 116.5 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-O 120.689 0.281 . . . . 0.0 111.179 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 124.69 -172.33 16.92 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.536 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -175.4 166.43 3.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.728 0.299 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 151' ' ' ARG . 0.5 OUTLIER -137.35 -174.34 3.73 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.388 -0.369 . . . . 0.0 111.059 179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -139.13 -43.33 0.46 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.119 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.615 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -158.6 -157.93 0.66 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.337 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 85.77 -179.73 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.47 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.967 ' HB1' ' HD2' ' A' ' 148' ' ' PRO . . . -56.71 -176.66 0.05 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.328 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.967 ' HD2' ' HB1' ' A' ' 147' ' ' ALA . 68.4 Cg_exo -41.31 98.68 0.03 OUTLIER 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 122.757 2.305 . . . . 0.0 112.928 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 164.74 41.83 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.341 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.079 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.493 HG23 ' H ' ' A' ' 152' ' ' VAL . 13.6 t -80.6 -7.19 59.17 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 111.575 0.213 . . . . 0.0 111.575 -179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 221' ' ' ILE . 4.4 mpt_? 60.56 25.96 15.63 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.738 0.304 . . . . 0.0 111.234 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.012 HG11 ' HB1' ' A' ' 218' ' ' ALA . 21.4 t 70.68 -58.24 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.215 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.535 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.475 ' O ' HG23 ' A' ' 153' ' ' ILE . 5.4 tt -55.41 79.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 CA-C-O 120.999 0.428 . . . . 0.0 111.39 -179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.511 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER 167.7 -35.35 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.382 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.87 ' HB1' HD21 ' A' ' 226' ' ' LEU . . . -52.27 -25.28 9.03 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.598 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.421 ' HB3' HG22 ' A' ' 112' ' ' VAL . . . -98.73 32.9 2.44 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.372 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.0 t -170.96 32.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.352 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.448 ' HB3' HD12 ' A' ' 226' ' ' LEU . 7.4 t -153.06 34.46 0.47 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.195 179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . 0.402 ' C ' HD13 ' A' ' 226' ' ' LEU . 41.2 ttm 66.44 75.29 0.33 Allowed Pre-proline 0 N--CA 1.463 0.192 0 CA-C-N 116.409 -0.359 . . . . 0.0 111.008 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.651 ' HA ' HD22 ' A' ' 226' ' ' LEU . 29.0 Cg_endo -62.83 152.85 76.56 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.843 2.362 . . . . 0.0 112.799 -179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.04 -45.26 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.678 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 11.9 mttt -170.2 124.97 0.75 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.706 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 193' ' ' VAL . 6.4 m -110.28 123.0 65.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-O 120.922 0.391 . . . . 0.0 111.488 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -84.22 102.09 12.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.874 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.681 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.2 OUTLIER -79.47 122.25 34.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.886 0.374 . . . . 0.0 110.649 179.839 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.606 ' N ' HD13 ' A' ' 165' ' ' ILE . 20.4 t -144.39 85.86 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.152 -179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.596 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 33.4 tt0 103.54 147.24 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.074 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.881 HG22 HG23 ' A' ' 221' ' ' ILE . 0.4 OUTLIER -149.59 -66.15 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.833 -0.622 . . . . 0.0 111.08 -179.811 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -177.96 -168.52 0.17 Allowed 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.543 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -125.03 -77.29 0.59 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.583 -0.281 . . . . 0.0 111.131 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.87 -175.57 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.105 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -163.7 -55.39 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.862 179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 36.4 tt0 -163.85 -65.88 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.902 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.541 ' O ' ' CG1' ' A' ' 174' ' ' VAL . 0.4 OUTLIER 72.0 107.2 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 121.292 0.568 . . . . 0.0 110.784 -179.876 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.59 55.79 0.49 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.954 -179.579 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 1.8 t -161.75 130.12 4.27 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -73.2 -22.43 60.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.285 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 15.8 mp0 -60.96 -31.49 71.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.539 -0.3 . . . . 0.0 111.293 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.493 ' CZ ' HD23 ' A' ' 135' ' ' LEU . 5.4 m-85 -76.09 -17.17 59.73 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.322 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 84.8 m -51.85 -43.84 63.39 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.77 0.319 . . . . 0.0 110.812 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . 0.423 ' HB3' ' CG ' ' A' ' 128' ' ' PHE . 55.4 mt-30 -70.83 -33.02 70.25 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.757 179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . . . . . . . . . 9.5 mp -74.58 -25.05 59.02 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.832 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.3 tp -84.48 -2.71 57.68 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.573 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -48.25 -50.25 30.37 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 120.781 0.324 . . . . 0.0 111.057 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -82.9 -23.37 33.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.129 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.431 ' O ' ' O ' ' A' ' 187' ' ' ILE . 9.3 m-20 65.89 16.2 10.38 Favored 'General case' 0 CA--C 1.529 0.17 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.413 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.741 HG22 ' H ' ' A' ' 132' ' ' ILE . 24.0 pt 38.15 99.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.268 0 CA-C-O 121.1 0.476 . . . . 0.0 111.988 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.84 134.49 42.67 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 33.6 m -74.93 141.82 15.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.777 179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.543 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 104.54 -8.65 47.83 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.842 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.491 ' O ' HG22 ' A' ' 165' ' ' ILE . 16.4 t -70.23 174.92 5.01 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.87 0.367 . . . . 0.0 110.953 -179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 -132.33 111.88 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.676 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.744 HG12 ' CD2' ' A' ' 206' ' ' HIS . 27.2 m -121.59 176.94 3.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.362 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -142.13 160.76 39.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.521 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.448 ' CG1' ' N ' ' A' ' 196' ' ' VAL . 1.8 tt -134.62 155.7 39.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.162 0.506 . . . . 0.0 111.152 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.448 ' N ' ' CG1' ' A' ' 195' ' ' ILE . 7.1 m -156.92 132.52 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.439 -0.801 . . . . 0.0 111.077 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -78.27 145.55 35.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.834 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 83.4 mtt180 -157.35 116.6 3.33 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.143 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 51.99 40.76 28.94 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.266 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.88 62.15 6.0 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.459 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 53.2 m-70 -159.48 158.47 32.01 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.77 0.319 . . . . 0.0 110.82 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 19.2 tt -106.42 141.79 20.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.208 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 203' ' ' THR . 6.3 t -159.9 111.42 2.0 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.853 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.875 HD23 HD22 ' A' ' 213' ' ' LEU . 3.6 mm? -81.19 98.4 8.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.748 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 2.7 m -77.07 110.15 11.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.126 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.744 ' CD2' HG12 ' A' ' 193' ' ' VAL . 24.6 t-80 -107.62 147.21 30.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.511 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -41.33 -34.4 0.51 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.296 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -77.25 -57.49 3.64 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.496 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 4.1 ptpt -160.68 -175.19 4.83 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.687 0.279 . . . . 0.0 110.875 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -110.6 149.0 31.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.542 179.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.495 HG12 ' O ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -116.71 175.64 2.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.181 -179.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.44 ' OE1' HD23 ' A' ' 214' ' ' LEU . 1.4 tm-20 -90.7 -66.56 0.92 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.952 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.875 HD22 HD23 ' A' ' 204' ' ' LEU . 7.8 mp 60.55 155.63 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.924 0.392 . . . . 0.0 111.36 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.603 HD22 ' O ' ' A' ' 213' ' ' LEU . 0.5 OUTLIER -144.69 -175.45 4.67 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.65 179.894 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -64.68 -29.13 70.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.998 179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.26 -45.58 11.84 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.808 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.447 HD22 ' HG ' ' A' ' 213' ' ' LEU . 0.1 OUTLIER -55.61 -69.74 0.13 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 1.012 ' HB1' HG11 ' A' ' 152' ' ' VAL . . . -90.52 49.78 1.73 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.904 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . . . . . . . . . 2.7 t-160 -84.65 -38.78 19.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.313 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.792 HG23 ' O ' ' A' ' 138' ' ' LEU . 0.5 OUTLIER -156.55 90.37 1.16 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.874 0.369 . . . . 0.0 111.891 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.881 HG23 HG22 ' A' ' 168' ' ' ILE . 23.8 mm -118.96 162.15 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.011 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.477 ' N ' HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -89.66 90.35 8.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.14 0.495 . . . . 0.0 111.268 -179.47 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.681 HG23 ' HA ' ' A' ' 165' ' ' ILE . 0.1 OUTLIER -137.62 175.16 9.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.124 179.553 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 148' ' ' PRO . 0.5 OUTLIER -89.64 162.78 15.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.0 110.824 179.732 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -89.66 56.04 3.4 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.797 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.87 HD21 ' HB1' ' A' ' 155' ' ' ALA . 6.0 mt . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.166 -0.921 . . . . 0.0 111.043 179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.182 0 N-CA-C 112.5 -0.24 . . . . 0.0 112.5 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 48.3 m -151.86 101.14 2.73 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.794 0.33 . . . . 0.0 110.957 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 51.6 m80 -93.45 174.45 7.19 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.9 ttm -152.45 -55.75 0.13 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 -90.01 59.76 4.64 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.006 180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.08 108.08 19.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.502 HG11 ' HB3' ' A' ' 156' ' ' ALA . 14.6 p -88.81 -46.06 15.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.136 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.476 ' N ' HG13 ' A' ' 112' ' ' VAL . 0.6 OUTLIER -90.34 48.86 1.6 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.88 0.371 . . . . 0.0 110.912 179.876 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 59.9 ttt180 -90.13 -41.24 11.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.054 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 15.6 ttt180 -85.54 144.0 28.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.977 -179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 5.1 mp -145.08 112.71 6.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.842 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -150.38 168.88 2.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.15 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -133.48 100.29 4.76 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.856 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 12.7 t -144.34 -44.12 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.191 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 tt 65.39 46.41 2.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.889 -179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 53.4 mttt -100.08 -46.46 5.32 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.832 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.8 t70 62.27 147.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.117 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.415 HG13 ' O ' ' A' ' 123' ' ' VAL . 11.1 p -168.26 125.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.131 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.4 t -169.71 157.68 7.12 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.92 179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 7.8 tpt180 -86.09 83.71 7.69 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.851 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -166.55 167.65 7.97 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.884 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -80.82 -19.26 8.6 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.705 2.27 . . . . 0.0 112.644 -179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 62.51 110.62 0.02 OUTLIER 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.782 0.325 . . . . 0.0 111.111 -179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.415 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -166.37 -150.78 6.49 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.701 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.469 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 8.1 p30 53.95 159.18 0.05 OUTLIER Pre-proline 0 N--CA 1.465 0.301 0 CA-C-O 120.966 0.412 . . . . 0.0 111.843 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.647 ' O ' ' HB ' ' A' ' 132' ' ' ILE . 83.2 Cg_endo -78.84 137.12 13.83 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.824 2.349 . . . . 0.0 111.98 179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 160.44 -31.03 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.447 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 179.373 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 23.8 Cg_exo -63.65 118.54 5.46 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 121.634 1.556 . . . . 0.0 112.986 -178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -91.23 -32.77 8.57 Favored Glycine 0 N--CA 1.451 -0.332 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.448 179.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.808 ' CB ' HD12 ' A' ' 217' ' ' LEU . 2.2 pp -36.59 -37.31 0.13 Allowed 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 36.4 m-20 -61.51 -50.76 71.42 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.207 -179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.679 ' HG2' HD11 ' A' ' 168' ' ' ILE . 2.1 pm0 -90.67 -21.3 21.71 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.634 -179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.742 HD12 HD11 ' A' ' 221' ' ' ILE . 6.5 tt -29.57 95.63 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.391 0 CA-C-O 121.029 0.443 . . . . 0.0 112.018 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -90.35 -93.15 1.23 Allowed Glycine 0 N--CA 1.452 -0.274 0 CA-C-N 115.681 -0.691 . . . . 0.0 112.427 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 4.8 t -145.46 42.56 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.823 0.344 . . . . 0.0 111.181 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -73.36 -149.23 1.22 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.236 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.433 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 0.9 OUTLIER 179.48 177.84 0.56 Allowed 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.925 0.393 . . . . 0.0 111.261 179.771 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 59.6 p -156.86 -173.47 4.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.778 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 t70 63.91 74.09 0.42 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.151 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -171.48 -69.98 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.944 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -126.37 -62.4 1.15 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.775 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -176.18 -63.01 0.0 OUTLIER Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.073 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.775 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 7.1 Cg_exo -33.94 97.35 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.361 0 C-N-CA 123.219 2.613 . . . . 0.0 113.188 179.218 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.624 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 97.82 112.41 3.07 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.797 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.452 ' HB ' ' O ' ' A' ' 149' ' ' GLY . 2.8 t 175.92 78.3 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.667 ' HB2' ' HB ' ' A' ' 221' ' ' ILE . 11.0 tpp180 -78.84 92.61 4.88 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.947 HG13 HD11 ' A' ' 202' ' ' ILE . 8.1 p 48.91 20.44 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.905 -178.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.828 HD13 ' O ' ' A' ' 219' ' ' HIS . 2.9 tt -106.32 10.55 9.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 CA-C-O 121.221 0.534 . . . . 0.0 110.312 179.281 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 177.9 -35.14 0.01 OUTLIER 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.4 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.572 ' HA ' HD11 ' A' ' 226' ' ' LEU . . . -88.41 43.72 1.15 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.151 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.502 ' HB3' HG11 ' A' ' 112' ' ' VAL . . . -140.76 33.54 1.8 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.15 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.48 ' H ' HD21 ' A' ' 226' ' ' LEU . 12.6 p -158.08 -41.95 0.06 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.088 179.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.647 ' HB3' HD13 ' A' ' 226' ' ' LEU . 0.4 OUTLIER -76.2 84.85 3.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.407 -179.719 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 16.2 mtt 57.36 61.31 6.35 Favored Pre-proline 0 CA--C 1.531 0.22 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.645 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.617 ' HA ' HD23 ' A' ' 226' ' ' LEU . 30.8 Cg_endo -63.2 124.74 14.4 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.848 2.365 . . . . 0.0 112.407 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 82.8 mtt180 -157.0 -47.67 0.07 Allowed 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 12.9 mttt -159.98 148.82 17.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.43 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.568 HG22 ' O ' ' A' ' 193' ' ' VAL . 15.4 m -134.03 131.41 55.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.031 0.444 . . . . 0.0 111.792 -179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.583 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 13.3 mtp85 -82.2 109.37 16.43 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.885 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 191' ' ' SER . 0.4 OUTLIER -84.13 132.72 30.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.978 0.418 . . . . 0.0 111.737 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.421 ' N ' HD13 ' A' ' 165' ' ' ILE . 3.9 t -138.45 42.2 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.867 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.777 ' O ' HD13 ' A' ' 168' ' ' ILE . 59.0 mt-30 39.56 -108.9 0.08 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.482 -179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.777 HD13 ' O ' ' A' ' 167' ' ' GLN . 0.0 OUTLIER -172.36 -64.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 CA-C-O 120.853 0.358 . . . . 0.0 110.527 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -138.15 -62.59 0.58 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.701 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -171.68 -75.57 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.011 179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -150.3 -176.18 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.1 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -163.94 -64.49 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.972 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . 0.619 ' O ' HG12 ' A' ' 174' ' ' VAL . 0.1 OUTLIER -117.98 -83.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.776 179.939 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.776 HG22 HD11 ' A' ' 183' ' ' LEU . 0.4 OUTLIER 68.95 13.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.767 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . 0.583 ' O ' HG23 ' A' ' 176' ' ' THR . 0.0 OUTLIER -106.06 94.41 5.15 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.797 0.332 . . . . 0.0 111.077 179.915 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 175' ' ' GLU . 0.6 OUTLIER -166.67 115.27 0.88 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.892 179.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.91 -41.25 95.74 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.083 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.4 tt0 -62.1 -33.82 75.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.901 179.875 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -90.14 5.94 44.7 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.278 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 24.2 m -57.47 -26.79 61.77 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-O 120.706 0.288 . . . . 0.0 110.888 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -63.45 -36.88 85.2 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.43 HD22 ' N ' ' A' ' 182' ' ' LEU . 3.7 mm? -73.74 -33.27 64.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.63 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.776 HD11 HG22 ' A' ' 174' ' ' VAL . 7.0 mt -78.0 -28.76 49.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.919 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -54.52 -34.48 61.79 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.86 179.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . . . . . . . . . . . -76.4 -14.66 60.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.283 179.744 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.543 ' O ' HG12 ' A' ' 187' ' ' ILE . 11.4 m-20 81.09 -47.48 0.25 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.406 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 186' ' ' ASP . 2.3 pt 53.76 125.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-O 121.081 0.467 . . . . 0.0 111.428 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -119.47 174.95 6.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.065 -179.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.429 HG23 ' N ' ' A' ' 167' ' ' GLN . 11.0 p -101.43 147.21 8.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.988 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 91.37 6.95 65.8 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.536 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.532 ' N ' HG22 ' A' ' 165' ' ' ILE . 6.1 t -66.75 -169.1 0.07 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.035 0.445 . . . . 0.0 111.203 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -137.4 97.06 3.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.501 179.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.686 HG12 ' CD2' ' A' ' 206' ' ' HIS . 33.4 m -110.91 -178.63 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.303 -179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -148.84 177.98 9.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.854 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.6 ' CG2' HD13 ' A' ' 204' ' ' LEU . 1.4 pp -136.12 169.22 20.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.487 ' O ' HG23 ' A' ' 196' ' ' VAL . 12.5 m -150.14 98.71 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.021 179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -71.64 98.37 1.89 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.009 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -70.01 -177.65 1.4 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.914 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -60.27 -26.44 66.47 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.118 179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . -175.76 49.32 0.12 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.517 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 62.6 m-70 -158.96 139.8 12.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.834 0.349 . . . . 0.0 110.992 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.947 HD11 HG13 ' A' ' 152' ' ' VAL . 15.0 tt -97.81 130.93 45.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . . . . . . . . . 9.2 t -160.01 145.98 15.6 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.914 0.387 . . . . 0.0 111.234 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.6 HD13 ' CG2' ' A' ' 195' ' ' ILE . 3.4 mm? -95.98 169.58 9.88 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.656 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.9 m -148.96 136.7 20.52 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.958 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.686 ' CD2' HG12 ' A' ' 193' ' ' VAL . 54.3 t-80 -153.12 157.24 40.08 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.787 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 20.1 m120 -51.04 97.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.057 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 141.37 -64.71 0.51 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.32 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 2.4 ptpt -160.04 173.2 16.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.782 0.325 . . . . 0.0 111.061 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -111.52 153.28 26.45 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.773 179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -124.22 161.63 26.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.048 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -79.94 -63.03 1.5 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.851 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.732 ' HA ' HD23 ' A' ' 217' ' ' LEU . 3.7 mp 53.81 93.43 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.369 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 1.7 tp -65.66 -164.71 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.859 179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 -69.64 -33.48 72.69 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.412 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.42 ' HB3' HD13 ' A' ' 217' ' ' LEU . 0.4 OUTLIER -50.75 -56.42 12.12 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.729 179.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.808 HD12 ' CB ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.65 -39.16 77.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.417 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.431 ' O ' ' HB ' ' A' ' 153' ' ' ILE . . . -90.5 33.76 0.9 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.313 179.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.828 ' O ' HD13 ' A' ' 153' ' ' ILE . 3.6 t-160 -90.57 -58.69 2.4 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.785 0.326 . . . . 0.0 111.623 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.485 HG23 ' CD2' ' A' ' 219' ' ' HIS . 71.5 p -149.25 71.23 1.11 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.481 -178.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.742 HD11 HD12 ' A' ' 138' ' ' LEU . 30.1 mm -98.8 166.26 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.151 0 CA-C-N 116.793 -0.185 . . . . 0.0 111.385 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.624 ' HA ' ' HA2' ' A' ' 149' ' ' GLY . 13.8 ttt180 -100.97 101.04 11.75 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 112.475 0.546 . . . . 0.0 112.475 -179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.582 HD11 ' HB ' ' A' ' 221' ' ' ILE . 1.9 mp -147.23 171.87 3.07 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 164' ' ' ARG . 1.5 tm-20 -89.12 167.82 12.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.796 0.332 . . . . 0.0 110.728 179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.628 ' C ' HD12 ' A' ' 226' ' ' LEU . 33.3 tt0 -89.55 81.53 6.5 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.19 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.647 HD13 ' HB3' ' A' ' 158' ' ' SER . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.189 -0.91 . . . . 0.0 111.352 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.233 0 N-CA-C 112.487 -0.245 . . . . 0.0 112.487 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 49.0 m -86.19 163.46 17.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.766 0.317 . . . . 0.0 110.922 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -155.78 -46.56 0.08 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.985 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 45.9 mtt -139.94 111.7 7.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.841 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -87.27 -50.7 6.41 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -77.47 140.28 39.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.897 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.554 HG21 HG12 ' A' ' 202' ' ' ILE . 24.1 m -65.23 -49.09 80.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.268 -179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.497 ' N ' HG23 ' A' ' 112' ' ' VAL . 22.3 mt-10 -90.45 52.8 2.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.003 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 41.7 ttt85 -89.94 -36.94 14.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.983 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 59.7 ttt180 -84.31 140.03 31.89 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.901 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 51.2 mt -111.75 151.32 29.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.86 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.4 p -155.07 146.85 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.135 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.72 -49.35 7.54 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.923 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 10.6 m -66.89 172.64 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.196 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -135.52 92.2 2.81 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.901 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.5 pttt -130.26 123.76 30.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.865 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -80.71 163.88 23.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 9.1 m -69.84 161.53 4.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.271 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 37.5 m -83.38 73.76 10.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.907 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 88.4 mtt180 -154.23 -51.22 0.09 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.898 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 27.4 m -143.4 108.55 5.25 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.793 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.62 -29.8 62.65 Favored 'Trans proline' 0 C--N 1.347 0.458 0 C-N-CA 122.552 2.168 . . . . 0.0 112.513 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . 0.611 ' HB3' HD12 ' A' ' 182' ' ' LEU . 4.2 p90 -125.96 169.22 12.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.894 179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.584 ' HA3' HG13 ' A' ' 211' ' ' VAL . . . -92.0 -134.42 6.45 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.459 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.628 ' CB ' ' HD3' ' A' ' 131' ' ' PRO . 0.1 OUTLIER -123.52 -60.97 0.03 OUTLIER Pre-proline 0 C--N 1.331 -0.197 0 CA-C-O 120.547 0.213 . . . . 0.0 111.513 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.813 ' HA ' HG21 ' A' ' 187' ' ' ILE . 3.3 Cg_exo -84.82 56.34 4.62 Favored 'Trans proline' 0 N--CA 1.459 -0.546 0 C-N-CA 123.495 2.797 . . . . 0.0 112.072 -179.29 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.801 ' O ' HG23 ' A' ' 132' ' ' ILE . 0.1 OUTLIER 36.81 68.72 1.44 Allowed Pre-proline 0 CA--C 1.533 0.301 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.886 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -50.94 138.49 42.79 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.998 2.466 . . . . 0.0 112.639 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.437 ' N ' ' CG2' ' A' ' 168' ' ' ILE . . . -90.83 78.53 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 CA-C-N 115.842 -0.617 . . . . 0.0 113.051 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.552 HD23 ' CD2' ' A' ' 182' ' ' LEU . 2.9 pp -76.88 -46.16 25.56 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.929 0.395 . . . . 0.0 110.44 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.53 ' N ' HD12 ' A' ' 135' ' ' LEU . 12.4 m-20 -90.56 4.09 52.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.051 179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -58.7 -167.89 0.01 OUTLIER 'General case' 0 CA--C 1.529 0.14 0 CA-C-O 120.847 0.356 . . . . 0.0 111.231 -179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.527 HD12 HD11 ' A' ' 171' ' ' ILE . 2.2 tt -80.44 59.73 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.785 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -77.32 95.91 1.21 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.611 -179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.0 t -147.53 -59.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 120.781 0.324 . . . . 0.0 111.093 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.78 -178.87 40.64 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.594 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -151.14 168.82 23.48 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.769 0.318 . . . . 0.0 110.95 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 25.8 m -120.48 148.73 43.43 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.998 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -125.18 -44.77 1.88 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.785 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 146' ' ' ALA . . . -118.59 -164.78 1.06 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.962 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 145' ' ' ALA . . . 69.75 132.07 0.03 OUTLIER 'General case' 0 C--O 1.231 0.121 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.213 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 148' ' ' PRO . . . -74.59 -46.92 5.53 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.884 -179.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 147' ' ' ALA . 12.5 Cg_exo -35.65 -38.81 0.25 Allowed 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.976 2.451 . . . . 0.0 113.367 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . -153.08 132.79 3.77 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.821 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.696 HG21 ' HB2' ' A' ' 155' ' ' ALA . 8.8 t -104.66 -26.44 12.31 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.769 0.319 . . . . 0.0 110.881 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.539 ' O ' ' N ' ' A' ' 153' ' ' ILE . 3.7 tpp180 66.95 63.54 0.47 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.538 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.784 HG11 HD12 ' A' ' 221' ' ' ILE . 0.0 OUTLIER 43.62 -82.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.015 -0.539 . . . . 0.0 112.178 179.416 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.672 HD13 ' CE1' ' A' ' 219' ' ' HIS . 3.1 tt -51.29 82.98 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-O 120.949 0.404 . . . . 0.0 111.285 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.528 ' N ' ' O ' ' A' ' 152' ' ' VAL . 0.6 OUTLIER 158.84 -40.51 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.026 -179.902 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.696 ' HB2' HG21 ' A' ' 150' ' ' THR . . . -68.63 -18.49 64.3 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.247 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.868 ' HB2' HG21 ' A' ' 195' ' ' ILE . . . -106.21 32.22 4.59 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.468 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 8.0 t -154.02 19.47 0.51 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.463 179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 34.2 t -134.2 -66.85 0.6 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.739 0.304 . . . . 0.0 110.836 179.742 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 25.2 ttm -167.48 56.35 0.35 Allowed Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.634 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.491 ' HB3' HD13 ' A' ' 195' ' ' ILE . 10.0 Cg_endo -51.83 146.26 28.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 123.172 2.581 . . . . 0.0 112.818 -179.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.1 ttt180 -161.77 -50.09 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.487 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -170.33 84.88 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.753 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 1.15 HG13 HD11 ' A' ' 195' ' ' ILE . 19.3 m -70.16 143.52 14.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.074 -179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.449 ' HB2' ' CB ' ' A' ' 224' ' ' GLU . 6.3 mtt85 -90.36 106.94 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.76 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.981 HD11 HG12 ' A' ' 168' ' ' ILE . 0.0 OUTLIER -77.4 143.24 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.455 179.265 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.839 ' N ' HD13 ' A' ' 165' ' ' ILE . 11.4 t -142.79 -40.05 0.18 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.15 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.658 ' O ' HD13 ' A' ' 168' ' ' ILE . 1.6 mt-30 -131.46 129.28 40.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.077 0.465 . . . . 0.0 111.828 -179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.981 HG12 HD11 ' A' ' 165' ' ' ILE . 15.1 mm -146.52 -42.18 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.05 179.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 23.6 m-20 -51.7 167.11 0.11 Allowed 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.992 0.425 . . . . 0.0 111.403 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -93.64 -175.27 3.71 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.94 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . 0.527 HD11 HD12 ' A' ' 138' ' ' LEU . 0.0 OUTLIER -131.66 -56.17 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.906 179.874 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -69.17 -66.48 0.57 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.944 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 30.0 mt-30 -88.91 170.36 10.77 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.87 179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 11.7 p -168.77 -40.83 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.263 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -80.8 98.38 7.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.874 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 16.5 p -153.87 138.65 17.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.921 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.63 -38.18 73.87 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.04 -179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -62.36 -26.19 68.32 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.189 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . . . . . . . . . 5.5 t80 -90.07 -31.92 16.94 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.125 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 10.8 m -54.22 -38.21 65.44 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.975 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -64.49 -28.12 69.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.086 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.611 HD12 ' HB3' ' A' ' 128' ' ' PHE . 7.2 mp -76.87 -34.24 57.81 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.901 179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -65.48 -32.25 73.75 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.355 -0.384 . . . . 0.0 111.0 179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.18 -25.07 20.68 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.06 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.584 ' HB1' ' O ' ' A' ' 130' ' ' ASN . . . -57.39 -21.01 33.32 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.608 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.449 ' O ' ' HB ' ' A' ' 187' ' ' ILE . 7.3 t70 65.42 85.19 0.14 Allowed 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.761 0.315 . . . . 0.0 110.759 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.813 HG21 ' HA ' ' A' ' 131' ' ' PRO . 0.0 OUTLIER 166.39 144.2 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.577 -179.524 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . 0.508 ' N ' HD13 ' A' ' 187' ' ' ILE . 11.2 mpt_? -115.53 -87.82 0.59 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.527 -0.306 . . . . 0.0 110.962 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.646 ' HA ' HD12 ' A' ' 165' ' ' ILE . 33.8 m -155.43 169.46 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.272 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . 0.667 ' H ' HG23 ' A' ' 165' ' ' ILE . . . 98.75 -13.44 62.42 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.179 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . 0.442 ' O ' HG22 ' A' ' 165' ' ' ILE . 5.4 t -68.56 -167.44 0.09 Allowed 'General case' 0 N--CA 1.455 -0.216 0 CA-C-O 120.939 0.4 . . . . 0.0 111.278 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -141.11 92.07 2.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.331 179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.588 HG12 ' HB3' ' A' ' 206' ' ' HIS . 31.0 m -100.06 148.03 7.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.628 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 44.8 tt0 -95.48 161.31 14.12 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.652 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 1.15 HD11 HG13 ' A' ' 163' ' ' VAL . 0.6 OUTLIER -113.9 156.35 14.89 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.138 -179.985 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.5 m -146.42 133.07 14.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.991 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -90.35 95.21 10.07 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.025 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . . . . . . . . . 37.3 mtp180 -74.21 178.91 4.79 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.922 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -70.44 86.16 0.61 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.845 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 65.96 44.7 91.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.642 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 36.3 m-70 -161.78 139.33 8.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 110.929 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.697 HD13 ' N ' ' A' ' 203' ' ' THR . 0.1 OUTLIER -97.27 126.17 50.16 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.912 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.697 ' N ' HD13 ' A' ' 202' ' ' ILE . 0.6 OUTLIER -160.07 137.72 9.77 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.831 -179.816 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.443 HD13 HG21 ' A' ' 193' ' ' VAL . 17.8 mt -80.0 178.7 8.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.58 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 3.6 m -150.4 93.46 1.99 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.769 0.319 . . . . 0.0 111.259 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.588 ' HB3' HG12 ' A' ' 193' ' ' VAL . 2.1 t60 178.66 -169.64 0.1 Allowed 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.944 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 60.51 -72.2 0.03 OUTLIER 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.926 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.503 ' N ' ' O ' ' A' ' 206' ' ' HIS . . . -118.62 -52.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.959 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -160.59 -77.76 0.06 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.756 0.312 . . . . 0.0 110.428 179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -142.21 160.76 39.6 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.338 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.584 HG13 ' HA3' ' A' ' 129' ' ' GLY . 10.8 t -114.69 142.97 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.104 -179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . 0.468 ' O ' ' C ' ' A' ' 213' ' ' LEU . 7.0 mm-40 -79.73 -51.86 8.67 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.957 -179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.547 HD11 ' HA ' ' A' ' 203' ' ' THR . 0.5 OUTLIER 23.14 93.97 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.079 -0.509 . . . . 0.0 112.164 179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 5.1 tp -62.14 161.72 10.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.898 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 1.8 m-20 -53.87 -30.67 46.77 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.322 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -54.29 -53.92 47.28 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.972 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.12 -40.99 11.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.038 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.527 ' HA ' HD11 ' A' ' 221' ' ' ILE . . . -55.41 -21.44 15.79 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.026 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.672 ' CE1' HD13 ' A' ' 153' ' ' ILE . 7.3 t60 -82.65 -16.65 47.45 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.675 -0.238 . . . . 0.0 111.301 -179.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . . . . . . . . . 1.2 t -141.7 80.82 1.74 Allowed 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.784 HD12 HG11 ' A' ' 152' ' ' VAL . 36.9 mt -126.51 159.62 35.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.005 178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.46 ' N ' HG22 ' A' ' 221' ' ' ILE . 0.0 OUTLIER -97.86 107.6 20.13 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 121.042 0.449 . . . . 0.0 112.161 -179.129 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.749 HD13 ' H ' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -148.04 168.23 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.678 178.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.571 ' O ' HG22 ' A' ' 150' ' ' THR . 3.4 tt0 -89.73 169.55 11.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.645 0.259 . . . . 0.0 110.452 179.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.414 ' HA ' ' HB ' ' A' ' 150' ' ' THR . 22.8 tt0 -89.53 125.45 35.2 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.89 0.376 . . . . 0.0 111.002 -179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.636 HD23 ' HA ' ' A' ' 155' ' ' ALA . 3.7 pp . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.258 -0.877 . . . . 0.0 111.316 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.503 -0.239 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 22.1 t -153.56 -53.87 0.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.746 0.307 . . . . 0.0 110.917 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 67.3 m80 -87.33 148.63 24.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.913 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 36.4 mtt -148.13 136.88 21.74 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.919 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -87.78 98.45 11.47 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.932 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -89.98 156.68 18.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.9 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.411 HG23 ' N ' ' A' ' 113' ' ' GLU . 28.8 m -69.53 -42.55 80.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.235 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 112' ' ' VAL . 0.7 OUTLIER -78.91 70.68 5.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.887 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.05 52.2 2.22 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 39.3 ptt85 -70.9 132.9 45.94 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.002 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 14.5 tp -157.61 -51.7 0.07 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.914 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 17.8 m -90.75 157.48 2.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.216 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 89.5 mttt -88.13 -38.68 15.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.994 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 8.6 m -64.38 140.04 20.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.24 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.253 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.2 tt -94.53 125.68 39.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.851 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -131.73 155.51 47.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.878 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -148.01 130.45 15.76 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.917 -179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 5.6 m -76.91 140.76 16.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.242 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.157 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 8.7 t 61.37 173.51 0.11 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.047 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -158.0 103.46 1.86 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.47 -61.92 0.01 OUTLIER Pre-proline 0 C--N 1.331 -0.211 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.041 179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.46 106.83 2.35 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.474 2.116 . . . . 0.0 112.567 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -139.99 44.38 1.91 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.656 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -135.19 120.38 2.33 Favored Glycine 0 C--N 1.332 0.326 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.247 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.468 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 2.0 p-10 -175.15 163.31 2.28 Favored Pre-proline 0 C--N 1.331 -0.225 0 N-CA-C 110.459 -0.2 . . . . 0.0 110.459 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.51 ' HG2' HG11 ' A' ' 193' ' ' VAL . 5.3 Cg_endo -47.15 140.79 13.83 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.97 2.447 . . . . 0.0 112.908 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.789 HD12 ' HD2' ' A' ' 222' ' ' ARG . 0.2 OUTLIER -6.86 84.01 0.03 OUTLIER Pre-proline 0 N--CA 1.471 0.587 0 CA-C-N 115.4 -0.818 . . . . 0.0 113.064 -179.719 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.31 142.75 74.24 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 123.04 2.493 . . . . 0.0 111.729 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.582 ' HA3' HG21 ' A' ' 221' ' ' ILE . . . -90.45 29.47 6.66 Favored Glycine 0 CA--C 1.52 0.385 0 C-N-CA 121.017 -0.611 . . . . 0.0 113.873 -179.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.467 ' O ' ' HG ' ' A' ' 217' ' ' LEU . 1.7 tt -79.03 -56.3 4.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.104 0.478 . . . . 0.0 110.198 179.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -90.19 12.02 19.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.229 179.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.41 ' HB2' ' HA2' ' A' ' 134' ' ' GLY . 3.9 tp10 -87.04 -149.28 0.15 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.668 -0.242 . . . . 0.0 110.95 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 4.8 tt -90.09 84.61 6.15 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 111.574 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . 0.478 ' HA3' ' HA ' ' A' ' 217' ' ' LEU . . . -90.33 111.42 3.91 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.248 179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.468 HG13 ' N ' ' A' ' 141' ' ' GLY . 8.7 p -146.76 -46.28 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.621 0.248 . . . . 0.0 111.477 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . 0.468 ' N ' HG13 ' A' ' 140' ' ' VAL . . . 134.26 115.45 1.56 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.549 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.49 -173.06 0.4 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.765 0.317 . . . . 0.0 110.825 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 67.76 122.07 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.192 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -170.07 -46.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.543 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -115.96 -173.99 2.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.876 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 62.05 -83.19 0.02 OUTLIER 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.206 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.685 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -179.15 -59.55 0.0 OUTLIER Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.49 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.685 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 5.1 Cg_exo -31.36 133.55 0.06 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 123.363 2.709 . . . . 0.0 113.546 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . . . . . . . . . . . 69.82 125.94 0.04 OUTLIER Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.951 -0.642 . . . . 0.0 112.688 179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.662 HG21 ' HA ' ' A' ' 225' ' ' GLU . 0.2 OUTLIER -167.97 -151.65 0.11 Allowed 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.462 0.172 . . . . 0.0 110.876 -179.914 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.94 ' HB2' HG21 ' A' ' 223' ' ' ILE . 36.4 ttp180 69.02 -70.15 0.14 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.743 0.306 . . . . 0.0 111.264 -179.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.732 HG21 ' HB1' ' A' ' 218' ' ' ALA . 0.7 OUTLIER -95.25 -17.79 6.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.413 -179.588 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.647 ' N ' HD13 ' A' ' 153' ' ' ILE . 0.1 OUTLIER -133.54 107.09 10.28 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-O 120.642 0.258 . . . . 0.0 111.419 179.801 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . 0.603 ' O ' HG22 ' A' ' 157' ' ' THR . 15.7 t70 99.12 -37.76 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.466 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.82 ' HB2' ' H ' ' A' ' 151' ' ' ARG . . . -48.33 -32.18 7.07 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 111.736 0.273 . . . . 0.0 111.736 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.03 -54.71 41.48 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.546 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.603 HG22 ' O ' ' A' ' 154' ' ' ASP . 7.9 t -63.23 -28.73 70.23 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.189 -179.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.573 ' HB2' HD12 ' A' ' 226' ' ' LEU . 3.0 m -71.99 -155.41 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.715 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 8.2 ttt -113.09 71.12 1.35 Allowed Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.712 0.291 . . . . 0.0 111.147 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . 0.404 ' N ' HD13 ' A' ' 226' ' ' LEU . 78.7 Cg_exo -38.32 132.48 0.94 Allowed 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.261 2.641 . . . . 0.0 113.148 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.8 ttt-85 -170.0 -49.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.475 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -170.17 84.73 0.11 Allowed 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.651 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 193' ' ' VAL . 31.3 m -69.95 -178.58 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.133 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.723 ' O ' HG23 ' A' ' 223' ' ' ILE . 8.9 mtp85 -124.31 -167.7 1.69 Allowed 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.529 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.716 HG23 ' HG3' ' A' ' 222' ' ' ARG . 28.4 mm -142.37 124.83 13.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.796 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.422 ' O ' HG12 ' A' ' 168' ' ' ILE . 15.4 t -152.11 68.79 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.668 ' CA ' ' HB3' ' A' ' 222' ' ' ARG . 14.5 tt0 44.77 -94.13 0.02 OUTLIER 'General case' 0 C--O 1.246 0.888 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.54 HG22 ' O ' ' A' ' 168' ' ' ILE . 48.6 mm 77.59 -5.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.875 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . . . . . . . . . 36.2 p30 -157.9 -178.81 7.59 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.744 0.306 . . . . 0.0 111.139 179.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -101.09 -88.71 0.36 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.164 -179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.14 -55.06 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.129 0 CA-C-O 120.683 0.278 . . . . 0.0 111.145 -179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 84.5 t80 63.55 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.06 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -104.63 171.74 7.16 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.829 179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.635 ' O ' HG13 ' A' ' 174' ' ' VAL . 9.4 p -172.55 98.31 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.969 0.414 . . . . 0.0 111.295 -179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -80.43 -173.33 4.01 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.645 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 21.4 p -128.0 -81.72 0.59 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.495 -0.321 . . . . 0.0 111.191 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -58.03 -43.78 86.99 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.537 -0.302 . . . . 0.0 111.453 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 2.9 tp-100 -67.86 -36.73 80.82 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.14 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.419 ' CD1' HD22 ' A' ' 182' ' ' LEU . 6.6 t80 -90.21 7.54 37.65 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.562 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 47.6 m -65.59 -48.4 72.44 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.775 0.321 . . . . 0.0 110.865 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -73.43 -34.41 65.44 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.034 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.419 HD22 ' CD1' ' A' ' 179' ' ' PHE . 11.0 mp -62.8 -23.96 67.51 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.088 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 9.2 mt -90.06 -32.09 16.87 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -55.78 -19.27 10.74 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.526 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.434 ' CB ' ' N ' ' A' ' 130' ' ' ASN . . . -81.6 11.9 4.29 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 112.028 0.381 . . . . 0.0 112.028 -179.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 62.35 100.93 0.03 OUTLIER 'General case' 0 C--O 1.231 0.109 0 CA-C-O 120.918 0.39 . . . . 0.0 110.644 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.56 HG22 ' HA ' ' A' ' 132' ' ' ILE . 2.7 pt -83.51 87.14 2.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.401 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 11.3 mpt_? -125.0 107.81 11.2 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.691 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.58 ' N ' HD11 ' A' ' 132' ' ' ILE . 18.3 m -56.77 156.91 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.028 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 96.05 -6.9 66.87 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.087 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 6.5 t -66.25 -170.43 0.09 Allowed 'General case' 0 C--O 1.233 0.223 0 CA-C-O 121.038 0.446 . . . . 0.0 111.525 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -148.34 136.21 20.88 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.716 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.793 HG12 ' CD2' ' A' ' 206' ' ' HIS . 35.5 m -138.92 -174.6 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.045 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.11 161.34 33.53 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-O 120.835 0.35 . . . . 0.0 111.027 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.576 HD12 ' H ' ' A' ' 196' ' ' VAL . 0.3 OUTLIER -121.19 153.93 24.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.786 -179.92 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.576 ' H ' HD12 ' A' ' 195' ' ' ILE . 13.5 p -141.89 141.4 29.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.142 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -87.36 91.6 8.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.928 -179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.432 ' HB2' HG22 ' A' ' 203' ' ' THR . 6.3 ttt180 -70.12 -179.71 2.04 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.871 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -76.78 92.92 3.63 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.891 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 64.17 35.0 91.43 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.913 -0.661 . . . . 0.0 112.673 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 18.7 m-70 -163.45 143.31 8.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.763 0.315 . . . . 0.0 110.861 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.651 HD13 HG12 ' A' ' 152' ' ' VAL . 20.9 tt -98.48 111.77 28.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.075 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.45 HG23 ' CG1' ' A' ' 196' ' ' VAL . 9.6 t -120.69 133.97 55.31 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.879 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.656 HD11 HG22 ' A' ' 152' ' ' VAL . 1.3 mm? -90.32 120.9 31.84 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 12.7 m -102.44 140.28 36.92 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.211 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . 0.793 ' CD2' HG12 ' A' ' 193' ' ' VAL . 26.3 t-80 -158.71 145.0 16.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.682 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 206' ' ' HIS . 21.2 m120 -28.56 -43.03 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.441 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . 0.489 ' O ' ' HG3' ' A' ' 209' ' ' LYS . . . -56.99 -76.97 0.18 Allowed Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.093 179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . 0.489 ' HG3' ' O ' ' A' ' 208' ' ' GLY . 20.1 mtmt -160.2 -174.51 4.56 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.771 0.319 . . . . 0.0 110.534 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.91 133.93 48.05 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 178.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.441 HG21 ' ND2' ' A' ' 130' ' ' ASN . 0.1 OUTLIER -112.86 148.66 15.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.99 0.424 . . . . 0.0 111.588 -179.362 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -81.39 -9.23 59.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.973 179.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.425 ' HB2' HD23 ' A' ' 204' ' ' LEU . 5.5 mp -36.99 106.92 0.05 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.784 0.326 . . . . 0.0 111.439 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.624 ' O ' ' HB3' ' A' ' 218' ' ' ALA . 4.1 mp -93.34 -176.52 4.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.402 ' O ' ' HB2' ' A' ' 219' ' ' HIS . 0.7 OUTLIER -63.08 -14.54 49.61 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.291 179.816 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -52.39 -74.76 0.03 OUTLIER 'General case' 0 N--CA 1.462 0.131 0 CA-C-O 120.851 0.358 . . . . 0.0 111.227 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . 0.478 ' HA ' ' HA3' ' A' ' 139' ' ' GLY . 2.5 mm? -86.28 -24.06 26.09 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.343 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.732 ' HB1' HG21 ' A' ' 152' ' ' VAL . . . -90.41 35.13 0.87 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.538 178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.465 ' HA ' HG21 ' A' ' 153' ' ' ILE . 0.9 OUTLIER -85.86 -7.22 58.85 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.358 -179.601 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.472 ' O ' HG23 ' A' ' 220' ' ' THR . 4.6 t -179.09 90.54 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.196 179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.582 HG21 ' HA3' ' A' ' 134' ' ' GLY . 0.1 OUTLIER -126.42 -163.84 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.789 ' HD2' HD12 ' A' ' 132' ' ' ILE . 0.4 OUTLIER -84.39 88.95 7.3 Favored 'General case' 0 C--N 1.334 -0.099 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 -177.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.94 HG21 ' HB2' ' A' ' 151' ' ' ARG . 1.7 mp -151.76 144.41 16.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.614 177.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.48 ' CB ' ' HB2' ' A' ' 164' ' ' ARG . 15.4 tt0 -89.86 161.15 16.1 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.968 -0.382 . . . . 0.0 109.968 178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.662 ' HA ' HG21 ' A' ' 150' ' ' THR . 35.7 tt0 -89.3 118.61 29.1 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.799 0.333 . . . . 0.0 111.086 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.573 HD12 ' HB2' ' A' ' 158' ' ' SER . 2.1 mt . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.267 -0.873 . . . . 0.0 111.288 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.142 0 N-CA-C 112.527 -0.229 . . . . 0.0 112.527 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' SER . . . . . . . . . . . . . 66.3 p -152.76 154.62 35.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.794 0.331 . . . . 0.0 110.944 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' HIS . . . . . . . . . . . . . 79.3 m80 -148.73 153.59 38.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.905 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 37.8 mtt -146.48 108.94 4.49 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -88.59 124.4 34.01 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.905 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -86.23 121.61 29.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.895 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 156' ' ' ALA . 14.7 p -75.66 -41.98 41.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.11 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.416 ' N ' HG13 ' A' ' 112' ' ' VAL . 35.2 mt-10 -66.07 93.48 0.2 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.899 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.1 tpt180 -73.23 73.83 1.29 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.812 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -58.07 92.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.014 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.7 mt -166.71 166.02 16.13 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.81 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.1 m -151.04 146.66 16.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.199 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LYS . . . . . . . . . . . . . 39.6 pttt -149.65 -48.38 0.14 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.949 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 24.9 t -146.76 -68.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.039 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.8 tp -172.75 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.944 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -98.24 176.07 5.85 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.992 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -139.21 -58.04 0.59 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.853 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 123' ' ' VAL . 10.6 p -164.53 123.34 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.121 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 1.6 t -166.7 164.8 16.72 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 34.6 ptt180 -114.91 -42.02 3.28 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.982 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 13.0 p -145.08 64.6 11.19 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -76.47 70.2 6.37 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.719 2.28 . . . . 0.0 112.416 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PHE . . . . . . . . . . . . . 2.2 p90 -164.09 38.34 0.08 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 130' ' ' ASN . . . -131.17 -175.24 13.93 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 121.048 -0.596 . . . . 0.0 112.161 179.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.66 ' HB2' ' HD2' ' A' ' 131' ' ' PRO . 1.8 p-10 50.62 166.51 0.04 OUTLIER Pre-proline 0 N--CA 1.468 0.443 0 C-N-CA 122.273 0.229 . . . . 0.0 111.148 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.66 ' HD2' ' HB2' ' A' ' 130' ' ' ASN . 43.5 Cg_exo -23.07 139.8 0.01 OUTLIER 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 124.31 3.34 . . . . 0.0 113.856 -179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.87 ' N ' HD13 ' A' ' 187' ' ' ILE . 18.7 tt -46.45 121.99 6.58 Favored Pre-proline 0 CA--C 1.529 0.138 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.17 -179.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.561 ' HB3' HD11 ' A' ' 213' ' ' LEU . 83.6 Cg_endo -81.2 140.16 12.16 Favored 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 122.771 2.314 . . . . 0.0 111.828 179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . 0.697 ' O ' HD11 ' A' ' 221' ' ' ILE . . . -90.52 68.66 2.36 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.002 -0.618 . . . . 0.0 113.306 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.426 ' C ' HD23 ' A' ' 135' ' ' LEU . 9.9 tt -70.6 -65.77 0.69 Allowed 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.98 3.43 54.7 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.168 179.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.503 ' CD ' HD13 ' A' ' 168' ' ' ILE . 2.6 mt-10 -77.71 -47.46 19.08 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.52 0.2 . . . . 0.0 111.331 -179.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.612 ' HB3' HD12 ' A' ' 221' ' ' ILE . 1.7 pp -41.91 -31.8 0.37 Allowed 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.805 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLY . . . . . . . . . . . . . . . -40.81 -34.56 0.78 Allowed Glycine 0 C--N 1.334 0.45 0 C-N-CA 121.183 -0.532 . . . . 0.0 113.153 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 18.0 t -116.68 103.36 14.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.76 0.314 . . . . 0.0 111.003 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 128.15 172.92 13.31 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.4 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.443 ' HA ' ' HB ' ' A' ' 220' ' ' THR . 9.6 p30 -156.9 150.35 24.3 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.798 0.332 . . . . 0.0 111.132 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 6.1 p -138.72 98.64 3.61 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.943 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -140.02 -53.47 0.52 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.703 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -99.45 153.0 19.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.947 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . 61.17 174.73 0.11 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.284 -0.417 . . . . 0.0 111.119 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ALA . . . . . 0.677 ' HB3' ' HD3' ' A' ' 148' ' ' PRO . . . -73.39 -57.49 2.71 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PRO . . . . . 0.677 ' HD3' ' HB3' ' A' ' 147' ' ' ALA . 7.6 Cg_exo -33.68 109.82 0.05 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 123.175 2.583 . . . . 0.0 113.216 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLY . . . . . 0.498 ' HA2' ' HA ' ' A' ' 222' ' ' ARG . . . 95.52 137.6 9.22 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.598 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' THR . . . . . 0.84 HG23 ' HB ' ' A' ' 223' ' ' ILE . 0.1 OUTLIER -179.14 -80.83 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.535 0.207 . . . . 0.0 111.431 179.771 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ARG . . . . . 0.689 ' O ' HG12 ' A' ' 152' ' ' VAL . 5.0 tpt180 70.08 38.98 1.42 Allowed 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.958 0.409 . . . . 0.0 110.609 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.697 HG23 HG21 ' A' ' 195' ' ' ILE . 0.3 OUTLIER 82.68 2.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.903 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ILE . . . . . 0.794 HG22 ' O ' ' A' ' 150' ' ' THR . 2.9 tp -92.78 25.96 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.25 0 CA-C-O 120.749 0.309 . . . . 0.0 111.369 179.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 170.46 -36.43 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.797 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 225' ' ' GLU . . . -67.4 -21.16 65.61 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . 0.637 ' O ' HG23 ' A' ' 157' ' ' THR . . . -86.73 56.31 3.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.925 0.393 . . . . 0.0 111.29 -179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.637 HG23 ' O ' ' A' ' 156' ' ' ALA . 0.9 OUTLIER -166.34 -43.52 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.712 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 31.1 t -91.12 83.91 5.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.915 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' MET . . . . . . . . . . . . . 66.8 mtt 59.49 62.59 3.79 Favored Pre-proline 0 CA--C 1.529 0.166 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.285 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.24 124.61 11.05 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.697 2.265 . . . . 0.0 112.282 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -153.08 -48.79 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.876 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LYS . . . . . . . . . . . . . 15.3 mttm -164.61 113.3 1.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.686 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 21.5 m -89.54 132.66 33.7 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.236 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . 0.453 ' HB2' ' HB2' ' A' ' 224' ' ' GLU . 13.8 mtt180 -79.88 98.24 7.03 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.283 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.974 ' HA ' HG23 ' A' ' 223' ' ' ILE . 0.3 OUTLIER -70.72 124.0 25.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.698 0.285 . . . . 0.0 110.888 179.943 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' VAL . . . . . 0.595 ' N ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -160.87 98.0 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.334 -0.105 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.404 -179.327 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLN . . . . . 0.489 ' CB ' ' O ' ' A' ' 166' ' ' VAL . 16.9 mt-30 93.15 137.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.872 179.265 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ILE . . . . . 0.56 HD12 ' H ' ' A' ' 169' ' ' ASN . 0.6 OUTLIER -143.74 -48.8 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.835 179.875 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASN . . . . . 0.56 ' H ' HD12 ' A' ' 168' ' ' ILE . 5.8 t-20 172.69 -85.36 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.512 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 172.63 -77.3 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.701 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -154.16 -60.5 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.903 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 78.9 t80 61.49 -81.4 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.207 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLN . . . . . . . . . . . . . 3.9 mm100 -116.63 134.89 54.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.972 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 174' ' ' VAL . 7.3 p -163.26 94.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.016 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -155.04 -42.72 0.08 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.267 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 8.7 t -59.79 144.02 49.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.02 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -70.35 -33.33 71.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.33 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -31.73 67.03 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.391 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PHE . . . . . 0.482 ' CD1' HD22 ' A' ' 182' ' ' LEU . 82.0 t80 -90.06 -29.24 18.5 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.068 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' THR . . . . . . . . . . . . . 9.3 m -54.45 -32.01 56.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.875 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLN . . . . . . . . . . . . . 49.8 mt-30 -71.37 -35.59 71.17 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.057 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LEU . . . . . 0.521 HD23 ' HG2' ' A' ' 133' ' ' PRO . 9.1 mp -55.78 -30.33 61.12 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.947 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 13.1 mt -78.72 -31.88 46.6 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.824 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -51.05 -23.78 3.32 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.103 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.795 ' HB3' HD11 ' A' ' 187' ' ' ILE . . . -51.9 -26.1 9.48 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.186 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ASP . . . . . 0.601 ' O ' HG23 ' A' ' 187' ' ' ILE . 7.8 t70 57.84 78.47 0.24 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.267 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ILE . . . . . 0.87 HD13 ' N ' ' A' ' 132' ' ' ILE . 0.1 OUTLIER 178.98 160.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 -179.849 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 5.5 mpt_? -144.61 172.58 12.78 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.214 -179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.664 HG12 ' CD1' ' A' ' 165' ' ' ILE . 24.6 m -54.21 174.41 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.839 179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 98.69 -15.13 61.29 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' SER . . . . . . . . . . . . . 1.6 t -86.95 -164.7 1.12 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.394 -179.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -132.2 86.62 2.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.397 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' VAL . . . . . 0.476 HG12 ' CG ' ' A' ' 131' ' ' PRO . 8.4 m -84.23 175.16 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.347 -179.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -137.89 168.17 20.25 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.844 179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ILE . . . . . 0.723 ' CG2' HD23 ' A' ' 204' ' ' LEU . 2.9 pp -139.96 167.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.333 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 15.4 m -154.94 142.19 12.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.005 179.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -70.08 85.02 0.53 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ARG . . . . . 0.543 ' HB2' HG21 ' A' ' 203' ' ' THR . 20.4 tpt180 -78.89 88.91 4.69 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.209 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 53.26 54.77 9.73 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.339 179.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' GLY . . . . . . . . . . . . . . . 61.41 39.07 96.77 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.654 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -145.19 145.0 31.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.736 0.303 . . . . 0.0 110.739 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . 0.694 HD11 ' C ' ' A' ' 214' ' ' LEU . 30.3 pt -80.0 139.09 18.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.241 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 198' ' ' ARG . 2.6 t -160.17 129.95 5.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.822 179.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . 0.871 HD12 HD22 ' A' ' 213' ' ' LEU . 25.7 mt -86.02 151.38 23.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.616 179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 43.5 m -143.44 123.08 13.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.916 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 43.2 t60 -174.87 168.79 3.55 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.715 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.6 t30 67.4 -69.92 0.13 Allowed 'General case' 0 C--O 1.232 0.132 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.449 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . 172.76 29.07 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.589 -0.815 . . . . 0.0 113.231 179.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -160.7 165.5 30.38 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.47 146.46 39.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.522 179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . 0.505 ' HB ' HD13 ' A' ' 213' ' ' LEU . 0.0 OUTLIER -117.85 163.57 14.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.09 -179.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.94 -65.15 1.04 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.381 179.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' LEU . . . . . 0.871 HD22 HD12 ' A' ' 204' ' ' LEU . 6.6 mp 36.0 79.43 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.778 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.694 ' C ' HD11 ' A' ' 202' ' ' ILE . 1.1 tp -75.95 -169.5 1.12 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.391 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASP . . . . . 0.401 ' N ' HD11 ' A' ' 202' ' ' ILE . 13.7 t70 -55.22 -25.09 30.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.998 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . 0.588 ' O ' HD22 ' A' ' 138' ' ' LEU . 0.3 OUTLIER -68.4 -57.26 6.15 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.963 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LEU . . . . . . . . . . . . . 6.3 mp -65.36 -49.98 67.3 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.191 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ALA . . . . . 0.514 ' O ' HD13 ' A' ' 153' ' ' ILE . . . -90.21 47.2 1.42 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.65 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' HIS . . . . . 0.418 ' O ' HG23 ' A' ' 220' ' ' THR . 3.2 t-160 -90.16 -43.09 10.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.708 -179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' THR . . . . . 0.443 ' HB ' ' HA ' ' A' ' 142' ' ' ASN . 3.0 p -155.39 70.13 0.72 Allowed 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ILE . . . . . 0.697 HD11 ' O ' ' A' ' 134' ' ' GLY . 0.7 OUTLIER -106.94 165.53 4.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' ARG . . . . . 0.672 ' C ' HD13 ' A' ' 223' ' ' ILE . 33.6 mtt-85 -101.8 92.57 4.89 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -177.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ILE . . . . . 0.974 HG23 ' HA ' ' A' ' 165' ' ' ILE . 3.8 mm -124.21 -162.76 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' GLU . . . . . 0.801 ' H ' HG22 ' A' ' 223' ' ' ILE . 12.8 tm-20 -112.14 133.22 54.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 117.943 0.338 . . . . 0.0 110.511 179.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLU . . . . . 0.486 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 0.8 OUTLIER -89.67 109.31 20.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.972 -179.588 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.244 179.939 . . . . . . . . 1 1 . 1 stop_ save_